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Summary
Prenylated indole alkaloids are widely distributed in plants, fungi and bacteria, especially in
the family of Clavicipitaceae and Trichocomaceae of Ascomycota, and commonly exhibit
interesting biological and pharmaceutical activities. In the biosynthetic pathway of prenylated
indole alkaloids, prenylation catalyzed by prenyltransferases contributes significantly to the
large structure diversity of these compounds in nature. Investigation on indole
prenyltransferases would help to understand the construction of prenylated indole alkaloids
in nature and also be useful for structural modification of indole derivatives and other
substances to produce analogues of prenylated derivatives.
Three indole prenyltransferases belonging to the dimethylallyltryptophan synthase (DMATS)
superfamily were biochemically identified and characterized in vitro, including CdpC3PT from
Neosartorya fischeri (N. fischeri), BrePT from Aspergillus versicolor (A. versicolor) and 5-
DMATS from Aspergillus clavatus (A. clavatus). The responsible genes cdpC3PT and brePT
were cloned into expression vector and heterologously expressed in Escherichia coli (E. coli).
These works were carried out by Dr. Wen-Bing Yin, Suqin Yin and Qing Wang, respectively.
In this thesis, CdpC3PT was confirmed to catalyze the formation of C3-prenylated products
with a characteristic 6/5/5/6-fused tetracyclic ring system from tryptophan-containing cyclic
dipeptides in one-step reaction. The NotF homologue BrePT showed much higher flexibility
towards its aromatic substrates than NotF, and was proven to catalyze the highly
regiospecific reverse prenylation at C-2 of the indole nucleus. The cloning of 5-dmats was
carried out by Yan Liu. Functional proof of this gene was provided within this thesis by
heterologous expression in E. coli and subsequent structure elucidation of enzyme products
by mass spectrometry (MS) and nuclear magnetic resonance (NMR) analyses. 5-DMATS
established high regiospecific activity to catalyze C5-prenylation on indole derivatives.
Given the importance of prenylation in structure diversity and bioactivity enhancement,
CdpC3PT, BrePT, 5-DMATS and other known prenyltransferases of the DMATS superfamily
were applied for the chemoenzymatic synthesis of prenylated compounds. By using AnaPT,
CdpC3PT and CdpNPT, eight and six stereoisomers of cis-configured prenylated
pyrroloindoline diketopiperazines from cyclo-Trp-Ala and cyclo-Trp-Pro isomers were
produced, respectively. The stereospecificity of AnaPT and CdpC3PT depended mainly on
the configuration of tryptophanyl moiety in cyclo-Trp-Ala and cyclo-Trp-Pro isomers, while
CdpNPT showed lower stereoselectivity, but higher conversion ability towards most tested
substrates.
5-DMATS and FgaPT2 from Aspergillus were used for chemoenzymatic synthesis of
prenylated indolocarbazoles. Reconstitution of enzyme activity of 5-DMATS and FgaPT2 in
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vitro revealed that they catalyzed regiospecific prenylation of indolocarbazoles at the para-
position of the indole N-atom. This is the first report for prenylated indolocarbazoles.
Subsequently, some indole prenyltransferases of the DMATS superfamily were found to
accept also hydroxynaphthalenes and flavonoids, which were substrates for enzymes from
the CloQ/NphB group and the UbiA superfamily, respectively. Nine prenylated flavonoids and
twenty prenylated hydroxynaphthalenes have been isolated, and their structures were
elucidated by MS and NMR analyses. It has been shown that, for an accepted
hydroxynaphthalene, different enzymes produced usually the same major prenylated product,
i.e. with a regular C-prenyl moiety at para- or ortho-position to a hydroxyl group. For
flavonoids accepted by 7-DMATS, C-6 between two hydroxyl groups was the favorable
prenylation position. The Michaelis-Menten constants (KM) and turnover numbers (kcat) of
some prenyltransferases towards selected hydroxynaphthalenes are comparable to those
obtained by using indole derivatives.
In addition to indole prenyltransferases, other genes in the biosynthetic cluster of prenylated
indole alkaloids were also investigated. A putative O-methyltransferase gene hasC and a
putative cytochrome P450 gene hasH involved in the biosynthesis of
hexadehydroastechrome (HAS) in Aspergillus fumigatus (A. fumigatus) were cloned into
pQE60 and pESC-URA, respectively. Soluble His6-HasC was successfully overproduced in E.
coli SG13009 and purified to near homogeneity by Ni-NTA. Constructs for co-expression with
the reductase gene NFIA_083630 from N. fischeri in pESC-URA and for expression as His6-
tagged protein in pESC-URA were also prepared for the putative cytochrome P450 gene
hasH.
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Zusammenfassung
Prenylierte Indolalkaloide sind ubiquitär in Pflanzen, Bakterien und Pilzen verbreitet, vor
allem in den Familien Clavicipitaceae und Trichocomaceae der Ascomyceten. Gemeinsam
weisen sie interessante biologische und pharmazeutische Aktivitäten auf. Bei der
Biosynthese von Indolalkaloiden ist die Prenylierung durch Prenyltransferasen maßgeblich
für die hohe Strukturvielfalt dieser Substanzen in der Natur verantwortlich. Biochemische
Untersuchungen zu Indolprenyltransferasen können helfen, die Entstehung von prenylierten
Indolalkaloiden in der Natur zu verstehen. Außerdem können Indolderivate und anderen
Substanzen durch Prenyltransferasen modifiziert werden.
Drei Indolprenyltransferasen der Dimethylallyltryptophan Synthase (DMATS) Superfamilie
wurden biochemisch identifiziert und in vitro charakterisiert, diese beinhalteten CdpC3PT aus
Neosartorya fischeri (N. fischeri), BrePT aus Aspergillus versicolor (A. versicolor) und 5-
DMATS aus Aspergillus clavatus (A. clavatus). Die verantwortlichen Gene cdpC3PT und
brePT wurden jeweils in einen Expressionsvektor kloniert und heterolog in Escherichia coli
(E. coli) exprimiert. Diese Arbeiten wurden von Dr. Wen-Bing Yin, Suqin Yin und Qing Wang
durchgeführt. In der vorliegenden Arbeit wurde herausgefunden, dass CdpC3PT die
Entstehung von C3-prenylierten Produkten mit einem charakteristischen 6/5/5/6-
tetrazyklischen Ringsystem aus tryptophan-haltigen zyklischen Dipeptiden in einem
Reaktionsschritt katalysiert. Das NotF-Homolog BrePT zeigte eine sehr viel höhere
Flexibilität gegenüber seinen aromatischen Substraten im Vergleich zu NotF. Dabei konnte
eine hohe Regiospezifität einer reversen Prenylierung an Position C-2 des Indolrings
nachgewiesen werden. Bei der Charakterisierung von 5-DMATS wurde die Klonierung von
Yan Liu durchgeführt. Im weiteren Verlauf dieser Arbeit erfolgte meinerseits die Aufklärung
der Genfunktion durch heterologe Expression in E. coli und die anschließende
Strukturaufklärung der Enzymprodukte mit Hilfe von Massenspektrometrie (MS) und
Kernresonanzspektroskopie (NMR). 5-DMATS katalysiert eine regiospezifische Prenylierung
von Indolderivaten an Position C-5.
Aufgrund der enormen Bedeutung der Prenylierung an der Strukturvielfalt und damit der
biologischen Aktivität, wurden CdpC3PT, BrePT, 5-DMATS und andere bekannte
Prenyltransferasen der DMATS-Superfamile zur chemoenzymatischen Synthese von
prenylierten Substanzen verwendet. Durch Einsatz von AnaPT, CdpC3PT und CdpNPT,
konnten jeweils acht und sechs Stereoisomere von cis-konfigurierten prenylierten
Pyrroloindolin-Diketopiperazinen von cyclo-Trp-Ala und cyclo-Trp-Pro Isomeren produziert
werden. Die Stereospezifität von AnaPT und CdpC3PT hängt dabei hauptsächlich von der
Konfiguration der Tryptophaneinheit in cyclo-Trp-Ala und cyclo-Trp-Pro Isomeren ab. Im
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Vergleich dazu, zeigte CdpNPT eine geringere Stereoselektivität, aber eine höhere
Umsetzungsrate gegenüber den getesteten Substraten.
Weiterführend wurden 5-DMATS und FgaPT2 für die chemoenzymatische Synthese von
prenylierten Indolcarbazolen eingesetzt. Die Rekonstruktion der Enzymaktivität von 5-
DMATS und FgaPT2 in vitro zeigte, dass sie in der Lage sind, die regiospezifische
Prenylierung von Indolcarbazolen an der para-Position des N-Atoms zu katalysieren. Dies ist
der erste Bericht über derartige prenylierte Indolcarbazole. Desweiteren konnte auch die
Akzeptanz einiger Hydroxynaphthalene und Flavonoide durch Indolprenyltransferasen der
DMATS Superfamilie nachgewiesen werden, wobei diese eigentlich Substrate der Enzyme
der CloQ/NphB-Gruppe, oder der UbiA-Superfamilie darstellen. Neun prenylierte Flavonoide
und zwanzig prenylierte Hydroxynaphthalene wurden isoliert und deren Strukturen
anschließend durch MS- und NMR-Analysen aufgeklärt. Dabei konnte festgestellt werden,
dass für ein akzeptiertes Hydroxynaphthalen, unterschiedliche Enzyme das gleiche
prenylierte Hauptprodukt produzieren, natürlich mit einer regulären C-Prenylierung an para-
oder ortho-Position zu einer Hydroxygruppe. Bei Flavonoiden, welche von 7-DMATS
akzeptiert wurden, war Position C-6 zwischen zwei Hydroxygruppen die bevorzugte
Prenylierungsstelle. Die erhaltenen Michaelis-Menten Konstanten (KM) und die
Wechselzahlen (kcat) einiger Prenyltransferasen für ausgewählte Hydroxynaphthalene waren
vergleichbar mit denen von Indolderivaten.
Ergänzend zu Prenyltransferasen wurden noch weitere Gene aus einem putativen
Biosynthesecluster für ein prenyliertes Indolalkaloid, das Hexadehydroastechrom (HAS)
untersucht. Ein putatives O-Methyltransferasegen hasC und ein putatives Cytochrome P450-
Gen hasH, welche in dessen Biosynthese in Aspergillus fumigatus (A. fumigatus) involviert
sind. Sie wurden jeweils in die Expressionsvektoren pQE60 und pESC-URA kloniert. Das
lösliche His6-HasC wurde erfolgreich in E.coli SG13009 überexprimiert und über Ni-NTA
aufgereinigt. Konstrukte für die Co-Expression mit dem Reduktasegen NFIA_083630 aus N.
fischeri in pESC-URA und für die Expression als His6-getaggtes Protein in pESC-URA
wurden auch für das putative Cytochrome P450-Gen hasH angefertigt.
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1 Introduction
1.1 Prenylated aromatic compounds
Prenylated aromatic compounds are hybrid natural products containing an aromatic scaffold
and one or more prenyl moieties derived from prenyl diphosphates. These compounds are
widely distributed in nature and often possess impressive better biological activities than their
non-prenylated precursors (Li, 2010; Botta et al., 2005b; Schardl et al., 2006; El-Seedi et al.,
2010; Sunassee and Davies-Coleman, 2012). Considering the various types of precursors,
the prenylated aromatic compounds represent a broad range of structural diversity, such as
prenylated indole alkaloids, flavonoids, xanthones, naphthalenes and quinones. According to
the connection patterns of the prenyl moiety to the aromatic ring, these compounds can be
classified into two types, i.e. “regularly” and “reversely” prenylated derivatives. The prenyl
moiety is substituted to the aromatic ring via C-1' in a regularly prenylated derivative, while
reverse prenylation represents the bridge between C-3' of the prenyl moiety and the aromatic
ring (Figure 1-1).
Figure 1-1: Regular and reverse prenyl moieties. Ar: aromatic ring.
1.1.1 Prenylated indole alkaloids
Prenylated indole alkaloids represent a group of compounds with diverse chemical structures
and are widely distributed in nature, especially in the family of Clavicipitaceae and
Trichocomaceae of Ascomycota (Li, 2010; Ruiz-Sanchis et al., 2011). Due to their impressive
pharmacological and biological activities as drugs or toxins (Li, 2010; Wallwey and Li, 2011),
prenylated indole alkaloids attract attention of scientists from different scientific disciplines
including chemistry, ecology, biology, pharmacology and biochemistry (Lindel et al., 2012;
Williams et al., 2000; Li, 2010; Schardl et al., 2006; Uhlig et al., 2009). This thesis deals with
enzymes for C2-, C3- and C5-prenylation of indole alkaloids. Therefore more details on C2-,
C3- and C5-prenylated indole alkaloids are described below.
1.1.1.1 C2-prenylated indole alkaloids
Prenylated indole alkaloids in this group carry one prenyl moiety at position C-2 on the indole
ring (Figure 1-2). A series of C2-prenylated cyclic dipeptides were isolated. For example,
echinulin (1) with antitubercular activity was isolated from several Aspergillus strains and
11
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other sources (Stipanovic and Schroeder, 1976; Wang et al., 2007a; Kanokmedhakul et al.,
2002). The anticancer agent tryprostatin A (2) from A. fumigatus is the methoxylated
derivative of regularly C2-prenylated cyclo-L-Trp-L-Pro (Cui et al., 1996; Wang et al., 2008;
Cui et al., 1995; Jain et al., 2008; Zhao et al., 2002). Cyclo-L-Trp-L-Trp is the precursor of
fellutanine B (3) from Penicillium fellutanum (Kozlovsky et al., 2000; Kozlovsky et al., 2001).
Another example is variecolortide B (4) from Aspergillus variecolor, which contains an
additional anthraquinone molecule (Wang et al., 2007b).
In addition to C2-prenylated cyclic dipeptides, derivatives of other indole alkaloids were also
reported. Ergot alkaloid (8S,9S)-fumigaclavine C (5) with a reverse prenyl moiety at C-2 of
the indole ring was identified in A. fumigatus (Ge et al., 2009). The prenylated bisindolyl
benzoquinone asterriquinone CT5 (6) from A. terreus bears a regular prenyl moiety at
position C-2 on both indole rings (Mocek et al., 1996; Kaji et al., 1994).
Figure 1-2: Examples of C2- and C3-prenylated indole alkaloids.
1.1.1.2 C3-prenylated indole alkaloids
C3-prenylated indole alkaloids represent a characteristic fused multicyclic ring system with
the prenyl moiety at the position C-3 on the indoline ring (Figure 1-2). Most of these
compounds are reversely C3-prenylated derivatives of cyclic dipeptides. For example,
roquefortine C (7) identified in Penicillium strains is a cyclic dipeptide derivative of tryptophan
and histidine (Ohmomo et al., 1977; O'Brien et al., 2006). Another example is fructigenine A
(8) from Penicillium fructigenum (Arai et al., 1989). This compound is a derivative of cyclo-L-
12
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Trp-L-Phe and was reported to be a plant growing inhibitor (Arai et al., 1989). The mycotoxin
acetylaszonalenin (9) and its non-acetylated form aszonalenin (10) were identified in various
fungal strains, e.g. N. fischeri (Wakana et al., 2006; Yin et al., 2009; Ellestad et al., 1973).
Their stereoisomers epi-aszonalenins A and C were isolated from Aspergillus novofumigatus
(Rank et al., 2006). These four compounds are derived from the amino acids tryptophan and
anthranilic acid. The cytotoxic compound 5-N-acetylardeemin (11) identified in N. fischeri
represents a cyclo-Trp-Ala derivative connected with an anthranilic acid moiety (Hochlowski
et al., 1993; Ge et al., 2010).
A detailed database search showed that only one regularly C3-prenylated cyclic dipeptide
nocardioazine B (12) was found in nature. Nocardioazine B (12) from Nocardiopsis sp. is
derived from cyclo-L-Trp-L-Trp (Raju et al., 2011). Besides prenylated derivatives of cyclic
dipeptides, a series of C3-prenylated simple indole derivatives with the C3-regular or reverse
prenyl moieties were isolated from the bryozoan Flustra foliacea (Peters et al., 2002; Peters
et al., 2003; Rochfort et al., 2009). One example is flustramine L (13) with regular prenyl
moieties at positions C-3 and C-5 (Rochfort et al., 2009). Antimicrobial activity was reported
for this compound (Rochfort et al., 2009).
1.1.1.3 C5-prenylated indole alkaloids
A number of biologically active indole alkaloids carrying a regular prenyl moiety at position C-
5 were discovered (Figure 1-3). The regularly C5-prenylated bisindolyl benzoquinones were
derived from two tryptophan molecules like semicochliodinol A (14) from the fungus
Chrysosporium merdarium (Fredenhagen et al., 1997) and petromurin B (15) from the fungus
Petromyces muricatus (Ooike et al., 1997). Semicochliodinol A (14) was reported to inhibit
HIV-1 protease (Fredenhagen et al., 1997). Regularly C5-prenylated derivatives were also
found for tryptophan-containing cyclic dipeptides like cyclo-L-Trp-L-Ala, e.g. echinulin (1)
from Aspergillus strains or tardioxopiperazine A (16) from the fungus Microascus tardifaciens
(Fujimoto et al., 1999). Immunosuppressive activity has been observed with
tardioxopiperazine A (16) (Fujimoto et al., 1999). Another type of C5-prenylated indole
alkaloids are derived from indole diterpenes. These compounds carry one prenyl moiety at
C-5, e.g. 21-isopentenylpaxilline (17) from Eupenicillium shearii (Belofsky et al., 1995), or
more prenyl moieties, e.g. shearinine K (18) from Penicillium sp. (Xu et al., 2007). 21-
isopentenylpaxilline showed antiinsectant activity in a previous report (Belofsky et al., 1995).
Only a few reversely C5-prenylated indole alkaloids have been found in nature, such as
lansai B (19) from Streptomyces sp. (Tuntiwachwuttikul et al., 2008).
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Figure 1-3: Examples of C5-, N1-, C4-, C6- and C7-prenylated indole alkaloids.
1.1.1.4 Other prenylated indole alkaloids
Besides positions C-2, C-3 and C-5, the prenyl moiety can be connected to positions N-1, C-
4, C-6 and C-7 on the indole ring in nature (Figure 1-3). N1-prenylated indole alkaloids were
found in various fungi. The mycotoxin fumitremorgin B (20) identified in a number of
Aspergillus and Penicillium strains bears two prenyl moieties at positions N-1 and C-2 of the
indole ring (Yamazaki et al., 1974; Yamazaki and Suzuki, 1986; Gallagher and Latch, 1977;
Sabater-Vilar et al., 2003). Asterriquinone (21) isolated from A. terreus contains one reverse
prenyl moiety at the position N-1 on each tryptophanyl moiety (Yamamoto et al., 1976b). This
compound showed inhibitory activity against tumour cells (Yamamoto et al., 1976a). Another
example of N1-prenylated benzoquinone is isoasterriquinone from A. terreus, which contains
reversely N1-prenylated and regularly C2-prenylated tryptophanyl moieties (Kaji et al., 1994).
4-dimethylallyltryptophan (22) firstly isolated from Claviceps fusiformis (Barrow and Quigley,
1975) is the precursor of ergot alkaloids in many strains (Wallwey and Li, 2011). A further
example of C4-prenylated indole alkaloids is the tremorgenic mycotoxin aflatrem (23) from
Aspergillus flavus (A. flavus) (Cole et al., 1981; Gallagher and Wilson, 1978), which is a
monoprenylated derivative of the indole diterpene. The potent antiflea agent nodulisporic
acid E containing two prenyl moieties at both positions C-5 and C-6 of the indole diterpene
scaffold was isolated from Nodulisporium sp. mutant MF6227 (ATCC74473) (Singh et al.,
2004). Semicochliodinol B (24) from Chrysosporium merdarium (Fredenhagen et al., 1997)
and isocochliodinol from Chaetomium sp. (Sekita, 1983) are prenylated bisindolyl
benzoquinone with prenyl moieties substituted at position C-6 on one and both indole rings,
14
Introduction
respectively. Semicochliodinol B (24) exhibits inhibitory activity against HIV-1 protease
(Fredenhagen et al., 1997). Terezine D (25) from fungi Sporormiella teretispora and
Aspergillus sydowi is a C7-prenylated derivative of cyclo-L-Trp-L-Ala (Wang et al., 1995;
Zhang et al., 2008), which is very likely the precursor of the tryptophan-derived iron(III)-
complex HAS (see section 1.2.1.3) (Yin et al., 2013b).
1.1.2 Prenylated flavonoids
Prenylated flavonoids are a group of compounds consisting of one or more prenyl moieties
on the flavonoid nucleus (C6-C3-C6). They are mainly distributed in the plant kingdom,
especially in the family Leguminosae and Moraceae (Botta et al., 2005b; Botta et al., 2009;
Tahara, 2007; Barron and Ibrahim, 1996). These compounds are well known for their
numerous pharmacological effects (Botta et al., 2005b; Botta et al., 2009). According to their
chemical structures, they can be classified into prenylated flavones, flavonols, flavanones,
flavanonols, isoflavones, isoflavanones, isoflavans, chalcones and so on. An example of
prenylated flavones is kuwanon C (26) isolated from various species of the genera Morus
and Artocarpus (Cho et al., 2011; Yang et al., 2011; Arung et al., 2006; Ko et al., 1997).
Inhibitory activities against β-secretase, melanin biosynthesis and nitric oxide production
were reported for kuwanon C (26) (Cho et al., 2011; Yang et al., 2011; Arung et al., 2006).
The diprenylated isoflavanone papyriflavonol A (27) was isolated from Broussonetia
papyrifera and Broussonetia kazinoki and showed inhibitory activities against 5-LOX, 12-LOX
and α-glucosidase (Zhang et al., 2001; Ryu et al., 2010; Chi et al., 2001). The prenylated
flavanone 8-prenylnaringenin (28) was purified from diverse plants, e.g. Azadirachta indica
and Macaranga conifera (Nakahara et al., 2003; Jang et al., 2002; Lukaseder et al., 2009;
Akazawa et al., 2012; Sasaki et al., 2012; Versiani et al., 2011). This compound exhibits
ABCG2 inhibitory, estrogenic, antibacterial and antitumor activities (Akazawa et al., 2012;
Sasaki et al., 2012; Versiani et al., 2011; Overk et al., 2005).
Wighteone (29) is the prenylated derivative of the isoflavone genistein and has been isolated
from many plants, especially from the species of the genus Erythrina (Morikawa et al., 2006;
Wang et al., 2005; Erasto et al., 2004; Bankeu et al., 2011; Tanaka et al., 2001; El-Masry et
al., 2002; Djiogue et al., 2009). Broad biological activities, including antifungal, antibacterial,
nitric oxide production inhibitory and β-glucuronidase inhibitory activities, were observed for
wighteone (29) (Morikawa et al., 2006; Wang et al., 2005; Erasto et al., 2004; Bankeu et al.,
2011). The prenylated isoflavan (3S)-(+)-7-methoxymanuifolin K (30) was found in the plant
Dalea aurea and exhibits antiprotozoal activity (Belofsky et al., 2006). Xanthohumol (31) is
the main prenylated flavonoid of hops and represents a wide range of biological activities,
especially well known for the potential cancer chemopreventive activity (Gerhauser et al.,
2002; Stevens and Page, 2004; Albini et al., 2006). The distribution, chemistry and biological
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activities of xanthohumol (31) were reviewed (Stevens and Page, 2004; Magalhaes et al.,
2009; Gerhauser, 2005).
Figure 1-4: Examples of prenylated flavonoids and xanthones.
1.1.3 Prenylated xanthones
Xanthones are a group of secondary metabolites found in higher plants, fungi and lichens
(El-Seedi et al., 2009; Vieira and Kijjoa, 2005). The key structure feature of these compounds
is the 9H-xanthen-9-one nucleus (Figure 1-4). Prenylated xanthones are emerged as an
important subgroup of naturally occurring xanthones and exhibit interesting biological and
pharmaceutical activities (El-Seedi et al., 2010; Pinto et al., 2005). Xanthone derivatives with
prenyl moieties at diverse positions were reported. In most cases, regular prenyl moieties
were found in prenylated xanthones, for example, the antihypotensive agent guanandin (32).
The compound found in various species of the plant genus Calophyllum is a dioxygenated
xanthone carrying a regular prenyl moiety at the para-position to the carbonyl moiety in the
structure (Iinuma et al., 1996; Gunasekera et al., 1977; Oku et al., 2005). Another example of
C-prenylated xanthone is 2-isoprenyl-1,7-dihydroxy-3-methoxy xanthone (33). This
compound was isolated from various species of the plant genus Garcinia (Huang et al., 2001;
Deachathai et al., 2005; Rukachaisirikul et al., 2003) and showed inhibitory effect towards
human leukemia HL60 cells (Matsumoto et al., 2003). Isocudraniaxanthone B (34) isolated
from the plants Cratoxylum formosum and Cudrania tricuspidata is a reversely prenylated
tetraoxygenated xanthone derivative (Park et al., 2006; Boonnak et al., 2006; Lee et al.,
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2005). Park et al. reported significant antioxidant activity of isocudraniaxanthone B (34) (Park
et al., 2006).
Besides C-prenylated xanthones, O-prenylated derivatives were also reported, e.g.
variecoxanthone A (35) from fungi A. nidulans and A. variecolor (Scherlach and Hertweck,
2006; Chexal et al., 1975). In addition, several prenylated xanthones with more than one
prenyl moieties were found in nature, such as the diprenylated xanthone α-mangostin (36)
and triprenylated xanthone garcinone E (37). The compound α-mangostin (36) isolated from
the plant genera Garcinia, Cratoxylum and Pentadesma (Ren et al., 2011; Lenta et al., 2011a;
Ryu et al., 2011; Kikuchi et al., 2010) carries one regular prenyl moiety on each aromatic ring
and was reported to have broad biological activities, such as inhibiting and dissociating the
Aβ aggregation, which indicated that α-mangostin is a potential candidate for treatment of
Alzheimer’s disease, as well as significant anti-inflammatory activity (Wang et al., 2012;
Chen et al., 2008). Garcinone E (37) isolated from various species of the plant genus
Garcinia as well as the species Pentadesma butyracea (Na and Xu, 2010; Jung et al., 2006;
Lenta et al., 2011b) also exhibits a wide range of biological activities, e.g. antiproliferative
and antiplasmodial activities (Han et al., 2008; Lenta et al., 2011b; Ho et al., 2002).
1.1.4 Prenylated naphthalenes and quinones
In comparison to the large number of prenylated indole alkaloids, flavonoids and xanthones,
database search showed that the number of natural occurring prenylated naphthalenes is
limited. Known prenylated naphthalenes with intact prenyl moieties were mostly isolated from
plants (Hussein et al., 2004; Monache et al., 1985; Hussein et al., 2003). Vismione E (38)
and adenaflorin C (39) are two examples of prenylated naphthalenes. Vismione E (38)
containing one prenyl moiety at the aromatic ring was isolated from Cratoxylum
cochinchinense, Cratoxylum formosum and Psorospermum febrifugum (Boonnak et al., 2007;
Botta et al., 1983; Laphookhieo et al., 2009). Vismione E (38) has antimalarial and
antibacterial activities (Boonnak et al., 2007; Laphookhieo et al., 2009). Adenaflorin C (39)
from Adenaria floribunda exhibits moderate cytotoxic activity (Hussein et al., 2004).
Prenylated quinones are widely distributed in plants, microorganisms as well as animals and
have broad biological activities (Sunassee and Davies-Coleman, 2012). For example, the
bis-prenylated quinone (40) isolated from the brown algae Perithalia capillaris and
Sporochnus comosus represents anti-inflammatory and antiproliferative properties (Sansom
et al., 2007; Ovenden et al., 2011). The naphthoquinone lapachol (41) containing one prenyl
moiety on the quinone ring has been found from dozens of plants. A wide range of
pharmacological activities were reported for lapachol (41), e.g. anticancer, anti-inflammatory
and antiviral activities. The occurrence, biological activities, synthesis and biosynthesis of
lapachol (41) has been reviewed (Hussain et al., 2007; Epifano et al., 2013). Another
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example is the prenylated anthraquinone 1-methyl-2-(3'-methyl-but-2'-enyloxy)-
anthraquinone (42). This compound was isolated from the plant Aegle marmelos and showed
antifungal activity (Mishra et al., 2010a; Mishra et al., 2010b). The antioxidative agent
naphterpin (43) derived from a hybrid structure containing a naphthoquinone unit and a
geranyl side chain has been isolated from the bacteria Streptomyces aeriouvifer and
Streptomyces sp. (Shin-Ya et al., 1990b; Seto et al., 1996). 1,3,6,8-tertrahydroxynaphthalene
is the precursor for the biosynthesis of naphterpin (43) in Streptomyces (Shin-Ya et al.,
1990a).
Figure 1-5: Examples of prenylated naphthalenes and quinones.
1.2 Biosynthetic pathways of prenylated indole alkaloids in
Aspergillus
Recently, significant progress has been achieved in the discovery of gene clusters
responsible for the biosynthesis of prenylated indole alkaloids in Aspergillus. Several
biosynthetic genes were identified by feeding experiments, gene deletion experiments and
biochemical characterization in vitro. Gene clusters related to enzymes used in this thesis
are described below.
1.2.1 Biosynthetic pathways of prenylated indole alkaloids derived from cyclic
dipeptides
1.2.1.1 The biosynthesis of fumitremorgins/verruculogen
In A. fumigatus, a gene cluster for the biosynthesis of fumitremorgins/verruculogen was
identified. The end product of this cluster is verruculogen (Steffan et al., 2009b), while three
tryprostatins together with three fumitremorgins are synthesized as intermediates (Figure 1-
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6). The biosynthesis of these compounds starts with the formation of brevianamide F from L-
tryptophan and L-proline by the nonribosomal peptide synthetase (NRPS) FtmPS, followed
by a prenylation reaction catalyzed by FtmPT1 to produce tryprostatin B (Maiya et al., 2006;
Grundmann and Li, 2005). The genes ftmPT1 and ftmPS were overexpressed in E. coli and
Aspergillus, respectively. The cytochrome P450 enzyme FtmP450-1 and the putative
methyltransferase FtmMT catalyze the addition of small functional groups, i.e. hydroxyl and
methyl groups, resulting in the formation of tryprostatin A (Kato et al., 2009). The second
cytochrome P450 enzyme FtmP450-2 is responsible for cyclization of tryprostatin A, and next
the hydroxylation is catalyzed by the third cytochrome P450 enzyme FtmP450-3
consequently for the production of 12,13-dihydroxyfumitremorgin C (Kato et al., 2009). The
identification of three cytochrome P450 genes was carried out by gene disruption (Kato et al.,
2009). The second prenyltransferase FtmPT2 was proven to catalyze the conversion of
12,13-dihydroxyfumitremorgin C to fumitremorgin B (Grundmann et al., 2008). The non-heme
Fe(II) α-ketoglutarate-dependent dioxygenase FtmOx1 catalyzes the formation of
verruculogen from fumitremorgin B (Steffan et al., 2009b).
Figure 1-6: The biosynthesis of fumitremorgins/verruculogen in A. fumigatus.
1.2.1.2 The biosynthesis of notoamides
A gene cluster for the biosynthesis of notoamides was found in a marine-derived strain
Aspergillus sp. MF297-2 (Ding et al., 2010). Similar to verruculogen, the biosynthesis of
notoamides also begins with the formation of brevianamide F from L-tryptophan and L-
proline (Figure 1-7). The prenyltransferase NotF catalyzes the prenylation of brevianamide F
to yield deoxybrevianamide E (Ding et al., 2010). Another prenyltransferase NotC generates
a regularly C7-prenylated derivative of 6-hydroxy-deoxybrevianamide E (Ding et al., 2010).
NotB was reported to catalyze the indole 2,3-oxidation of notoamide E through an apparent
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pinacol-like rearrangement to produce notoamides C and D (Li et al., 2012). The biochemical
characterization of NotF, NotC and NotB has been carried out in vitro (Ding et al., 2010; Li et
al., 2012). Feeding experiment with doubly 13C-labeled racemic stephacidin A carried out in
Aspergillus sp. MF297-2 showed that (+)-stephacidin A was converted into (-)-notoamide B in
the biosynthetic pathway of notoamides (Finefield et al., 2011b). The biosynthesis of
notoamides in A. versicolor was also reported, which was demonstrated by feeding
experiments with isotope-labelled precursors (Finefield et al., 2011b; Finefield et al., 2011c;
Finefield et al., 2011a).
Figure 1-7: The biosynthesis of notoamides in Aspergillus sp. MF297-2.
1.2.1.3 The biosynthesis of hexadehydroastechrome
Figure 1-8: The proposed biosynthetic pathway of HAS in A. fumigatus (Yin et al., 2013b).
Gene disruption experiments of the HAS cluster in A. fumigatus revealed that the end
product of this cluster is a tryptophan-derived iron(III)-complex, HAS (Figure 1-8) (Yin et al.,
2013b). Five putative biosynthetic genes are proposed to be involved in this pathway,
including one NRPS gene hasD, one 7-dimethylallyltryptophan synthase gene hasE (also
named 7-dmats) (Kremer et al., 2007), one putative FAD binding protein gene hasG, one
putative O-methyltransferase gene hasC and one putative cytochrome P450 gene hasH. In
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addition, two putative C6 transcription factor genes hasA and hasF and one putative
transporter gene hasB are also located in this cluster. It was suggested that the
intermediates produced by this cluster are all in a NRPS-bound mode (Figure 1-8) (Yin et al.,
2013b). However, C7-prenylated L-tryptophan and C7-prenylated cyclo-L-Trp-L-Ala (terezine
D) were isolated as precursors for HAS. Orthologues of these genes (Table 1-1) were also
found in N. fischeri and A. terreus (Kremer et al., 2007).
Table 1-1: Orthologous proteins of HasA-HasH.
A. fumigatus Af293 N. fischeri NRRL181 A. terreus NIH2624
Protein Protein Identity* Protein Identity*
HasA (EAL92294) EAW21279 93 EAU31597 73
HasB (EAL92293) EAW21278 96 EAU31598 87
HasC (EAL92292) EAW21277 96 EAU31599 88
HasD (EAL92291) EAW21276 93 EAU31600 76
HasE (EAL92290, i.e.
7-DMATS) EAW21275 95 EAU31601 82
HasF (EAL92289) EAW21274 96 EAU31602 84
HasG (EAL92288) EAW21273 95 - -
HasH (EAL92287) EAW21272 92 EAU31603 85
*: the identity to the orthologous protein from A. fumigatus Af293.
Figure 1-9: Biosynthetic clusters of HAS in different strains (A-C). A: A. fumigatus; B: N.
fischeri; C: A. terreus.
In a previous work in our group, 7-DMATS was overproduced in E. coli and characterized
biochemically (Kremer et al., 2007). However, the biochemical functions of HasC and HasH
are still unknown. In this thesis, hasC and hasH were cloned from A. fumigatus and
overexpressed in E. coli and Saccharomyces cerevisiae (S. cerevisiae), respectively.
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1.2.2 Biosynthetic pathway of ergot alkaloids in Aspergillus fumigatus
Another subgroup of prenylated indole alkaloids in A. fumigatus are ergot alkaloids. The
biosynthesis of ergot alkaloids (Figure 1-10) starts with the conversion of L-tryptophan to 4-
dimethylallyltryptophan by the 4-dimethylallyltryptophan synthase (4-DMATS), i.e. FgaPT2
(Unsöld and Li, 2005). Formation of the 4-dimethylallyl-L-abrine is catalyzed by the
methyltransferase FgaMT (Rigbers and Li, 2008), followed by the production of
chanoclavine-1 (Coyle et al., 2010). FgaDH has been proven to catalyze the formation of
chanoclavine-I aldehyde from chanoclavine-I (Wallwey et al., 2010a). The conversion of
chanoclavine-1 aldehyde to festuclavine needs two enzymes, i.e. FgaOx3 and FgaFS
(Wallwey et al., 2010b). Subsequently, a further hydroxylation reaction leads to the formation
of (8S,9S)-fumigaclavine B, and this reaction was speculated to be catalyzed by the
cytochrome P450 enzyme FgaP450-2 (Wallwey and Li, 2011). FgaAT was proven to
catalyze the next step, which produces (8S,9S)-fumigaclavine A by an acetylation reaction
(Liu et al., 2009). Finally, the second prenyltransferase FgaPT1 catalyzes the formation of
(8S,9S)-fumigaclavine C from (8S,9S)-fumigaclavine A (Unsöld and Li, 2006). The
biochemical characterization of FgaPT2, FgaMT, FgaDH, FgaOx3, FgaFS, FgaAT and
FgaPT1 has been carried out in vitro after overexpression of the encoding genes in E. coli or
S. cerevisiae (Unsöld and Li, 2005; Rigbers and Li, 2008; Wallwey et al., 2010a; Wallwey et
al., 2010b; Liu et al., 2009; Unsöld and Li, 2006).
Figure 1-10: The biosynthesis of fumigaclavine C in A. fumigatus.
1.3 Aromatic prenyltransferases
Aromatic prenyltransferases are responsible for the attachment of prenyl moieties to an
aromatic ring and contribute significantly to the structural and biological diversity of
prenylated compounds in nature. In the last decade, significant progress has been achieved
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in the molecular biological, biochemical and structural biological investigation of the aromatic
prenyltransferases, since a vast volume of sequences from genome projects were released.
1.3.1 Prenyltransferases of the DMATS superfamily
As mentioned above, 4-DMATS was identified as the first pathway-specific enzyme in the
biosynthesis of ergot alkaloids (Tsai et al., 1995; Unsöld and Li, 2005). It catalyzes the
prenylation of L-tryptophan at C-4 of the indole ring and therefore functions as an indole
prenyltransferase (Unsöld and Li, 2005; Steffan et al., 2009a). Genes with sequence
homology to 4-DMATS are classified as prenyltransferase genes of the
dimethylallyltryptophan synthase (DMATS) superfamily. Prenyltransferases of the DMATS
superfamily are involved in the biosynthesis of fungal secondary metabolites and mainly
catalyze prenylation of diverse indole derivatives, including tryptophan and tryptophan-
containing cyclic dipeptides.
Figure 1-11: Known examples of fungal indole prenyltransferases of the DMATS superfamily
prior to this thesis.
Biochemical characterization of the encoded enzymes began in summer 2004 after
availability of the genome sequence for A. fumigatus (Unsöld and Li, 2005). A number of
indole prenyltransferases have been biochemically identified and characterized from that
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time (Figure 1-11). For example, FtmPT2 from A. fumigatus catalyzes the regular N1-
prenylation of 12,13-dihydroxyfumitremorgin C (Grundmann et al., 2008). An additional
example of N1-prenyltransferase is CTrpPT from Aspergillus oryzae, which uses cyclo-L-Trp-
L-Trp as the best substrate (Zou et al., 2010). The regular and reverse C2-prenylations were
observed for FtmPT1 (Grundmann and Li, 2005) and NotF (Ding et al., 2010) from
Aspergillus strains, respectively. C3-prenylations of cyclic dipeptides by AnaPT from the
fungus N. fischeri (Yin et al., 2009) and CdpNPT from A. fumigatus (Schuller et al., 2012),
lead to the formation of indoline derivatives with a reverse prenyl moiety at opposite sides.
As described above, FgaPT2 and its orthologues from different fungi catalyze the regular
prenylation of L-tryptophan at position C-4 (Unsöld and Li, 2005; Wallwey and Li, 2011).
CpaD from Aspergillus sp. catalyzes regular C4-prenylation as well, but uses cyclo-
acetoacetyl-L-tryptophan as natural substrate (Liu and Walsh, 2009). 7-DMATS from A.
fumigatus was reported to prenylate L-tryptophan at position C-7 (Kremer et al., 2007).
Another C7-prenyltransferase NotC from a marine-derived Aspergillus sp. catalyzes the
prenylation of 6-hydroxy-deoxybrevianamide E (Ding et al., 2010).
Figure 1-12: Prenyltransferases of the DMATS superfamily which use compounds other than
indole alkaloids as substrates.
In addition to the indole prenyltransferases, some members of the DMATS superfamily
catalyze prenylations of other substances (Figure 1-12). VrtC from Penicillium aethiopicum,
and its homologues NscD from N. fischeri, Mc03599 from Microsporum canis as well as
Tt06703 from Trichophyton tonsurans transfer a geranyl and a dimethylallyl moiety to
tetracyclic naphthacenedione compounds, respectively (Figure 1-12) (Chooi et al., 2012;
Chooi et al., 2013). XptB from A. nidulans, SirD from Leptosphaeria maculans (L. maculans)
and PAPT from Phomopsis amygdali are O-prenyltransferases. XptB uses 1,7-dihydroxy-6-
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methyl-8-hydroxymethyl-xanthone (Pockrandt et al., 2012), while SirD and PAPT accept L-
tyrosine and fusicoccin P as natural substrates, respectively (Kremer and Li, 2010; Noike et
al., 2012).
1.3.2 Prenyltransferases of the LtxC group
Prenyltransferases from the LtxC group are soluble proteins from bacteria. Although the
enzymes from this group show very low sequence similarity to the members of the DMATS
superfamily, they also utilize indole derivatives as common substrates (Figure 1-13). CymD
from Salinispora arenicola, SCO7467 from Streptomyces coelicolor and IptA from
Streptomyces sp. SN-593 prenylate L-tryptophan at positions N-1, C-5 and C-6, respectively
(Schultz et al., 2010; Subramanian et al., 2012; Ozaki et al., 2013; Takahashi et al., 2010).
The results on SCO7467 were published after those of 5-DMATS in this thesis. MpnD from
Marinactinospora thermotolerans catalyzes the reverse C7-prenylation of (-)-indolactam-Ile
(Ma et al., 2012). LtxC is the first known member of this group and responsible for transfer of
a geranyl group to (-)-indolactam V to give lyngbyatoxin A in Lyngbya majuscule (Edwards
and Gerwick, 2004).
Figure 1-13: Prenyltransferases of the LtxC group.
1.3.3 Prenyltransferases of the CloQ/NphB group
Prenyltransferases of the CloQ/NphB group catalyze the prenylation of naphthalenes,
quinones, simple phenols and phenzines (Figure 1-14) (Heide, 2009). These enzymes are
mainly found in bacterial, but also in some fungi. NphB from Streptomyces sp. and the
homologue SCO7190 from Streptomyces coelicolor accept 1,6-dihydroxynaphthalene as
substrate, and catalyze the transfer of a geranyl and a dimethylallyl group to the substrate,
respectively (Kuzuyama et al., 2005; Kumano et al., 2008). Fur7 from Streptomyces sp. and
Fnq26 from Streptomyces cinnamonensis transfer the geranyl groups to 2-methoxy-3-
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methylflaviolin and flaviolin, respectively (Kumano et al., 2010; Haagen et al., 2007). CloQ
from Streptomyces roseochromogenes, which is the first known member of this group, and
its homologue NovQ from Streptomyces niveus were reported to prenylate 4-
hydroxyphenylpyruvic acid (Metzger et al., 2010; Ozaki et al., 2009). Both EpzP from
Streptomyces cinnamonensis and PpzP from Streptomyces anulatus catalyze the C-
prenylation of 5,10-dihydrophenazine-1-carboxylic acid (Seeger et al., 2011; Saleh et al.,
2009).
Figure 1-14: Prenyltransferases of the CloQ/NphB group.
1.3.4 Prenyltransferases of the UbiA superfamily
Prenyltransferases of the UbiA superfamily are membrane-bound proteins and widely
distributed in bacteria, fungi and plants. These enzymes accept diverse aromatic compounds
as substrates (Figure 1-15). Four plant flavonoid prenyltransferases of the UbiA superfamily
have been identified and characterized. LaPT1 from Lupinus albus and SfG6DT from
Sophora flavescens are responsible for the prenylation of genistein to produce isowighteone
and wighteone, respectively (Shen et al., 2012; Sasaki et al., 2011). SfN8DT-1 identified from
Sophora flavescens transfers the dimethylallyl group to position C-8 of naringenin (Sasaki et
al., 2008), while G4DT from Glycine max shows activity to prenylate (-)-glycinol (Akashi et al.,
2009). Three enzymes LePGT1, Coq2p and UbiA, which were identified from the medicinal
plant Lithospermum erythrorhizon, S. cerevisiae and E. coli, respectively, catalyze the
transfer of a short or long-chain prenyl moiety to 4-hydroxybenzoic acid (Ohara et al., 2009;
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Pierrel et al., 2010; Melzer and Heide, 1994). AuaA from the bacterium Stigmatella
aurantiaca is responsible for transfer of a farnesyl group to 2-methyl-4-hydroxyquinoline to
yield aurachin D in the biosynthetic pathway of aurachin A (Stec et al., 2011). The plant
prenyltransferase HlPT-1 from Humulus lupulus has the ability to prenylate
phlorisovalerophenone (Tsurumaru et al., 2012).
Figure 1-15: Prenyltransferases of the UbiA superfamily
1.3.5 Chemoenzymatic synthesis of prenylated derivatives by using aromatic
prenyltransferases
Prenylation improves often the affinity of a compound to biomembranes and the interaction of
the substance with proteins (Botta et al., 2005b), leading to dramatically increased biological
activities. Therefore, it is attractive for scientists to use prenyltransferases as strategies for
regioselective chemoenzymatic synthesis of prenylated derivatives. Aromatic
prenyltransferases, especially the soluble indole prenyltransferases of the DMATS
superfamily, show promising flexibility towards their aromatic substrates and catalyze highly
regio- and stereoselective prenyltransfer reactions. These features provided evidence for the
potential of aromatic prenyltransferases as biocatalysts for chemoenzymatic synthesis. Many
series of prenylated derivatives have been successfully synthesized by these enzymes.
Details are described below.
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Figure 1-16: Chemoenzymatic synthesis of prenylated simple
indole derivatives by 7-DMATS, FgaPT2, MaPT and IptA.
1.3.5.1 Chemoenzymatic synthesis of prenylated indole alkaloids
Dimethylallyltryptophan
synthases 7-DMATS,
FgaPT2, MaPT and
IptA showed noble
substrate flexibility
towards simple indole
derivatives (Kremer
and Li, 2008; Steffan et
al., 2007; Ding et al.,
2008; Takahashi et al.,
2010) (Figure 1-16). Eleven C7-prenylated, ten C4-prenylated, four C4-prenylated and five
C6-prenylated simple indole derivatives were successfully produced by 7-DMATS, FgaPT2,
MaPT and IptA, respectively (Kremer and Li, 2008; Steffan et al., 2007; Takahashi et al.,
2010; Ding et al., 2008; Unsöld and Li, 2005). At higher enzyme concentration, FgaPT2
accepted as well tryptophan-containing cyclic dipeptides and five C4-prenylated derivatives
were obtained (Figure 1-17) (Steffan and Li, 2009). CpaD showed substrate promiscuity
towards tryptophan-containing diketopiperazines and catalyzed the formation of five enzyme
products (Liu and Walsh, 2009). In addition, CpaD accepted three tryptophan-containing
thiohydantoins and produced C4-prenylated products (Liu and Walsh, 2009). Cyclic dipeptide
prenyltransferase FtmPT1 catalyzed high efficient prenylation of fourteen tryptophan-
containing cyclic dipeptides to produce regularly C2-prenylated derivatives (Figure 1-17)
(Wollinsky et al., 2012a). The cytotoxic study showed that prenylation at C-2 led to a
significant increase of the cytotoxicity of all the fourteen tested cyclic dipeptides (Wollinsky et
al., 2012a). Detailed analysis of the incubation mixtures of FtmPT1 with cyclic dipeptides
revealed the presence of additional product peaks for regularly C3-prenylated
hexahydropyrrolo[2,3-
b]indoles in the high
performance liquid
chromatography (HPLC)
chromatograms
(Wollinsky et al., 2012b).
Seven regularly C3-
prenylated
hexahydropyrrolo[2,3-
b]indoles were obtained
(Wollinsky et al., 2012b).
Figure 1-17: Chemoenzymatic synthesis of prenylated
derivatives of tryptophan-containing cyclic dipeptides.
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As shown in Figure 1-17, the enzyme reactions catalyzed by AnaPT and CdpNPT were
found to be not only regiospecific, but also stereospecific towards tryptophan-containing
cyclic dipeptides (Yin et al., 2010a; Schuller et al., 2012).
1.3.5.2 Chemoenzymatic synthesis of other prenylated derivatives
The tyrosine prenyltransferase SirD (Figure 1-18) of the DMATS superfamily showed
substrate promiscuity towards phenylalanine/tyrosine derivatives and has successfully
applied for synthesis of eight regularly O-prenylated products (Kremer and Li, 2010; Zou et
al., 2011). The xanthone prenyltransferase XptB could be applied for chemoenzymatic
synthesis of O-prenylated xanthones (Pockrandt et al., 2012). Four prenylated xanthones
were obtained. Six hydroxyquinolines were well accepted by AuaA as substrates and
converted to the respective C3-farnesylated products (Stec et al., 2011). NphB, Fur7 and
NovQ from the CloQ/NphB group showed also broad substrate promiscuity towards several
substrates. However, low specificity was observed for these enzymes, since more than one
enzyme products were detected for most substrates (Kumano et al., 2008; Shindo et al.,
2011; Kumano et al., 2010; Ozaki et al., 2009; Macone et al., 2009).
Figure 1-18: Chemoenzymatic synthesis of prenylated derivatives from other substrates.
1.3.6 Relationship of aromatic prenyltransferases
The enzymes of the DMATS superfamily share very low sequence similarity with the
members of the LtxC group and almost no sequence similarity with other known
prenyltransferases, e.g. the soluble prenyltransferases of the CloQ/NphB group from bacteria
and fungi as well as the membrane-bound prenyltransferases of the UbiA superfamily from
bacteria, fungi and plants. Similar to enzymes of the DMATS superfamily, the members of
the CloQ/NphB group don’t contain a DDxxD motif. In contrast to those enzymes, the
members of the UbiA superfamily contain a NQxxDxxxD motif for prenyl diphosphate binding
and are strictly dependent on Mg2+ or other divalent cations.
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Surprisingly, structure analysis revealed that FgaPT2, FtmPT1 and CdpNPT of the DMATS
superfamily contain a PT-barrel (Figure 1-19) (Metzger et al., 2009; Jost et al., 2010; Schuller
et al., 2012), which has been only found in the bacterial aromatic prenyltransferases of the
CloQ/NphB group (Metzger et al., 2010; Kuzuyama et al., 2005). Therefore, it is proposed
that all the proteins from both the DMATS superfamily and the CloQ/NphB group share a
common ancestry (Bonitz et al., 2011). It would be interesting to test the acceptance of
substrates for the members of the CloQ/NphB group by the prenyltransferases of the DMATS
superfamily. An acceptance of hydroxynaphthalenes by a member of the DMATS
superfamily was not reported previously. Correspondingly, substrates tyrosine or indole
derivatives for the DMATS superfamily were not prenylated by enzymes of the CloQ/NphB
group. In vitro assays were carried out in this thesis to test the enzyme activity of
prenyltransferases of the DMATS superfamily towards hydroxynaphthalenes. Furthermore,
the acceptance of flavonoids by members of the DMATS superfamily was also tested in this
thesis.
NphB FtmPT1
Figure 1-19: The structures of NphB (also named Orf2, PDB 1ZB6) and FtmPT1 (PDB 3O2K)
in cartoon representation (Kuzuyama et al., 2005; Jost et al., 2010).
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2 Aims of this thesis
The following issues have been addressed in this thesis:
Functional proof of putative indole prenyltransferase genes in Neosartorya and Aspergillus
Blast search in GenBank indicated two proteins which showed significant sequence similarity
to members of the DMATS superfamily: 5-DMATS from A. clavatus and CdpC3PT from N.
fischeri. 5-DMATS and CdpC3PT showing 52% identity with FgaPT2 and 53% identity with
CdpNPT, respectively, indicated similar roles. BrePT from A. versicolor is an orthologue of
NotF from Aspergillus sp. MF297-2 and was expected to compensate for low substrate
promiscuity of NotF. In order to characterize 5-DMATS, BrePT and CdpC3PT biochemically,
the following experiments were carried out:
 Overproduction of cdpC3PT, 5-dmats and brePT in E. coli.
 Enzyme assays with CdpC3PT, 5-DMATS and BrePT. Analysis and isolation of
enzyme products by HPLC.
 Structure elucidation of enzyme products by NMR and MS.
 Kinetic study of CdpC3PT, 5-DMATS and BrePT reactions.
Chemoenzymatic synthesis of prenylated indole derivatives by indole prenyltransferases of
the DMATS superfamily
AnaPT, CdpC3PT and CdpNPT were reported to catalyze reverse prenylation at opposite
sides in tryptophan-containing cyclic dipeptides to produce cis-configured prenylated
pyrroloindoline diketopiperazines in previous studies (Yin et al., 2010a; Yin et al., 2010b;
Schuller et al., 2012). In this thesis, the stereoselectivity of these three enzymes was
demonstrated by analysis of product formation from four cyclo-Trp-Ala and four cyclo-Trp-Pro
isomers. In addition, indolocarbazoles, a class of natural products with well known
remarkable biological inhibitory effects against protein kinases, were tested for the
acceptance by indole prenyltransferases. The following experiments were carried out:
 Synthesis of stereoisomers of several cyclic dipeptides and indolocarbazoles.
 Enzyme assays of cyclic dipeptides and indolocarbazoles with indole
prenyltransferases. Analysis and isolation of enzyme products by HPLC.
 Structure elucidation of enzyme products by NMR and MS.
 Kinetic study of the enzyme reactions.
Chemoenzymatic synthesis of prenylated hydroxynaphthalenes and flavonoids by indole
prenyltransferases of the DMATS superfamily
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As mentioned previously, indole prenyltransferases of the DMATS superfamily showed no
sequence similarity and catalytic activity to known aromatic prenyltransferases of the
CloQ/NphB group and the UbiA superfamily. However, recent studies indicated that
prenyltransferases of the DMATS superfamily share structure similarity with those of the
CloQ/NphB group. Therefore, it is interesting to prove if the members of the DMATS
superfamily could also accept the substrates for enzymes of the CloQ/NphB group, e.g.
hydroxynaphthalenes. In addition, it is also interesting to know if the members of the DMATS
superfamily could catalyze the prenylation of substrates for other known aromatic
prenyltransferases, e.g. flavonoids accepted by the members of the UbiA superfamily. In
order to investigate the acceptance of hydroxynaphthalenes and flavonoids by the members
of the DMATS superfamily, the following experiments were carried out:
 Enzyme assays of hydroxynaphthalenes and flavonoids with indole
prenyltransferases. Analysis and isolation of enzyme products by HPLC.
 Structure elucidation of enzyme products by NMR and MS.
 Kinetic study of the enzyme reactions.
Biosynthetic genes other than prenyltransferases involved in the biosynthesis of a prenylated
indole alkaloid in A. fumigatus
A gene cluster for the biosynthesis of HAS was identified in A. fumigatus. One NRPS, one
putative transporter, two putative C6 transcription factors, one 7-dimethylallyltryptophan
synthase (7-DMATS), one putative FAD binding protein, one putative O-methyltransferase
(HasC) and one putative cytochrome P450 (HasH) were proposed to be involved in the
biosynthesis (Yin et al., 2013b). HasC and HasH were expected to catalyze the O-
methylation and N-hydroxylation, respectively. In order to elucidate the biochemical function
of HasC and HasH in the biosynthesis of HAS, the following experiments were carried out:
 Cloning of hasC and hasH into cloning vector pGEM-T easy.
 Preparing the expression vector of hasC in pQE60.
 Preparing expression constructs containing hasH: expression vectors of hasH in
pESC-URA with or without His6-tag, and the co-expression vector of hasH with a
reductase gene NFIA_083630 in pESC-URA.
 Overproduction of hasC in E. coli and hasH in S. cerevisiae.
 Enzyme assays with HasC and HasH.
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3 Materials and methods
3.1 Chemicals
Dimethylallyl diphosphate (DMAPP), geranyl diphosphate (GPP) and farnesyl diphosphate
(FPP)
DMAPP, GPP and FPP were prepared according to the method described for GPP
(Woodside et al., 1988). DMAPP was prepared by Lena Ludwig and Dr. Marco Matuschek
(Institut für Pharmazeutische Biologie und Biotechnologie, Philipps-Universität Marburg),
while GPP and FPP were synthesized by Dr. Edyta Stec.
Cyclic dipeptides
Cyclo-L-Trp-L-Pro and cyclo-L-Trp-D-Pro were synthesized in this thesis, while cyclo-D-Trp-
L-Pro and cyclo-D-Trp-D-Pro were synthesized by Beate Wollinsky. The four isomers of
cyclo-Trp-Ala were synthesized by Lena Ludwig. These compounds were synthesized from
tryptophan methyl ester and N-Boc protected proline according to the method published
previously (Cacciatore et al., 2005; Caballero et al., 1998). Cyclo-L-Trp-L-Pro and cyclo-L-
Trp-D-Pro were synthesized from H-L-Trp-OMe·HCl and N-Boc-D-Pro-OH, cyclo-D-Trp-L-Pro
and cyclo-D-Trp-D-Pro from H-D-Trp-OMe·HCl and N-Boc-D-Pro-OH. Similarly, the two pairs
H-L-Trp-OMe·HCl and N-Boc-D-Ala-OH as well as H-D-Trp-OMe·HCl and N-Boc-D-Ala-OH
were used for the preparation of the four stereoisomers of cyclo-Trp-Ala.
Cyclo-L-Trp-L-His was synthesized in this thesis from N-Boc-L-Trp-OH and H-L-His-
OMe·HCl according to the literature (Bivin et al., 1993; Cacciatore et al., 2005). Other cyclic
dipeptides were purchased from Bachem (Bubendorf, Switzerland).
Synthesis of indolocarbazoles in this thesis
Treatment of indole-3-acetamide with methyl indolyl-3-glyoxylate in the presence of KOBut
afforded the intermediate arcyriarubin A (Faul et al., 1998), which was converted to N-
methylarcyriarubin A by treatment with methyl iodide (Nakazono et al., 2007). Arcyriaflavin A
and its N6-methylated derivative were obtained after oxidative cyclization of the two
bisindolylmaleimides arcyriarubin A and N-methylarcyriarubin A, respectively (Burtin et al.,
2000; Wilson et al., 2007). Reduction of arcyriaflavin A with tin metal in AcOH/HCl and LiAlH4
in THF resulted in the formation of K252c (Wilson et al., 2007) and 7-hydroxy-K252c (Harris
et al., 1993), respectively.
Simple indole derivatives, hydroxynaphthalenes and flavonoids
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These substrates were purchased from Fluka, TCI, Acros Organics, Aldrich, Roth, Sigma,
Bachem and Alfa Aesar.
3.2 Bacterial and yeast strains, plasmids and oligonucleotides
Table 3-1: Overview of the used E. coli and S. cerevisiae strains.
Strain Genotype Supplier/
Manufacturer
E. coli XL1 Blue MRF' ∆(mcrA)183 ∆(mcrCB-hsdSMR-mrr)173 endA1
supE44 thi-1 recA1 gyrA96 relA1 lac [F′ proAB
laclqZΔM15 Tn10 (Tetr)]
Agilent
(Waldbronn)
E. coli BL21 (DE3) pLysS F– ompT hsdSB(rB– mB–) gal dcm (DE3) pLysS
(CamR)
Novagen
(Darmstadt)
E. coli M15 [pREP4] NalS, StrS, RifS, Thi, Lac, Ara+, Gal+, Mtl, F,
RecA+, Uvr+, Lon+.
Qiagen
(Hilden)
E. coli SG13009 [pREP4] NalS, StrS, RifS, Thi, Lac, Ara+, Gal+, Mtl, F,
RecA+, Uvr+, Lon+
Qiagen
(Hilden)
S. cerevisiae INVSc1 MATa/α his3Δ1/his3Δ1 leu2/leu2 trp1-289/trp1-
289 ura3-52/ura3-52
Invitrogen
(Karlsruhe)
Table 3-2: Commercial cloning and expression vectors.
Vector Description Supplier/
Manufacturer
pESC-URA Expression vector for S. cerevisiae, GAL1 and GAL10
promoters, URA3, with epitope tags
Agilent
(Waldbronn)
pGEM®-T easy Cloning vector with T-overhangs for PCR cloning Promega
(Mannheim)
pQE60 Expression vector for E. coli, T5-promoter, AmpR, with C-
terminal His6-tag
Qiagen
(Hilden)
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Table 3-3: List of plasmids used in this work.
Plasmid Description Reference
pAG012 Construct of ftmPT1 from A. fumigatus B5233 in
pQE70 for expression in E. coli.
(Grundmann and Li, 2005)
pAK2 Construct of sirD from L. maculans M1 in pQE70 for
expression in E. coli.
(Kremer and Li, 2010)
pHL5 Construct of cdpNPT from A. fumigatus B5233 in
pQE60 for expression in E. coli.
(Yin et al., 2007)
pIU18 Construct of fgaPT2 from A. fumigatus B5233 in
pHis8 for expression in E. coli.
(Steffan et al., 2007)
pLW40 Construct of 7-dmats from A. fumigatus B5233 in
pQE60 for expression in E. coli.
(Kremer et al., 2007)
pSY1 Construct of brePT from A. versicolor NRRL573 in
pET28a for expression in E. coli.
(Yin et al., 2013a)
pVW41 Construct of NFIA_083630 from N. fischeri
NRRL181 in pESC-URA for expression in S.
cerevisiae.
Viola Wohlgemuth,
unpublished
pWY22 Construct of anaPT from N. fischeri NRRL181 in
pQE70 for expression in E. coli.
(Yin et al., 2009)
pWY25 Construct of cdpC3PT from N. fischeri NRRL181 in
pQE60 for expression in E. coli.
(Yin et al., 2010b)
pXY01 AFUA_3G12910 in pGEM-T easy, containing the
PCR product (10-1296 under the accession number
XM_749237.1 at GenBank) amplified from gDNA
from the bacterial artificial chromosome (BAC)
AfB28B10 (616042-693705 under the accession
number AAHF01000002.1 at GenBank) of A.
fumigatus Af293 by using fusion PCR. In the first
round, primers AFUA_3G12910_1 and
AFUA_3G12910_4 were used for amplification of
the first exon of hasC, and AFUA_3G12910_2 and
AFUA_3G12910_3 for the second exon of hasC. In
the second round, primers AFUA_3G12910_1 and
AFUA_3G12910_2 were used.
this thesis
pXY02 904 bp BamHI-BglII fragment from pXY01 in the
same sites of pQE60, containing the sequence of
394-1296 under the accession number
XM_749237.1 at GenBank.
this thesis
pXY03 AFUA_3G12910 from A. fumigatus Af293 between
the sites BamHI and BglII of pQE60 for expression
in E. coli, containing the entire coding sequence of
AFUA_3G12910 (10-1296 under the accession
number XM_749237.1 at GenBank). 389 bp
BamHI-BamHI fragment from pXY01 was cloned
into the site BamHI in pXY02 to give pXY03.
this thesis
pXY11 AFUA_3G12960 from A. fumigatus B5233 in
pGEM-T easy, containing the PCR product (58-
1228, 1262-1653 under the accession number
XM_749232.1 at GenBank) by using cDNA from a
cDNA library of A. fumigatus B5233 as template
and AFUA_3G12960_1 as well as
this thesis
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AFUA_3G12960_2 as primers.
pXY12 Construct of AFUA_3G12960 from A. fumigatus
B5233 in pESC-URA for expression in S.
cerevisiae, containing the entire coding sequence of
AFUA_3G12960 (58-1228, 1262-1653 under the
accession number XM_749232.1 at GenBank).
1569 bp XhoI-NheI fragment from pXY11 was
cloned into the same sites in pESC-URA to give
pXY12.
this thesis
pXY13 Co-expression construct of AFUA_3G12960 from A.
fumigatus B5233 with NFIA_083630 from N. fischeri
in pESC-URA for S. cerevisiae, containing the
entire coding sequence of AFUA_3G12960 (58-
1228, 1262-1653 under the accession number
XM_749232.1 at GenBank). 1569 bp XhoI-NheI
fragment from pXY11 was cloned into the same
sites in pVW41 to give pXY13.
this thesis
pXY14 Construct of AFUA_3G12960 (58-1228, 1262-1653
under the accession number XM_749232.1 at
GenBank) with six His residues, obtained by
inserting a double-stranded oligonucleotide
(prepared from PXY12-1 and PXY12-2) into the
sites BamHI and XhoI of the plasmid pXY12 to give
pXY14.
this thesis
pYL09 Construct of 5-dmats from A. clavatus NRRL1
between the sites SphI and BglII of pQE70 for
expression in E. coli.
(Yu et al., 2012)
Table 3-4: List of oligonucleotides used in this thesis.
Primer Sequence (5'→3') Plasmid
AFUA_3G12910_1 TGGGATCCGAACTTGAGCATTTGA (BamHI) pXY01
AFUA_3G12910_2 CCAGATCTCAACTCAGACTCCCATT (BglII) pXY01
AFUA_3G12910_3 GGTAGATGGAGTTTTTGCTTTTACGAACAGCAAGG pXY01
AFUA_3G12910_4 CCTTGCTGTTCGTAAAAGCAAAAACTCCATCTACC pXY01
AFUA_3G12960_1 AACTCGAGGATTCCGCTCAACCTA (XhoI) pXY11
AFUA_3G12960_2 TAGCTAGCTCAAGACTCTCTTGGC (NheI) pXY11
PXY12-1 GATCCATGCATCATCATCATCATCATTCCGGAC
(BamHI + ATG + CAT×6 + BspEI + XhoI)
pXY14
PXY12-2 TCGAGTCCGGAATGATGATGATGATGATGCATG
(XhoI + BspEI + ATG×6 + CAT + BamHI)
pXY14
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3.3 Gene cloning
3.3.1 PCR amplification
Table 3-5: Standard components for PCR amplification from gDNA or cDNA. Expand High
Fidelity Kit (Roche, Mannheim) was used.
Substance Final concentration
gDNA or cDNA ca. 3 nmol/μl
primers (10 pmol/μl) each 0.2 pmol/μl
dNTPs (each 10 mM) each 0.2 mM
Expand High Fidelity Buffer (10×) 1 ×
Expand High Fidelity Enzyme mix (3.3 U/μl) 0.05 U/μl
final volume 50 μl
Table 3-6: Components for the second round PCR to amplify hasC. Expand High Fidelity Kit
(Roche, Mannheim) was used.
Substance Final concentration
PCR products of the two exons a molar ratio of 1:1
primer AFUA_3G12910_1 0.2 pmol/μl
primer AFUA_3G12910_2 0.2 pmol/μl
dNTPs (each 10 mM) each 0.2 mM
Expand High Fidelity Buffer (10×) 1 ×
Expand High Fidelity Enzyme mix (3.3 U/μl) 0.05 U/μl
final volume 50 μl
Table 3-7: Conditions used for PCR amplification.
Step Temperature Duration Cycles
initialization 94 °C 5 min 1 x
denaturation 94 °C 45 sec
30 xannealing
60 °C for hasC
52 °C for hasH 1 min
elongation 72 °C 1 min 30 sec for hasC2 min for hasH
final elongation 72 °C 10 min 1 x
final hold 4 °C forever final temperature
The coding regions of hasC and hasH were amplified by using gDNA from the BAC
AfB28B10 of A. fumigatus Af293 and cDNA from a cDNA library of A. fumigatus B5233 as
templates, respectively. Fusion PCR consisting of two rounds was used for amplification of
hasC from gDNA. In the first round, primers AFUA_3G12910_1 and AFUA_3G12910_4 were
used for amplification of the first exon of hasC (239 bp), and AFUA_3G12910_2 and
AFUA_3G12910_3 for the second exon of hasC (1099 bp). Then the PCR products of the
two exons from the first round PCR were used as templates (in a molar ratio of 1:1) for the
second round PCR in the presence of primers AFUA_3G12910_1 and AFUA_3G12910_2 to
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obtain the entire coding region of hasC (1303 bp). Amplification of hasH (1579 bp) was
performed with primers AFUA_3G12960_1 and AFUA_3G12960_2. The components and
conditions for PCR reactions are listed in Tables 3-5, 3-6 and 3-7.
3.3.2 DNA sequencing and sequence analysis
DNA sequencing of the plasmids were performed by Eurofins MWG Operon (Ebersberg) and
Sequence Laboratories Göttingen GmbH (Göttingen) by using Chain-termination methods.
Sequence identities were obtained by alignments of amino acid sequences using the
program “BLAST 2 SEQUENCES” (www.ncbi.nlm.nih.gov). Multiple sequence alignments at
the amino acid level were carried out with ClustalW2
(http://www.ebi.ac.uk/Tools/msa/clustalw2). The hydrophobic transmembrane domains of the
putative cytochrome P450 protein HasH were analyzed by the SOSUI server
(http://bp.nuap.nagoya-u.ac.jp/sosui/) and the TMHMM server v.2.0
(http://www.cbs.dtu.dk/services/TMHMM/).
3.4 Protein overproduction
3.4.1 Growth media
All growth media were sterilized at 121 °C for 20 min.
Luria-Bertani (LB) medium
LB medium contains 1.0% (w/v) tryptone, 1.0% (w/v) NaCl and 0.5% (w/v) yeast extract.
Add the corresponding antibiotics before use.
Solid medium for agar plates contains 2% (w/v) agar.
Terrific-Broth (TB) medium
TB medium contains 12 g tryptone, 24 g yeast extract and 4 ml glycerol for per 900 ml
medium.
Add 100 ml sterile potassium phosphate buffer (0.17 M KH2PO4 and 0.72 M K2HPO4) and the
corresponding antibiotics to per 900 ml medium before use.
Solid medium for agar plates contains 2% (w/v) agar.
SCU (synthetic medium devoid of uracil) minimal medium
SCU minimal medium contains 0.67% (w/v) yeast nitrogen base (without amino acids but
with ammonium sulfate), 0.01% each of adenine, arginine, cysteine, leucine, lysine,
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threonine and tryptophan, 0.005% each of aspartic acid, histidine, isoleucine, methionine,
phenylalanine, proline, serine, tyrosine and valine.
Add filter-sterilized carbon source after cooling down, i.e. glucose and galactose with a final
concentration of 2% and 3% in medium, respectively.
Solid medium for agar plates contains 2% (w/v) agar.
3.4.2 Gene expression in Escherichia coli and purification of proteins
E. coli cells harboring an expression plasmid were cultivated in 2000 ml Erlenmeyer flasks
containing 1000 ml liquid TB or LB medium supplemented with the respective antibiotics, and
then grown at 37 °C to an adsorption of approximate 0.6 at 600 nm. For induction, isopropyl
β-thiogalactopyranoside (IPTG) was added to a final concentration of 0.1-1.0 mM and the
cells were cultivated for further 6-16 h at 22-37 °C before harvest. The cells were collected
by centrifugation and stored at -20 °C.
Protein purification was performed at 4 °C. The cell pellets were resuspended in lysis buffer
(10 mM imidazole, 50 mM NaH2PO4 and 300 mM NaCl, pH 8.0) at 2-5 ml per gram wet
weight. After addition of lysozyme to a final concentration of 1 mg·ml-1 and incubation for 30
min, the cells were sonicated six times for 10 s each at 200 W, with 10 s for cooling after
each burst. To separate soluble proteins from cellular debris, the lysate was centrifuged at
13,000 rpm for 30 min. The supernatant was mixed with nickel-nitrilotriacetic acid (Ni-NTA)
agarose resin (Qiagen, Hilden) according to the manufacturer’s instruction and then stirred
for 1 h. The mixture was then loaded to an 8 ml empty column with bottom sieve. The
obtained residue was washed with 4 ml wash buffer (20 mM imidazole, 50 mM NaH2PO4 and
300 mM NaCl, pH 8.0) for twice, followed by elution of protein with 2.5 ml elution buffer (250
mM imidazole, 50 mM NaH2PO4 and 300 mM NaCl, pH 8.0). Finally, the protein was
obtained after buffer changing by using a PD-10 column with Sephadex G-25 (GE
Healthcare, Freiburg), which has been equilibrated with PD-10 buffer (50 mM Tris-HCl
containing 15% (v/v) glycerol, pH 7.5). The aliquots of purified protein were stored at -80 °C
for enzyme assays and the purity was proven by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE).
3.4.3 Gene expression in Saccharomyces cerevisiae and purification of proteins
S. cerevisiae cells harboring an expression plasmid were grown in 2000 ml Erlenmeyer
flasks with 400 ml SCU minimal medium containing 2% (w/v) glucose at 30°C and 300 rpm
for 24 h. Then the cells were washed with SCU minimal medium without glucose for twice
and subsequently cultivated in 2000 ml Erlenmeyer flasks with 400 ml SCU liquid medium
containing 3% (w/v) galactose for further 23 h before harvest by centrifugation (5 min, 3,000
× g, 4°C).
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Protein purification was performed at 4 °C. The cell pellets were resuspended in 250 µl 50
mM Tris-HCl (pH 7.5) for per 100 ml culture. After transfer of the suspension into a mortar
with liquid nitrogen by using an injection syringe, the frozen suspension was grinded into fine
powder. Then per volume of the powder was resuspend in 2 volumes buffer containing 50
mM Tris-HCl pH 7.5, 15 % (v/v) glycerol, 1 mM DTT, 1 mM EDTA, 1 µM FAD, 1 µM FMN and
1 mM PMSF (add freshly before use), and the mixture was stirred on ice for 1h. After
centrifugation at a low speed (20,000 × g, 20 min, 4°C), the obtained supernatant was
centrifuged at a high speed (200,000 × g, 1 h 30 min, 4°C) to separate “microsomes” (pellet)
from the “soluble proteins” (supernatant). The “microsomes” was resuspended in 50 mM
Tris-HCl (with 15 % glycerol, pH 7.5). For the recombinant His6-tagged fusion protein, affinity
chromatography with Ni-NTA agarose resin (Qiagen, Hilden) was used for purification after
centrifugation at the low speed. “Soluble proteins”, “microsomes” and “purified His6-tagged
protein” were detected on SDS-PAGE gel by using Western Blot for the myc epitope tagged
proteins and Coomassie Brilliant Blue dye staining for the His6-tagged protein. All these
proteins were stored at -80 °C and used for further experiments.
3.5 Enzyme assays
3.5.1 Assays with prenyltransferases
The enzyme reaction mixtures (100 µl) for determination of the relative activities with different
aromatic substrates contained 50 mM Tris-HCl (pH 7.5), 5 or 10 mM CaCl2, 0.5-1 mM
aromatic substrate, 1-2 mM DMAPP, GPP or FPP, 0.15-5% (v/v) glycerol, 0-5% (v/v) DMSO
and 1-20 µg of purified recombinant protein. The reaction mixtures were incubated at 30 or
37 °C for 0.5-24 h. The enzyme reactions were terminated by addition of 100 μl methanol per
100 μl reaction mixture or extraction with ethyl acetate for three times. For determination of
kinetic parameters, protein amount and incubation time in the linear region of reactions were
used.
To isolate the enzyme products, reactions were carried out in large scales (5-50 ml) with the
same condition described above. After incubation for overnight, reaction mixtures were
treated in different ways due to solubility difference of the enzyme products. For assays with
simple indoles, the reactions were terminated by addition of 1 volume of methanol each.
After removal of the precipitated protein by centrifugation at 13,000 rpm for 20 min, the
reaction mixtures were concentrated on a rotating vacuum evaporator at 30 °C to a final
volume of 1 ml before injection onto HPLC. For assays with tryptophan-containing cyclic
dipeptides, indolocarbazoles, hydroxynaphthalenes or flavonoid aglycones, the reaction
mixtures were extracted three times with ethyl acetate. After evaporation of the solvent, the
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residues of the ethyl acetate phase containing both substrate and enzyme products were
dissolved in methanol before injection onto HPLC.
3.5.2 Assays with the putative methyltransferase HasC
The enzyme reaction mixtures (100 µl) contained 50 mM Tris-HCl (pH 7.5), 5 mM MgCl2 or
KCl, 1 mM aromatic substrate, 0.5 mM S-adenosyl methionine (SAM), 0.15-5% (v/v) glycerol,
0-5% (v/v) DMSO and 10 µg of purified recombinant protein. The enzyme reactions were
terminated by addition of 100 μl methanol. The proteins were removed by centrifugation at
13,000 rpm for 20 min.
3.5.3 Assays with the putative cytochrome P450 enzyme HasH
The enzyme reaction mixtures (100 µl) contained 50 mM Tris-HCl (pH 7.5), 0.1-1 mM
aromatic substrate, 1 mM freshly prepared NADPH and NADH, 0-5 mM MgCl2, 0-5 mM
freshly prepared Fe(NH4)2(SO4)2, 5-15% glycerol and different fractions of proteins (see
section 3.4.3). The enzyme reactions were terminated by addition of 100 µl methanol or
extraction with ethyl acetate for three times.
3.6 Analytic methods
3.6.1 HPLC methods
HPLC on an Agilent series 1200 with a Multospher 120 RP-18 column (250 x 4 mm, 5 μm,
C+S Chromatographie Service, Langenfeld) at a flow rate of 1 ml•min-1 was used for analysis
of incubation mixtures. A non-gradient HPLC method with acetonitrile and water as solvents
was used for analysis of incubation mixtures of four cyclo-Trp-Ala and four cyclo-Trp-Pro
isomers with AnaPT, CdpC3PT and CdpNPT, while different gradient HPLC methods by
increasing methanol (with or without 0.5% TFA) in water (with or without 0.5% TFA) were
used for analysis of those with other aromatic substrates. For isolation of enzyme products,
the same HPLC equipment with a Multospher 120 RP-18 column (250×10 mm, 5 μm, C+S
Chromatographie) was used at a flow rate of 2.5 ml•min-1. Enzyme products were purified by
using gradient methods by increasing methanol in water or acetonitrile in water.
3.6.2 NMR spectroscopic analysis and high-resolution mass spectrometry
NMR spectra were recorded on a JEOL ECX-400, JEOL ECX-500, Bruker Avance 500 MHz
or Bruker Avance 600 MHz spectrometer. Chemical shifts were referenced to the signal of
acetone-d6 at 2.05 ppm, CDCl3 at 7.26 ppm, CD3OD at 3.31 ppm or DMSO-d6 at 2.50 ppm.
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All spectra were processed with MestReNova 5.2.2. The isolated products were also
analyzed by mass spectroscopy on a Q-Trap Quantum (Applied Biosystems) using a high
resolution electron spray ionization (HR-ESI) mode or on an Auto SPEC with an electron
impact (HR-EI) mode.
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4 Results and discussion
4.1 Biochemical characterization of a cyclic dipeptide
prenyltransferase CdpC3PT from Neosartorya fischeri
Based on the bioinformatic analysis of prenyltransferase genes from the genome sequence
of N. fischeri NRRL181, one putative gene NFIA_074280 was found. Its deduced product,
EAW17508, showed significant sequence similarity to known indole prenyltransferases of the
DMATS superfamily. To identify its function, the coding sequence of NFIA_074280, termed
cdpC3PT, was amplified from gDNA by fusion PCR through three rounds reactions. The
PCR fragment consisting exclusively of the two exons was cloned via pGEM-T easy vector
into pQE60, resulting in the expression construct pWY25. The plasmid pWY25 was
transformed into E. coli for protein overproduction. The soluble His6-tagged protein CdpC3PT
was purified with Ni-NTA agarose to near homogeneity as judged by SDS-PAGE. HPLC
analysis of incubation mixtures of CdpC3PT with tryptophan-containing cyclic dipeptides in
the presence of DMAPP showed clearly the formation of enzyme products. The parts of
works described above were carried out by Dr. Wen-Bing Yin. In this thesis, enzyme
products of CdpC3PT were isolated on HPLC and their structures were elucidated by HR-
ESI-MS and NMR analyses, including 1H- and 13C-NMR analyses as well as by long-range
1H-13C connectivities in heteronuclear multiple-bond correlation (HMBC) spectra. 1H-1H
spatial correlations in nuclear overhauser effect spectroscopy (NOESY) were used to
determine absolute configuration.
The results showed that CdpC3PT catalyzed regio- and stereospecific reverse prenylations
of cyclo-L-Trp-L-Leu, cyclo-L-Trp-L-Trp, cyclo-L-Trp-L-Phe, cyclo-L-Trp-L-Tyr as well as
cyclo-L-Trp-Gly and meanwhile the formation of a five-membered ring between the original
indole and diketopiperazine rings with a cis-configuration between H-2 and C3-dimethylallyl
moiety in one-step reaction. To understand the biochemical behavior of CdpC3PT, kinetic
parameters were determined for DMAPP and all the five aromatic substrates. The range of
KM as well as the kcat values indicated different preference of CdpC3PT towards these
substrates. Comparing the enzyme activity of CdpC3PT with AnaPT, both enzymes
catalyzed the formation of reversely C3-prenylated cyclic dipeptides, however, they
introduced the prenyl moiety from opposite sides, so that two compounds with different
stereochemistry at position C-2 and C-3 can be obtained from one substrate. They therefore
complement to each other regarding the prenylation and the results expand their potential
usage for chemoenzymatic synthesis.
For details of this work see please the publication (section 5.1):
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Yin, W.-B.*, Yu, X.*, Xie, X.-L. & Li, S.-M. (2010). Preparation of pyrrolo[2,3-b]indoles
carrying a ß-configured reverse C3-dimethylallyl moiety by using a recombinant
prenyltransferase CdpC3PT. Org. Biomol. Chem. 8, 2430-2438. (*: equal contribution)
4.2 Biochemical characterization of a 5-dimethylallyltryptophan
synthase from Aspergillus clavatus
Before we started this work, a literature search of indole prenyltransferases showed that 20
enzymes from bacteria and fungi have been characterized biochemically (Li, 2010; Yin et al.,
2010b; Zou et al., 2010; Schultz et al., 2010; Takahashi et al., 2010; Ding et al., 2010; Li,
2009). These enzymes catalyzed the transfer of prenyl moieties onto positions N-1, C-2, C-3,
C-4, C-6 or C-7 at the indole ring resulting in the formation of “regularly” or “reversely”
prenylated derivatives (Figures 1-11 and 1-13). However, a prenyltransferase being
responsible for transferring a prenyl moiety onto position C-5 of the indole ring has not been
reported. Database searching revealed, on the other hand, the presence of a number of
biologically active indole alkaloids carrying a prenyl moiety at position C-5 in nature (see
section 1.1.1.3). The discrepancy between the natural occurrence of a large number of C5-
prenylated indole derivatives on one hand and undiscovered C5-prenyltransferases on the
other hand prompted us to search for such enzymes. One putative prenyltransferase
EAW08391, encode by the ACLA_031240 from the genome sequence of A. clavatus NRRL1
raised our attention. EAW08391 shares on the amino acid level sequence identity 52% with
4-dimthylallyltryptophan synthase FgaPT2, therefore it can be expected that EAW08391
catalyzes a similar reaction as FgaPT2. To prove the function of EAW08391, the coding
region of ACLA_031240, termed 5-dmats, was amplified by PCR from cDNA synthesized
from mRNA. The PCR product was cloned via pGEM-T easy vector into pQE70, resulting in
the expression construct pYL09. The works described above were carried out by Yan Liu. In
this thesis, the plasmid pYL09 was transformed into E. coli for overproduction of His6-5-
DMATS. The soluble His6-tagged protein 5-DMATS was purified to near homogeneity and
used for biochemical investigation with diverse aromatic substrates in the presence of
different prenyl diphosphates.
Due to the high sequence similarity with tryptophan C4-prenyltransferase FgaPT2 mentioned
above, L-tryptophan and 17 simple indole derivatives were firstly incubated with 5-DMATS in
the presence of DMAPP. With the exception for C5-substituted derivatives, the most tested
simple indole derivatives with modifications at the indole ring or side chain have been well
accepted by 5-DMATS with L-tryptophan as the best substrate. A previous study showed that
FgaPT2 accepted also tryptophan-containing cyclic dipeptides as substrates (Steffan and Li,
2009). 5-DMATS was therefore assayed with five such cyclic dipeptides in the presence of
DMAPP. It has been shown that these compounds were also substrates for 5-DMATS, but
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accepted with significantly lower yields than most of the simple indole derivatives in the
presence of DMAPP. In addition, 5-DMATS was also incubated with L-tyrosine in the
presence of DMAPP or with L-tryptophan in the presence of GPP or FPP. However, no
formation of any enzyme product was detected in these assays.
To confirm the prenylation position, enzyme products of 12 well accepted substrates were
isolated on HPLC and subjected to HR-ESI-MS and NMR analyses. The results revealed
unequivocally the highly regioselective regular prenylation at C-5 of the indole nucleus of the
12 enzyme products. 5-DMATS was therefore a 5-dimethylallyltryptophan synthase and filled
therewith the last gap in the toolbox of indole prenyltransferases regarding their prenylation
positions. To study the behavior of 5-DMATS towards indole derivatives and DMAPP, kinetic
parameters including KM and kcat values, were determined. KM values of 5-DMATS were
found for L-tryptophan and DMAPP at 34 µM and 76 µM, respectively. Average kcat value at
1.1 s-1 was calculated from kinetic data of L-tryptophan and DMAPP. Catalytic efficiencies of
5-DMATS were detected for L-tryptophan at 25,588 s-1·M-1 and for other 11 simple indole
derivatives up to 1,538 s-1·M-1. It can be therefore expected that 5-DMATS could serve as an
effective biocatalyst for chemoenzymatic synthesis of prenylated derivatives in the program
of drug discovery and development.
For details of this part see please the publication (section 5.2):
Yu, X., Liu, Y., Xie, X., Zheng, X.-D. & Li, S.-M. (2012). Biochemical characterization of
indole prenyltransferases: Filling the last gap of prenylation positions by a 5-
dimethylallyltryptophan synthase from Aspergillus clavatus. J. Biol. Chem. 287, 1371-1380.
4.3 Biochemical characterization of a brevianamide F reverse
prenyltransferase BrePT from Aspergillus versicolor
A prenyltransferase NotF involved in the biosynthesis of notoamides in Aspergillus sp.
MF297-2 was reported by the work group of Prof. Sherman from University of Michigan (Ding
et al., 2010). NotF is responsible for the reverse prenylation of brevianamide F at position C-
2 of the indole ring resulting in the formation of deoxybrevianamide E and uses a limited
number of compounds as clearly favorable prenylation substrates. The low flexibility of NotF
towards aromatic substrates prohibits its usage as biocatalyst for production of desired
compounds. It was necessary to find a NotF homologue with broad substrate specificity and
to be used as biocatalyst for synthesis of reversely C2-prenylated indole derivatives.
Literature search revealed that several A. versicolor strains produced brevianamides or
notoamides, which are very likely derived from deoxybrevianamide E and therefore a notF
homologue must be involved in their biosynthesis. To amplify the notF homologue brePT
from A. versicolor NRRL573, the PCR reaction using primers deduced from notF sequence
was performed. The PCR fragment was cloned into pET28a via pGEM-T easy vector to
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create the expression construct pQW2 with a C-terminal His6-tag. After failed expression with
pQW2, brePT was recloned in pET28a by introducing five histidine residues directly
connected to the C-terminus of the overproduced protein. The new expression vector pSY1
was transformed and overexpressed in E. coli. The His5-BrePT was obtained after one-step
purification on Ni-NTA agarose. HPLC analysis of incubation mixtures of BrePT with 14
tryptophan-containing cyclic dipeptides in the presence of DMAPP showed clearly the
formation of enzyme products. The works described above were carried out by Qing Wang
and Suqin Yin. In this thesis, the enzyme products were isolated and their structures were
identified by 1H-NMR and MS analyses. The data proved unequivocally the attachment of the
reverse prenyl (tert-prenyl) moiety at C-2 of the indole ring and the regiospecific C2-
prenylation catalyzed by BrePT. BrePT showed much higher substrate flexibility than NotF.
To study the behavior of BrePT towards DMAPP and twelve different cyclic dipeptides,
kinetic parameters including KM and kcat values, were measured. Average turnover number
(kcat) at 0.4 s-1 was calculated from kinetic data of brevianamide F and DMAPP. KM values in
the range of 0.082-2.9 mM and kcat values from 0.003 to 0.15 s-1 were determined for other
eleven cyclic dipeptides. To test the acceptance of other prenyl donors, GPP or FPP instead
of DMAPP was used in the reaction mixtures of the 14 tryptophan-containing cyclic
dipeptides and His5-BrePT. Similar to known fungal indole prenyltransferases, BrePT did not
accept GPP or FPP as a prenyl donor for its prenylation.
For details of this work see please the publication (section 5.3):
Yin, S.*, Yu, X.*, Wang, Q., Liu, X. Q. & Li, S.-M. (2013). Identification of a brevianamide F
reverse prenyltransferase BrePT from Aspergillus versicolor with a broad substrate specificity
towards tryptophan-containing cyclic dipeptides. Appl. Microbiol. Biotechnol. 97, 1649-1660.
(*: equal contribution)
4.4 Production of enantiomers of cis-configured prenylated
pyrroloindoline diketopiperazines by fungal indole
prenyltransferases
Previously, three C3-prenyltransferases belonging to the DMATS superfamily were identified
and characterized biochemically in our group (Yin et al., 2009; Yin et al., 2010b; Schuller et
al., 2012), i.e., AnaPT and CdpC3PT from N. fischeri and CdpNPT from A. fumigatus. They
could introduce a dimethylallyl moiety to position C-3 of the tryptophanyl moiety and catalyze
the formation of a five-membered ring between the original indole and diketopiperazine rings
with a cis-configuration between H-2 and C3-dimethylallyl moiety to produce prenylated
pyrroloindoline diketopiperazines. However, the used cyclic dipeptides usually contained only
L-configured amino acid moieties, and little was known about their behavior on substrates
with D-configured amino acid moieties. This feature prohibits their usage as biocatalysts for
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producing stereoisomers of prenylated pyrroloindoline diketopiperazines. In order to
understand the different stereoselectivity of AnaPT, CdpC3PT and CdpNPT, four cyclo-Trp-
Ala and four cyclo-Trp-Pro isomers were synthesized and incubated with these enzymes in
the presence of DMAPP.
HPLC analysis showed that all the substrates were accepted by AnaPT, CdpC3PT and
CdpNPT in the incubation mixtures. The enzyme products were isolated on HPLC from
incubation mixtures and their structures were elucidated by NMR and MS analyses as
prenylated pyrroloindoline diketopiperazines. The results showed that AnaPT always transfer
the prenyl moiety to C-3 at the opposite side to the carbonyl moiety at C-11 to produce anti-
cis configured prenylated pyrroloindoline diketopiperazines, while CdpC3PT transfer it to C-3
at the same side as the carbonyl moiety at C-11 to produce syn-cis configured prenylated
pyrroloindoline diketopiperazines. Therefore, it could be concluded that the stereospecificity
of AnaPT and CdpC3PT depends largely on the configuration of tryptophanyl moiety in cyclic
dipeptides. CdpNPT was reported to catalyze the same reaction as CdpC3PT in the previous
study (Schuller et al., 2012). However, we found in this thesis that CdpNPT could also
produce enzyme products catalyzed by AnaPT. CdpNPT could catalyze the formation of both
anti-cis and syn-cis configured prenylated pyrroloindoline diketopiperazines but showed
different stereoselectivity towards isomers of cyclo-Trp-Ala and cyclo-Trp-Pro. It is likely that
not the configuration of amino acids moiety in cyclic dipeptides, but the structure of the
second amino acid moiety plays an important role for the stereoselectivity of CdpNPT.
The enzyme reactions with tested substrates catalyzed by AnaPT and CdpC3PT always
complemented to each other, and the stereoselectivity of both enzymes were approximately
100%. Although CdpNPT showed lower stereoselectivity compared to AnaPT and CdpC3PT,
higher conversion ability towards most tested substrates was observed. Thereby CdpNPT
could be useful for prenylation of poor substrates of AnaPT and CdpC3PT. These results
expand the usage of the three C3-prenyltransferases as biocatalysts for production of
stereoisomers of prenylated pyrroloindoline diketopiperazines.
For details of this work see please the manuscript (section 5.4):
Yu, X., Xie, X. & Li, S.-M., Complementary stereospecific synthesis of cis-configured
prenylated pyrroloindoline diketopiperazines by indole prenyltransferases of the DMATS
superfamily. (manuscript)
4.5 Production of prenylated indolocarbazoles by using 5-DMATS
and FgaPT2 from Aspergillus
Indolocarbazoles are a class of natural products with well known remarkable biological
activities, especially their inhibitory effects against protein kinases in various organisms
(Sánchez et al., 2006; Nakano and Ômura, 2009). However, prenylated indolocarbazoles
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have been reported, neither from natural sources, nor from chemical synthetic approaches,
although diverse prenylated carbazoles have been isolated from different sources (Schmidt
et al., 2012). In this thesis, we used prenyltransferases of the DMATS superfamily to catalyze
regiospecific prenylation of indolocarbazoles.
For this purpose, four indolocarbazoles arcyriaflavin A, N6-methylarcyriaflavin A, K252c and
7-hydroxy-K252c and two non-bridged intermediates arcyriarubin A and N-methylarcyriarubin
A were synthesized. The six synthesized compounds together with two indolocarbazole
glycosides staurosporine and K252d, which had been isolated from Streptomyces
nitrosporeus CQT14-24, were incubated with nine prenyltransferases of the DMATS
superfamily in the presence of DMAPP. The tested enzymes included five cyclic dipeptide
prenyltransferases AnaPT, BrePT, CdpC3PT, CdpNPT and FtmPT1, three
dimethylallyltryptophan synthases FgaPT2, 5-DMATS and 7-DMATS and one tyrosine O-
prenyltransferase SirD (Yin et al., 2010a; Yin et al., 2013a; Yin et al., 2010b; Schuller et al.,
2012; Grundmann and Li, 2005; Steffan et al., 2007; Yu et al., 2012; Kremer and Li, 2008;
Kremer and Li, 2010). HPLC analysis showed that 5-DMATS from A. clavatus and FgaPT2
from A. fumigatus displayed more substrate flexibilities towards the tested substances than
other enzymes and were studied in details.
Arcyriaflavin A was poor substrates for both 5-DMATS and FgaPT2, while other three
indolocarbazoles were clearly accepted. The two non-bridged intermediates of
indolocarbazoles were not accepted by 5-DMATS and FgaPT2, indicating the importance of
the presence of the indolocarbazole skeleton. Glycosides of indolocarbazoles were also not
substrates for the enzymes of the DMATS superfamily.
The enzyme products were isolated and their structures were elucidated by NMR and MS
analyses. C3-prenylated products were isolated from the incubation mixtures of K252c and
7-hydroxy-K252c with both 5-DMATS and FgaPT2 as well as the incubation mixture of N6-
methylatedarcyriaflavin A with 5-DMATS. In addition to those products, C9-prenylation and
diprenylation at both C-3 and C-9 were also catalyzed by 5-DMATS in the incubation mixture
with K252c. This proved that both 5-DMATS and FgaPT2 catalyzed regiospecific C-
prenylation on the indolocarbazole system, i.e. the para-position to the indole N-atom (C3,
C9 or both) and function therefore as biocatalysts for Friedel-Crafts alkylations. To elucidate
the behavior of 5-DMATS and FgaPT2 towards indolocarbazoles, kinetic parameters were
determined for the best accepted substrate 7-hydroxy-K252c with both enzymes. KM values
were calculated to be at 87 and 136 µM for 5-DMATS and FgaPT2, respectively, while kcat
values were found at 6.8 and 7.3 min-1. This work expands the potential usage of enzymes of
the DMATS superfamily in the structural modifications. To best of our knowledge, this is the
first reported on the (chemoenzymatic) synthesis of prenylated indolocarbazoles.
For details of this work see please the publication (section 5.5):
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Yu, X., Yang, A., Lin, W. & Li, S.-M. (2012). Friedel-Crafts alkylation on indolocarbazoles
catalyzed by two dimethylallyltryptophan synthases from Aspergillus. Tetrahedron Lett. 53,
6861-6864.
4.6 Production of prenylated hydroxynaphthalenes by using fungal
indole prenyltransferases
As described in section 1.3.6, fungal prenyltransferases of the DMATS superfamily share no
sequence, but structure similarity with prenyltransferases of the CloQ/NphB group. However,
an acceptance of substrates for CloQ/NphB group by a member of the DMATS superfamily
was not reported previously. This prompted us to investigate the acceptance of
hydroxynaphthalenes by enzymes of the DMATS superfamily.
For initial investigation, eight prenyltransferases of the DMATS superfamily including five
cyclic dipeptide prenyltransferases AnaPT, CdpC3PT, CdpNPT, CTrpPT and FtmPT1, two
dimethylallyltryptophan synthases FgaPT2 and 7-DMATS and one tyrosine O-
prenyltransferase SirD (Yin et al., 2010a; Yin et al., 2010b; Schuller et al., 2012; Grundmann
and Li, 2005; Zou et al., 2010; Steffan et al., 2007; Kremer and Li, 2008; Kremer and Li, 2010)
were incubated with the simple naphthalene derivative 1-naphthol in the presence of DMAPP.
HPLC analysis showed clear formation of one additional peak each in all the incubation
mixtures with an exception of SirD. The intriguing results obtained with 1-naphthol
encouraged us to test the acceptance of more hydroxynaphthalenes by the members of the
DMATS family. Five enzymes including AnaPT, CdpC3PT, CdpNPT, 7-DMATS and SirD
were selected for incubation with naphthalene and 11 hydroxynaphthalenes in the presence
of DMAPP. HPLC analysis showed that non-hydroxylated naphthalene was not accepted by
the tested enzymes, indicating the importance of an activation of the naphthalene ring, e.g.
by hydroxylation. Most of the 11 hydroxynaphthalenes were accepted by AnaPT, 7-DMATS,
CdpNPT and CdpC3PT, while they were very poor substrates for SirD. The enzyme activities
and preference of the tested prenyltransferases towards hydroxynaphthalenes differed
clearly from each other.
For structure elucidation, enzyme products were isolated on HPLC and sent for NMR and
MS analyses. Inspection of the structures of the enzyme products revealed clearly that
different enzymes catalyzed usually the formation of the same major prenylated product. The
prenylation has preferentially taken place at para-position of the hydroxyl group at C-1. If this
was impossible, the ortho-position to the hydroxyl group at C-2 was prenylated. Regularly O-
prenylated and diprenylated derivatives were also identified as enzyme products of
substrates with low conversion rates and regioselectivity. To get information on the catalytic
efficiencies of indole prenyltransferases towards hydroxynaphthalenes, kinetic parameters of
AnaPT, CdpNPT, CdpC3PT and 7-DMATS with six selected substrates were determined.
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The KM and kcat values were determined to be in the range of 0.064-2.8 mM and 0.038-1.30
s-1, respectively. These data are in the similar concentration range as those for indole
derivatives. In this study, we have shown that the substrate specificity of the members of the
DMATS superfamily towards hydroxynaphthalene derivatives doesn’t correlate with those
obtained for tyrosine or indole derivatives, and provided experimental evidence for their
potential application as biocatalysts for chemoenzymatic synthesis of prenylated
hydroxynaphthalenes.
For details of this work see please the publication (section 5.6):
Yu, X., Xie, X. & Li, S.-M. (2011). Substrate promiscuity of secondary metabolite enzymes:
prenylation of hydroxynaphthalenes by fungal indole prenyltransferases. Appl. Microbiol.
Biotechnol. 92, 737-748.
4.7 Production of prenylated flavonoids by using 7-DMATS from
Aspergillus fumigatus
Prenylated flavonoids are a group of compounds predominantly found in plants (Botta et al.,
2009; Botta et al., 2005b). Due to their broad pharmacological activities (Botta et al., 2009;
Botta et al., 2005b; Wätjen et al., 2007), various strategies have been developed for both
regioselective chemical and chemoenzymatic synthesis of prenylated flavonoids, especially
for C-prenylated derivatives (Tischer and Metz, 2007; Hossain et al., 2006; Yazaki et al.,
2009). In previous studies, many prenylated flavonoids have been produced by using
recombinant enzymes (Sasaki et al., 2011; Sasaki et al., 2008; Ozaki et al., 2009; Kumano et
al., 2008). However, only a few of such derivatives carry a dimethylallyl moiety at position C-
6. Our studies in section 4.6 have shown that several members of the DMATS superfamily
accepted also hydroxynaphthalene derivatives. These results encouraged us to test the
acceptance of flavonoids including chalcones, flavanones and isoflavonoids by the members
of the DMATS superfamily.
For initial investigation, seven fungal prenyltransferases including 7-DMATS, AnaPT,
CdpC3PT, CdpNPT, SirD, FtmPT1 and FgaPT2 (Yin et al., 2010a; Yin et al., 2010b; Schuller
et al., 2012; Grundmann and Li, 2005; Steffan et al., 2007; Kremer and Li, 2008; Kremer and
Li, 2010) were incubated with up to thirty flavonoids in the presence of DMAPP. HPLC
analysis showed that 7-DMATS has a more flexible substrate specificity towards these
compounds than other enzymes. Detailed study was therefore carried out with 7-DMATS
from A. fumigatus. 7-DMATS was then incubated with 16 flavonoids and analogues in the
presence of DMAPP. Product formation was detected for 14 substrates after incubation with
14 µg protein per 100 µl assay at 37°C for 16 h. Six of them, i.e. genistein, biochanin A,
naringenin, eriodictyol, hesperetin and phloretin, represented a yield of more than 12% and
were selected for further research.
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For structure elucidation, enzyme products of the six substrates were isolated on HPLC and
sent for NMR and MS analyses. The results showed that C6-prenylated products were found
in all the six incubation mixtures. In cases of eriodictyol and hesperetin, products with
prenylation at ring B were also isolated from the incubation mixtures. From the structures of
the enzyme products, it is obviously that the favorable prenylation position for 7-DMATS was
C-6 between the two hydroxyl groups. To get information on the catalytic efficiencies of 7-
DMATS towards flavonoids, kinetic parameters were determined for the six substrates. The
KM and kcat values for flavonoids were determined to be in the range of 0.07-1.26 mM and
0.02-0.4 s−1, respectively. These data provided evidence that the tryptophan
prenyltransferase 7-DMATS can also be used for production of prenylated flavonoids,
especially for C6- or ring B-prenylated flavanones and isoflavonoids by chemoenzymatic
approach and therefore complements the production gap of other reported
prenyltransferases for prenylated flavonoids (Kumano et al., 2008; Ozaki et al., 2009; Sasaki
et al., 2011; Botta et al., 2005a).
For details of this work see please the publication (section 5.7):
Yu, X., Li, S.-M. (2011). Prenylation of flavonoids by using a dimethylallyltryptophan
synthase 7-DMATS from Aspergillus fumigatus. Chembiochem 12, 2280-2283.
4.8 Prenyltransferases of the dimethylallyltryptophan synthase
superfamily
Besides the experimental works on prenyltransferases of the DMATS superfamily, general
methods for biochemical characterization of these enzymes were summarized in a review
article. The first part in this review was devoted to a general introduction of
prenyltransferases of the DMATS superfamily. Subsequently the procedures for spore
preparation as well as cultivation of fungi were described. RNA and DNA isolation and cDNA
synthesis were followed by gene cloning, in which both normal PCR amplification from cDNA
and fusion PCR amplification from gDNA were described. Protein overproduction in E. coli as
well as S. cerevisiae and protein purification were detailed after gene cloning.
The next part described details on carrying enzyme assays. General procedures for
biochemical characterization of prenyltransferases were then described, including test of
enzyme activities and determination of kinetic parameters. For chemoenzymatic synthesis of
prenylated compounds, protocols of enzyme reactions and sample preparation before
product isolation on HPLC were presented. HPLC components and conditions used for
assays with diverse types of substrates were then shown in this review.
For details of this review see please the publication (section 5.8):
Yu, X., Li, S.-M. (2012). Prenyltransferases of the dimethylallyltryptophan synthase
superfamily. Methods Enzymol. 516, 259-278.
51
Results and discussion
4.9 Cloning and overexpression of a putative methyltransferase
gene hasC from Aspergillus fumigatus
4.9.1 Cloning of hasC from Aspergillus fumigatus
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Lane PCR product or plasmid Restrictionenzyme Expected sizes (bp) Observed sizes (kb)
1 PCR product produced afterthe second round PCR - 1303 1.3
2 pXY01 EcoRI 131/ 1192/ 2997 1.2/3.0
3 pXY03 SphI 140/1046/3532 1.0/3.5
Figure 4-1: Cloning of hasC into pQE60. Lane M: DNA ladder.
The putative methyltransferase gene hasC is proposed to be involved in the biosynthesis of a
prenylated indole alkaloid HAS in A. fumigatus (see section 1.2.1.3). In order to identify the
function of hasC, the coding sequence of hasC was cloned from A. fumigatus.
This gene consists of two exons of 223 and 1079 bp interrupted by one intron of 60 bp. The
whole coding sequence of hasC was amplified from gDNA from the BAC AfB28B10 of A.
fumigatus Af293 by using two rounds fusion PCR (see section 3.3.1). Primers
AFUA_3G12910_1 and AFUA_3G12910_4 as well as AFUA_3G12910_2 and
AFUA_3G12910_3 were used for amplification of the first and second exons in the first round
PCR, respectively. In the second round of PCR, a PCR fragment of 1303 bp containing the
entire coding sequence of hasC was obtained by using two PCR products from the first
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round as templates in the presence of primers AFUA_3G12910_1 and AFUA_3G12910_2
(Figure 4-1).
The PCR product (1303 bp) was cloned into pGEM-T easy vector resulting in plasmid pXY01
(Figure 4-1), which was subsequently confirmed to be correct by sequencing. The plasmid
pXY01 was digested with BamHI alone or together with BglII to obtain BamHI-BamHI
fragment of 389 bp and BamHI-BglII fragment of 904 bp, respectively. In order to get the
expression construct pXY03 (Figure 4-1), the two fragments were cloned into pQE60
subsequently.
4.9.2 Overexpression of hasC in Escherichia coli
Table 4-1: Induction conditions tested for expression of hasC (pXY03) in E. coli XL1 Blue,
M15 and SG13009.
Strain Medium Temperature (°C) IPTG (mM) Induction time (h) Speed (rpm)
XL1 Blue LB, TB 37, 30, 22
0.05, 0.1, 0.2,
0.4, 0.6, 0.8
0, 1, 3, 4, 5, 6, 9,
16
220
0 0, 1, 3, 4, 5, 6, 9,16, 24, 48, 72
M15 LB, TB 37, 30, 22 0.1, 0.8 1, 2, 3, 16
SG13009 TB
30 0 6, 9, 16
37, 30, 22 0.05, 0.1, 0.3,0.5 3, 6, 16
4 0.1 5, 16 200
22 0.1 5, 16 150
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Figure 4-2: SDS-PAGE analysis of hasC overexpression in the absence of IPTG.
  
   M       1        2   
                      
 
kDa 
97.0 
66.0 
 
45.0 
 
 
 
 
30.0 
Figure 4-3: Analysis of purified His6-HasC on SDS-PAGE.
Lane M: protein marker.
Lane 3: total protein obtained after
induction without IPTG at 30°C for 16h
by using E. coli XL1 Blue cells.
Other lanes: total proteins obtained
after induction under other conditions.
Lane M: protein marker.
Lanes 1 and 2: purified His6-HasC.
Different induction conditions were used.
The induction condition for lane 2 was the
best condition described above.
Expected size: 49.6 kDa.
Observed size: with migration near the
45.0 kDa size marker.
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For overexpression of hasC, pXY03 was firstly transformed into E. coli XL1 Blue. The cells
were induced with IPTG at different conditions (Table 4-1). A high yield of insoluble protein
was detected instead of soluble protein. Comparison of the total protein obtained before
induction and after induction on SDS-PAGE showed that IPTG was not necessary for gene
expression (Figure 4-2, lane 3). Therefore, different induction conditions in the absence of
IPTG were tested (Table 4-1). Unfortunately, no soluble protein was obtained. Then another
two E. coli host strains, i.e. M15 and SG13009, were used for overexpression of hasC. After
condition optimization (Table 4-1), the best condition was found to be 16 h induction in TB
medium with 0.1 mM IPTG at 22 °C and 150 rpm by using E. coli SG13009 cells (Figure 4-3,
lane 2). A yield of 500 µg of purified protein was achieved from 100 ml of bacterial culture. A
significant band with migration near the 45.0 kDa size marker was observed on SDS-PAGE
of the purified protein, corresponding to the calculated mass of 49.6 kDa for His6-HasC
(Figure 4-3, lane 2).
Table 4-2: Conditions of enzyme assays with HasC.
Substrate Ion Other components
terezine D
5 mM MgCl2
50 mM Tris-HCl (pH 7.5),
0.5 mM SAM,
1 mM tryptophan derivatives,
10 µg protein,
in 100 µl assay,
37 °C incubation, 19 h
5 mM KCl
7-dimethylallyl-L-tryptophan
5 mM MgCl2
5 mM KCl
cyclo-L-Trp-L-Ala
5 mM KCl
L-tryptophan
5 mM MgCl2
5 mM KCl
Motif search of amino acid sequences revealed the presence of motif I of SAM-dependent
methyltransferases in HasC: VVDVGAGVG (238-246 amino acids under the accession
number EAL92292 at GenBank). SAM is therefore probably the methyl donor for the reaction
catalyzed by HasC (Kagan and Clarke, 1994). HasC doesn’t possess the typical CxxxCxxC
motif for [4Fe-4S] cluster nucleating (Sofia et al., 2001), indicating that HasC is likely a
normal SAM-dependent protein rather than a radical SAM-dependent protein. Enzyme
reactions of HasC were carried out with several possible precursors of HAS in the presence
of SAM (Table 4-2). Unfortunately, no product formation was observed.
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4.10 Cloning of a putative cytochrome P450 gene hasH from
Aspergillus fumigatus
4.10.1 Cloning of hasH from Aspergillus fumigatus
As described in section 1.2.1.3, the putative cytochrome P450 gene hasH is proposed to be
involved in the biosynthesis of a prenylated indole alkaloid HAS (Figure 1-8) in A. fumigatus.
For functional proof of hasH, this gene was cloned from A. fumigatus.
Sequence analysis showed that hasH comprises six exons of 192, 185, 631, 220, 206 and
219 bp, interrupted by five introns of 51, 76, 59, 31 and 56 bp. Multiple alignments of HasH
with the two orthologues EAW21272 and EAU31603 (Table 1-1), showed that HasH from A.
fumigatus contains one additional fragment of 18 amino acids at the N-terminus of the
sequence (Figure 4-4), which could be due to a prediction error. So we decided to start the
amplification of the coding sequence at the 58th base pair in the sequence.
Figure 4-4: Multiple alignment of HasH with the two orthologues EAW21272 and EAU31603.
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bp  
 
3000 
 
1500 
 
 
Figure 4-5: The entire coding sequence of hasH obtained after PCR reaction. Lane M: DNA
ladder; lane 1: the PCR product.
The whole coding sequence of hasH was amplified by using cDNA from a cDNA library of A.
fumigatus B5233 as template and primers AFUA_3G12960_1 and AFUA_3G12960_2. A
PCR fragment with a size of about 1.6 kb was observed on the agarose gel, corresponding to
the calculated size of 1612 bp. The PCR fragment was cloned into pGEM-T easy vector
resulting in plasmid pXY11 (Figure 4-6), which was subsequently sequenced to confirm the
sequence.
Expected size Observed size
1612 bp 1.6 kb
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Lane plasmid Restriction enzyme Expected sizes (bp) Observed sizes (kb)
1 pXY11 Before digestion - -
2 pXY11 PstI 677/3909 0.7/4.0
3 pXY12 PstI 3256/4922 3.3/4.9
4 pXY13 NcoI 2930/7386 2.9/7.4
5 pXY14 BspEI 8141 8.1
Figure 4-6: Cloning and expression construction of hasH. Lane M: DNA ladder.
Comparing the sequencing results with the sequence of hasH obtained from NCBI under the
accession number XM_749232.1, one additional gap of 33 bp was found in the PCR product
(Figure 4-7, pXY11). This gap was directly connected to one intron in the genome sequence,
therefore it could be speculated that the gap was also a part of the intron. Interestingly, the
gap was also observed in the homologue gene NFIA_064360 from N. fischeri under the
accession number XM_001263168.1 (Figure 4-7), which provided an evidence for our
speculation. The true size of the PCR product was calculated to be 1579 bp.
 
 
 
hasH 
pXY11 
NFIA_064360 
hasH 
pXY11 
NFIA_064360 
Figure 4-7: Multiple alignment of sequence of pXY11 with the sequence of hasH from A.
fumigatus Af293 and NFIA_064360 from N. fischeri NRRL 181.
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Plasmid pXY11 was digested with XhoI and NheI to obtain a fragment of 1569 bp. The XhoI-
NheI fragment was cloned into pESC-URA vector to give the single expression vector pXY12
(Figure 4-6). For construct of co-expression vector with a reductase gene, the XhoI-NheI
fragment was inserted into pVW41 containing the coding sequence of NFIA_083630 from N.
fischeri to give pXY13 (Figure 4-6).
TMHMM server SOSUI server
Figure 4-8: Amino acids sequence analysis of HasH by using TMHMM and SOSUI servers.
Figure 4-9: Construct of expression vector pXY14.
Amino acid sequence analysis by using SOSUI and TMHMM servers predicted that HasH is
a membrane-bound protein (Figure 4-8). However, due to little information on fungal
cytochrome P450 enzymes on these servers, the solubility of HasH remains unclear. We
would like to prepare one additional expression vector with His6-tag for purification of HasH
from crude extracts, in case that HasH is a soluble protein. Therefore, the expression
plasmid pXY14 was obtained after insertion of a double-stranded oligonucleotide containing
amino acid codons for six His residues and BspEI restriction site for validation between
BamHI and XhoI sites in the plasmid pXY12, which was digested with BamHI and XhoI
previously (Figures 4-6 and 4-9). The double-stranded oligonucleotide was prepared by
heating primers PXY12-1 and PXY12-2 and gradually cooling.
4.10.2 Overexpression of hasH in Saccharomyces cerevisiae
For protein overproduction, the plasmids pXY12, pXY13 and pXY14 were transformed into S.
cerevisiae INVSc-1 separately. The resulting transformants were proven by yeast colony
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PCR reactions with primers AFUA_3G12960_1 and AFUA_3G12960_2. The PCR reaction
with S. cerevisiae INVSc-1 cells was used as negative control.
Both “soluble proteins” and “microsomes” (see section 3.4.3) from the transformants of S.
cerevisiae cells harbouring pXY12 or pXY13 and “purified His6-tagged protein” (see section
3.4.3) from cells harbouring pXY14 after induction with 3% galactose at 30 °C for 23 h were
obtained and analyzed by SDS-PAGE. A Western Blot and Coomassie Brilliant Blue dye
staining were used for detection of myc epitope tagged and His6-tagged proteins,
respectively. However, no obvious band of target protein was observed on SDS-PAGE.
Allowing for the possibility of low protein yield, enzyme assays were carried out with high
volume of proteins. Terezine D, 7-dimethylallyl-L-tryptophan, L-tryptophan, cyclo-L-Trp-L-Ala
and tryptophan methyl ester were incubated with different fractions of HasH in the presence
of NADPH and NADH at 30 or 37 °C. Unfortunately, no product formation was observed on
HPLC.
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5.1 Preparation of pyrrolo[2,3-b]indoles carrying a ß-
configured reverse C3-dimethylallyl moiety by using a
recombinant prenyltransferase CdpC3PT
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Preparation of pyrrolo[2,3-b]indoles carrying a b-configured reverse
C3-dimethylallyl moiety by using a recombinant prenyltransferase CdpC3PT†
Wen-Bing Yin,‡§a Xia Yu,‡a Xiu-Lan Xieb and Shu-Ming Li*a
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First published as an Advance Article on the web 22nd March 2010
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Six b-configured reversely C3-prenylated pyrrolo[2,3-b]indoles were successfully prepared by using a
recombinant prenyltransferase from Neosartorya fischeri. For this purpose, the putative
prenyltransferase gene NFIA_074280 (termed herewith cdpC3PT) was cloned into pQE60 and
overexpressed in Escherichia coli. The overproduced His6-CdpC3PT was purified to near homogeneity
and incubated with five cyclic tryptophan-containing dipeptides in the presence of dimethylallyl
diphosphate (DMAPP). All of the substrates were accepted by CdpC3PT and converted to reversely
C3-prenylated pyrrolo[2,3-b]indoles. Using cyclo-L-Trp-L-Trp as substrate, both mono- and
diprenylated derivatives were obtained. The structures of the enzymatic products were confirmed by
HR-ESI-MS, 1H- and 13C-NMR analyses as well as by long-range 1H-13C connectivities in
heteronuclear multiple-bond correlation (HMBC) spectra after preparative isolation. 1H-1H spatial
correlations in nuclear overhauser effect spectroscopy (NOESY) were used for determination of
absolute configuration. The KM values were determined at about 1.5 mM for DMAPP and in the range
from 0.22 to 5.5 mM for cyclic dipeptides. The turnover number kcat were found in the range of 0.023 to
0.098 s-1 and specificity constants kcat/KM from 14.2 to 122.7 M-1 s-1. In contrast to the products of
AnaPT bearing a-configured C3-dimethylallyl residues, the C3-prenyl moieties in the products of
CdpC3PT have a b-configuration. Discovery and characterisation of CdpC3PT expand the usage of the
chemoenzymatic approach for stereospecific synthesis of C3-prenylated derivatives.
Introduction
A number of naturally occurring indoline alkaloids carry a
reverse prenyl moiety at position C3 of the indoline ring and
a five-membered ring system between the indoline and the
diketopiperazine ring (Fig. 1). These compounds are mainly
found in the genera Penicillium and Aspergillus of ascomycota.1
All of the known natural products from this group have a
cis-configuration between H-2 and C3-prenyl moiety. Both a-
and b-configured C3-dimethylallyl residues have been identified
(Fig. 1). 5-N-acetylardeemin,2 aszonalenin and epiaszonalenin
as well as their acetylated form1,3,4 belong to the first subgroup.
Examples of b-configured derivatives are roquefortinesC andD,5–7
fructigenines A and B (verrucofortine),8,9 rugulosuvines A and
B,10 brevicompanines A, B and C,11,12 as well as amauromine.13
Both a- and b-configured C3-dimethylallyl residues are found
in the structure of epiamauromine derived from two tryptophan
molecules.14 Until now, more b-configured derivatives have been
isolated from fungal strains than the a-configured ones. C3-
aPhilipps-Universita¨t Marburg, Institut fu¨r Pharmazeutische Biologie,
Deutschhausstrasse 17A, D-35037Marburg, Germany. E-mail: shuming.li@
Staff.uni-Marburg.de; Fax: +49-6421-2825365; Tel: +49-6421-2822461
bPhilipps-Universita¨t Marburg, Fachbereich Chemie, Hans-Meerwein-
Strasse, 35032 Marburg, Germany
† Electronic supplementary information (ESI) available: Spectra of com-
pounds. See DOI: 10.1039/c000587h
‡ These authors contributed equally to this work
§ Present address: University of Wisconsin-Madison, Medical Microbi-
ology and Immunology, 3455 Microbial Sciences Building, 1550 Linden
Drive, Madison WI 53706, USA.
prenylated indolines have been reported to show diverse biological
activities.15
By using two indole prenyltransferases AnaPT and CdpNPT,
four aszonalenin stereoisomers were synthesised successfully
from (R)- and (S)-benzodiazepinedione.16 Seven C3-prenylated
pyrrolo[2,3-b]indoles (2a–2f and 4) have been obtained by enzy-
matic conversion of six tryptophan-containing cyclic dipeptides
(1a–1f) with AnaPT (Scheme 1).15 By using HPLC, only one
stereoisomer each was detected from the incubation mixtures with
thementioned prenyltransferases.MS, CDandNMRanalyses, in-
cluding nuclear overhauser effect spectroscopy (NOESY), showed
clearly that all of the isolated products of AnaPT reactions carried
an a-configured C3-dimethylallyl moiety. To expand the usage of
prenyltransferases for chemoenzymatic synthesis, we identified an
additional cyclic dipeptide C3-prenyltransferase (CdpC3PT) gene
from the genome sequence of Neosartorya fischeri. In contrast to
those of AnaPT, the products of CdpC3PT bear b-configured C3-
dimethylallyl residues. Here, we report the gene cloning, protein
overproduction and biochemical investigation of CdpC3PT.
Results and discussion
In the course of our investigation on indole prenyltrans-
ferases, one putative gene NFIA_074280 from the genome
sequence of Neosartorya fischeri NRRL181 raised our atten-
tion. NFIA_074280 spans bp 569563-570866 of DS027696.1
in GenBank. Its deduced product, EAW17508, comprises 423
amino acids and showed significant sequence similarity to
known indole prenyltransferases.17,18 NFIA_074280 and a putative
2430 | Org. Biomol. Chem., 2010, 8, 2430–2438 This journal is © The Royal Society of Chemistry 2010
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Scheme 1 Preparation of C3-prenylated pyrrolo[2,3-b]indoles by using recombinant prenyltransferases.
Fig. 1 Examples of C3-prenylated pyrrolo[2,3-b]indoles.
non-ribosomal peptide synthetase (NRPS) gene NFIA_074300
are separated from each other by only 3.9 kb (Fig. 2) and could
therefore belong to a same gene cluster for a secondarymetabolite.
The deduced product of NFIA_074300, EAW17510, showed
a similar domain structure as the cyclic dipeptide synthetase
FtmPT1 (brevianamide F synthetase) involved in the biosynthesis
of fumitremorgins,19 i.e. ATCATC (A: adenylation; T: thiolation
and C: condensation), and could therefore be responsible for
the formation of a cyclic dipeptide. Thus, we speculated that
EAW17508 would function as a cyclic dipeptide prenyltransferase.
By sequence comparison and analysis, it was neither possible to
propose the natural substrate for the putative prenyltransferase,
nor its prenylation pattern, i.e. regular or reverse, or prenylation
position at the indole ring. The end product encoded by this
cluster is also unknown. One putative cytochrome P450 oxi-
doreductase gene NFIA_074290 is located between the putative
prenyltransferase geneNFIA_074280 and the putativeNRPS gene
NFIA_074300. Orthologous genes, i.e. pc21g15430, pc21g15470
and pc21g15480, with sequence identities of 67, 60 and 59%
on the amino acid level to NFIA_074280, NFIA_074290 and
NFIA_074300, respectively, have been identified in the genome
sequence of Penicillium chrysogenum (Fig. 2).20 Three additional
genes pc21g15440, pc21g15450 and pc21g15460 are located be-
tween pc21g15430 and pc21g15470, indicating that the product
encoded by the cluster from P. chrysogenum is very likely different
from that in N. fischeri.
To prove the function of EAW17508, i.e. CdpC3PT, the
coding region of NFIA_074280 was amplified by homologous
recombinant DNA technique through three rounds PCR.1,21 The
PCR fragment consisting exclusively of the two exons was cloned
via pGEM-T easy vector into pQE60 to create the expression
construct pWY25 (see Experimental section). Soluble proteins
were obtained from transformants of E. coli cells harbouring
pWY25 after 6 h induction by 0.5 mM of IPTG at 37 ◦C. His6-
CdpC3PTwas purifiedwithNi-NTAagarose to near homogeneity
as judged by SDS-PAGE (Fig. 3) and a protein yield of 7 mg of
purified His6-tagged CdpC3PT per litre of cultures was obtained.
A major protein band with migration near the 45 kDa size marker
was observed, which corresponded well to the calculated value of
47.6 kDa for His6-CdpC3PT.
In analogy to AnaPT,15 the purified CdpC3PT (1.3 mM)
was incubated with five tryptophan-containing cyclic dipeptides
(1a–1d and 1f) (1 mM) in the presence of DMAPP (2 mM)
for different time. HPLC analysis of the incubation mixtures
(Fig. 4) showed that all of the five substrates were accepted by
This journal is © The Royal Society of Chemistry 2010 Org. Biomol. Chem., 2010, 8, 2430–2438 | 2431
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Fig. 2 Putative clusters containing cdpC3PT and its orthologue from Neosartorya fischeri (A) and Penicillium chrysogenum (B).
Fig. 3 Purification of CdpC3PT as a His6-tagged protein. The 12% (w/v)
SDS polyacrylamide gel was stained with Coomassie brilliant blue G-250.
Lanes 1: molecular mass standard; 2: total protein before induction; 3:
total protein after induction; 4: purified His6- CdpC3PT.
CdpC3PT. In all the cases, product formation has been clearly
observed already after incubation for 1 h (Fig. 4) and was
dependent on the presence of active protein and DMAPP (data
not shown). Increasing of product formation with extension of
incubation time has also been observed. After incubation for 24 h,
conversion rates of 31, 12, 6, 30 and 37% were determined for
cyclo-L-Trp-L-Leu (1a), cyclo-L-Trp-L-Trp (1b), cyclo-L-Trp-L-Phe
(1c), cyclo-L-Trp-L-Tyr (1d) and cyclo-L-Trp-Gly (1f), respectively,
which were calculated from the 1H-NMR signal intensity of
the enzymatic products and remained respective substrate in the
reaction mixtures (see Experimental section). One product peak
each was detected for 1a, 1c, 1d and 1f (Fig. 4). In the HPLC
chromatogram of the incubation mixture of 1b (Fig. 4), two
product peaks have been observed.
For structure elucidation, the enzymatic products were isolated
on a preparative scale and substances in the range of 0.2–1mgwere
subjected to high resolutionESI-MSandNMRanalyses.HR-ESI-
MS (Table 1) confirmed the presence of one dimethylallylmoiety in
the structures of 3a–3d and 3f by detection of [M+1]+ or [M+Na]+
ions, which are 68 daltons larger than those of the respective
substrates. The assignments of theNMRdata listed inTable 2were
Table 1 HR-ESI-MS data of the enzymatic products
HR-ESI-MS data Deviation
Comp.
Chemical
Formula Calculated Measured ppm
3a C22H29N3O2 368.2338 [M+1]+ 368.2362 6.5
3b C27H28N4O2 441.2291 [M+1]+ 441.2308 3.9
3c C25H27N3O2 402.2182 [M+1]+ 402.2216 8.4
3d C25H27N3O3 418.2131 [M+1]+ 418.2112 4.5
3f C18H21N3O2 334.1531 [M+Na]+ 334.1540 2.7
4b C32H36N4O2 509.2917 [M+1]+ 509.2920 0.6
verified by analysing the 1H-13C heteronuclear single-quantum
correlation (HSQC) and heteronuclear multiple bond correlation
(HMBC) spectra (Figures S1–S6, ESI†). Comparison of the 1H-
NMR data of the isolated products 3a–3d and 3f (Table 2) with
those of the respective substrates (data not shown) revealed clearly
the presence of signals for a reverse dimethylallyl moiety in the
spectra of the isolated compounds at 5.08–5.14 (d or dd) for H-1¢,
5.95–5.98 (dd) for H-2¢, 1.00–1.01 ppm (s) for H-4¢ and 1.11–1.13
(s) for H-5¢, respectively. The signals of H-2 were strongly upfield
shifted from approximately 7.0–7.2 in the spectra of the substrates
to 5.50–5.56 ppm in the spectra of the enzymatic products (Figures
S1–S6, ESI†). This indicated that the prenylation has very likely
taken place at position C3 of the cyclic dipeptides and pyrrolo[2,3-
b]indole derivatives were formed during the enzymatic reactions.
Cross peaks in the HSQC spectra of 3a–3d and 3f revealed that
the singlets of H-2 at 5.5 ppm correlated with the signals of C-2 at
77.5–77.6 ppm, proving the disappearance of the double bonds
between C-2 and C-3 of the indole rings in the structures of
3a–3d and 3f. HMBC spectra showed clear connectivity from H-2
to C-11, which is conducted by the formation of a chemical bond
between C-2 and N-12 of the diketopiperazine ring. Furthermore,
HMBC spectra showed strong connectivities from H2 to C3¢, H4¢
to C3, and H5¢ to C3. These results proved that the structures of
3a–3d and 3f are indeed C3-prenylated indolines with a fused five-
membered ring between the indoline and diketopiperazine ring.
This means that CdpC3PT catalysed, in analogy to AnaPT,15 the
reverse C3-prenylation of tryptophan-containing cyclic dipeptides
and meanwhile the formation of a pyrrolo[2,3-b]indole structure.
The 1H-NMR spectra and the assigned chemical shifts of 3a–3d
and 3f (Table 2) are similar to those of 2a–2d and 2f (Scheme 1)
reported previously.15 Without considering the NOESY spectra,
however, clear differences of chemical shifts were found for H-
2 and H-10syn. The chemical shifts of H-2 in 3a–3d and 3f were
detected at approximately 5.5 ppm, while those of 2a–2d and 2f
with a-configured C3-prenyl moieties at approximately 5.4 ppm.15
The chemical shifts of H-10syn in 3a–3d and 3f are found from 2.52
to 2.56 ppm, about 0.3 ppm upfield shifted in comparison to those
of 2a–2d and 2f at 2.79 to 2.84 ppm.15 These data indicated that the
structures of 3a–3d and 3f differ from those of 2a–2d and 2f very
likely by different configurations at C-2 and C-3 of the indoline
rings.
Unambiguous proof of the stereochemistry was provided by
NOESY experiments for 3a–3d and 3f (Table 3). Strong NOE
correlations between H-2 and the protons of the prenyl moiety,
i.e. H-2¢, H-4¢and H-5¢, proved the cis-configuration between H-2
and C3-prenyl moieties of the indoline rings.
For compounds 3a–3d and 3f, only very weak NOE correlation
was observed between H-2 and H-11. In the cases of 2a–2d and
2f, the NOE correlation for these protons was determined as
2432 | Org. Biomol. Chem., 2010, 8, 2430–2438 This journal is © The Royal Society of Chemistry 2010
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Fig. 4 HPLC chromatograms of incubationmixtures of five tryptophan–
containing cyclic dipeptides with recombinant CdpC3PT. Detection was
carriedwith a diode array detector and illustrated for absorption at 254 nm.
medium. Moreover, H-10anti in 3a–3d and 3f instead of H-
10syn in 2a–2d and 2f,15 showed medium or strong NOE
correlations with protons of the prenyl moiety (Table 3). H-10syn
in 3a–3d and 3f as well as 2a–2d and 2f showed strong correlation
with H-11. The correlations observed for 2a–2d and 2f between
H-11 and those of the prenyl group were not detected in 3a–3d
and 3f. From the results of NOE correlations, we concluded that
H-2 and C3-prenyl moiety must be substituted on the opposite
side to H-11. This demonstrated that, in contrast to 2a–2d and
2f, 3a–3d and 3f carry b-configured C3-dimethylallyl moieties
as illustrated in Table 2 and Scheme 1. The steric hindrance of
the b-configured prenyl residue makes the indoline ring bend in
opposite direction and causes a spatial proximity between H4
and H10syn. This is confirmed by the observation of strong NOE
correlation between these two protons (Table 3).
The NMR data of 3a and 3c corresponded also well to
those reported for brevicompanine B22 and rugulosuvine A,23
respectively.
The second product peak 4b of cyclo-L-Trp-L-Trp (1b) (Fig. 4)
was also isolated by repeated chromatography and subjected to
MS analysis. The positive HR-ESI-MS of 4b showed an ion at
m/z 509.2920 (Table 1), which could be interpreted as [M+1]+ of a
diprenylated derivative with a molecular mass 136 daltons larger
than that of the substrate.
The 1H-NMR spectrum of 4b showed signals of two identical
tryptophanyl moieties, which are reversely prenylated at position
C3 of the indoline rings. C3-diprenylated derivatives of cyclo-
L-Trp-L-Trp containing two pyrrolo[2,3-b]indole systems have
been reported, e.g. amauromine (Fig. 1) from Amauroascus sp13
and epiamauromine (Fig. 1) from Aspergillus ochraceus.14 1H-
NMR data of 4b (Table 2) corresponded perfectly to those of
amauromine,13 indicating that 4b has an identical structure as
amauromine or both compounds are enantiomers. The absolute
configuration of 4b was not determined in this study. However, it
can be expected that the symmetrical 4b was formed by a second
prenylation and cyclisation of 3b under the catalysis of CdpC3PT
(Scheme 1). Therefore, both tryptophanyl moieties must have the
same configuration as in 3b. Therefore, 4b and amauromine have
same configuration as illustrated in Fig. 1 and Scheme 1.
The results provided in this study proved that both AnaPT and
CdpC3PT catalyse the formation of indoline derivatives carrying
fused five-membered rings with a cis-configuration. However,
they introduced the ring system from opposite sides. Similar as
observed with AnaPT,15,16 the reaction catalysed by CdpC3PT
includes at least three steps, i.e. attachment of a reverse prenyl
moiety to C3 of the indole ring, breaking of the double bond
between C2 and C3 and the formation of a C–N bond between C2
and N12. The detailed mechanism of this reaction is unknown.
As proposed for AnaPT,15 it can be speculated that attacking of
dimethylallyl cation via its C3¢ to C3 of the indole ring of the cyclic
dipeptides would result in formation of an intermediate with a
positive charge at C2. Formation of a C–N bond between C2 and
N12 would lead to an intermediate with positive charge at N12,
which is to be converted to the enzymatic products by releasing of
a proton.
After structure elucidation of the enzymatic products,
CdpC3PT was characterised biochemically. For determination
of the dependence of the CdpC3PT activity on metal ions,
incubations of 1awithDMAPPwere carried out in the presence of
different metal ions at a final concentration of 5 mM. Incubations
with EDTA at a final concentration of 5 mM and without
additives were used as controls. Our results showed that product
This journal is © The Royal Society of Chemistry 2010 Org. Biomol. Chem., 2010, 8, 2430–2438 | 2433
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Table 3 NOE results of C3-prenylated pyrrolo[2,3-b]indoles (with an
exception for 4b)
Protons Strength
H-2 to H-1¢ Weak
H-2 to H-2¢ Strong
H-2 to H-4¢ Strong
H-2 to H-5¢ Strong
H-2 to H-11 Weak
H-10anti to H-1¢ Weak
H-10anti to H-2¢ Medium
H-10anti to H-4¢ Strong
H-10anti to H-5¢ Strong
H-10anti to H-11 Medium
H-10syn to H-11 Strong
H-10syn to H-4 Strong
H-11 to H-2¢ Not observed
H-11 to H-4¢ Not observed
H-11 to H-5¢ Not observed
Table 4 Preliminary parameters of the tested substratesa
Substrate KM/mM kcat/s-1 kcat/KM/M-1 s-1
1a 2.1 0.085 40.5
1b 0.35 0.023 65.7
1c 0.22 0.027 122.7
1d 1.5 0.06 40.0
1f 5.5 0.078 14.2
DMAPPb 1.4 0.098 70.0
DMAPPc 1.6 0.035 21.9
a Due to low solubility, the aromatic substrates were only tested up to 1mM
(1b–1d) or 5 mM (1a and 1f). b 1a as aromatic substrate. c 1b as aromatic
substrate.
formation was independent of the presence of metal ions. Even in
the presence of the chelating agent EDTA, no decreasing of the
enzyme activity was detected, in comparison to that of incubation
without additives. This finding correspondedwell to the behaviour
of other known prenyltransferases.17,18 The enhancing effect of
Ca2+ on the activity of CdpC3PT seems stronger than other
prenyltransferases. Addition of Ca2+, Mg2+ and Mn2+ to the
reaction mixtures increased the enzyme activity to 400, 240 and
220% of that without additives, respectively.
For comparison of the behaviour of CdpC3PT towards the
cyclic dipeptides, kinetic parameters were determined forDMAPP
and all of the five aromatic substrates by incubation with
CdpC3PT at 37 ◦C for 30 min. For this purpose, the dependence
of the product formation on incubation time had been proven and
found to be linear up to 30 min for 1a, nearly linear up to 30 min
for 1b and 45 min for 1c, 1d and 1f (see please Figure S7, ESI†).
Michaelis–Menten constants (KM) as well as the turnover numbers
(kcat) were determined by Hanes-Woolf analysis and are given in
Table 4. The obtained values were also confirmed by Lineweaver–
Burk and Eadie-Hofstee analyses.
Using 1a and 1b as aromatic substrates, comparable KM values
for DMAPP were determined at 1.4 and 1.6 mM, respectively,
which are much higher than the KM values of other cyclic
dipeptide prenyltransferases for DMAPP, e.g. FtmPT1 at 56 mM24
and AnaPT at 156 mM.1 However, the natural substrates were
used for determination of kinetic parameters of FtmPT1 and
AnaPT. In the case of CdpC3PT, the natural substrate is still
unknown. 1b and 1c were found to have similar KM values of
0.35 and 0.22 mM and turnover numbers of 0.023 and 0.027 s-1,
respectively (Table 4). 1a, 1d and 1f with KM values of 2.1, 1.5
and 5.5 mM, respectively, showed much lower affinity towards
CdpC3PT than 1b and 1c. Interestingly, the turnover numbers of
these three substrates were two- to three-fold of those of 1b and
1c. Consequently, CdpC3PT showed similar catalytic efficiency
towards 1a, 1b and 1d with specificity constants kcat/KM of 40.5,
65.7 and 40 M-1 s-1, respectively. Using 1c as substrate, CdpC3PT
was found to have the best catalytic efficiency with a specificity
constant of 122.7 M-1 s-1. This value is however only 1.9% of
that of AnaPT at 6522 M-1 s-1 determined by using its natural
substrates DMAPP and (R)-benzodiazepinedinone.1
Conclusions
In this study, we described the cloning and biochemical in-
vestigation of a new indole prenyltransferase CdpC3PT, which
catalysed the reverse prenylation of cyclic dipeptides at position
C3 of the indole ring. Similar to AnaPT from the biosynthetic
gene cluster of acetylaszonalenin1 from the same fungus, i.e.
N. fischeri NRRL181, CdpC3PT showed also broad substrate
specificity and accepted all of the five tryptophan-containing
cyclic dipeptides tested. Both AnaPT and CdpC3PT catalysed
the formation of a five-membered ring between the original
indole and diketopiperazine ringswith a cis-configuration between
H-2 and C3-dimethylallyl moiety. However, they introduce the
prenyl moiety from different sides, i.e. AnaPT from behind and
CdpC3PT from the front, so that two compounds with different
stereochemistry at position C2 and C3 could be obtained from
one substrate. They are therefore complement to each other
regarding the prenylation and expand their potential to be used
for chemoenzymatic synthesis.
Experimental section
Chemicals
Dimethylallyl diphosphate was prepared according to the method
described for geranyl diphosphate by Woodside.25 Cyclo-L-Trp-
L-Leu (1a), cyclo-L-Trp-L-Trp (1b), cyclo-L-Trp-L-Phe (1c), cyclo-
L-Trp-L-Tyr (1d) and cyclo-L-Trp-Gly (1f) were purchased from
Bachem (Bubendorf, Switzerland).
Bacterial strains, plasmids and cultural conditions
pGEMT easy vector and pQE60 were obtained from Promega
(Mannheim, Germany) and Qiagen (Hilden, Germany), respec-
tively.
Escherichia coli XL1 Blue MRF¢ (Stratagene) was used for
cloning and over expression experiments and grown in liquid or
on solid Luria-Bertani medium with 1.5% (w/v) agar at 37◦ C.26
Carbenicillin (50 mg mL-1) was used for selection of recombinant
E. coli strains.
Neosartorya fischeri NRRL181 was kindly provided by ARS
Culture Collection (Peoria, Illinois USA).
Cultivation of N. fischeri and DNA isolation
For DNA isolation, mycelia of N. fischeri from plates were
inoculated into 300 mL Erlenmeyer flask containing 100 mL YES
This journal is © The Royal Society of Chemistry 2010 Org. Biomol. Chem., 2010, 8, 2430–2438 | 2435
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media consisting of yeast extract (0.6% (w/v)), sucrose 0.2% (w/v)
(pH 5.8) and cultivated at 30 ◦C and 170 rpm for 48 h. DNA
isolation fromN. fischeriwas carried out according to the protocol
described by Ausubel et al.27
DNA isolation, PCR amplification and gene cloning
Standard procedures for DNA isolation and manipulation were
performed as described.26
PCR amplification was carried out on an iCycler from BioRad
(Munich, Germany). The entire coding sequence of cdpC3PT
was obtained after three rounds PCR amplification by using
genomic DNA as template and Expand High Fidelity Kit (Roche
Diagnostics GmbH, Mannheim, Germany). The first round PCR
is used for amplification of the two exons. The primers for the first
exon were CdpC3PT_a1 (5¢-TCGTCTGATAAACCTCATCCT-
3¢) at the 5¢-end and CdpC3PT_a2 (5¢- TCTGTGGCAATAGC-
CAAGTCCTCGCCAGGGTAATATGATTG CAGATTCTCC-
3¢) at the 3¢-end. The primers for the second exon
were CdpC3PT_b1 (5¢- GGGTCTACCCGGAGAATCTGCAAT-
CATATTACCCTGGCGAGGACTTGGCT-3¢) at the 5¢-end and
CdpC3PT_b2 (5¢- AACAGGAAGGCACTAATAAGC-3¢) at the
3¢-end. Bold letters represent overlapping region of the two exons.
The PCR products of the first and second exon were mixed in
a molar ratio of 1 : 1 and used as template for a second round
of PCR to get a fragment consisting of the two exons with help
of the overlapping region. A third round PCR was then carried
out by using a nested primer pair and the PCR product from the
second round as template. The nested primers are CdpC3PT_for
(5¢-ATTCCATGGCAGTGTCGTCGACCG-3¢) at the 5¢-end and
CdpC3PT_rev (5¢-GAAGATCTGTGGTAGTACATGGTCA-3¢)
at the 3¢-end of the gene. Bold letters represent mutations inserted
in comparison to the original genome sequence to give the
underlined restriction sites NcoI located in the start codon in
CdpC3PT_for and BglII located in the predicted stop codon
in CdpC3PT_rev, respectively. A PCR fragment of 1286 bp
containing the entire coding sequence of cdpC3PT could be
amplified after the third round PCR. The PCR fragment was
cloned into pGEMT easy vector resulting in plasmid pWY24,
which was subsequently sequenced (Eurofins MWG Operon,
Ebersberg, Germany) to confirm the sequence. To create the
expression vector pWY25, pWY24 was digested with NcoI and
BglII and the resulted NcoI-BglII fragment of 1278 bp was ligated
into pQE60, which had been digested with the same enzymes,
previously.
Overproduction and purification of His6-CdpC3PT
For cdpC3PT expression,E. coliXL1BlueMRF¢ cells harbouring
the plasmid pWY25 were cultivated in 300 mL Erlenmeyer flasks
containing 100 mL liquid Luria-Bertani medium supplemented
with carbenicillin (50mgmL-1) andgrownat 37 ◦Ctoanabsorption
at 600 nm of 0.6. For induction, isopropyl thiogalactoside (IPTG)
was added to a final concentration of 0.5 mM and the cells were
cultivated for further 6 h at 37 ◦C before harvest. The bacterial
cultures were centrifuged and the pellets were resuspended in
lysis buffer (10 mM imidazole, 50 mM NaH2PO4, 300 mM
NaCl, pH 8.0) at 2–5 mL per gram wet weight. After addition
of 1 mg mL-1 lysozyme and incubation on ice for 30 min,
the cells were sonicated 6 times for 10 s each at 200 W. To
separate the cellular debris from the soluble proteins, the lysate
was centrifuged at 13,000 x g for 30 min at 4 ◦C. One-step
purification of the recombinant His6-tagged fusion protein by
affinity chromatography with Ni-NTA agarose resin (Qiagen,
Hilden,Germany)was carried out according to themanufacturer’s
instructions. The protein was eluted with 250 mM imidazole in
50 mM NaH2PO4, 300 mM NaCl, pH 8.0. In order to change the
buffer, the protein fraction was passed through a NAP-5 column
(GEHealthcare, Freiburg,Germany),whichhadbeen equilibrated
with 50 mM Tris-HCl, 15% (v/v) of glycerol, pH 7.5, previously.
CdpC3PT was eluted with the same buffer and stored frozen at
-80 ◦C for enzyme assays.
Protein analysis and determination of molecular mass of active
His6-CdpC3PT
Proteins were analysed by SDS-PAGE according to the method of
Laemmli28 and stained with Coomassie brilliant blue G-250.
The molecular mass of the recombinant His6-CdpC3PT was
determined by size exclusion chromatography on a HiLoad 16/60
Superdex 200 column (GE Health Care, Freiburg, Germany),
which had been equilibrated with 20 mMTris-HCl buffer (pH 7.5)
containing 150 mM NaCl. The column was calibrated with
dextran blue 2000 (2000 kDa), ferritin (440 kDa), aldolase
(158 kDa), conalbumin (75 kDa), carbonic anhydrase (29 kDa)
and ribonuclease A (13.7 kDa) (GE Health Care, Freiburg,
Germany). The proteins were eluted with 20 mM Tris-HCl buffer
(pH 7.5) containing 150 mM NaCl. The molecular mass of the
recombinant His6-CdpC3PT was determined as 130 kDa. This
indicated that CdpC3PT acts likely as a homotrimer.
Assay for CdpC3PT activity
For quantitative determination of the enzyme activity, the reaction
mixture (100 mL) contained 50 mM Tris-HCl (pH 7.5), 5 mM
CaCl2, 1 mM aromatic substrates, 1 mM DMAPP, 1.5% (v/v)
glycerol, and 0.07 mM of purified recombinant CdpC3PT. The
reaction mixtures were incubated at 37 ◦C and the reactions were
terminated by addition of 100 ml methanol per 100 ml reaction
mixtures. The protein was removed by centrifugation at 13,000 x g
for 20min. The enzymatic products were analysed byHPLCunder
conditions described below. For quantitative measurement of the
enzyme activity, duplicate values were determined routinely. For
determination of kinetic parameters of DMAPP, cyclic dipeptides
at 1 mM, DMAPP at final concentrations of 0.0, 0.16, 0.40, 0.81,
1.62 and 4.05 mM were used as substrates. For determination
of the kinetic parameters of cyclic dipeptides, DMAPP at a
final concentration of 5 mM was used. Due to low solubility,
concentrations of 1a and 1f up to 5.0 mM and 1b–1d up to 1 mM
were used.
Quantification of the enzymatic products
For quantification of the enzymatic products, CdpC3PT was
incubated in a large scale (10mL) containing each of the five cyclic
dipeptides (1 mM), DMAPP (2 mM), CaCl2 (5 mM), Tris-HCl
(50 mM, pH 7.5), glycerol 1.5% (v/v) and CdpC3PT (2 mg). The
reaction mixtures were extracted after incubation at 37 ◦C for 24 h
with ethyl acetate. After evaporation of the solvent, the residues of
2436 | Org. Biomol. Chem., 2010, 8, 2430–2438 This journal is © The Royal Society of Chemistry 2010
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the ethyl acetate phase containing both enzymatic products and
substrates were subjected to 1H-NMR analysis. The conversion
rate of a given substrate was determined by comparison of the
integrals of the enzymatic product and the remained substrate in
1H-NMR spectra. The absorption coefficients of the enzymatic
products were then calculated by HPLC analysis of the samples
after NMR analysis.
Preparative synthesis of enzymatic products for structure
elucidation
The NMR samples for quantification of the enzymatic products
were then purified onHPLC under the conditions described below
for structure elucidation. The isolated products were subjected to
1H-NMR, 13C-NMR, 1H-1H COSY, 1H-13C HSQC and HMBC as
well as high resolution electrospray ionization mass spectrometry
(HR-ESI-MS).
HPLC conditions for analysis and isolation of enzymatic products
of CdpC3PT
The enzymatic products of the incubation mixtures of CdpC3PT
were analysed by HPLC on an Agilent series 1200 by using a
LiChrospher RP 18-5 column (125 ¥ 4 mm, 5 mm, Agilent) at a
flow rate of 1 mL min-1. Water (solvent A) and methanol (solvent
B) were used as solvents. For analysis of enzymatic products, linear
gradients of 50–80% (v/v) solvent B in 10 min and then of 80–
100% (v/v) solvent B in 5 min were used. The column was then
washed with 100% solvent B for 5 min and equilibrated with 50%
(v/v) solvent B for 5 min. Detection was carried out by a Photo
Diode Array detector and illustrated at 254 nm in the figures in
this paper.
For isolation, the same HPLC equipment with a Multospher
120 RP-18 column (250 ¥ 10 mm, 5 mm, C+S Chromatographie
Service, Langenfeld, Germany) was used. Linear gradients of 50–
80% (v/v) solvent B in 10 min and then of 80–100% (v/v) solvent
B in 5 min at a flow rate of 2.5 mL min-1 were used. The column
was then washed with 100% solvent B for 5 min and equilibrated
with 50% (v/v) solvent B for 5 min.
NMR experiments
Small amount (less than 1 mg) of each sample was dissolved in
0.2 mL of CDCl3. Samples were filled into Wilmad 3 mm tubes
fromRototec Spintec. Spectra were recorded at room temperature
on a Bruker Avance 600 MHz spectrometer equipped with an
inverse probewith z-gradient. TheHSQCandHMBCspectrawere
recorded with standard methods.29 Gradient-selected NOESY
experiment30 was performed in phase-sensitive mode. For all two-
dimensional spectra, 32 to 64 transients were used. For NOESY
spectra, a mixing time of 1.5 s and a relaxation delay of 3.0 s. 1H
spectra were acquired with 65 536 data points, while 2D spectra
were collected using 4096 points in the F 2 dimension and 512
increments in the F 1 dimension. Typical experiment time for the
HMBC and NOESY measurements was about 12 h. Chemical
shifts were referenced to CDCl3. All spectra were processed with
Bruker TOPSPIN 2.1.
Mass spectrometry
The isolated products were analysed by HR-ESI-MS with a Q-
Trap Quantum (Applied Biosystems).Positive HR-ESI-MS data
of the enzymatic products are given in Table 1.
Nucleotide sequence accession number
The nucleotide sequence of the genomic DNA from Neosartorya
fischeri NRRL181 reported in this study is available at GenBank
under accession number DS027696. The coding sequence of
cdpC3PT is available at GenBank under the name NFIA_074280.
Acknowledgements
This work was supported by a grant from the LOEWE program
des Landes Hessen (SynMikro to S.-M. Li). Xie acknowledges
the Deutsche Forschungsgemeinschaft for funding the Bruker
AVANCE 600 spectrometer. Xia Yu is a recipient of a fellowship
from China Scholarship Council.
References
1 W.-B. Yin, A. Grundmann, J. Cheng and S.-M. Li, J. Biol. Chem., 2008,
284, 100–109.
2 J. P. Karwowski, M. Jackson, R. R. Rasmussen, P. E. Humphrey, J. B.
Poddig, W. L. Kohl, M. H. Scherr, S. Kadam and J. B. McAlpine,
J. Antibiot. (Tokyo), 1993, 46, 374–379.
3 Y. Kimura, T. Hamasaki, H. Nakajima and A. Isogai, Tetrahedron
Lett., 1982, 23, 225–228.
4 C. Rank, R. K. Phipps, P. Harris, J. C. Frisvad, C. H. Gotfredsen and
T. O. Larsen, Tetrahedron Lett., 2006, 47, 6099–6102.
5 P. M. Scott and B. P. C. Kennedy, J. Agric. Food Chem., 1976, 24,
865–868.
6 T. Rundberget, I. Skaar and A. Flaoyen, Int. J. Food Microbiol., 2004,
90, 181–188.
7 C. Finoli, A. Vecchio, A. Galli and I. Dragoni, J. Food Prot., 2001, 64,
246–251.
8 R. P. Hodge, C. M. Harris and T. M. Harris, J. Nat. Prod., 1988, 51,
66–73.
9 K. Arai, K. Kimura, T. Mushiroda and Y. Yamamoto, Chem. Pharm.
Bull., 1989, 37, 2937–2939.
10 A. G. Kozlovsky, V. M. Adanin, H. M. Dahse and U. Gra¨fe, Appl.
Biochem. Microbiol., 2001, 37, 253–256.
11 M. Kusano, G. Sotoma, H. Koshino, J. Uzawa, M. Chijimatsu, S.
Fujioka, T. Kawano and Y. Kimura, J. Chem. Soc., Perkin Trans. 1,
1998, 2823–2826.
12 K. Sprogoe, S. Manniche, T. O. Larsen and C. Christophersen,
Tetrahedron, 2005, 61, 8718–8721.
13 S. Takase, Y. Kawai, I. Uchida, H. Tanaka and H. Aoki, Tetrahedron
Lett., 1984, 25, 4673–4676.
14 F. S. De Guzman and J. B. Glober, J. Nat. Prod., 1992, 55, 931–939.
15 W.-B. Yin, X.-L. Xie,M.Matuschek and S.-M. Li,Org. Biomol. Chem.,
2010, 8, 1133–1141.
16 W.-B. Yin, J. Cheng and S.-M. Li, Org. Biomol. Chem., 2009, 7, 2202–
2207.
17 N. Steffan, A. Grundmann, W.-B. Yin, A. Kremer and S.-M. Li, Curr.
Med. Chem., 2009, 16, 218–231.
18 S.-M. Li, Phytochemistry, 2009, 70, 1746–1757.
19 S. Maiya, A. Grundmann, S.-M. Li and G. Turner, ChemBioChem,
2006, 7, 1062–1069.
20 M. A. van den Berg, R. Albang, K. Albermann, J. H. Badger, J. M.
Daran, A. J. Driessen, C. Garcia-Estrada, N. D. Fedorova, D. M.
Harris, W. H. Heijne, V. Joardar, J. A. Kiel, A. Kovalchuk, J. F. Martin,
W. C. Nierman, J. G. Nijland, J. T. Pronk, J. A. Roubos, d. K. van,
I. N. N. van Peij, M. Veenhuis, H. von Dohren, C. Wagner, J. Wortman
and R. A. Bovenberg, Nat. Biotechnol., 2008, 26, 1161–1168.
21 J. H. Yu, Z. Hamari, K. H. Han, J. A. Seo, Y. Reyes-Dominguez and
C. Scazzocchio, Fungal Genet. Biol., 2004, 41, 973–981.
This journal is © The Royal Society of Chemistry 2010 Org. Biomol. Chem., 2010, 8, 2430–2438 | 2437
D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f M
ar
bu
rg
 o
n 
04
 A
pr
il 
20
11
Pu
bl
ish
ed
 o
n 
22
 M
ar
ch
 2
01
0 
on
 h
ttp
://
pu
bs
.rs
c.
or
g 
| do
i:1
0.1
039
/C0
005
87H
View Online
66
22 L. Du, X. Yang, T. Zhu, F. Wang, X. Xiao, H. Park and Q. Gu, Chem.
Pharm. Bull., 2009, 57, 873–876.
23 J. H. Chang and H.Moon, Biotechnol. Bioprocess Eng., 2004, 9, 59–61.
24 A. Grundmann and S.-M. Li, Microbiology, 2005, 151, 2199–2207.
25 A. B. Woodside, Z. Huang and C. D. Poulter, Org. Synth., 1988, 66,
211–215.
26 J. Sambrook, and D. W. Russell, Molecular Cloning: a Laboratory
Manual, Cold Spring Harbor Laboratory Press, New York, 2001.
27 F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman,
J. A. Smith, and K. Struhl, Current Protocols in Molecular Biology,
John Wiley and Sons Inc, New York, 1996.
28 U. K. Laemmli, Nature, 1970, 227, 680–685.
29 S. Berger, and S. Braun, 200 and More NMR Experiments. A Practical
Course, Weiley-VCH, Weinheim, Germany, 2004.
30 T.-L. Hwang and A. J. Shaka, J. Am. Chem. Soc., 1992, 114, 3157–
3159.
2438 | Org. Biomol. Chem., 2010, 8, 2430–2438 This journal is © The Royal Society of Chemistry 2010
D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f M
ar
bu
rg
 o
n 
04
 A
pr
il 
20
11
Pu
bl
ish
ed
 o
n 
22
 M
ar
ch
 2
01
0 
on
 h
ttp
://
pu
bs
.rs
c.
or
g 
| do
i:1
0.1
039
/C0
005
87H
View Online
67
PRIVILEGED DOCUMENT FOR REVIEW PURPOSES ONLY
1
Electronic supporting information to:
Preparation of pyrrolo[2,3-b]indoles carrying a ß-configured 
reverse C3-dimethylallyl moiety by using a recombinant 
prenyltransferase CdpC3PT
Wen-Bing Yin,a,b,c Xia Yu,a,b Xiu-Lan Xie,d and Shu-Ming Li a,*
a Philipps-Universität Marburg, Institut für Pharmazeutische Biologie, 
Deutschhausstrasse 17A, D-35037 Marburg, Germany. Email: 
shuming.li@Staff.uni-Marburg.de, Tel: 0049-6421-2822461
Fax: 0049-6421-2825365
b These authors contributed equally to this work
c Present address: University of Wisconsin-Madison, Medical Microbiology and 
Immunology, 3455 Microbial Sciences Building, 1550 Linden Drive, Madison WI 53706, 
USA.
d Philipps-Universität Marburg, Fachbereich Chemie, Hans-Meerwein-Strasse, 35032 
Marburg, Germany.
68
PRIVILEGED DOCUMENT FOR REVIEW PURPOSES ONLY
2
Figure S1.1: 1H-NMR spectrum of 3a in CDCl3.
Figure S1.2: HSQC spectrum of 3a in CDCl3. The solvent signal is partially cut in the 1D projection 
for clarity.
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3
Figure S1.3: HMBC spectrum of 3a in CDCl3. The solvent signal is partially cut in the 1D projection 
for clarity.
Figure S1.4: NOESY spectrum of 3a in CDCl3. The solvent signal is partially cut in the 1D projection 
for clarity.
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Figure S2.1: 1H-NMR spectrum of 3b in CDCl3. The label X indicates signal of impurity.
Figure S2.2: HSQC spectrum of 3b in CDCl3. The label X indicates signal of impurity and the 
solvent signal is partially cut in the 1D projection for clarity.
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Figure S2.3: HMBC spectrum of 3b in CDCl3. The label X indicates signal of impurity and the 
solvent signal is partially cut in the 1D projection for clarity.
Figure S2.4: NOESY spectrum of 3b in CDCl3. The label X indicates signal of impurity and the 
solvent signal is partially cut in the 1D projection for clarity.
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Figure S3.1: 1H-NMR spectrum of 3c in CDCl3. The label X indicates signal of impurity.
Figure S3.2: HSQC spectrum of 3c in CDCl3. The label X indicates signal of impurity and the solvent 
signal is partially cut in the 1D projection for clarity.
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Figure S3.3: HMBC spectrum of 3c in CDCl3. The label X indicates signal of impurity and the 
solvent signal is partially cut in the 1D projection for clarity.
Figure S3.4: NOESY spectrum of 3c in CDCl3. The label X indicates signal of impurity and the 
solvent signal is partially cut in the 1D projection for clarity.
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Figure S4.1: 1H-NMR spectrum of 3d in CDCl3. The label X indicates signal of impurity.
Figure S4.2: HSQC spectrum of 3d in CDCl3. The label X indicates signal of impurity and the 
solvent signal is partially cut in the 1D projection for clarity.
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Figure S4.3: HMBC spectrum of 3d in CDCl3. The label X indicates signal of impurity and the 
solvent signal is partially cut in the 1D projection for clarity.
Figure S4.4: NOESY spectrum of 3d in CDCl3. The label X indicates signal of impurity and the 
solvent signal is partially cut in the 1D projection for clarity.
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Figure S5.1: 1H-NMR spectrum of 3f in CDCl3. The label X indicates signals of impurity.
Figure S5.2: HSQC spectrum of 3f in CDCl3. The label X indicates signals of impurity and the 
solvent signal is partially cut in the 1D projection for clarity.
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Figure S5.3: HMBC spectrum of 3f in CDCl3. The label X indicates signals of impurity and the 
solvent signal is partially cut in the 1D projection for clarity.
Figure S5.4: NOESY spectrum of 3f in CDCl3. The label X indicates signals of impurity and the 
solvent signal is partially cut in the 1D projection for clarity.
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Figure S6.1: 1H-NMR spectrum of 4b in CDCl3. The label X indicates signals of impurity.
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Figure S7: Time dependence of the product formation. The assay condition including components, 
substrate and enzyme concentrations as well as incubation temperature was identical to that for 
determination of the kinetic parameters
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Biochemical Characterization of Indole Prenyltransferases
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Background: Known indole prenyltransferases catalyzed regioselective prenylations at N-1, C-2, C-3, C-4, C-6, and C-7 of
the indole ring.
Results: Recombinant 5-DMATS was assayed with tryptophan and derivatives in the presence of DMAPP.
Conclusion: 5-DMATS prenylated indole derivatives at C-5.
Significance: 5-DMATS fills the last prenylation gap of indole derivatives and could be used as a potential catalyst for chemoen-
zymatic synthesis.
The putative prenyltransferase gene ACLA_031240 be-
longing to the dimethylallyltryptophan synthase superfamily
was identified in the genome sequence ofAspergillus clavatus
and overexpressed in Escherichia coli. The soluble His-tagged
protein EAW08391 was purified to near homogeneity and
used for biochemical investigation with diverse aromatic sub-
strates in the presence of different prenyl diphosphates. It has
shown that in the presence of dimethylallyl diphosphate
(DMAPP), the recombinant enzyme accepted very well sim-
ple indole derivatives with L-tryptophan as the best substrate.
Product formation was also observed for tryptophan-con-
taining cyclic dipeptides but with much lower conversion
yields. In contrast, no product formationwas detected in the reac-
tion mixtures of L-tryptophan with geranyl or farnesyl diphos-
phate. Structure elucidation of the enzyme products by NMR and
MS analyses proved unequivocally the highly regiospecific regular
prenylation atC-5 of the indole nucleus of the simple indole deriv-
atives. EAW08391 was therefore termed 5-dimethylallyltrypto-
phan synthase, and it filled the last gap in the toolbox of indole
prenyltransferases regardingtheirprenylationpositions.Kmvalues
of5-dimethylallyltryptophansynthaseweredetermined for L-tryp-
tophan and DMAPP at 34 and 76 M, respectively. Average turn-
over number (kcat) at 1.1 s1 was calculated from kinetic data of
L-tryptophan and DMAPP. Catalytic efficiencies of 5-dimethyl-
allyltryptophan synthase for L-tryptophan at 25,588 s1M1 and
for other 11 simple indole derivatives up to 1538 s1M1 provided
evidence for its potential usage as a catalyst for chemoenzymatic
synthesis.
Prenylated indole alkaloids represent a group of natural prod-
uctswith diverse chemical structures and arewidely distributed in
bacteria, fungi, plants, and marine organisms (1, 2). Because of
their impressive pharmacological and biological activities as drugs
or as toxins (1, 3), prenylated indole alkaloids attract the attention
of scientists from different scientific disciplines, including chem-
istry, ecology, biology, pharmacology, and biochemistry (1, 4–7).
These compounds are hybrid molecules containing prenyl moi-
eties derived fromprenyl diphosphates and indole or indoline ring
from tryptophan or its precursors (1, 5). Indole prenyltransferases
catalyze the connection of these two characteristic structural fea-
tures and contribute significantly to the structural diversity of the
prenylated indole alkaloids. Significantprogresshasbeenachieved
for molecular biological, biochemical, and structural biological
investigations on different prenyltransferase groups, including
indole prenyltransferases (1, 8, 9). By the end of October 2011, 20
indole prenyltransferases from bacteria and fungi have been char-
acterized biochemically (1, 10–15). These enzymes catalyzed the
transfer of prenyl moieties onto nitrogen or carbon atoms at the
indole ring resulting in formation of “regularly” or “reversely” pre-
nylated derivatives (15). More interestingly, indole prenyl-
transferases showed the usually broad substrate specificity
but catalyzed regiospecific prenylation at different positions
of indole or indoline rings (Fig. 1) (15). CymD from the
marine actinobacterium Salinispora arenicola catalyzed the
reverse prenylation at the indole nitrogen of L-tryptophan
(12), whereas FtmPT2 from the fungusAspergillus fumigatus
catalyzed the regular prenylation of 12,13-dihydroxyfumit-
remorgin C at this position (16). Regular and reverse C2-pre-
nylations were observed for FtmPT1 (17) and FgaPT1 (18),
both from A. fumigatus, respectively. Prenylations at C-3 of
cyclic dipeptides by AnaPT (19) and CdpC3PT (10), both
from the fungus Neosartorya fischeri, lead to the formation
of indoline derivatives with an - and -configured reverse
* This work was supported in part by Deutsche Forschungsgemeinschaft
Grant Li844/4-1 (to S.-M. L.) and by the Deutscher Akademischer
Austauschdienst within the Programme des Projektbezogenen
Personenaustauschs.
Thenucleotide sequence(s) reported in this paper hasbeen submitted to theGen-
BankTM/EBI Data Bank with accession number(s) XM_001269816.
□S This article contains supplemental Tables S1–S4 and Figs. S1–S14.
1 Recipient of a Ph.D. scholarship from the China Scholarship Council for
fellowships.
2 Recipient of a project-related person exchange program from the China
Scholarship Council for fellowships.
3 Towhomcorrespondence shouldbe addressed. Tel.: 49-6421-2822461; Fax:
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prenyl moiety, respectively. FgaPT2 and its orthologues
from different fungi represent the first pathway-specific
enzyme in the biosynthesis of ergot alkaloids and catalyzed
the regular prenylation of L-tryptophan at C-4 (3, 20). CpaD
from Aspergillus oryzae catalyzed regular C4-prenylation as
well but used cyclo-acetoacetyl-L-tryptophan as substrate
(21). IptA from a soil bacterium Streptomyces sp. was
reported to prenylate L-tryptophan at C-6 (13) and
7-DMATS4 from A. fumigatus at C-7 (22). An additional
4 The abbreviations used are: 7-DMATS, 7-dimethylallyltryptophan synthase;
DMAPP, dimethylallyl diphosphate; 5-DMATS, 5-dimethylallyltryptophan
synthase; HMBC, heteronuclear multiple-bond correlation spectroscopy;
FPP, farnesyl diphosphate; GPP, geranyl diphosphate.
FIGURE 1. Examples of indole prenyltransferases with different prenylation positions.
5-DMATS fromAspergillus clavatus
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example of C7-prenyltransferase is CTrpPT from A. oryzae,
which used cyclo-L-Trp-L-Trp as the best substrate (11).
In summary, indole prenyltransferases with regioselectivity
for N-1, C-2, C-3, C-4, C-6, and C-7 have already been identi-
fied and characterized in detail (Fig. 1). However, a prenyltrans-
ferase responsible for transferring a prenyl moiety to C-5 of the
indole ring has not been reported prior to this study. However,
database searching revealed the presence of a number of bio-
logically active indole alkaloids carrying a prenyl moiety at C-5
in nature (Fig. 2). These compounds include simple prenylated
indole derivatives like the antifungal compound 3,5-hexalobine
D from the plantHexalobus crispiflorus (23) or the brominated
tryptamine derivative flustramine D from the bryozoan Flustra
foliacea (24). Semicochliodinol A from the fungus Chrysospo-
riummerdarium (25) and petromurin B from the fungus Petro-
mycesmuricatus (26) are C5-prenylated indolyl benzoquinones
derived from two tryptophanmolecules (27). Semicochliodinol
A was reported to inhibit HIV-1 protease (25). C5-prenylated
derivatives were also found for tryptophan-containing cyclic
dipeptides like cyclo-L-Trp-L-Ala, e.g. echinulin from Aspergil-
lus strains (28) or tardioxopiperazine A from the fungus
Microascus tardifaciens (29). A relatively large indole alkaloid
group are the indole diterpenes fromPenicillium (30) and other
Ascomycetes (31). The members of this group carry prenyl
moieties at C-5 (21-isopentenylpaxilline) (32), C-6, or at both
positions (shearinine K) (30), or modified structures thereof.
The discrepancy between the natural occurrence of a large
number of C5-prenylated indole derivatives on the one hand
and undiscovered C5-prenyltransferases on the other hand
prompted us to search for such enzymes. In this study, we
reported the identification and characterization of the first
C5-prenyltransferase of indoles, i.e. 5-dimethylallyltryptophan
synthase (5-DMATS) from Aspergillus clavatus and its poten-
tial usage as a catalyst for chemoenzymatic synthesis.
EXPERIMENTAL PROCEDURES
Computer-assisted Sequence Analysis—Sequence identities
were obtained by alignments of amino acid sequences using the
program “BLAST 2 SEQUENCES” (www.ncbi.nlm.nih.gov).
FGENESH from Softberry and the DNASIS software package
(version 2.1, Hitachi Software Engineering, San Bruno, CA)
were used for exon prediction and sequence analysis,
respectively.
Chemicals—Dimethylallyl diphosphate (DMAPP), geranyl
diphosphate (GPP), and farnesyl diphosphate (FPP) were pre-
pared according to the method described for geranyl diphos-
phate by Woodside et al. (33). Indole derivatives of the highest
available purity were purchased from TCI, Acros Organics,
Aldrich, Sigma, Bachem, and Alfa Aesar.
Bacterial Strains, Plasmids, and Culture Conditions—
pGEM-T Easy and pQE70were obtained fromPromega andQia-
gen (Hilden, Germany), respectively. Escherichia coli XL1 Blue
MRF (Stratagene, Amsterdam, the Netherlands) and M15
[pREP4] (Qiagen) were used for cloning and expression experi-
ments, respectively.Theyweregrownin liquidTerrific-Broth (TB)
or Luria-Bertani (LB)medium and on solid LBmediumwith 1.5%
(w/v) agar at 37 or 22 °C. 50gml1 of carbenicillinwere used for
selection of recombinant E. coliXL1 BlueMRF strains. Addition
of carbenicillin at 50 gml1 and kanamycin at 25 gml1 was
used for selection of recombinant E. coliM15 [pREP4] strains.
Cultivation of A. clavatus, RNA Isolation, and cDNA
Synthesis—A. clavatusNRRL1 was kindly provided by Agricul-
tural Research Service Culture Collection, United States
Department of Agriculture, and was cultivated on solid YME
media consisting of 0.4% (w/v) yeast extract, 1% (w/v) malt
extract, 0.4% (w/v) glucose, pH 7.3, and 2% (w/v) agar at 26 °C.
For RNA isolation, mycelia of A. clavatus NRRL1 from plates
were inoculated into a 300-ml Erlenmeyer flask containing 100
ml of liquid YMEmedia and cultivated at 26 °C and 160 rpm for
7 days. After separation of mycelia from the medium, RNAwas
isolated by using the High Pure RNA isolation kit (Roche Diag-
nostics) according to the manufacturer’s protocol. cDNA was
synthesized with the Transcriptor High Fidelity cDNA synthe-
sis kit (Roche Diagnostics).
PCR Amplification and Gene Cloning—PCR amplification
was carried out on aMiniCycler fromBio-Rad. A PCR fragment
of 1300 bp containing the entire coding sequence of 5-dmats
was amplified from cDNA by using Expand high fidelity kit
(Roche Diagnostics). The primers were 5-DMATS_for (5-
FIGURE 2. Examples of naturally occurring C5-prenylated indole alkaloids.
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GCCCAGC/ATGCCTCACCAAAACAGC-3) at the 5-end,
and 5-DMATS_rev (5-GGTCGAAGATCTCAATTTCCAA-
GACTT-3) at the 3-end of the gene. Bold letters represent
mutations inserted in comparison with the original genome
sequence to give the underlined restriction site SphI at the start
codon in 5-DMATS_for and BglII located at the predicted stop
codon in 5-DMATS_rev. A programof 30 cycleswith annealing
at 58 °C for 50 s and elongation at 72 °C for 90 s was used for
PCR amplification. The PCR fragment was cloned into
pGEM-T easy vector resulting in plasmid pYL08, which was
subsequently sequenced (Eurofins MWG Operon, Ebersberg,
Germany) to confirm the sequence. Plasmid pYL08 was
digested with BglII alone or together with SphI to obtain BglII-
BglII fragment of 748 bp and SphI-BglII fragment of 531 bp,
respectively. To get the expression construct pYL09, these two
fragments were cloned into pQE70 subsequently.
Overproduction and Purification of His6-5-DMATS—For
overproduction of 5-DMATS, E. coli M15 [pREP4] cells har-
boring the plasmid pYL09 were cultivated in 2000-ml Erlen-
meyer flasks containing 1000 ml of liquid TB medium, supple-
mented with carbenicillin (50 gml1) and kanamycin (25
gml1), and then grown at 37 °C to an absorption at 600 nm
of 0.6. For induction, isopropyl thiogalactoside was added to a
final concentration of 0.4mM, and the cells were cultivated for a
further 16 h at 22 °C before harvest. The bacterial cultures were
centrifuged, and the pellets were resuspended in lysis buffer (10
mM imidazole, 50 mM NaH2PO4, 300 mM NaCl, pH 8.0) at 2–5
ml/g wet weight. After addition of 1 mgml1 lysozyme and
incubation on ice for 30 min, the cells were sonicated six times
for 10 s each at 200 watts. To separate the cellular debris from
the soluble proteins, the lysate was centrifuged at 13,000 g for
30 min at 4 °C. One-step purification of the recombinant His6-
tagged fusion protein by affinity chromatography with nickel-
nitrilotriacetic acid-agarose resin (Qiagen) was carried out
according to the manufacturer’s instructions. The protein was
eluted with 250 mM imidazole in 50 mM NaH2PO4, 300 mM
NaCl, pH 8.0. To change the buffer, the protein fraction was
passed through a PD-10 column (GE Healthcare), which had
been equilibrated with 50 mM Tris-HCl, 15% (v/v) of glycerol,
pH 7.5, previously. 5-DMATS was eluted with the same buffer
and frozen at80 °C for enzyme assays.
Protein Analysis and Determination of Relative Molecular
Mass of ActiveHis6-5-DMATS—Proteins were analyzed by 12%
(w/v) SDS-polyacrylamide gels according to the method of
Laemmli (34) and stained with Coomassie Brilliant Blue G-250.
The Mr value of the recombinant active His6-5-DMATS was
determined by size exclusion chromatography on a HiLoad
16/60 Superdex 200 column (GE Healthcare), which had been
equilibrated with 50 mM Tris-HCl buffer, pH 7.5, containing
150 mM NaCl. The column was calibrated with dextran blue
2000 (2000 kDa), ferritin (440 kDa), aldolase (158 kDa), conal-
bumin (75 kDa), carbonic anhydrase (29 kDa), and ribonuclease
A (13.7 kDa) (GE Healthcare). The proteins were eluted with
the same buffer as for equilibration.
Enzyme Assays with 5-DMATS—The enzyme reaction mix-
tures for determination of the relative activities with different
indole derivatives or L-tyrosine (100 l) contained 50 mM Tris-
HCl, pH 7.5, 5 mM CaCl2, 1 mM aromatic substrate, 2 mM
DMAPP, GPP, or FPP, 0.15–5% (v/v) glycerol, 0–5% (v/v)
DMSO, and 1 M purified recombinant protein. The reaction
mixtures were incubated at 37 °C for 7 h (with DMAPP) or 24 h
(with GPP or FPP). The enzyme reactions were terminated by
addition of 100 l of methanol per 100 l reaction mixture.
For determination of kinetic parameters of DMAPP, L-tryp-
tophan at 1 mM and DMAPP at final concentrations of up to 3
mM were used as substrates. For determination of kinetic
parameters of L-tryptophan and derivatives, the assays con-
tained 2 mM DMAPP. Because of the difference of solubility in
the aqueous system, various concentrations were used for aro-
matic substrates as follows: for 8a and 12a up to 5 mM, for
1a–3a, 7a, and 9a–11a up to 2 mM, and for 4a–6a up to 1 mM.
The protein concentration was 20 nM (1a), 40 nM (DMAPP), or
200 nM (other substrates), and the incubation time was 30 min
(1a), 40 min (DMAPP) or 60 min (other substrates).
Preparative Synthesis of Enzyme Products for Structure
Elucidation—For isolation of the enzyme products, reactions
were carried out in large scale (10 ml) containing each of the 12
substrates 1a–12a (1mM), DMAPP (2mM), CaCl2 (5mM), Tris-
HCl (50 mM, pH 7.5), glycerol 0.15–5% (v/v), and 5-DMATS
(1.4 M). After incubation for 16 h, the reactions were termi-
nated by addition of 10 ml of methanol each. After removal of
the precipitated protein by centrifugation at 6000 rpm for 30
min, the reaction mixtures were concentrated on a rotating
vacuum evaporator at 30 °C to a final volume of 1 ml before
injection onto HPLC.
HPLC Conditions for Analysis and Isolation of Enzyme
Products—The enzyme products of the incubation mixtures
were analyzed by HPLC on an Agilent series 1200 by using a
Multiphor 120 RP-18 column (250 4 mm, 5 m, CS Chro-
matographie Service, Langerwehe, Germany) at a flow rate of 1
mlmin1. Water (solvent A) and methanol (solvent B) each
with 0.5% (v/v) trifluoroacetic acid were used as solvents. For
analysis of enzyme products of tryptophan, simple indole deriv-
atives and L-tyrosine, a linear gradient of 20–100% (v/v) solvent
B, for 15 min were used. The column was then washed with
100% (v/v) solvent B for 5 min and equilibrated with 20% (v/v)
solvent B for 5 min. For analysis of enzyme products of trypto-
phan-containing cyclic dipeptides, the gradient beganwith 40%
(v/v) solvent B and increased from 40 to 100% (v/v) solvent B in
15 min. After washing with 100% (v/v) solvent B for 5 min, the
column was equilibrated with 40% (v/v) solvent B after each
run. For assays with GPP or FPP, a linear gradient of 20–84%
(v/v) solvent B for 12min and then 84–100% (v/v) solvent B for
18min was used. The columnwas then washed with 100% (v/v)
solvent B for 10 min and equilibrated with 20% (v/v) solvent B
for 5 min. Detection was carried out with a Photo Diode Array
Detector.
For isolation of the enzyme products, the sameHPLC equip-
ment with a Multospher 120 RP-18 column (250  10 mm, 5
m, CS Chromatographie Service) was used. The flow rate
was 2.5 mlmin1. Water (solvent C) and methanol (solvent D)
without acid were used as solvents. Gradients of 20–100% (v/v)
solvent D for different times were used for isolation. The col-
umn was then washed with 100% (v/v) solvent D for 8 min and
equilibrated with 20% (v/v) solvent D for 8 min.
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NMR Spectroscopic Analysis and High Resolution ESI-MS—
1H NMR spectra were recorded on a Bruker Avance 500 MHz
spectrometer or a JEOL ECX-400 spectrometer. The HSQC
and HMBC spectra were recorded with standard methods (35)
on the Bruker Avance 500 MHz spectrometer. Chemical shifts
were referenced to the signal of CD3OD at 3.31 ppm or
DMSO-d6 at 2.50 ppm. All spectra were processed with
MestReNova 5.2.2.
The isolated products were also analyzed by high resolution
ESI-MS with a Q-Trap Quantum (Applied Biosystems). Posi-
tive ESI-MS data are given in supplemental Table S3.
Nucleotide Sequence Accession Number—The coding se-
quence of 5-dmats (ACLA_031240) is available at GenBankTM
under the accession number XM_001269816.
RESULTS
Sequence Analysis and Cloning of 5-Dimethylallyltryptophan
SynthaseGene 5-dmats—In the course of our search for prenyl-
transferases responsible for prenylation of tryptophan or indole
derivatives at C-5, one putative gene ACLA_031240 from the
genome sequence ofA. clavatusNRRL1 raised our interest. The
deduced gene product EAW08391 consists of 427 amino acids
and shares high sequence similarities with C4-prenyltrans-
ferases of tryptophan, e.g. 52% identity with FgaPT2 from A.
fumigatus (20) at the amino acid level. Based on this homology,
it can be expected that EAW08391 catalyzes a similar reaction
as FgaPT2.
Inspection of down- and upstream genes ofACLA_031240 in
the genome sequence of A. clavatus (www.ncbi.nlm.nih.gov)
revealed that the enzymes encoded by these genes are very
likely involved in the fungal development and biosynthesis of
primary rather than secondary metabolites, e.g. prenylated
indole alkaloids. This means that ACLA_031240 is very likely
not clustered with genes for the biosynthesis of secondary
metabolites. For example, in the downstream sequence of
ACLA_031240, the putative gene ACLA_031250 is separated
from ACLA_031240 by a segment of 13 kb and encodes a
putative MYB family conidiophore development protein.
ACLA_031260, downstream of ACLA_031250, was predicted
to be a glycosyl hydrolase gene. In the upstream sequence of
ACLA_031240, ACLA_031230was predicted to encode aUDP-
N-acetylglucosaminyltransferase involved in the cell wall bio-
synthesis.ACLA_031220 is likely a 60 S ribosomal protein gene.
Blast search with EAW08391 from A. clavatus in Gen-
BankTM indicated the presence of three homologues as follows:
XP_001818057 encoded by AOR_1_1880174 from A. oryzae
RIB40; EED57628 encoded by AFLA_083250 from Aspergillus
flavus NRRL3357, and EEQ32624 encoded by MCYG_05443
from Arthroderma otae CBS113480. EAW08391 shares on the
amino acid level sequence identities of 76, 75, and 74% with
XP_001818057, EED57628, and EEQ32624, respectively. It can
be expected that these three enzymes catalyze the same reac-
tion as EAW08391.
Inspection of down- and upstream genes ofAOR_1_1880174
in the genome sequence ofA. oryzae,AFLA_083250ofA. flavus,
and MCYG_05443 of A. otae (www.ncbi.nlm.nih.gov) indi-
cated also their nonclustering with other secondary metab-
olite biosynthesis genes. The direct neighboring genes of
AOR_1_1880174 were predicted to encode L-arabitol/xylitol
dehydrogenase (AOR_1_1878174) and a putative trans-
porter gene for choline, -aminobutyric acid, or other amino
acids (AOR_1_1882174). Orthologues of these two genes
(AFLA_083240 and AFLA_083270) were also found directly
at AFLA_083250. A gene AFLA_083260 coding for a small
hypothetical protein with 84 amino acids was located
between AFLA_083250 and AFLA_083270. In the genome of
A. otae, MCYG_05443was found between an L-allothreonine
aldolase gene (MCYG_05442) and a hypercellular protein
HypA gene (MCYG_05444).
To prove the function of EAW08391, the coding region of
ACLA_031240, termed 5-dmats in this study, was amplified by
PCR from cDNA synthesized from mRNA. The PCR product
was cloned via pGEM-T easy vector into pQE70, resulting in
the expression construct pYL09. For overproduction of His6-5-
DMATS, E. coliM15 cells harboring pYL09 were cultivated in
TBmedium and inducedwith 0.4mM isopropyl thiogalactoside
at 22 °C for 16 h. A significant band with migration near the
45-kDa sizemarker was observed on SDS-PAGE of the purified
protein (see supplemental Fig. S1), corresponding to the calcu-
latedMr value of 50,411 for His6-5-DMATS. The yield was cal-
culated to be 1.8 mg of purified protein/liter of culture. TheMr
value of the native recombinant His6-5-DMATS was deter-
mined by size exclusion chromatography at about 79,000. This
indicated that 5-DMATS acted likely as a homodimer.
5-DMATS Accepted Well L-Tryptophan and Simple Indole
Derivatives as Substrates—Because of the high sequence simi-
larity with tryptophanC4-prenyltransferasesmentioned above,
L-tryptophan and 17 simple indole derivatives (Table 1 and sup-
plemental Table S1) were incubated with the purified
5-DMATS in the presence of DMAPP (2 mM). These sub-
stances included eight tryptophan derivatives with modifica-
tion at the indole ring and nine at the side chain. The reaction
mixtures were incubated with 5-DMATS at a final concentra-
tion of 1M for 7 h. HPLC analysis was used formonitoring the
enzyme product formation. Assays with heat-inactivated pro-
tein by boiling for 20 min were used as negative control.
HPLC analysis of the incubation mixtures showed clear
product formation for 17 of the 18 tested indole derivatives
with L-tryptophan as the best substrate (Table 1 and supple-
mental Table S1). HPLCs of incubation mixtures of 12 sub-
strates (1a–12a, Table 1) showed clearly the presence of one
product peak for each substrate. Similar behavior was also
observed for other five accepted substrates (data not shown).
Under this condition, L-tryptophanwas almost completely con-
sumed, and the 11 other substrates (2a–12a) were accepted
with total yields between 38 and 91%. Even in the incubation
mixtures with 0.40 M protein for 1 h, the conversion yield for
L-tryptophan was calculated to be 95.4% (see supplemental
Table S2).
Inspection of the activities of the tested substances (Table 1
and supplemental Table S1) revealed that, with the exceptions
for C5-substituted derivatives, all of the substances with mod-
ifications by fluoro or methyl group at the indole ring were well
accepted by 5-DMATS. These results could indicate the prenyl-
ation position at C-5 of the indole rings of the accepted
substrates. 5-Bromo-DL-tryptophan was not accepted by
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5-DMATS. The conversion yields of 5-fluoro-L-tryptophan and
5-methyl-DL-tryptophan at 7.4 and 1.7%, respectively, were sig-
nificantly lower than those with substitution at other positions
of the indole ring. The prenylation of these substances had very
likely taken place at other positions rather than C-5 (see under
“Discussion”). Modification at the side chain of tryptophan
reduced enzyme activity, especially by shortening the chain
length, as in the case of indole-3-acetic acid and tryptamine. In
comparison, changes at the amino group such as N-methyla-
tion (L-abrine,7a), replacement by a hydroxyl group (DL-indole-
3-lactic acid, 10a), or deamination (indole-3-propionic acid,
11a) showed less influence on the enzyme activity.
Aprevious study (36) showed that the tryptophanC4-prenyl-
transferase FgaPT2 also accepted tryptophan-containing cyclic
dipeptides as substrates. 5-DMATS was therefore also assayed
with five such cyclic dipeptides and analyzed on HPLC. It has
been shown that these compounds were also substrates for
5-DMATS but were accepted with significantly lower yields
(10%) than most of the simple indole derivatives (see supple-
mental Table S1). Incubations of 5-DMATS with L-tyrosine in
the presence ofDMAPPorwith L-tryptophan in the presence of
GPP or FPP did not result in the formation of any enzyme prod-
uct, even after incubation with 1 M protein for 24 h (see sup-
plemental Table S2).
5-DMATS Catalyzed the Regular C5 Prenylation at the
Indole Ring—To confirm the prenylation position, enzyme
products of 12 substrates (1a–12a, Table 1) were isolated on
HPLC and subjected to high resolutionMS and NMR analyses.
High resolution ESI-MS (see supplemental Table S3) con-
firmed the presence of one dimethylallyl moiety each in the
products of 1a–12a by detection of masses, which are 68 dal-
tons larger than those of the respective substrates.
In the 1H NMR spectra of all the enzyme products (taken in
CD3ODorDMSO-d6), signals at H3.34–3.47 (d, 2H-1), 5.17–
5.40 (t or m, H-2), 1.71–1.78 (s, 3H-4), and 1.67–1.77 (s,
3H-5) were observed (see supplemental Table S4 and supple-
mental Figs. S3–S14), proving unequivocally the attachment of
a regular dimethylallyl moiety to a carbon atom (37, 38).
Substrates 2a and 7a–11a are derivatives of L-tryptophan
(1a) with modifications at N-1 at the indole ring or at the side
chain. Characteristic signals of the four coupling protons at the
indole ring (H-4, -5, -6, and -7) appeared as two doublets and
two triplets, all with coupling constants of 7–9 Hz in the 1H
NMR spectra of 1a, 2a, and 7a–11a (data not shown). In com-
parison, the two triplets had disappeared in the 1H NMR spec-
tra of their enzyme products 1b, 2b, and 7b–11b. One addi-
tional singlet or doublet with a coupling constant smaller than 2
Hz was observed instead. These changes indicated that prenyl-
ations had taken place at C-5 or C-6. As given in Table 2, the
signals of the remaining three protons at H-4, H-5 or H-6 and
H-7 in the 1HNMR spectra (all taken in CD3OD)were found to
be in the same order, i.e. (from low to high magnetic field)
doublet (1.6 Hz) or broad singlet, doublet (8.3–8.4 Hz), and
double doublet (8.3–8.4 and 1.5–1.6 Hz). The singlets for H-2
were found between the doublet (8.3–8.4 Hz) and double dou-
blet. It is plausible that the structures of these compounds have
the same prenylation position.
TABLE 1
Enzyme activity of 5-DMATS towards tryptophan and other simple
indole derivatives (1a–12a)
The reaction mixtures containing indole derivatives and DMAPP were incubated
with 1 M protein for 7 h. Under this condition, L-tryptophan was completely
consumed.
TABLE 2
Signals for aromatic protons in the 1H NMR spectra of the selected
products (CD3OD)
For structures, see Fig. 3. The signals are arranged in an order from low to high
magnetic field so that the relative signal positions caused by C5-prenylation can be
better compared.
# ,Due to the presence of a double bond between C-10 and C-11, the signal of H-2
was downshifted in the 1H NMR spectrum.
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Enzyme products of 1a and 7a with prenylation at C-6 were
reported by Takahashi et al. (13). TheNMRdata of 6-dimethyl-
allyl-L-tryptophan and 6-dimethylallyl-L-abrine (also taken in
CD3OD) differed clearly from those of 1b and 7b, especially in
the region for aromatic protons. The aromatic protons in the
1H NMR spectra of 6-dimethylallyl-L-tryptophan and 6-di-
methylallyl-L-abrine appeared (from low to highmagnetic field)
in a different order than in the spectra of 1b and 7b, i.e. doublet
(7.8–8.2 Hz), two singlets, and double doublet. Therefore, the
prenylation position in 1b and 7bmust be C-5. This conclusion
was also confirmed by interpretation of the two-dimensional
NMR spectra of 1b (in DMSO-d6) and 7b (in CD3OD). In the
HMBC spectrum of 1b (see supplemental Figs. S2 and S3), con-
nectivity from H 7.32 (1H, br. s, H-4) to C-1 of the prenyl
moiety at C 34.1 proved unequivocally the attachment of the
dimethylallyl moiety to C-5. The signal at H 7.32 (1H, s) for
protonH-4was unambiguously confirmed by the detected con-
nectivities between this signal and C-8 at 134.9 ppm as well as
C-3 at 109.3 ppm. For 7b, similar phenomena were also
observed in the HMBC spectrum (see supplemental Figs. S2
and S9). It can be concluded that the prenyl moieties in 1b, 2b,
and 7b–11b are attached to C-5 of the indole rings.
Substrate 12a is also a derivative of L-tryptophan with alter-
ation at the side chain. Because of the presence of a double bond
between C-10 and C-11, the signal of H-2 was downshifted in
1HNMR spectrum to H 7.60 (1H, s), in comparison with those
of 1b, 2b, and 7b–11b between 7.00 and 7.18 ppm. However,
the signals for H-4, H-6, and H-7 of 12b appeared in the same
order as in the spectra of 1b, 2b, and 7b–11b (Table 2), proving
the C5-prenylation in the structure of 12b.
In the 1H NMR spectrum of 3b (see supplemental Fig. S5),
the two doublets at H 6.85 (1H, d, 8.2Hz,H-6) and H 7.08 (1H,
d, 8.2 Hz, H-7) represent signals for two protons at the ortho-
position and indicated the prenylation at C-5 or C-7. The con-
nectivity from H-6 to C 31.4 of C-1 and from H 2.55 (3H, s,
H-13) of the methyl group at C-4 to C 128.9 of C-5 in the
HMBC spectrum confirmed the prenylation at C-5 in 3b (see
supplemental Fig. S2).
The structures of 4b, 5b, and 6bwere elucidated by interpre-
tation of their 1HNMR spectra (see supplemental Figs. S6–S8).
Three singlets observed at H 7.14 (1H, s, H-2), H 7.44 (1H, s,
H-4), and H 7.08 (1H, s, H-7) in the 1H NMR spectrum of 4b
proved the prenylation at C-5. In the 1H NMR spectrum of 5b,
the two doublets at H 7.02 (1H, d, 10.8 Hz, H-7) and H 7.49
(1H, d, 7.3 Hz, H-4) with clearly different coupling constants
are caused by the different distances of the protons to fluoro
atomatC-6. In the 1HNMRspectrumof the enzyme product of
6a, signals for two products 6b and 6cwith a ratio of 1.5:1 were
detected. Unfortunately, these two compounds could not be
separated from each other. Based on their different contents in
the mixture, we were able to identify the major product 6b as
C5-prenylated derivative, which is characteristic of the pres-
ence of three singlets at H 7.14 (1H, br. s), 7.14 (1H, br. s), and
6.69 (1H, br. s) for H-2, H-4, and H-6, respectively.
In conclusion, 5-DMATS catalyzed the C5-prenylation of
L-tryptophan and simple indole derivatives (Fig. 3). To the best
of our knowledge, the structures 1b–12b were not described
previously. The structure of 6c could not be unequivocally elu-
cidated in this study. The presence of two doublets with a cou-
pling constant of 8.1 Hz in the 1H NMR spectrum indicated a
prenylation at C-4 or C-6.
Biochemical Characterization and Kinetic Parameters of
5-DMATS—For determination of the metal ion dependence of
5-DMATS, incubations of L-tryptophan (1a) with DMAPP
were carried out in the presence of differentmetal ions at a final
concentration of 5 mM. Incubations with the chelating agent
EDTA or without additives were used as controls. In the incu-
bation mixture with EDTA, no decrease of the enzyme activity
was observed, in comparison with that of incubation without
additives. As observed for other members of the DMATS
superfamily (15, 39), several divalent metal ions enhanced
slightly the enzyme activity of 5-DMATS. For example, the
enzyme activities with Ca2 and Mg2 were found to be 250
and 204% of that without additives, respectively.
To study the behavior of 5-DMATS toward 12 indole deriv-
atives (1a–12a) and DMAPP in detail, kinetic parameters,
FIGURE 3. Prenyl transfer reactions catalyzed by 5-DMATS, exemplified with simple indole derivatives 1a–12a.
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including Michaelis-Menten constants (Km) and turnover
numbers (kcat), were determined by Hanes-Woolf and Eadie-
Hofstee plots and are given in Table 3. The reactions catalyzed
by 5-DMATS apparently followed Michaelis-Menten kinetics.
TheKm values forDMAPPand L-tryptophan (1a)were found to
be 76 and 34 M, respectively, whereas Km values of 0.10–1.0
mM were determined for 2a–12a, much higher than that
observed for 1a. The turnover numbers were calculated for
DMAPP and 1a at 1.3 and 0.87 s1, respectively. Lower turn-
over numbers of 0.059–0.76 s1 were determined for 2a–12a.
The catalytic efficiencies (kcat/Km) of 5-DMATS toward
DMAPP and 1a were calculated to be 17,105 and 25,588
s1M1, respectively. In comparison, lower catalytic efficien-
cies at 155–1538 s1mM1 were found for 2a–12a, only 0.6–
6.0% that of 1a.
DISCUSSION
Prenyltransferases catalyze transfer reactions of prenyl moi-
eties from prenyl diphosphates to diverse aliphatic or aromatic
receptors, including proteins, terpenes, benzoic acids, naphtha-
lenes, flavonoids, and indole alkaloids (1, 8, 9, 40, 41). These
enzymes are involved in both primary and secondary metabo-
lism, play an important role in living organisms (42), and con-
tribute significantly to the structural diversity of natural prod-
ucts (43). Prenylated indole alkaloids represent a large group of
natural products, predominantly identified as mycotoxins in
Ascomycetes (1, 44). Indole prenyltransferases catalyze transfer
reactions of prenyl moieties onto the indole nucleus and are
involved in the biosynthesis of diverse natural products, espe-
ciallymycotoxins (1, 15). A large number of indole prenyltrans-
ferases, mainly belonging to the DMATS superfamily from
fungi of Ascomycetes, have been identified in the last years and
characterized biochemically (1, 10, 11). The members of the
DMATS superfamily are soluble proteins, showed usually
broad substrate specificity and accepted tryptophan, simple
indole derivatives, tryptophan-containing cyclic dipeptides, or
other indole-containing structures as aromatic substrates and
DMAPP as prenyl donor (1, 10, 11). A few examples of soluble
indole prenyltransferases have also been identified in bacteria
(13, 45). One of the important features of indole prenyltrans-
ferases is the regioselectivity of their prenylation reactions.
With the exception for C-5, diverse indole prenyltransferases
for the other six positions (N-1, C-2, C-3, C-4, C-6, and C-7)
have been identified and characterized (Fig. 1). No enzyme for
prenylation at C-5 of the indole ring was reported prior to this
study, although a number of C5-prenylated derivatives have
been isolated fromdifferent organisms (Fig. 2). Therefore, there
is a need to find enzymes for C5-prenylation at the indole
nucleus, so that these enzymes could be better used as tools for
chemoenzymatic synthesis of prenylated indole derivatives or
even for synthesis of prenylated hydroxynaphthalenes and fla-
vonoids, which have been very recently described for several
members of the DMATS superfamily (46, 47).
In this study, we identified and characterized the first tryp-
tophan C5-prenyltransferase 5-DMATS from A. clavatus,
which catalyzes the regiospecific C5-prenylation of indole
derivatives and fills herewith the last gap in the search for indole
prenyltransferases regarding their prenylation positions. Blast
searching in the database with 5-DMATS from A. clavatus
NRRL1 revealed the presence of three orthologues in the
genome sequences ofA. oryzaeRIB40 (48),A. flavusNRRL3357
(49), and A. otae CBS 113480 (GenBankTM). Analysis of genes
in the genomic region of these prenyltransferase genes in all
four strains did not provide any indication for their clustering
with genes for secondary metabolite biosynthesis. No C5-pre-
nylated derivative was reported for these fungi. Therefore, their
roles in these strains could not be predicted in this study. It
seems that these genes are the results of redundant copies in the
evolution. Nevertheless, considering the low Km values of 34
and 76 M for L-tryptophan and DMAPP, respectively, as well
as the high turnover number of 1.1 s1 (Table 3), it can be
speculated that L-tryptophan and DMAPP are very likely the
natural substrates of 5-DMATS in the four fungal strains. Inac-
tivation of these genes in the fungal strains could provide
detailed information about their roles in nature, if the genes are
expressed and the gene products involved in the biosynthesis of
certain substance. Therefore, we tried to detect the production
of C5-prenylated indole derivatives by A. clavatus NRRL1. For
this purpose, the funguswas cultivated in different liquidmedia
like YME. Culture filtrates and mycelia were extracted with
ethyl acetate and methanol, respectively. In the 1H NMR spec-
tra of both extracts, no signal for aromatic protons was
observed, which could be assigned to C5-substituted indole
rings. Signals for prenyl moieties were also absent in their 1H
NMRspectra (data not shown). Thismeans thatC5-substituted
indole derivatives were not or only in a very low yield produced
by this fungus under the tested conditions. These results could
indicate that 5-DMATS is not involved in the biosynthesis of
secondary metabolites in A. clavatus. It cannot be excluded,
however, that 5-DMATS catalyzed a C5-prenylation in the bio-
synthesis of a fungal product. It is plausible that the expression
level of 5-dmats and other related genes would be too low to
produce a substantial amount of prenylated derivative. In both
cases, cultivation of A. clavatus NRRL1 and 5-dmats-defective
mutants would very likely not result in significant changes of
secondary metabolite accumulation, which prohibited the
potential usage of knock-out experiments to prove gene func-
tion. Therefore, optimization of culture conditions should be
carried out to improve the level of gene expression in A. clava-
tus. Cultivation ofA. oryzae,A. flavus, orA. otae under different
conditions and proof of the accumulated C5-prenylated sec-
ondary metabolites, e.g. by NMR analysis, after purification or
TABLE 3
Kinetic parameters of 5-DMATS for selected substrates
Substrate Km kcat kcat/Km
mM s1 s1M1
L-Tryptophan (1a) 0.034 0.87 25,588
1-Methyl-DL-tryptophan (2a) 0.10 0.059 590
4-Methyl-DL-tryptophan (3a) 0.25 0.29 1160
6-Methyl-DL-tryptophan (4a) 1.0 0.76 760
6-Fluoro-DL-tryptophan (5a) 0.27 0.29 1074
7-Methyl-DL-tryptophan (6a) 0.47 0.40 851
L-Abrine (7a) 0.26 0.40 1538
N-Acetyl-DL-tryptophan (8a) 0.35 0.10 286
L--Homotryptophan (9a) 0.97 0.15 155
DL-Indole-3-lactic acid (10a) 0.67 0.43 642
Indole-3-propionic acid (11a) 0.39 0.39 1000
trans-Indole-3-acrylic acid (12a) 0.40 0.14 350
DMAPP 0.076 1.3 17,105
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as extracts, would also be a prerequisite for gene knock-out
experiments in these strains. This work is now in progress.
In addition to 5-DMATS described in this study, several
DMATSs using L-tryptophan as natural or best aromatic sub-
strate with different regioselectivity have been studied bio-
chemically in detail, e.g. the 4-DMATS FgaPT2 fromA. fumiga-
tus (20) and its orthologues MaPT from Malbranchea
aurantiaca (50) and DmaW from a clavicipitalean fungus (51,
52), the 6-DMATS IptA from Streptomyces sp. SN-593 (13), and
the 7-DMATS from A. fumigatus (22). All of these enzymes
catalyzed regular C-prenylation (13, 20, 22, 50, 51). As men-
tioned above, 5-DMATS shares high sequence similarities on
the amino acid level with 4-DMATSs, e.g. 52% with FgaPT2
from A. fumigatus, 50% with MaPT from M. aurantiaca, and
47% with DwaW from the clavicipitalean fungus. As observed
for the low sequence similarity between FgaPT2 and 7-DMATS
(22), 5-DMATS also showed low sequence similarity (27%) to
7-DMATS. No meaningful similarity was found for 5-DMATS
and IptA. These data proved again that substrates of indole
prenyltransferases and their prenylation positions could not be
predicted by sequence analysis and comparison (15).
As observed for other members of the DMATS superfamily
(15, 39), the enzyme activity of 5-DMATS was enhanced by
some metal ions such as Ca2 or Mg2. 5-DMATS accepted
only DMAPP but not GPP or FPP as prenyl donor. It showed,
however, similar tomanymembers of theDMATS superfamily,
broad promiscuity toward its aromatic substrates. With the
exception for C5-substituted derivatives, the most tested sim-
ple indole derivatives with modifications at the indole ring or
side chain have been well accepted by 5-DMATS (Table 1 and
supplemental Table S1). It is not surprising that C5-substituted
derivatives were poor substrates for a 5-DMATS with a high
regioselectivity at C-5. No product formation was observed for
5-bromo-DL-tryptophan, although low conversion yields of 7.4
and 1.7% were detected for 5-fluoro-L-tryptophan and 5-meth-
yl-DL-tryptophan, respectively. These results indicated a lim-
ited feasibility of 5-DMATS to prenylate C5-substituted tryp-
tophan derivatives. Similar phenomena were also observed for
the tryptophan C6-prenyltransferase IptA, which also accepted
6-methyl-DL-tryptophanassubstrateandcatalyzedaC7-prenyl-
ation (13). Because of the low amounts, the enzyme products of
5-fluoro-L-tryptophan and 5-methyl-DL-tryptophan were not
identified in this study. It could be speculated, however, that
prenylation had taken place at another position rather than
C-5. We have shown in this study that 5-DMATS prenylated
predominantly tryptophan and derivatives at C-5 but occasion-
ally also catalyzed prenylations at other positions, as observed
in the incubationmixture of 7-methyl-DL-tryptophan. BothC5-
and C4- or C6-prenylated derivatives were identified in this
case (supplemental Table S4). The acceptance of C5-substi-
tuted tryptophan derivatives by 5-DMATS could also be
explained by the substrate promiscuity of indole prenyltrans-
ferases of the DMATS superfamily, which accepted even
hydroxynaphthalenes and flavonoids as substrates and cata-
lyzed C-, O-, or both prenylations (46, 47).
As given in Table 1, high conversion yields of more than 38%
were detected for 12 simple indole derivatives after incubation
with 1 M 5-DMATS for 7 h. NMR and MS analyses proved
unequivocally that the reaction catalyzed by 5-DMATS was
highly regioselective regular prenylation at C-5 of the indole
nucleus in most cases. It can therefore be expected that
5-DMATS could serve as an effective catalyst for chemoenzy-
matic synthesis of prenylated derivatives in the programof drug
discovery and development. Acceptance of tryptophan-con-
taining cyclic dipeptides by 5-DMATS could also be used to
increase the structural diversity of prenylated derivatives,
although the conversion yields detected in this study were still
very low, which perhaps could be improved in the future by
mutagenesis experiments.
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N
H
COOH
 
20.2 
indole-3-acetic acid 
N
H
COOH
 
1.8 
tryptamine 
N
H

 
6.1 
cyclo-L-Trp-L-Ala 
N
H
HN
NH
O
O  
1.9 
cyclo-L-Trp-L-Leu 
N
H
HN
NH
O
O
6.4 
cyclo-L-Trp-L-Phe 
N
H
HN
NH
O
O  
2.2 
cyclo-L-Trp-L-Pro 
N
H
HN
N
O
O  
0.9 
cyclo-L-Trp-L-Trp 
N
H
HN
NH
O
O
H
N
 
9.0 
The reaction mixtures containing aromatic compounds and DMAPP were incubated with 1 
µM protein for 7 h. 
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Table S2. Enzyme activity of 5-DMATS towards prenyl diphosphates  
 
Name Structure 
Product yield (%) 
1h incubation 
0.40 µM 5-DMATS 
7h incubation 
1 µM 5-DMATS  
24h incubation 
1 µM 5-DMATS 
DMAPP 
PPO  
95.4 100 100 
GPP 
PPO  
< 0.5 < 0.5 < 0.5 
FPP 
PPO  
< 0.5 < 0.5 < 0.5 
L-tryptophan was used as aromatic substrate. 
 
 
 
Table S3. HR-ESI-MS data of enzyme products of 5-DMATS 
Comp. Chemical formula 
HR-ESI-MS data 
Deviation (ppm) Calculated Measured 
1b C16H20N2O2 273.1603 [M+H]+ 273.1604 -0.3 
2b C17H22N2O2 287.1760 [M+H]+ 287.1746 4.5 
3b C17H22N2O2 287.1760 [M+H]+ 287.1753 2.4 
4b C17H22N2O2 287.1760 [M+H]+ 287.1791 -11.0 
5b C16H19FN2O2 291.1509 [M+H]+ 291.1473 12.4 
6b and 6c C17H22N2O2 287.1760 [M+H]+ 287.1725 11.9 
7b C17H22N2O2 287.1760 [M+H]+ 287.1750 3.3 
8b C18H22N2O3 337.1528 [M+Na]+ 337.1499 8.7 
9b C17H22N2O2 287.1760 [M+H]+ 287.1744 5.4 
10b C16H19NO3 296.1263 [M+Na]+ 296.1245 5.9 
11b C16H19NO2 280.1313 [M+Na]+ 280.1346 -11.6 
12b C16H17NO2 278.1157 [M+Na]+ 278.1153 1.4 
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Table S4. 1H- and 13C- NMR data of enzyme products obtained in CD3OD or DMSO- d6.  
Compd 
N
H
COOH
NH2
1
2
3
45
6
7 8
9
10 11
12
1'
2'
3' 4'
5'
 
1b (in DMSO- d6) 
N
H
COOH
NH2
1
2
3
45
6
7 8
9
10 11
12
1'
2'
3' 4'
5'
 
1b (in CD3OD) 
N
COOH
NH2
1
2
3
45
6
7 8
9
10 11
12
13
1'
2'
3' 4'
5'
 
2b (in CD3OD) 
N
H
COOH
NH2
1
2
3
45
6
7 8
9
10 11
12
131'
2'
3' 4'
5'
 
3b (in DMSO- d6) 
N
H
COOH
NH2
1
2
3
45
6
7 8
9
10 11
12
13
1'
2'
3' 4'
5'
 
4b (in CD3OD) 
N
H
COOH
NH2
1
2
3
45
6
7 8
9
10 11
12
1'
2'
3' 4'
5'
F
 
5b (in CD3OD) 
N
H
COOH
NH2
1
2
3
45
6
7
8
9
10 11
12
13
1'
2'
3' 4'
5'
 
6b (in DMSO- d6) 
Pos. δC δH, multi., J δH, multi., J δH, multi.,J δC δH, multi.,J δH, multi., J δH, multi., J δH, multi., J 
2 124.1 7.18, s 7.15, s 7.05, s 124.5 7.11, s 7.14, s 7.14, s 7.14, br. s 
3 109.3 - - - § - - - - 
4 117.2 7.32, br. s 7.49, d, 1.6 7.49, br. s 126.5 - 7.44, s 7.49, d, 7.3 7.14, br. s 
5 131.0 - - - 128.9 - - - - 
6 121.8 6.88, br. d, 8.3 6.95, dd, 8.4, 1.6 7.02, dd, 8.4, 1.5 123.0 6.85, d, 8.2 - - 6.69, br. s 
7 111.2 7.25, d, 8.3 7.27, d, 8.4 7.25, d, 8.4 108.8 7.08, d, 8.2 7.08, s 7.02, d, 10.8 - 
8 134.9 - - - 135.6 - - - - 
9 127.4 - - - 125.5 - - - - 
10 27.2 3.30, dd, 15.1, 3.6 3.51, dd, 15.3, 4.0 3.48, dd, 15.3, 4.0 29.2 3.63, d, 15.2 3.50, dd, 15.2, 3.7 3.48, dd, 15.2, 3.8 # 
10  2.90, dd, 15.1, 9.3  3.10, dd, 15.2, 9.8 3.09, dd, 15.3, 9.5  2.89, dd, 15.4, 10.6 3.08, dd, 15.2, 9.8 3.09, dd, 15.3, 9.6 2.87, dd, 14.9, 9.5 
11 54.8 3.44, dd, 9.3, 3.6 3.86, dd, 9.8, 4.0 3.83, dd, 9.5, 4.0 § # 3.85, dd, 9.8, 3.7 3.83, dd, 9.6, 3.8 # 
12 170.2 - - - § - - - - 
13 - - - 3.75, s 14.9 2.55, s 2.34, s - 2.40, s 
14 - - - - - - - - - 
1' 34.1 3.36, d, 7.4 3.43, d, 7.4 3.44, d, 7.3 31.4 3.34 3.41, d, 6.8 3.41, d, 7.1 # 
2' 124.9 5.33, t, 7.4 5.37, m 5.37, m 124.3 5.17, t, 7.1 5.24, m 5.33, t, 7.1 5.32, m 
3' 130.4 - - - 129.5 - - -  
4' 17.7 1.72, s 1.76, s 1.76, s 17.3 1.73, s 1.77, s 1.76, s 1.71, s 
5' 25.5 1.70, s 1.74, s 1.74, s 25.1 1.67, s 1.72, s 1.72, s 1.69, s 
Chemical shifts (δ) were given in ppm and coupling constants (J) in Hz. #: overlapping signals with those of solvents; §: due to low amount, the signals were not observed. 
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Table S4 (continued) 
Compd 
N
H
COOH
NH2
1
2
3
45
6
7 8
9
10 11
12
13
N
H
COOH
NH2
1
2
3
45
6
7 8
9
10 11
12
13
or
1'
2'
3'
4'
5'
1'
2'
3' 4'
5'  
6c (in DMSO- d6) 
N
H
COOH
HN
1
2
3
45
6
7 8
9
10 11
12
13
1'
2'
3' 4'
5'
 
7b (in CD3OD) 
N
H
COOH
HN
1
2
3
45
6
7 8
9
10 11
12
13
1'
2'
3' 4'
5'
O
14
 
8b (in CD3OD) 
N
H
NH2
1
2
3
45
6
7 8
9
10 11
12 13
1'
2'
3' 4'
5'
COOH
 
9b (in CD3OD) 
N
H
COOH
OH
1
2
3
45
6
7 8
9
10 11
12
1'
2'
3' 4'
5'
 
10b (in CD3OD) 
N
H
COOH
1
2
3
45
6
7 8
9
10 11
12
1'
2'
3' 4'
5'
 
11b (in CD3OD) 
N
H
COOH
1
2
3
45
6
7 8
9
10 11
12
1'
2'
3' 4'
5'
 
12b (in CD3OD) 
Pos. δH, multi., J δC δH, multi., J δH, multi., J δH, multi., J δH, multi., J δH, multi., J δH, multi., J 
2 7.12, d, 2.2 125.3 7.18, s 7.05, s 7.13, s 7.09, s 7.00, s 7.60, s 
3 - 108.6 - - - - - - 
4 7.29, d, 8.1 
6.80, d, 8.1 
118.3 7.47, br. s 7.35, br. s 7.36, d, 1.6 7.45, br. s 7.33, br. s 7.61, br. s 
5 133.8 - - - - - - 
6 123.8 6.95, dd, 8.4, 1.5 6.88, dd, 8.3, 1.5 6.95, dd, 8.4, 1.6 6.88, dd, 8.3, 1.5 6.89, dd, 8.3, 1.5 7.05, dd, 8.3, 1.5 
7 - 112.3 7.26, d, 8.4 7.19, d, 8.3 7.27, d, 8.4 7.19, d, 8.3 7.20, d, 8.3 7.33, d, 8.3 
8 - 136.9 - - - - - - 
9 - 128.7 - - - - - - 
10 # 27.6 3.46, dd, 15.5, 4.6 3.34, dd, 14.6, 4.8 2.54, dd, 16.8, 3.9 3.26, dd, 14.8, 3.4 2.57, m 6.34, d, 15.9 
10 2.90, dd, 14.3, 9.3  3.23, dd, 15.5, 8.2 3.13, dd, 14.6, 6.7 2.35, dd, 16.8, 9.2 2.92, dd, 14.8, 8.2 - - 
11 # 65.4 3.77, dd, 8.2, 4.6 4.58, dd, 6.7, 4.8 3.66, m 4.21, dd, 8.2, 3.4 3.01, m 7.90, d, 15.9 
12 - 173.4 - - 3.05, d, 7.2 - - - 
13 2.36, s 33.1 2.56, s - - - - - 
14 - - - 1.86, s - - - - 
1' # 35.6 3.43, d, 7.3 3.40, d, 7.3 3.42, d, 6.9 3.40, d, 7.3 3.40, d, 7.2 3.47, d, 7.3 
2' 5.18, m 126.0 5.37, m 5.37, m 5.37, m 5.38, m 5.37, m 5.40, m 
3' - 132.0 - - - - - - 
4' 1.72, s 17.9 1.76, s 1.76, s 1.76, s 1.76, s 1.76, s 1.78, s 
5' 1.67, s 25.9 1.74, s 1.74, s 1.74, s 1.74, s 1.75, s 1.77, s 
#: overlapping signals with those of solvents; §: due to low amount, the signals were not observed.   
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Figure S1. Analysis of purified His6-5-DMATS on SDS-PAGE. Lane 1: purified 
His6-5-DMATS; 2: molecular mass standard. 
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Figure S2. Summary of the HMBC connectivities of enzyme products 1b, 3b and 7b. 
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Figure S3.1. 1H-NMR spectrum of 1b in DMSO-d6 (500 MHz) 
 
 
Figure S3.2. 13C-NMR spectrum of 1b in DMSO-d6 (500 MHz) 
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Figure S3.3. HSQC spectrum of 1b in DMSO-d6 (500 MHz) 
 
Figure S3.4. HMBC spectrum of 1b in DMSO-d6 (500 MHz) 
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Figure S3.5. 1H-NMR spectrum of 1b in CD3OD (400 MHz) 
 
 
Figure S4. 1H-NMR spectrum of 2b in CD3OD (400 MHz) 
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Figure S5.1. 1H-NMR spectrum of 3b in DMSO-d6 (500 MHz) 
 
 
Figure S5.2. HSQC spectrum of 3b in DMSO-d6 (500 MHz) 
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Figure S5.3. HMBC spectrum of 3b in DMSO-d6 (500 MHz) 
 
 
Figure S6. 1H-NMR spectrum of 4b in CD3OD (500 MHz) 
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Figure S7. 1H-NMR spectrum of 5b in CD3OD (500 MHz) 
 
 
Figure S8. 1H-NMR spectrum of 6b and 6c in DMSO-d6 (500 MHz). The protons of 6b and 
6c were labeled with Hb and Hc, respectively. 
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Figure S9.1. 1H-NMR spectrum of 7b in CD3OD (500 MHz) 
 
 
Figure S9.2. 13C-NMR spectrum of 7b in CD3OD (500 MHz) 
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Figure S9.3. HSQC spectrum of 7b in CD3OD (500 MHz) 
 
Figure S9.4. HMBC spectrum of 7b in CD3OD (500 MHz) 
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Figure S10. 1H-NMR spectrum of 8b in CD3OD (500 MHz) 
 
 
Figure S11. 1H-NMR spectrum of 9b in CD3OD (400 MHz) 
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Figure S12. 1H-NMR spectrum of 10b in CD3OD (500 MHz) 
 
 
Figure S13. 1H-NMR spectrum of 11b in CD3OD (500 MHz) 
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Figure S14. 1H-NMR spectrum of 12b in CD3OD (500 MHz) 
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5.3 Identification of a brevianamide F reverse
prenyltransferase BrePT from Aspergillus versicolor with a
broad substrate specificity towards tryptophan-containing
cyclic dipeptides
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Abstract A putative brevianamide F reverse prenyltransfer-
ase gene brePT was amplified from Aspergillus versicolor
NRRL573 by using primers deduced from its orthologue notF
in Aspergillus sp. MF297-2 and overexpressed in Escherichia
coli. The soluble His-tagged protein BrePT was purified to
near homogeneity and assayed with tryptophan-containing
cyclic dipeptides in the presence of dimethylallyl diphosphate.
BrePT showed much higher flexibility towards its aromatic
substrates than NotF and accepted all of the 14 tested
tryptophan-containing cyclic dipeptides. Structure elucidation
of the enzyme products by NMR and MS analyses proved
unequivocally the highly regiospecific reverse prenylation at
C2 of the indole nucleus. KM values of BrePT were deter-
mined for its putative substrates brevianamide F and DMAPP
at 32 and 98 μM, respectively. Average turnover number (kcat)
at 0.4 s−1 was calculated from kinetic data of brevianamide
F and DMAPP. KM values in the range of 0.082–2.9 mM
and kcat values from 0.003 to 0.15 s
−1 were determined for
other 11 cyclic dipeptides. Similar to known fungal indole
prenyltransferases, BrePT did not accept geranyl or farne-
syl diphosphate as prenyl donor for its prenylation.
Keywords Brevianamide . Cyclic dipeptide . DMATS
superfamily . Prenylated derivative . Prenyltransferase
Introduction
Prenyltransferases are found in all domains of the life and
are involved in the biosynthesis of primary and secondary
metabolites in nature (Heide 2009; Li 2009a; Liang 2009;
Yazaki et al. 2009). They catalyze the transfer reactions of a
prenyl moiety from a prenyl donor, usually as diphosphate,
to a terpenoid, serine residue of a protein or an aromatic
nucleus (Li 2009a). The later mentioned enzymes are known
as aromatic prenyltransferases, which are mainly found in
plants, bacteria and fungi (Heide 2009; Li 2009a; Yazaki et
al. 2009). A subgroup of the aromatic prenyltransferases
from ascomycetes show clear sequence homology to dime-
thylallyltryptophan synthase (DMATS) in the biosynthesis
of ergot alkaloids from Claviceps purpurea (Tudzynski et al.
1999) and are therefore classified as prenyltransferases of
the DMATS superfamily. The members of this group cata-
lyze mainly the prenylation of diverse indole derivatives
including tryptophan and tryptophan-containing cyclic
dipeptides at different positions of the indole ring and are
involved in the biosynthesis of a number of prenylated
indole alkaloids (Li 2009b; Li 2010; Steffan et al. 2009).
Prenylated indole alkaloids are widely distributed in terres-
trial and marine organisms, especially in the genera Clav-
iceps, Penicillium, and Aspergillus. They are important
mycotoxins like fumitremorgin- or roquefortine-type alka-
loids (Li 2010; Williams et al. 2000) and drugs, e.g., ergot
alkaloids (Wallwey and Li 2011).
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The characteristic features of the enzymes of the DMATS
superfamily are their flexibility towards aromatic substrates
and high regioselectivity regarding prenylation position at
the indole ring. Usually, tryptophan prenyltransferases, e.g.,
FgaPT2 and 7-DMATS from Aspergillus fumigatus (A.
fumigatus), MaPT from Malbranchea aurantiaca, or 5-
DMATS from Aspergillus clavatus, accepted also very well
a number of tryptophan derivatives with modifications both
at the side chain and the indole ring as substrates (Ding et al.
2008; Kremer et al. 2007; Steffan et al. 2007; Yu et al.
2012). FgaPT2 used even a number of tryptophan-
containing cyclic dipeptides as substrates (Steffan and Li
2009). The same prenylation position at the indole ring was
however found for products of a given enzyme, i.e., at
C-4 with FgaPT2 and MaPT (Ding et al. 2008; Steffan
et al. 2007), C-5 with 5-DMATS (Yu et al. 2012) and
C-7 in the case of 7-DMATS (Kremer and Li 2008).
Similar phenomena were also observed for cyclic dipep-
tide prenyltransferases from this family. For example,
the regular prenyltransferase FtmPT1 from A. fumigatus
catalyzes the prenylation of brevianamide F (cyclo-L-
Trp-L-Pro) at C2 of the indole ring (Grundmann and
Li 2005). The reverse prenyltransferases AnaPT and
CdpC3PT from Neosartorya fischeri used almost all of
the tested tryptophan-containing cyclic dipeptides as
substrates and catalyzed regiospecific prenylation at C-
3 of the indole ring (Yin et al. 2009, 2010).
Until now, two cyclic dipeptide prenyltransferases
were reported to use a limited number of compounds as
clearly favorable prenylation substrates. CTrpPT from
Aspergillus oryzae accepted cyclo-L-Trp-L-Trp much bet-
ter than other cyclic dipeptides as substrate (Zou et al.
2010). NotF from Aspergillus sp. MF297-2 is involved in
the biosynthesis of notoamides and only used breviana-
mide F as aromatic substrate (Ding et al. 2010). This
feature prohibits their usage as catalysts for production
of desired compounds. It was necessary to find a NotF
homologue with broad substrate specificity and to be
used as catalyst for synthesis of reversely C2-prenylated
indole derivatives.
Literature search revealed that several Aspergillus
versicolor strains produced brevianamides or notoamides
(Finefield et al. 2011; Li et al. 2009), which are very
likely derived from deoxybrevianamide E and therefore
a brevianamide F reverse prenyltransferase must be in-
volved in their biosynthesis. We decided therefore to
amplify notF homologue from A. versicolor NRRL573
by using PCR primers deduced from notF sequence in
Aspergillus sp. MF297-2. In this paper, we report the
cloning and expression of a notF homologue brePT
from A. versicolor. Biochemical characterization with
BrePT revealed its high flexibility towards tryptophan-
containing cyclic dipeptides.
Materials and methods
Chemicals
Dimethylallyl diphosphate (DMAPP), geranyl diphosphate
(GPP), and farnesyl diphosphate (FPP) were prepared
according to the method described for GPP (Woodside et
al. 1988). The four cyclo-Trp-Pro isomers were synthesized
from tryptophan methyl ester and N-Boc protected proline
according to the method published previously (Caballero et
al. 2003). Cyclo-L-Trp-L-Pro and Cyclo-L-Trp-D-Pro were
synthesized from H-L-Trp-OMe·HCl and N-Boc-D-Pro-OH,
cyclo-D-Trp-L-Pro and cyclo-D-Trp-D-Pro from H-D-Trp-
OMe·HCl and N-Boc-D-Pro-OH. Similarly, the two pairs
H-L-Trp-OMe·HCl and N-Boc-D-Ala-OH as well as H-D-
Trp-OMe·HCl and N-Boc-D-Ala-OH were used for the prep-
aration of the four stereoisomers of cyclo-Trp-Ala. Cyclo-L-
Trp-L-His was synthesized from N-Boc-L-Trp-OH and H-L-
His-OMe·HCl according to the literature (Bivin et al. 1993;
Cacciatore et al. 2005). The other cyclic dipeptides were
purchased from Bachem (Bubendorf, Switzerland).
Computer-assisted sequence analysis
FGENESH (Softberry, Inc.) and the DNASIS software pack-
age (version 2.1: Hitachi Software Engineering, San Bruno,
CA) were used for intron prediction and sequence analysis,
respectively. Amino acid sequence similarity searches were
carried out by using BLAST program from GenBank.
Bacterial strains, plasmids, and culture conditions
pGEM-T easy and pET28a were obtained from Promega
(Mannheim, Germany) and Novagen (Beijing, China), respec-
tively. Escherichia coli XL1 Blue MRF’ (Stratagene, Amster-
dam, the Netherlands) and BL21 (DE3) pLysS (Newprobo,
Beijing, China) were used for cloning and expression experi-
ments, respectively. They were grown in liquid Luria-Bertani
(LB) medium or on solid LB mediumwith 1.5 % (w/v) agar at
37 or 20 °C. 50 μg·ml−1 of kanamycin were used for selection
of recombinant E. coli cells.
Cultivation of A. versicolor NRRL573 for DNA isolation
A. versicolor NRRL573 was kindly provided by Agricul-
tural Research Service Culture Collection of the United
States Department of Agriculture. For DNA isolation, the
fungus was cultivated in liquid potatoe dextrose medium at
25 °C and 160 rpm for 5 days. Fungal mycelia were col-
lected and washed with phosphate-buffered saline consist-
ing of 137 mM NaCl, 2.7 mM KCl, 1 mM Na2HPO4, and
0.18 mM KH2PO4 (pH 7.3). Genomic DNAwas isolated by
using freeze–thaw method.
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DNA propagation in E. coli, PCR amplification,
and gene cloning
Standard procedures for DNA isolation and manipulation
were performed as described (Sambrook and Russell 2001).
PCR amplification was carried out on an iCycler from
BioRad (Munich, Germany). A PCR fragment of 1,384 bp
was amplified from genomic DNA of A. versicolor by using
the DNA sequences of Aspergillus sp. MF297-2, 5′-
ATATATGACGGCCCCAGAGCTCCGT-3 ′ and 5 ′-
GGCCTCAATCTTCTTCCCACAGATAGG-3′ as primers.
The underlined bold triplets ATG and TCA represent the
start and stop codon of notF, respectively.
To delete the intron sequence, a two round fusion PCR
was carried out as described previously (Yin et al. 2009).
Two primers brePT1-for (5 ′ -CATGCCATGGCA
ATGACGGCCCCAGAGCTCCGTG-3′) and brePT1-rev
(5 ′-ACGTCCAGGTCCGGGTACAGCTGTTGCAA
CATATC-3′) were used for amplification of the first exon,
a n d b r e P T 2 - f o r ( 5 ′ - TATGTTGCAACAGCT
GTACCCGGACCTGGACGTTT-3′) and brePT2-rev (5′-
ATAAGAATGCGGCCGCATCTTCTTCCCACAG
ATAGGTACTTTGT-3′) for the second exon. The under-
lined sequences with bold letter in brePT1-for and brePT2-
rev represent the restriction sites NcoI and NotI for cloning
in pET28a vector, respectively. The underlined letters in
bePT1-rev and brePT2-for indicated the overlapping region
of the two exons with a length of 1,178 and 130 bp, respec-
tively. The entire coding sequence of brePTwas obtained as
a PCR fragment of 1,333 bp and subsequently cloned into
pGEM-T easy vector, resulting in plasmid pQW1. pQW1
was sequenced (Eurofins MWG Operon, Ebersberg, Ger-
many) to confirm the sequence. To create the expression
vector pQW2, pQW1 was digested with NcoI and NotI and
the resulted NcoI–NotI fragment of 1,314 bp was ligated
into pET28a, which had been digested with the same
enzymes, previously. After unsuccessful expression with
pQW2 in E. coli under different conditions, the brePT
sequence was amplified from pQW2 by using the primers
5 ′ -TACCATGGATATGACGGCCCCA-3 ′ and 5 ′ -
AT G C G G C C G C T C A AT G AT G AT G AT G A
TGATCTTCTTCC-3′. The underlined sequence codes five
histidine residues for purification on Ni-NTA agarose. The
PCR product of 1,343 bp was then cloned into the restriction
sites NcoI and NotI in pET28a, resulting in the new expres-
sion plasmid pSY1.
Overproduction and purification of His5-BrePT
For gene expression, E. coli BL21 (DE3) pLysS cells har-
boring the plasmid pSY1 were cultivated in liquid LB
medium supplemented with kanamycin (50 μg ml−1) and
grown at 37 °C to an A600 of 0.7 and induced with 0.1 mM
IPTG for 5 h at 20 °C. Protein extraction and purification
were carried out as described previously (Yu et al. 2012).
Protein analysis and determination of molecular mass
of active His5-BrePT
Proteins were analyzed on SDS-PAGE according to the meth-
od described by Laemmli (Laemmli 1970) and stained with
Coomassie Brilliant Blue G-250. The molecular mass of the
recombinant His5-BrePT was determined by size exclusion
chromatography on a HiLoad 16/60 Superdex 200 column
(GE Healthcare) that had been equilibrated with 50 mM Tris–
HCl buffer (pH 7.5) containing 150 mM NaCl. The column
was calibrated with dextran blue 2000 (2,000 kDa), ferritin
(440 kDa), aldolase (158 kDa), conalbumin (75 kDa), carbon-
ic anhydrase (29 kDa), and ribonuclease A (13.7 kDa; GE
Healthcare). The proteins were eluted with 50 mM Tris–HCl
buffer (pH 7.5) containing 150 mM NaCl.
Assays for BrePT activity
For determination of the BrePT activity, the reaction mixtures
(100 μl) contained 50 mM Tris–HCl (pH 7.5), 10 mM CaCl2,
1 mM cyclic dipeptide, 2 mM DMAPP, GPP, or FPP, and
18 μg of purified recombinant BrePT and were incubated at
37 °C for 4 h. The reactions were then terminated by addition
of 100 μl of methanol. After removal of protein by centrifu-
gation at 13,000×g for 20 min, the enzyme products were
analyzed on HPLC under the conditions described below. For
quantitative measurement of the enzyme activity, duplicate
values were determined routinely. The assays for determina-
tion of the kinetic parameters (100 μl) of cyclic dipeptides
contained 2 mM DMAPP, 0.5–10 μg of BrePT. Due to the
difference in solubility in assay system, various concen-
trations were used for cyclic dipeptides: 1d–1g, 1i, and
1j up to 5 mM, 1b and 1c up to 2 mM, 1a up to 0.8 mM,
and 1h, 1k, and 1l up to 0.5 mM. For determination of
the kinetic parameters of DMAPP, the assays (100 μl)
contained 1 μg of BrePT, 1 mM cyclo-L-Trp-L-Pro and
DMAPP at final concentrations of up to 2 mM. The
incubation time was 30 min.
Preparative synthesis of the enzyme products for structural
elucidation
BrePT assays for isolation of the enzyme products (10 ml)
contained 1 mM DMAPP, 1 mM cyclic dipeptide, 10 mM
CaCl2, 50 mM Tris–HCl (pH 7.5), and 2 mg of BrePT.
The reaction mixtures were incubated at 37 °C for 16 h
and extracted subsequently with ethyl acetate. After evap-
oration of the solvent, the residues were dissolved in
methanol and purified on HPLC under the conditions
described below.
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HPLC conditions for analysis and isolation of the enzyme
products of BrePT
The enzyme products of the incubation mixtures of BrePT
were analyzed on HPLC with an Agilent series 1200 by using
a Multospher 120 RP-18 column (250×4 mm, 5 μm, C+S
Chromatographie Service, Langerwehe, Germany) at a flow
rate of 1 ml min−1. Water (solvent A) and methanol (solvent
B) each with 0.5 % (v/v) trifluoroacetic acid were used as
solvents. For analysis of enzyme products, a linear gradient of
40–100 % (v/v) solvent B in 15 min was used. The column
was then washed with 100 % solvent B for 5 min and equil-
ibrated with 40 % (v/v) solvent B for 5 min. Detection was
carried out by a photodiode array detector at 296 nm.
For isolation, the same HPLC equipment with a Multospher
120 RP-18 column (250×10 mm, 5 μm, C+S Chromatogra-
phie) was used. Water (solvent C) and methanol (solvent D)
without acid were used as solvents. A linear gradient of 40–
100 % (v/v) solvent D in 30 min at a flow rate of 2.5 ml min−1
was used. The column was then washed with 100 % solvent D
for 8 min and equilibrated with 40 % (v/v) solvent D for 8 min.
NMR spectroscopic analysis and high resolution mass spectra
1H-NMR spectra were recorded on a JEOL ECX-400 or
ECX-500 spectrometer. Chemical shifts were referenced to
the signal of CD3OD at 3.31 ppm or DMSO-d6 at 2.50 ppm.
All spectra were processed with MestReNova 5.2.2. The
isolated products were also analyzed by mass spectroscopy
on a Q-Trap Quantum (Applied Biosystems) using a high
resolution electron spray ionization (HR-ESI) mode or on an
AutoSPEC with an electron impact (HR-EI) mode. Positive
MS data are given in Table 1.
Nucleotide sequence accession number
The genomic and coding sequences of brePT from A. versi-
color NRRL573 is available at GenBank under the acces-
sion number JQ013953.
Results
Cloning and sequence analysis of a notF homologue brePT
from A. versicolor as well as protein overproduction and
purification
Whole genome sequencing of the marine-derived Aspergillus
sp. MF297-2 led to the identification of a biosynthetic gene
cluster for notoamides (Ding et al. 2010). NotF from this
cluster was found to be responsible for the reverse prenylation
of brevianamide F at position C2 of the indole ring resulting in
Table 1 HR-ESI-MS and HR-
EI-MS data of the enzyme
products of BrePT
Compounds Chemical formula HR-MS data Deviation
(ppm)
MS Calculated Measured
2a C21H25N3O2 HR-ESI-MS 374.1844 [M+Na]
+ 374.1811 8.9
2b C21H25N3O2 HR-ESI-MS 374.1844 [M+Na]
+ 374.1808 9.8
2c C21H25N3O2 HR-ESI-MS 374.1844 [M+Na]
+ 374.1814 8.1
2d C21H25N3O2 HR-EI-MS 351.1947 [M]
+ 351.1928 5.3
2e C19H23N3O2 HR-EI-MS 325.1790 [M]
+ 325.1777 4.0
2f C19H23N3O2 HR-ESI-MS 348.1688 [M+Na]
+ 348.1672 4.6
2g C19H23N3O2 HR-EI-MS 325.1790 [M]
+ 325.1773 5.3
2h C19H23N3O2 HR-EI-MS 325.1790 [M]
+ 325.1771 5.8
2i C18H21N3O2 HR-ESI-MS 312.1712 [M+H]
+ 312.1710 0.8
2j C22H29N3O2 HR-ESI-MS 368.2338 [M+H]
+ 368.2328 2.8
2k C25H27N3O2 HR-ESI-MS 424.2001 [M+Na]
+ 424.2039 −9.0
2l C25H27N3O3 HR-ESI-MS 440.1950 [M+Na]
+ 440.1952 −0.4
Fig. 1 Prenyl transfer reaction
catalyzed by NotF as well as its
role in the biosynthesis of
fungal natural products
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the formation of deoxybrevianamide E (Fig. 1) (Ding et al.
2010). It was also reported that NotF was highly specific
towards its aromatic substrate and no prenylated product
was detected for L-tryptophan, cyclo-L-Trp-L-Trp or cyclo-L-
Trp-L-Tyr by LC-MS analysis (Ding et al. 2010).
In course of our search for NotF homologues with broad
substrate specificity, a 1,384 bp PCR fragment was ampli-
fied from genomic DNA of A. visicolor NRRL573 by using
two oligonucleotides containing sequences at the beginning
and the end of notF. The obtained fragment was cloned into
pGEM-T easy vector and sequenced subsequently. Sequenc-
ing results showed that the putative notF homologue from
A. versicolor, termed brePT (brevianamide F prenyltrans-
ferase) in this study, has a size of 1,376 bp consisting of two
predicted exons of 1,178 and 130 bp, respectively, disrupted
by one intron of 68 bp. brePT shares an identity of 87 % on
the nucleotide level with notF from Aspergillus sp. MF297-
2. The deduced polypeptide BrePT has a length of 435
amino acids and is therefore of 17 amino acids shorter than
NotF. These amino acids correspond to two gaps of five and
seven amino acids at the N terminus and one gap of five
amino acids between amino acids 183 and 187 in NotF
(Fig. 2). BrePT and NotF share an identity of 83 % with
each other on the amino acid level.
To clone the entire coding region of brePT, the two exons
were amplified parallel from the genomic DNA and com-
bined with the help of a short overlapped region by further
PCR amplification (see Materials and methods). The suc-
cessfully amplified PCR product was cloned via pGEM-T
easy vector into the expression vector pET28a to create the
expression construct pQW2. After failed expression with
pQW2, we recloned brePT in pET28a by introducing five
histidine residues in the C-terminus of the overproduced
protein. E. coli BL21 cells harboring the newly constructed
expression vector pSY1 were cultivated in LB medium and
induced with 0.1 mM IPTG at 20 °C for 5 h. One-step
purification on Ni-NTA agarose resulted in a significant band
with similar migration behavior as the 45 kDa size marker on
SDS-PAGE (Fig. 3), corresponding to the calculated mass
BrePT  1    MTAPELR-----APAGHPQEP-------PARSSPAQALSSYHHFPTSDQERWYQETGSLC  48 
NotF   1    MTAPELRVDTFRAPEDAPKEPSAQQPRLPSSPSPAQALASYHHFPTNDQERWWEETGSLF  60 
BrePT  49   SRFLEAGQYGLHQQYQFMFFFMHHLIPALGPYPQKWRSTISRSGLPIEFSLNFQKGSHRL  108 
NotF   61   SRFLEAGQYGLPQQYQFMFFFMHHLIPALGPYPQKWRSTISRSGLPIEFSLNFQKGSHRL  120 
BrePT  109  LRIGFEPVNFLSGSSQDPFNRIPIADLLAQLARLQLRGFDTQCFQQLLTRFQLSLDEVRQ  168 
NotF   121  LRIGFEPVSFLSGSSQDPFNRIPITDLLNRLSKLQLSNFDTPFFQHLLSKFQLSLSEVRQ  180 
BrePT  169  LP-----PDDQPLKSQGAFGFDFNPDGAILVKGYVFPYLKAKAAGVPVATLIAESVRAID  223 
NotF   181  LQKQGSGPDAHPLKSQAAFGFDFNPDGAILVKGYVFPYLKAKAADVPVGTLIAEAVRTID  240 
BrePT  224  ADRNQFMHAFSLINDYMQESTGYNEYTFLSCDLVEMSRQRVKIYGAHTEVTWAKIAEMWT  283 
NotF   241  VERNQFTHAFGLINDYMQESTGYNEYTFLSCDFVETSEQRLKIYGAHTEVTWAKIAEMWT  300 
BrePT  284  LGGRLIEEPEIMEGLARLKQIWSLLQIGEGSRAFKGGFDYGKASATDQIPSPIIWNYEIS  343 
NotF   301  LGGRLIEEPEIIAGLARLKQIWSLLQIGEGSRAFKGGFDYDKSSATDQIASPIIWNYEIH  360 
BrePT  344  PGSSFPVPKFYLPVHGENDLRVARSLAQFWDSLGWSEHACAYPDMLQQLYPDLDVSRTSR  403 
NotF   361  PGSRFPVPKFYLPVHGENDLHVARALAQFWDSLGWPEHACAYPDTLQQLYPDQDISQTTR  420 
BrePT  404  LQSWISYSYTAKKGVYMSVYFHSQSTYLWEED  435 
NotF   421  LQSWISYSYTAKRGVYMSVYYHSQSTYLWEED  452 
Fig. 2 Alignments of BrePT
from Aspergillus versicolor
NRRL573 (JQ013953) with
NotF from Aspergillus sp.
MF297-2 (ADM34132.1).
Identical amino acids in both
proteins are highlighted with
grey background
Fig. 3 Analysis of the purified His5-BrePT on SDS-PAGE. The pro-
teins were separated on a 12 % SDS-polyacrylamide gel and stained
with Coomassie Brilliant Blue G-250. Lane 1 molecular mass standard
and lane 2 purified His5-BrePT
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Fig. 4 HPLC analysis of reaction mixtures of BrePT with cyclic dipeptides
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of 50 kDa for His5-BrePT. The yield was calculated to be
1.5 mg of purified protein per liter of culture. The molec-
ular mass of the native recombinant His5-BrePT was de-
termined by size exclusion chromatography as 56 kDa,
which indicated that BrePT likely acts as a monomer.
BrePT accepted all of the tested tryptophan-containing
cyclic dipeptides as substrates in the presence of DMAPP
BrePT was firstly assayed with brevianamide F (1a), the
natural substrate of its homologue NotF from Aspergillus sp.
MF297-2 (Ding et al. 2010), in the presence of DMAPP. A
product peak was clearly detected in the HPLC chromato-
gram of the incubation mixture (Fig. 4). A conversion yield
of about 91 % was achieved after incubation with 18 μg of
His5-BrePT for 4 h. Detection of this peak was strictly
dependent on the presence of DMAPP and the active en-
zyme (data not shown). Incubation of His5-BrePT with 13
additional tryptophan-containing cyclic dipeptides (1b–1n)
showed also clearly product formation with conversion
yields from 6 to 92 % (Fig. 4). L-tryptophan and L-tyrosine
were not accepted by His5-BrePT in the presence of
DMAPP under this condition. No production formation
was observed, when GPP or FPP instead of DMAPP was
used as a prenyl donor in reaction mixtures of the 14
tryptophan-containing cyclic dipeptides and His5-BrePT.
The accepted substrates included all of the four dike-
topiperazine stereoisomers of tryptophan and proline as
well as of tryptophan and alanine. As shown in Fig. 4,
cyclo-L-Trp-D-Pro (1b) was also well accepted by BrePT
with an almost same conversion yield as 1a. In contrast, the
other two isomers cyclo-D-Trp-D-Pro (1c) and cyclo-D-Trp-L-
Pro (1d) showed conversion yields of less than 15 %. It seems
that the stereochemistry of tryptophanyl moiety in these dipep-
tides plays an important role for their binding to BrePT and L-
form is the preferable configuration. Similar phenomena were
Table 2 1H-NMR data of C2-prenylated cyclic dipeptides produced by using BrePT
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also observed with the four isomers of cyclic dipeptides from
tryptophan and alanine (Fig. 4). Cyclo-L-Trp-L-Ala (1e) and
cyclo-L-Trp-D-Ala (1f) showed comparable activities with con-
version yields of 25 and 21 %, respectively. The two isomers
with D-tryptophanyl moiety, i.e., cyclo-D-Trp-D-Ala (1g) and
cyclo-D-Trp-L-Ala (1h) showed significantly lower conversion
yields of 6 and 14 %, respectively. In comparison to that of
cyclo-L-Trp-L-Ala (1e), comparable activities were detected for
cyclo-L-Trp-Gly (1i) and cyclo-L-Trp-L-Leu (1j) with conver-
sion yields of 23 and 32%, respectively. BrePTshowed slightly
lower activities towards tryptophan-containing dipeptides with
an additional aromatic amino acid such as cyclo-L-Trp-L-Phe
(1k), cyclo-L-Trp-L-Tyr (1l), cyclo-L-Trp-L-His (1m), and
cyclo-L-Trp-L-Trp (1n) than those consisting of L-tryptophan
and an aliphatic amino acid (Fig. 4).
BrePT catalyzed reverse C2-prenylation of tryptophan-
containing cyclic dipeptides
For structure elucidation, enzyme products of 12 selected sub-
strates (1a–1l, Fig. 4) were isolated on HPLC in preparative
scales and subjected to MS and NMR analyses. High-resolution
electron spray ionization mass spectroscopy (HR-ESI-MS) and
high resolution electron impact mass spectroscopy (HR-EI-MS)
confirmed that the molecular masses of the isolated products are
68Daltons larger than those of the respective substrates (Table 1),
indicating the monoprenylation of these substrates. Comparing
the 1H-NMR data of the enzyme products (2a–2l, Table 2; for
spectra see Figs. S1–S12 in the Electronic supplementary
material) with those of the respective substrates (data not shown)
revealed clearly the presence of the characteristic signals for
reverse prenyl residues, i.e., δH 6.08–6.22 (dd, 1H-2′), 4.98–
5.16 (d, 1H-1′), 4.97–5.12 (d, 1H-1′), 1.43–1.58 (s, 3H-4′), and
1.43–1.56 ppm (s, 3H-5′). Inspection of the 1H-NMR spectra of
the enzyme products revealed also the disappearance of the
singlets for H-2 of the substrates. Other signals for aromatic
protons did not changed significantly. This proved unequivocal-
ly the attachment of the reverse prenyl (tert-prenyl) moieties at
C2 of the indole ring and the regiospecific C2-prenylation
catalyzed by BrePT (Fig. 5). The 1H-NMR data of 2a, 2d, 2e,
2h, and 2i corresponded to those reported previously (Guo et al.
2011; Kuramochi et al. 2008; Ritchie and Saxton 1981).
Table 2 (continued)
L
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Biochemical characterization and kinetic parameters
of BrePT
For determination of the ion dependence of BrePT, incuba-
tions of cyclo-L-Trp-L-Pro (1a) with DMAPP were carried
out in the presence of different metal ions at a final concen-
tration of 5 mM. Incubations with the chelating agent EDTA
or without additives were used as controls. In the incubation
mixture with EDTA, slight increase of the enzyme activity
to 116 % was observed, in comparison to that of incubation
without additives. As observed for other members of the
DMATS superfamily (Li 2009b; Steffan et al. 2009), Ca2+
clearly enhanced the enzyme activity of BrePT. The enzyme
activity with Ca2+ was found to be 266 % of that without
additives.
To study the behavior of BrePT towards DMAPP and
twelve different cyclic dipeptides (1a–1l) in detail, kinetic
parameters including Michaelis–Menten constants (KM) and
turnover numbers (kcat), were determined by Hanes–Woolf
and Eadia–Hofstee plots and are given in Table 3. The
reactions catalyzed by BrePT apparently followed Michae-
lis–Menten kinetics. BrePT showed the best affinity to
cyclo-L-Trp-L-Pro (1a) with the largest reaction velocity.
KM values for DMAPP and cyclo-L-Trp-L-Pro (1a) were
found to be 98 and 32 μM, respectively. The turnover
number and catalytic efficiency were calculated for 1a at
Table 2 (continued)
D D D D D D
L L L L L L L L
a Overlapping signals with those of solvents
b After addition of D2O
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0.276 s−1 and 8,639 s−1 M−1, respectively. The KM values of
other tested substrates were found to be in the range of 82–
2,906 μM. Some of these values are much higher than that
of 1a but still in the concentration range expected for non-
natural substrates. Comparing the kinetic data showed that
BrePT has much higher catalytic efficiencies towards cyclo-
Trp-Pro isomers with L-tryptophanyl moiety, i.e., 1a and 1b,
than with their D-configured counter partners, i.e., 1c and
1d. As aforementioned, cyclo-L-Trp-D-Pro (1b) was also
very well accepted by BrePT with a KM value at 82 μM
and turnover number at 0.15 s−1. The catalytic efficiency of
1b was 21 % of that of 1a. Significant higher KM values at
0.7 and 2.9 mM were calculated for 1c and 1d, respectively.
The catalytic efficiency ratios of 1a to 1c and 1a to 1d were
calculated to be approximately 64 and 960, respectively.
Similar to the data obtained for cyclo-Trp-Pro isomers,
higher catalytic efficiency was also calculated for cyclo-
Trp-Ala isomers with L-configured tryptophanyl moiety
than for their respective D-configured counter partners,
i.e., with ratios of about 1.8 for cyclo-L-Trp-L-Ala (1e) to
cyclo-D-Trp-L-Ala (1h) and cyclo-L-Trp-D-Ala (1f) to cyclo-
D-Trp-D-Ala (1g). Cyclo-L-Trp-L-Leu (1j) was also found to
be a good substrate for BrePTwith a KM value of 0.106 mM
and turnover number of 0.014 s−1, corresponding to a cata-
lytic efficiency of 134 s−1 M−1.
Discussion
In a previous study, Ding et al. (2010) showed the high
specificity of the brevianamide F reverse prenyltransferase
NotF. In that study, the natural substrate cyclo-L-Trp-L-Pro
(1a) was very well, but cyclo-L-Trp-L-Tyr (1l) and cyclo-L-
Trp-L-Trp (1n) were not accepted by NotF. In this study, we
cloned, overexpressed and characterized a NotF homologue
BrePT from A. versicolor, which accepted all of the 14 tested
tryptophan-containing cyclic dipeptides with cyclo-L-Trp-L-
Pro (1a) as the best substrate. This could indicate the different
substrate specificities of BrePT and NotF. BrePT from A.
versicolor shares a sequence identity of 83 % on the amino
acid level with NotF from Aspergillus sp. MF297-2 and is of
17 amino acids shorter than NotF. These 17 amino acids were
found as three gaps in NotF (Fig. 2). Given the difference of
their substrate specificity, it could be speculated that these
three gaps would be responsible for the different flexibility
of these enzymes towards aromatic substrates.
On the other hand, cyclic dipeptides consisting of two
aromatic amino acids were also poor substrates for BrePT
(Fig. 4). Cyclo-L-Trp-L-Tyr (1l) and cyclo-L-Trp-L-Trp (1n)
were accepted by BrePT with conversion yields of 13.6 and
12.7 % after incubation with 18 μg of BrePT for 4 h, i.e., a
relative activity of 14.8 and 13.9 % of that of cyclo-L-Trp-L-
Pro (1a), respectively. The catalytic efficiency was calculat-
ed for cyclo-L-Trp-L-Tyr (1l) at 27 s−1 M−1, i.e., only 0.3 %
of that of 1a (Table 3). Unfortunately, the conversion yield
of cyclo-L-Trp-L-Pro was not given for NotF in the previous
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Fig. 5 Conversion of cyclic
dipeptides to reversely C2-
prenylated derivatives by
BrePT
Table 3 Kinetic parameters of BrePT for selected substrates
Name KM (mM) kcat (s
−1) kcat/KM (s
−1 M−1)
Cyclo-L-Trp-L-Pro (1a) 0.032 0.276 8639
Cyclo-L-Trp-D-Pro (1b) 0.082 0.150 1830
Cyclo-D-Trp-D-Pro (1c) 0.709 0.095 134
Cyclo-D-Trp-L-Pro (1d) 2.906 0.027 9
Cyclo-L-Trp-L-Ala (1e) 0.942 0.035 37
Cyclo-L-Trp-D-Ala (1f) 0.793 0.013 17
Cyclo-D-Trp-D-Ala (1g) 1.318 0.011 9
Cyclo-D-Trp-L-Ala (1h) 0.139 0.003 21
Cyclo-L-Trp-Gly (1i) 1.300 0.032 25
Cyclo-L-Trp-L-Leu (1j) 0.106 0.014 134
Cyclo-L-Trp-L-Phe (1k) 0.094 0.004 40
Cyclo-L-Trp-L-Tyr (1l) 0.214 0.006 27
DMAPP 0.098 0.489 4,992
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study (Ding et al. 2010). Given a similar behavior of BrePT
and NotF regarding their substrate specificities, it would not
be surprising that no product formation was observed for
NotF with cyclo-L-Trp-L-Trp (1n) and cyclo-L-Trp-L-Tyr
(1l) as substrates. It would be interesting now to test the
acceptance of other substances investigated in this study by
NotF, e.g., 1b or/and 1j.
From the catalytic efficiencies obtained for the four ster-
eoisomers of cyclo-Trp-Pro (1a–1d) as well as for those of
cyclo-Trp-Ala (1e–1h), it seems that an acceptance by
BrePT is strongly dependent on the configuration of trypto-
phan. Isomers with L-tryptophanyl moiety were much better
substrates for BrePT than those with a D-configuration
(Fig. 4). The natural substrate of BrePT is unknown. Base
on its high sequence similarity of 83 % on the amino acid
level to NotF, the low KM value and high turnover number
with cyclo-L-Trp-L-Pro (1a), it can be however speculated
that the natural substrate of BrePT should be brevianamide
F. As mentioned in the “Introduction,” the product of BrePT,
i.e., deoxybrevianamide E, is a precursor of brevianamides
and notoamides, which were isolated from several strains of
A. versicolor (Finefield et al. 2011). BrePT is therefore very
likely involved in the biosynthesis of these compounds in A.
versicolor (Finefield et al. 2011; Li et al. 2009).
We demonstrated in this study that BrePT catalyzed the
reverse prenyltransfer reaction onto C2 of the indole nu-
cleus of the tryptophan-containing diketopiperazines, at
least for the 12 isolated and identified enzyme products
(Fig. 5). This feature provides experimental evidence for a
possible application of BrePT as a catalyst in the chemo-
enzymatic synthesis of C2 reversely prenylated cyclic
dipeptides.
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Figure S1. 1H-NMR spectrum of 2a in CD3OD (500 MHz)   
 
 
 
Figure S2. 1H-NMR spectrum of 2b in CD3OD (500 MHz)   
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Figure S3. 1H-NMR spectrum of 2c in CD3OD (500 MHz)   
 
 
 
Figure S4. 1H-NMR spectrum of 2d in CD3OD (400 MHz)   
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Figure S5. 1H-NMR spectrum of 2e in CD3OD (400 MHz)   
 
 
 
 
Figure S6. 1H-NMR spectrum of 2f in CD3OD (500 MHz)   
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Figure S7. 1H-NMR spectrum of 2g in CD3OD (400 MHz)   
 
 
 
 
Figure S8. 1H-NMR spectrum of 2h in CD3OD (400 MHz)   
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Figure S9. 1H-NMR spectrum of 2i in CD3OD (500 MHz)   
 
 
 
Figure S10. 1H-NMR spectrum of 2j in CD3OD (500 MHz)   
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Figure S11. 1H-NMR spectrum of 2k in DMSO-d6 (400 MHz) with addition of one drop of D2O   
 
 
 
Figure S12. 1H-NMR spectrum of 2l in DMSO-d6 (400 MHz) with addition of one drop of D2O   
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Complementary stereospecific synthesis of cis-configured prenylated 
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Prenylated pyrroloindoline diketopiperazines are a subgroup of prenylated indole alkaloids with a 
characteristic 6/5/5/6-fused tetracyclic ring system. Three indole prenyltransferases of the 
dimethylallyltryptophan synthase (DMATS) superfamily, i.e., AnaPT and CdpC3PT from Neosartorya 
fischeri and CdpNPT from Aspergillus fumigatus, had been found to catalyze the formation of prenylated 10 
pyrroloindoline diketopiperazines from tryptophan-containing cyclic dipeptides in one-step reactions. In 
this study, we investigated their behavior towards all of the four stereoisomers of cyclo-Trp-Ala and 
cyclo-Trp-Pro. Our results demonstrated that the enzymes showed different preference for these 
substrates and different stereospecificity of the product formation. The stereoselectivity of AnaPT and 
CdpC3PT depends mainly on the configuration of the tryptophanyl moiety in the tested cyclic dipeptides. 15 
AnaPT usually catalyze the anti-substitution of the prenyl moiety at C-3 to the carbonyl moiety at C-11, 
while CdpC3PT introduces the prenyl moiety from the opposite side, i.e. syn-configuration to the 
carbonyl moiety at C-11. CdpNPT catalyzes both syn- and anti-substitution of the prenyl moiety and the 
structure of the second amino acid moiety of the tested dipeptides is important for the stereospecificity in 
its enzyme catalysis. These enzymes are therefore efficient tools for enantioselective synthesis of cis-20 
configured prenylated pyrroloindoline diketopiperazines. As examples, we prepared in this study eight 
and six stereoisomers of cis-configured prenylated pyrroloindoline diketopiperazines from cyclo-Trp-Ala 
and cyclo-Trp-Pro isomers, respectively. 
Introduction 
Prenylated indole alkaloids are mainly found in the family of 25 
Clavicipitaceae and Trichocomaceae of Ascomycota, and carry 
important pharmacological and biological activities.1-5 Prenylated 
pyrroloindoline diketopiperazines, a subgroup of these alkaloids, 
contain a 6/5/5/6-fused tetracyclic core with at least three or four 
chiral centres (Fig. 1).6-11 Their structural complexity prohibited a 30 
conventional synthesis of these compounds.12,13 In previous 
studies, three C3-prenyltransferases belonging to the 
dimethylallyltryptophan synthase (DMATS) superfamily were 
identified and characterized biochemically, i.e., AnaPT and 
CdpC3PT from Neosartorya fischeri and CdpNPT from 35 
Aspergillus fumigatus.14-16 They introduced a dimethylallyl 
moiety to position C-3 of a tryptophanyl moiety. In addition, they 
catalyzed also the formation of a five-membered ring between the 
original indole and diketopiperazine rings with a cis-
configuration between H-2 and C3-dimethylallyl moiety, 40 
resulting in the formation of prenylated pyrroloindoline 
diketopiperazines (Fig. 1). Attacking of the dimethylallyl cation 
by C-3 of the indole ring was proposed to be the first step in the 
reaction mechanism, resulting in the formation of an intermediate 
with a positive charge at C-2. This is followed by the formation 45 
 
Fig. 1: Prenyl transfer reactions catalyzed by AnaPT, CdpC3PT and CdpNPT. 
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of a C–N bond between C-2 and N-12 with a positive charge at 
N-12.17-19 Release of a proton from N-12 leads to the enzymatic 
products.17-19 The substrate promiscuity of AnaPT, CdpC3PT and 
CdpNPT towards tryptophan-containing cyclic dipeptides 
provided evidence for their potential application as catalysts for 5 
highly regio- and stereoselective conversions.15-17,19 By using 
AnaPT and CdpNPT, four aszonalenin stereoisomers were 
prepared from benzodiazepinedione enantiomers.20 However, the 
most of the reported cyclic dipeptides usually contained only L-
configured amino acid moieties, and little was known about their 10 
behavior on substrates with D-configured amino acid moieties. In 
order to understand more about the stereospecificity of AnaPT, 
CdpC3PT and CdpNPT, we carried out enzyme incubation with 
four cyclo-Trp-Ala isomers (1a-4a) and four cyclo-Trp-Pro 
isomers (5a-8a) and analyzed the chemical structures of the 15 
enzyme products.  
Results and Discussion  
The four cyclo-Trp-Ala (1a-4a) and cyclo-Trp-Pro isomers (5a-
8a) (Table 1) were synthesized according to the methods 
published previously.21,22 Incubation of these substrates was 20 
carried out with 40 µg of AnaPT, CdpC3PT or CdpNPT in the 
presence of DMAPP for 3 h. Assays with heat-inactivated 
proteins by boiling for 20 min were used as negative controls. 
HPLC analysis of the incubation mixtures showed that isomers of 
cyclo-Trp-Ala (1a-4a) were well accepted by all of the three 25 
enzymes (Fig. 2). Substrate consumptions were found to be in the 
range of 13.9-52.4% in the assays with AnaPT and CdpC3PT 
(Table 1). In comparison to those of 13.9% for cyclo-D-Trp-D-
Ala (3a) and 21.7% for cyclo-D-Trp-L-Ala (4a), AnaPT accepted 
cyclo-L-Trp-L-Ala (1a) and cyclo-L-Trp-D-Ala (2a) significantly 30 
better (Table 1) with substrate consumption at 39.7% and 29.1%, 
respectively. These results indicated the preference of AnaPT for 
L-configured tryptophanyl moiety. CdpC3PT represented a 
similar behavior as AnaPT. The substrate consumption of cyclo-
L-Trp-L-Ala (1a) at 52.4% and cyclo-L-Trp-D-Ala (2a) at 34.2% 35 
were twice or even higher than those for cyclo-D-Trp-D-Ala (3a) 
and cyclo-D-Trp-L-Ala (4a). As given in Table 1, CdpNPT 
showed much higher activity towards four cyclo-Trp-Ala isomers 
(1a-4a) than AnaPT and CdpC3PT. Substrate consumptions in 
the range of 62.3–87.0% were detected in the enzyme assays with 40 
CdpNPT. The comparable activity of CdpNPT towards cyclo-
Trp-Ala isomers (1a-4a) indicated that CdpNPT exhibited no 
obvious preference for L- or D-configured cyclic dipeptides.  
In the incubation mixtures with the four cyclo-Trp-Pro isomers 
(5a-8a), preference of AnaPT and CdpC3PT towards substrates 45 
with L-tryptophanyl moiety was also observed (Fig. 3). By using 
AnaPT, higher substrate consumption of 15.2% for cyclo-L-Trp-
L-Pro (5a) and 30.0% for cyclo-L-Trp-D-Pro (6a) were detected, 
in comparison to 7.1% for cyclo-D-Trp-D-Pro (7a) and 8.7% for 
cyclo-D-Trp-L-Pro (8a) (Table 1). CdpC3PT represented 50 
significant higher activity towards cyclo-L-Trp-L-Pro (5a) and 
cyclo-L-Trp-D-Pro (6a) with substrate consumption of 88.3 and 
76.1%, respectively, approximately three times or even higher 
than those for cyclo-D-Trp-D-Pro (7a) and cyclo-D-Trp-L-Pro 
(8a). As observed for cyclo-Trp-Ala isomers (1a-4a), relative 55 
higher activity than those of AnaPT and CdpC3PT was also 
detected for CdpNPT in the assays with cyclo-Trp-Pro isomers 
(5a-8a). Yields of the product formation were found in the range 
of 68.5-98.0%.  
Detailed inspection of the HPLC chromatograms of the 60 
incubation mixtures of 1a-4a with AnaPT and CdpC3PT (Fig. 2) 
revealed the formation of one product peak in each assay. The 
presence of one dominant peak for 3a or two comparable peaks 
for 1a, 2a and 4a were observed in the assays of CdpNPT. 
Incubation of AnaPT with cyclo-L-Trp-L-Pro (5a), cyclo-L-Trp-65 
D-Pro (6a) and cyclo-D-Trp-L-Pro (8a) resulted in the formation 
of one dominant enzyme product in each assay (Fig. 3). AnaPT 
catalyzed the conversion of two dominant products from cyclo-D-
Trp-D-Pro (7a). In cases of the assays with CdpC3PT, one 
dominant product each was detected for cyclo-L-Trp-D-Pro (6a), 70 
cyclo-D-Trp-D-Pro (7a) and cyclo-D-Trp-L-Pro (8a), and three 
products for cyclo-L-Trp-L-Pro (5a). In the incubation mixtures 
with CdpNPT, one dominant product peak each was observed for 
cyclo-L-Trp-D-Pro (6a) and cyclo-D-Trp-D-Pro (7a), while two 
and three products were for cyclo-L-Trp-L-Pro (5a) and cyclo-D-75 
Trp-L-Pro (8a), respectively.  
UV-detection revealed that 1b-8b and 1c-8c were likely 
prenylated pyrroloindoline diketopiperazines with maximal 
Table 1: Conversion of cyclo-Trp-Ala (1a-4a) and cyclo-Trp-Pro isomers (5a-8a) catalyzed by AnaPT, CdpC3PT and CdpNPT. The 
assays contained 40 µg of the recombinant enzymes each and were incubated at 37 °C for 3 h. 
 
Subs. 
Conversion (%) 
AnaPT CdpC3PT CdpNPT 
S.C. Anti- (1b-8b) 
Syn- 
(7c) S.C. 
Anti- 
(7b) 
Syn- 
(1c-8c) S.C. 
Anti- 
(1b-5b, 7b, 8b) 
Syn- 
(1c-7c) 
cyclo-L-Trp-L-Ala (1a) 39.7 39.7 n.d. 52.4 n.d. 39.5 72.5 38.4 22.0 
cyclo-L-Trp-D-Ala (2a) 29.1 29.1 n.d. 34.2 n.d. 32.0 86.2 34.3 51.9 
cyclo-D-Trp-D-Ala (3a) 13.9 10.8 n.d. 15.9 n.d. 11.0 87.0 72.7 2.6 (n.i.) 
cyclo-D-Trp-L-Ala (4a) 21.7 21.7 n.d. 17.8 n.d. 17.8 62.3 26.1 36.2 
cyclo-L-Trp-L-Pro (5a) 15.2 15.2 n.d. 88.3 n.d. 58.3 89.6 4.8 75.1 
cyclo-L-Trp-D-Pro (6a) 30.0 23.9 (n.i.) n.d. 76.1 n.d. 69.6 68.5 n.d. 62.5 
cyclo-D-Trp-D-Pro (7a) 7.1 3.2 0.2 26.0 2.7 2.7 98.0 94.1 2.0 (n.i.) 
cyclo-D-Trp-L-Pro (8a) 8.7 5.6 (n.i.) n.d. 5.1 n.d. 3.7 86.5 25.6 (n.i.) n.d. 
S.C.: substrate consumption. 
Anti-: conversion yields of anti-cis configured prenylated pyrroloindoline diketopiperazines. 5 
Syn-: conversion yields of syn-cis configured prenylated pyrroloindoline diketopiperazines. 
n.d.: not detected. 
n.i.: not isolated due to low stability 
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abosorptions at 205, 240 and 295 nm. The dominant products 
(1b-4b, 1c-4c) of the four cyclo-Trp-Ala isomers (1a-4a) 
catalyzed by AnaPT and CdpC3PT were isolated on HPLC, 
respectively, and subjected to 1H-NMR and MS analyses. 
Products (1b-4b, 1c, 2c and 4c) were also purified from the 5 
incubation mixtures with CdpNPT. 1H-NMR and MS analyses 
proved that the products from CdpNPT were identical to those 
from AnaPT and CdpC3PT assays. Similar experiments were also 
carried out for the four cyclo-Trp-Pro isomers (5a-8a). Products 
5b-8b and 7c from the reaction mixtures of AnaPT, 5c-8c, 7b, 5d 10 
and 6d of CdpC3PT and 5b, 7b, 8b, 5c-7c, 6d and 8d of CdpNPT 
were isolated on HPLC and subjected to MS and NMR analyses.  
Positive EI-MS or ESI-MS (see Electronic Supplementary 
Information, Table S1) confirmed the presence of one 
dimethylallyl moiety each in 1b-5b, 7b and 1c-8c by detection of 15 
masses, which are 68 daltons larger than those of the respective 
substrates. In the 1H-NMR spectra of all of the enzyme products 
(taken in CDCl3), signals at δH 5.15-5.07 (d, 2H-1'), 5.94-5.99 
(dd, H-2'), 1.11-1.14 (s, 3H-4'), 0.99-1.11 (s, 3H-5') were 
observed (Tables S2-3 and Figs. S1-S17), proving unequivocally 20 
the presence of a reverse dimethylallyl moiety in their 
structures.15,19  
Cross peaks in HSQC spectra of 5b, 5c and 6c revealed that the 
singlets of H-2 (δH 5.39-5.71, 1H, s) correlated with C-2 (δC 77.2-
79.4), proving the disappearance of the double bond between C-2 25 
and C-3 of the original indole ring. Connectivities from H-2 to C-
 
Fig. 2: HPLC chromatograms of incubation mixtures of 1a-4a with AnaPT, CdpC3PT and CdpNPT. The assays contained 40 µg of the
recombinant enzymes each and were incubated at 37 °C for 3 h. Detection was carried with a diode array detector and illustrated for
absorption at 254 nm.   
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11 (δC 59.1-60.5) in the HMBC spectra of 5b, 5c and 6c showed 
clearly that a chemical bond between C-2 and N-12 was formed 
and therefore the three C3-prenylated products contained a fused 
five-membered ring between the indoline and diketopiperazine 
ring. In the HMBC spectra of 5b, 5c and 6c (Figs. S9-S11), 5 
connectivities from H-2 of the indoline ring to C-3' (δC 40.8-41.6) 
of the prenyl moiety, and from both H-4' (δH 1.11-1.14, 3H, s) 
and H-5' (δH 0.99-1.01, 3H, s) of the prenyl moiety to C-3 (δC 
61.9-62.8) of the indoline ring, proved unequivocally the 
attachment of the dimethylallyl moiety to C-3 of the indoline 10 
ring. NOESY experiments provided unambiguous evidences for a 
cis-configuration between H-2 and C3-prenyl moiety (Figs. S9-
S11). For example, strong or medium NOE correlations were 
observed for H-2 with H-2', H-4' and H-5' of the dimethylallyl 
moieties. For compound 5b, strong NOE correlation was 15 
observed between H-4' of the prenyl moiety and H-10b, which 
has the anti-configuration to the carbonyl moiety at C-11. NOE 
correlation was not observed for the protons of the prenyl moiety 
with H-10a, which has the syn-configuration to the carbonyl 
moiety at C-11. Therefore, H-2 and C3-prenyl moiety must be 20 
substituted on the same side to H-10b, consequently the opposite 
side of the carbonyl moiety at C-11 and proving that 5b is an 
anti-cis configured prenylated pyrroloindoline diketopiperazine. 
In contrast to 5b, weak or none NOE correlations were observed 
 
Fig. 3: HPLC chromatograms of incubation mixtures of 5a-8a with AnaPT, CdpC3PT and CdpNPT. The assays contained 40 µg of the
recombinant enzymes each and were incubated at 37 °C for 3 h. Detection was carried with a diode array detector and illustrated for
absorption at 254 nm. X: enzyme products with unknown structures.  
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for protons of the prenyl moiety with H-10b and H-11 in the 
spectra of compounds 5c and 6c. Moreover, H-4' of the 
dimethylallyl moieties showed strong or medium NOE 
correlation with H-10a. Therefore, H-2 and C3-prenyl moiety of 
5c and 6c must be situated on the opposite side to H-10b, 5 
consequently the same side of the carbonyl moiety at C-11. 
Products 5c and 6c were therefore assigned to be syn-cis 
configured prenylated pyrroloindoline diketopiperazines. 
Compound 5c was also reported as enzyme product of the G115T 
mutant of FtmPT1.18 The NMR data of 5c corresponded well to 10 
those published previously.18 
The 1H-NMR spectrum of the enzyme product 7b obtained from 
substrate 7a was identical to that of 5b obtained from 5a (Figs. 
S9 and S12). Considering that 7a is the enantiomer of 5a, 7b and 
5b should also be enantiomers. The structure of 7b was therefore 15 
assigned to be an anti-cis configured prenylated pyrroloindoline 
diketopiperazine. Similar phenomena were also observed for 
enzyme product 7c and 5c as well as 8c and 6c. It can be 
therefore concluded that the prenyl moiety has a syn-
configuration to the carbonyl moiety at C-11 in 7c and 8c.  20 
Detailed inspection of the 1H-NMR spectra revealed significant 
difference between anti-configured (5b and 7b) and syn-
configured derivatives (5c, 6c and 8c) for the coupling patterns of 
H-11 and chemical shift of H-10b. A triplet was detected for H-
11 in 5b and 7b, while a double doublet was observed for H-11 in 25 
5c, 6c, and 8c. Concerning the chemical shifts for H-10b, it seems 
that H-10b in products with an anti-configured prenyl moiety was 
low-field shifted approximate 0.25 ppm in comparison to H-10b 
in those with a syn-configured prenyl moiety (Table 2). To 
understand the observed difference for H-11 and H-10b, 1H-NMR 30 
data of known anti-cis and syn-cis configured prenylated 
pyrroloindoline diketopiperazines from literature and from this 
study are summarized in Table 2.15,19 The observed difference for 
H-11 and H-10b in this study can be indeed also found for other 
product pairs of known compounds. In addition, similar coupling 35 
constants were observed for H-11 in products bearing a prenyl 
moiety in the same orientation. The coupling constants of H-11 
were approximately 9 Hz for the triplets in anti-cis configured 
prenylated pyrroloindoline diketopiperazines and about 11 Hz 
and 6 Hz for the double doublets in syn-cis configured prenylated 40 
pyrroloindoline diketopiperazines. Therefore, the 1H-1H vicinal 
coupling patterns of H-11 and chemical shifts for H-10b in 1H-
NMR spectra could be used for prediction of the stereochemistry 
of cis-configured prenylated pyrroloindoline diketopiperazines.  
In the 1H-NMR spectra of the product pairs obtained from cyclo-45 
Trp-Ala isomers, triplets with coupling constants of 8.7-9.1 Hz 
were observed for H-11 in products 1b-4b, while double doublets 
with coupling constants of 11.1-11.2 Hz and 6.2 Hz were 
detected for H-11 in 1c-4c. Furthermore, comparison of the 
signals in the 1H-NMR spectra of 1b to 1c, 2b to 2c, 3b to 3c and 50 
4b to 4c revealed that H-10b of the former was low-field shifted 
0.26-0.30 ppm to the latter in respective product pairs. Thus, 1b-
4b and 1c-4c were assigned to be anti- and syn-cis configured 
prenylated pyrroloindoline diketopiperazines, respectively. A 
literature search revealed that the 1H-NMR data of 2c 55 
corresponded well to those published previously.23 Unfortunately, 
6b and 8b were very unstable and their structures cannot be 
elucidated in this study. In addition to cis-configured prenylated 
pyrroloindoline diketopiperazines, N-regularly prenylated 
derivatives of cylco-Trp-Pro (5d, 6d and 8d) were also detected 60 
in the enzyme assays of CdpNPT and CdpC3PT, and their 
structures were confirmed by 1H-NMR and MS analyses (Figs. 
S15-S17).    
From the obtained data, it is obvious that the configuration of 
tryptophanyl moiety in the tested cyclic dipeptides has a 65 
significant influence on the attack direction of the indole ring to 
the dimethylllalyl cation. AnaPT converted all cyclo-Trp-Ala 
stereoisomers (1a-4a) to anti-cis configured prenylated 
pyrroloindoline diketopiperazines (1b-4b). This means that the 
Table 2: Signals of H-10b and H-11 in the 1H-NMR spectra of 
cis-configured prenylated pyrroloindoline diketopiperazines 
from the incubation mixtures of C3-prenyltransferases with 
cyclic dipeptides. 
Substrates Enzymes 
Products 
Configu
-rations 
H-11, 
multi. 
JH11-H10a 
(Hz) 
JH11-H10b 
(Hz) 
H-10b, 
δH, ppm Ref.  
cyclo-L-Trp-
L-Pro 
AnaPT 
CdpNPT anti-cis t 8.9 8.9 2.79 
this 
study 
cyclo-D-Trp-
D-Pro 
AnaPT 
CdpNPT 
CdpC3PT 
anti-cis t 8.9 8.9 2.79 this study 
cyclo-L-Trp-
L-Leu AnaPT anti-cis t 8.5 8.5 2.81 19 
cyclo-L-Trp-
L-Trp AnaPT anti-cis t 9.2 9.2 2.79 19 
cyclo-L-Trp-
L-Phe AnaPT anti-cis t 9.2 9.2 2.81 19 
cyclo-L-Trp-
L-Tyr AnaPT anti-cis t 8.8 8.8 2.81 19 
cyclo-L-Trp-
Gly AnaPT anti-cis t 9.0 9.0 2.84 19 
cyclo-L-Trp-
L-Ala 
AnaPT 
CdpNPT anti-cis t 8.7 8.7 2.81 
this 
study 
cyclo-L-Trp-
D-Ala 
AnaPT 
CdpNPT anti-cis t 9.1 9.1 2.87 
this 
study 
cyclo-D-Trp-
D-Ala 
AnaPT 
CdpNPT anti-cis t 8.8 8.8 2.81 
this 
study 
cyclo-D-Trp-
L-Ala 
AnaPT 
CdpNPT anti-cis t 9.2 9.2 2.87 
this 
study 
cyclo-L-Trp-
L-Pro 
CdpC3PT 
CdpNPT syn-cis dd 6.7 10.8 2.54 
this 
study 
cyclo-L-Trp-
D-Pro 
CdpC3PT 
CdpNPT syn-cis dd 5.3 12.0 2.51 
this 
study 
cyclo-D-Trp-
L-Pro CdpC3PT syn-cis dd 5.3 12.0 2.51 
this 
study 
cyclo-L-Trp-
L-Leu 
CdpC3PT 
CdpNPT syn-cis dd 5.1 10.5 2.55 15 
cyclo-L-Trp-
L-Trp 
CdpC3PT 
CdpNPT syn-cis dd 6.2 11.1 2.52 15 
cyclo-L-Trp-
L-Phe 
CdpC3PT 
CdpNPT syn-cis dd 6.2 11.2 2.52 15 
cyclo-L-Trp-
L-Tyr 
CdpC3PT 
CdpNPT syn-cis dd 6.1 10.7 2.52 15 
cyclo-L-Trp-
Gly 
CdpC3PT 
CdpNPT syn-cis dd 5.9 11.0 2.56 15 
cyclo-L-Trp-
L-Ala 
CdpC3PT 
CdpNPT syn-cis dd 6.2 11.1 2.55 
this 
study 
cyclo-L-Trp-
D-Ala 
CdpC3PT 
CdpNPT syn-cis dd 6.2 11.2 2.57 
this 
study 
cyclo-D-Trp-
D-Ala 
CdpC3PT 
CdpNPT syn-cis dd 6.5 10.9 2.55 
this 
study 
cyclo-D-Trp-
L-Ala 
CdpC3PT 
CdpNPT syn-cis dd 6.2 11.3 2.57 
this 
study 
H-10a and H-10b has the syn- and anti-configuration to to the carbonyl 
moiety at C-11, respectively. 
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prenyl moiety was always attached at the opposite side of the 
carbonyl moiety at C-11. Similar phenomena were also observed 
for assays of AnaPT with cyclo-L-Trp-L-Pro (5a) and cyclo-D-
Trp-D-Pro (7a). In the incubation mixture with cyclo-L-Trp-L-
Pro (5a), only the product with anti-configured prenylation was 5 
detected. Although both anti- and syn-cis configured prenylated 
pyrroloindoline diketopiperazines were isolated from assays of 
AnaPT with cyclo-D-Trp-D-Pro (7a), the anti-cis configured 
product with 94% of the C3-prenylated deivatives (Table 1) was 
the clearly dominant product.  10 
1H-NMR spectra confirmed the formation of syn-cis configured 
prenylated pyrroloindoline diketopiperazines (1c-8c) from all 
substrates with CdpC3PT. In the incubation mixture of cyclo-D-
Trp-D-Pro (7a) with CdpC3PT, conversion yield of C3-
 
Fig. 4: Prenyl transfer reactions catalyzed by AnaPT, CdpC3PT and CdpNPT towards 1a-4a and 5a-8a. Only C3-prenylated products 
with yields more than 3% are illustrated.  
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prenylated products was very low. In this case, one additional 
anti-cis configured prenylated pyrroloindoline diketopiperazine 
7b was also isolated. These data confirmed that the 
stereospecificity of CdpC3PT was also mainly influenced by the 
configuration of tryptophanyl moiety other than alaninyl or 5 
prolinyl moiety in the tested cyclic dipeptides. The prenylation 
almost took place at the same side of the carbonyl moiety at C-
11. 
It was reported in a previous study that CdpNPT catalyzed only 
syn-prenylation of cyclo-L-Trp-L-Pro (5a).17 Detailed inspection 10 
of the HPLC chromatogram of incubation mixture of CdpNPT 
with 5a revealed that one minor peak with a ratio of 6 : 94 to the 
syn-cis configured prenylated pyrroloindoline diketopiperazine 5c 
with the characteristic UV absorption of prenylated 
pyrroloindoline diketopiperazines was also detected. The minor 15 
peak had the same retention time with the anti-cis configured 
prenylated pyrroloindoline diketopiperazine (5b) produced by 
AnaPT and was subsequently confirmed to be an identical 
structure by the 1H-NMR analysis. Similar to 5a, one minor peak 
each (3c and 7c) with a characteristic UV absorption of 20 
prenylated pyrroloindoline diketopiperazines, in addition to the 
anti-cis configured prenylated pyrroloindoline diketopiperazines 
(3b and 7b), were also detected in the assays of CdpNPT with 
cyclo-D-Trp-D-Ala (3a) and cyclo-D-Trp-D-Pro (7a). The ratio 
of the products was found to be about 3 : 97 for 3c and 3b and 2 : 25 
98 for 7c and 7b in these assays. Products 3c and 7c formed by 
CdpNPT had the same retention time with syn-cis configured 
prenylated pyrroloindoline diketopiperazines 3c and 7c formed 
by CdpC3PT, and thereby could be assigned to syn-cis configured 
prenylated pyrroloindoline diketopiperazines. It seems that 30 
CdpNPT showed different stereospecificity towards the four 
isomers of cyclo-Trp-Ala isomers (1a-4a) and cyclo-Trp-Pro 
isomers (5a-7a). CdpNPT preferred to catalyze the formation of 
syn-cis configured prenylated pyrroloindoline diketopiperazines 
(5c and 6c) from cyclo-L-Trp-L-Pro (5a) and cyclo-L-Trp-D-Pro 35 
(6a), and an anti-cis configured prenylated pyrroloindoline 
diketopiperazine (7c) from cyclo-D-Trp-D-Pro (7a). These 
products were found as major products in the enzyme assays with 
5a-7a. Although a main product (3b) with anti-configured prenyl 
moiety was observed in the assay with cyclo-D-Trp-D-Ala (3a), 40 
product yields of derivatives with syn- and anti-configured prenyl 
moiety were comparable in the assays with cyclo-L-Trp-L-Ala 
(1a), cyclo-L-Trp-D-Ala (2a) and cyclo-D-Trp-L-Ala (4a). In 
contrast to AnaPT and CdpC3PT, it is likely that not the 
configuration of amino acids moiety in the tested cyclic 45 
dipeptides, but the size of the second amino acid moiety plays an 
important role for the stereospecificity of CdpNPT. The size 
reduction from cyclo-Trp-Pro (5a-8a) to cyclo-Trp-Ala (1a-4a) 
leaded to lower stereoselectivity of CdpNPT.  
Furthermore, free rotation of the residue at C-14 of the 50 
diketopiperazine ring plays also an important role for the 
stereoselectivity observed in this study. In a previous study,20 we 
have observed that the stereoselectivity of a given enzyme for 
benzodiazepinedinones differed clearly from that of tested 
diketopiperazines. AnaPT introduced in that case a prenyl moiety 55 
from different sides of (R)- and (S)-benzodiazepinedinone, so 
that an -prenylation took place in both cases, resulting in the 
formation of anti-cis and syn-cis configured aszonalenin, 
respectively (Fig. 5). In contrast, CdpNPT catalyzed a ß-
prenylation of both substrates, i.e. introduced the prenyl moiety 60 
from the opposite side of the AnaPT reactions, resulting in the 
formation of other two anti-cis and syn-cis configured isomers 
(Fig. 5). In all of the four reactions, only one of the four 
stereoisomers was detected as enzyme product.  
 65 
Conclusions 
In this study, we presented the substrate promiscuity of AnaPT, 
CdpC3PT and CdpNPT towards all of the four stereoisomers of 
cyclo-Trp-Ala and cyclo-Trp-Pro, and demonstrated clearly the 
distinct stereospecific preference of the three C3-70 
prenyltransferases. The configuration of tryptophanyl moiety in 
the tested cyclic dipeptides strongly influences the prenylation 
orientation of the AnaPT and CdpC3PT reactions, but not that of 
CdpNPT. The stereoselectivity of the AnaPT and CdpC3PT 
reactions were approximately 100% in incubation mixtures with 75 
different stereoisomers and complemented to each other. In 
comparison to AnaPT and CdpC3PT, CdpNPT showed lower 
stereospecificity, but higher conversion yields towards most of 
the tested substrates. Therefore, CdpNPT could be useful for 
prenylation of poor substrates of AnaPT and CdpC3PT. 80 
Experimental Section 
Chemicals 
Dimethylallyl diphosphate (DMAPP) was prepared according to 
the methods described for GPP.24 Synthesis of the four cyclo-Trp-
Ala (1a-4a) isomers and cyclo-Trp-Pro isomers (5a-8a) was 85 
according to the method published previously.21,22 
 
Overproduction and purification of the recombinant proteins 
as well as enzyme assays with recombinant purified protein 
AnaPT, CdpNPT and CdpC3PT were overproduced in E. coli and 90 
purified as described.14-16 The enzymatic reaction mixtures (100 
 
Fig. 5. Prenylations of (R)- and (S)-benzodiazepinedione  catalyzed by AnaPT and CdpNPT. 
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μl) for determination of the relative activities with different 
tryptophan-containing cyclic dipeptides contained 50 mM Tris-
HCl (pH 7.5), 10 mM CaCl2, 1 mM substrate, 2 mM DMAPP, 
0.15-2% (v/v) glycerol, 5% (v/v) DMSO and 40 μg of purified 
recombinant protein. The reaction mixtures were incubated at 37 5 
°C for 3 h. The enzyme reactions were terminated by addition of 
100 μl methanol per 100 μl reaction mixtures. Enzymatic assays 
for isolation of the enzyme products contained 2 mM DMAPP, 1 
mM cyclic dipeptide, 10 mM CaCl2, 50 mM Tris-HCl (pH 7.5), 
and 2 mg of purified recombinant protein per 10 ml assay. The 10 
reaction mixtures were incubated at 37 °C for 16 h and extracted 
subsequently with ethyl acetate. After evaporation of the solvent, 
the residues were dissolved in methanol and purified on HPLC. 
 
HPLC conditions for analysis and isolation of synthetic 15 
products 
The enzyme products of the incubation mixtures were analyzed 
on HPLC with an Agilent series 1200 by using a Multospher 120 
RP-18 column (250 x 4 mm, 5 µm, C+S Chromatographie 
Service, Langerwehe, Germany) at a flow rate of 1 ml•min-1. 20 
Water (solvent A) and acetonitrile (solvent B) each with 0.5% 
(v/v) trifluoroacetic acid were used as solvents. For analysis of 
enzyme products, 37% (v/v) solvent B in 30 min was used. The 
column was then washed with 85% solvent B for 5 min and 
equilibrated with 37% (v/v) solvent B for 5 min. Detection was 25 
carried out by a photodiode array detector at 254 nm.  
For isolation, the same HPLC equipment with a Multospher 120 
RP-18 column (250 x 10 mm, 5 um, C＋S Chromatographie) at a 
flow rate of 2.5 ml•min-1 was used. Water (solvent C) and 
acetonitrile (solvent D) without acid were used as solvents. 30 
Repeated chromatography was carried out with different 
gradients for isolation.  
 
NMR spectroscopic analysis and high resolution mass spectra  
NMR spectra were recorded on a JEOL ECX-400, Bruker 35 
Avance 500 MHz or Bruker Avance 600 MHz spectrometer. 
Chemical shifts were referenced to the signal of CDCl3 at 7.26 
ppm. All spectra were processed with MestReNova 5.2.2. The 
isolated products were also analyzed by mass spectroscopy on a 
Q-Trap Quantum (Applied Biosystems) using an electron spray 40 
ionization (ESI) or on an Auto SPEC with an electron impact 
(HR-EI) mode.. Positive MS data are given in Table S1 in 
Electronic Supplementary Information. 
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Table S1: HR-EI-MS and ESI-MS data of enzyme products. 
Comp. Chemical formula MS Calculated Measured 
Deviation 
(ppm) 
1b C19H23N3O2 ESI-MS 326.2 [M+H]+  326.1 - 
1c C19H23N3O2  ESI-MS 326.2 [M+H]+  326.1 - 
2b C19H23N3O2  ESI-MS 326.2 [M+H]+  326.1 - 
2c C19H23N3O2  ESI-MS 326.2 [M+H]+  326.1 - 
3b C19H23N3O2  ESI-MS 326.2 [M+H]+  326.1 - 
3c C19H23N3O2  ESI-MS 326.2 [M+H]+  326.1 - 
4b C19H23N3O2  ESI-MS 326.2 [M+H]+  326.1 - 
4c C19H23N3O2  ESI-MS 326.2 [M+H]+  326.1 - 
5b C21H25N3O2 HR-EI-MS 351.1947 [M]+ 351.1952 -1.5 
5c C21H25N3O2 HR-EI-MS 351.1947 [M]+ 351.1967 -5.8 
5d C21H25N3O2 ESI-MS 352.2 [M+H]+ 352.1 - 
6c C21H25N3O2 HR-EI-MS 351.1947 [M]+ 351.1974 -7.8 
6d C21H25N3O2 ESI-MS 352.2 [M+H]+ 352.1 - 
7b C21H25N3O2 ESI-MS 352.2 [M+H]+ 352.2 - 
7c C21H25N3O2 HR-EI-MS 351.1947 [M]+ 351.1981 -9.6 
8c C21H25N3O2 ESI-MS 352.2 [M+H]+ 352.2 - 
8d C21H25N3O2 ESI-MS 352.2 [M+H]+ 352.2 - 
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Table S2. 1H-NMR data of enzyme products obtained from cyclo-Trp-Ala isomers (1a-4a) in CDCl3 (400 MHz). Chemical shifts (δ) were given in ppm and 
coupling constants (J) in Hz.  
Compd 
 
1b* 
 
1c 
 
2b 
 
2c 
 
3b* 
 
3c 
 
4b* 
 
4c 
Pos. δH, multi., J in Hz δH, multi., J in Hz δH, multi., J in Hz δH, multi., J in Hz δH, multi., J in Hz δH, multi., J in Hz δH, multi., J in Hz δH, multi., J in Hz 
2 5.41, s 5.52, s 5.38, s 5.57, s 5.40, s 5.51, s 5.39, s 5.58, s 
4 7.18, d, 7.6 7.16, d, 7.6 7.15, d, 7.6 7.16, d, 7.6 7.17, d, 7.6 7.16, d, 7.5 7.16, d, 7.6 7.17, d, 7.4 
5 6.76, t, 7.6 6.77, t, 7.6 6.74, t, 7.6 6.77, t, 7.6 6.75, t, 7.6 6.76, t, 7.5 6.76, t, 7.6 6.78, t, 7.4 
6 7.09, t, 7.6 7.11, t, 7.6 7.08, t, 7.6 7.11, t, 7.6 7.08, t, 7.6 7.10, t, 7.5 7.09, t, 7.6 7.12, t, 7.4 
7 6.61, d, 7.6 6.60, d, 7.6 6.57, d, 7.6 6.60, d, 7.6 6.58, d, 7.6 6.58, d, 7.5 6.61, d, 7.6 6.61, d, 7.4 
10a 2.54, dd, 13.9, 8.7 2.48, dd, 12.7, 11.1 2.44, dd, 13.8, 9.1 2.43, dd, 12.6, 11.2 2.54, dd, 13.9, 8.8 2.47, dd, 12.7, 10.9 2.43, dd, 13.8, 9.2 2.43, dd, 12.6, 11.3 
10b 2.81, dd, 13.9, 8.7 2.55, dd, 12.7, 6.2 2.87, dd, 13.8, 9.1 2.57, dd, 12.6, 6.2 2.81, dd, 13.9, 8.8 2.55, dd, 12.7, 6.5 2.87, dd, 13.8, 9.2 2.57, dd, 12.6, 6.2 
11 4.13, t, 8.7 3.96, dd, 11.1, 6.2 4.09, t, 9.1 3.93, dd, 11.2, 6.2 4.13, t, 8.8 3.96, dd, 10.9, 6.5 4.09, t, 9.2 3.93, dd, 11.3, 6.2 
14 4.06, q, 6.9 4.05, q, 6.9 3.96, qd, 7.2, 3.7 4.01, qd, 7.1, 3.8 4.06, q, 6.9 4.04, q, 6.9 3.96, qd, 7.2, 3.8 4.01, qd, 7.1, 3.8 
17 1.42, d, 6.9 1.47, d, 6.9 1.48, d, 7.2 1.41, d, 7.1 1.42, d, 6.9 1.46, d, 6.9 1.47, d, 7.2 1.41, d, 7.1 
1' 5.16, d, 10.8 5.13, d, 10.8 5.17, d, 10.8 5.13, d, 10.8 5.16, d, 10.8 5.12, d, 10.8 5.17, d, 10.8 5.13, d, 10.8 
1' 5.13, d, 17.4 5.08, d, 17.4 5.13, d, 17.4 5.08, d, 17.3 5.12, d, 17.4 5.08, d, 17.4 5.14, d, 17.4 5.08, d, 17.4 
2' 5.95, dd, 17.4, 10.8 5.98, dd, 17.4, 10.8 5.95, dd, 17.4, 10.8 5.97, dd, 17.3, 10.8 5.95, dd, 17.4, 10.8 5.98, dd, 17.4, 10.8 5.94, dd, 17.4, 10.8 5.97, dd, 17.4, 10.8 
4' 1.15, s 1.12, s 1.15, s 1.12, s 1.14, s 1.12, s 1.15, s 1.12, s 
5' 0.99, s 1.02, s 0.99, s 1.01, s 0.99, s 1.02, s 0.99, s 1.01, s 
H-10a and H-10b: has the syn- and anti-configuration to the carbonyl moiety at C-11, respectively. 
*: measured on 500 MHz spectrometer. 
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Table S3. 1H- and 13C- NMR data of enzyme products obtained from cyclo-Trp-Pro isomers (5a-8a) in CDCl3 (400 MHz). Chemical shifts (δ) were given in ppm 
and coupling constants (J) in Hz.  
Compd 
N
H
N
N
O
O
1
4
5
6
7
2 12
10
11
14
1'
2'
4' 5'
H 13
3
8
9 3'
15
16
171819
 
5b* 
N
H
N
N
O
O
1
4
5
6
7
2 12
10
11
14
1'
2'
4' 5'
H 13
3
8
9 3'
15
16
171819
 
5c∆ 
N
H
N
N
O
O
1
4
5
6
7
2 12
10
11
14
1'
2'
4' 5'
H 13
3
8
9 3'
15
16
171819
 
6c* 
 
7b 
 
7c 
 
8c 
Pos. 
13C NMR 
δ ppm 
1H NMR 
δH, multi., J in Hz 
13C NMR 
δ ppm 
1H NMR 
δH, multi., J in Hz 
13C NMR 
δ ppm 
1H NMR 
δH, multi., J in Hz 
1H NMR 
δH, multi., J in Hz 
1H NMR 
δH, multi., J in Hz 
1H NMR 
δH, multi., J in Hz 
2 79.4 5.39, s 77.4 5.46, s 77.2 5.71, s 5.39, s 5.46, s 5.71, s 
3 62.3 / 61.9 / 62.8 / / / / 
4 125.8 7.17, d, 7.6 125.1 7.16, d, 7.6 125.5 7.17, d, 7.6 7.17, d, 7.6 7.16, d, 7.6 7.17, d, 7.6 
5 118.7 6.73, t, 7.6 119.0 6.77, t, 7.6 119.0 6.74, t, 7.6 6.73, t, 7.6 6.77, t, 7.6 6.75, t, 7.6 
6 128.3 7.06, t, 7.6 128.9 7.11, t, 7.6 129.0 7.08, t, 7.6 7.07, t, 7.6 7.11, t, 7.6 7.08, t, 7.6 
7 108.9 6.55, d, 7.6 109.4 6.59, d, 7.6 108.7 6.56, d, 7.6 6.55, d, 7.6 6.59, d, 7.6 6.57, d, 7.6 
8 148.4 / 149.9 / 150.3 / / / / 
9 131.5 / 129.4 / 128.6 / / / / 
10a 35.7 2.56, dd, 14.0, 8.9 35.1 2.49, dd, 12.9, 10.8  38.3 2.31, t, 12.0 2.56, dd, 14.0, 8.9 2.48, § 2.31, t, 12.0 
10b 35.7 2.79, dd, 14.0, 8.9 35.1 2.54, dd, 12.9, 6.7 38.3 2.51, dd, 12.0, 5.3 2.79, dd, 14.0, 8.9 2.54, § 2.51, dd, 12.0, 5.3 
11 59.1 4.16, t, 8.9 60.5 3.99, dd, 10.8, 6.7 59.9 3.97, dd, 12.0, 5.3 4.16, t, 8.9 3.99, § 3.98, dd, 12.0, 5.3 
13 168.7 / 166.2 / 164.2 / / / / 
14 60.7 4.09, t, 8.0 60.5 4.05, † 60.7 4.02, dd, 11.7, 5.7 4.09, dd, 8.9, 7.2 4.05, § 4.03, dd, 11.6, 5.6 
15 27.8 2.31, m 2.05, m 27.7 
2.32, m 
2.12, m 29.4 
2.40, m 
1.75, m 
2.32, m 
2.06, m 
2.31, m 
2.12, m 
2.41, m 
1.75, m 
16 23.0 1.97, m 1.86, m 22.9 
2.04, m, 
1.89, m 21.5 
1.98, m 
1.89, m 
1.97, m 
1.87, m 
2.03, m 
1.89, m 
1.98, m 
1.89, m 
17 44.9 3.42, m 45.1 3.56, m 3.50, m 44.4 
3.91, m 
3.28, m 3.43, m 
3.56, m 
3.50, m 
3.90, ddd, 12.2, 8.8, 7.3 
3.29, ddd, 12.2, 9.9, 4.1 
19 165.7 / 167.0 / 164.5 / / / / 
1’ 114.6 5.15, d, 10.8 5.12, d, 17.4 114.5 
5.12, d, 10.8 
5.07, d, 17.4 114.6 
5.12, d, 10.8 
5.08, d, 17.4 
5.15, d, 10.8 
5.12, d, 17.3 
5.11, d, 10.8 
5.07, d, 17.3 
5.12, d, 10.8 
5.08, d, 17.4 
2’ 143.7 5.95, dd, 17.4, 10.8 143.7 5.98, dd, 17.4, 10.8 143.5 5.94, dd, 17.4, 10.8 5.95, dd, 17.3, 10.8 5.99, dd, 17.3, 10.8 5.94, dd, 17.4, 10.8 
3’ 41.6 / 40.8 / 41.0 / / / / 
4’ 22.2 1.14, s 22.4 1.11, s 22.1 1.12, s 1.14, s 1.11, s 1.12, s 
5’ 22.4 0.99, s 22.7 1.01, s 23.0 1.01, s 0.99, s 1.01, s 1.01, s 
H-10a and H-10b: has the syn- and anti-configuration to the carbonyl moiety at C-11, respectively. 
†: the coupling constant can't be determined due to overlapping of this peak with impurity. 
§: the coupling constants can't be determined due to low resolution of these peaks. 
*: measured on 500 MHz spectrometer. 
∆: measured on 600 MHz spectrometer 
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Table S3 (continued) 
Compd 
 
5d* 
 
6d*  8d 
Pos. 
1H NMR 
δH, multi., J in Hz 
1H NMR 
δH, multi., J in Hz 
1H NMR 
δH, multi., J in Hz 
2 7.01, s 6.96, s 6.95, s 
4 7.56, d, 8.1 7.59, d, 8.1 7.59, d, 8.1 
5 7.12, dd, 8.1, 7.0 7.12, dd, 8.1, 7.0 7.11, dd, 8.1, 7.0 
6 7.24, dd, 8.1, 7.0 7.20, dd, 8.1, 7.0 7.20, dd, 8.1, 7.0 
7 7.33, d, 8.1 7.30, d, 8.1 7.30, d, 8.1 
10 3.76, dd, 15.1, 3.7 2.92, dd, 15.1, 11.1 
3.35, dd, 14.5, 6.7 
3.20, dd, 14.5, 3.7 
3.35, dd, 14.4, 6.7 
3.20, dd, 14.4, 3.7 
11 4.36, dd, 11.1, 3.7 4.23, dt, 6.7, 3.7 4.23, dt, 6.7, 3.7 
14 4.08, t, 8.2 3.57, dt, 12.0, 8.6 3.57, dt, 12.2, 8.6 
15 2.33, m 2.02, m‡ 
2.11, m 
1.74, m‡ 
2.10, m 
1.72, m‡ 
16 2.02, m
‡ 
1.91, m‡ 
1.86, m‡ 
1.48, m‡ 
1.86, m‡ 
1.47, m‡ 
17 3.65, m 3.59, m 
3.22, overlaps 
2.92, dd, 10.9, 6.4 
3.22, overlaps 
2.91, dd, 11.0, 6.5 
1’ 4.67, d, 6.9 4.65, d, 6.9 4.65, d, 6.9 
2’ 5.38, tm, 6.9 5.31, tm, 6.9 5.31, tm, 6.9 
4’ 1.83, s 1.82, s 1.82, s 
5’ 1.78, s 1.76, s 1.76, s 
*: measured on 500 MHz spectrometer. 
‡: assignments interchangeable. 
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Fig. S1: 1H-NMR spectrum of 1b in CDCl3 (500 MHz). 
 
 
Fig. S2: 1H-NMR spectrum of 1c in CDCl3 (400 MHz). 
 
N
H
N
NH
O
O
1
4
5
6
7
2 12
10
11
14
1'2'
4' 5'
H 13
3
8
9 3'
17
1516
N
H
N
NH
O
O
1
4
5
6
7
2 12
10
11
14
1'2'
4' 5'
H 13
3
8
9 3'
17
1516
145
8 
 
 
Fig. S3: 1H-NMR spectrum of 2b in CDCl3 (400 MHz). 
 
 
Fig. S4: 1H-NMR spectrum of 2c in CDCl3 (400 MHz). 
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Fig. S5: 1H-NMR spectrum of 3b in CDCl3 (500 MHz). 
 
 
 
Fig. S6: 1H-NMR spectrum of 3c in CDCl3 (400 MHz). 
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Fig. S7: 1H-NMR spectrum of 4b in CDCl3 (500 MHz). 
 
 
 
Fig. S8: 1H-NMR spectrum of 4c in CDCl3 (400 MHz). 
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Fig. S9.1: 1H-NMR spectrum of 5b in CDCl3 (500 MHz). 
 
Fig. S9.2: HSQC spectrum of 5b in CDCl3 (500 MHz). 
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Fig. S9.3: HMBC spectrum of 5b in CDCl3 (500 MHz). 
 
 
Fig. S9.4: NOESY spectrum of 5b in CDCl3 (500 MHz). 
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Fig. S10.1: 1H-NMR spectrum of 5c in CDCl3 (600 MHz). 
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Fig. S10.2: HSQC spectrum of 5c in CDCl3 (600 MHz). 
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Fig. S10.3: HMBC spectrum of 5c in CDCl3 (600 MHz). 
 
Fig. S10.4: NOESY spectrum of 5c in CDCl3 (600 MHz). 
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Fig. S11.1: 1H-NMR spectrum of 6c in CDCl3 (500 MHz). 
 
Fig. S11.2: HSQC spectrum of 6c in CDCl3 (500 MHz). 
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Fig. S11.3: HMBC spectrum of 6c in CDCl3 (500 MHz). 
 
 
Fig. S11.4: NOESY spectrum of 6c in CDCl3 (500 MHz). 
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Fig. S12: 1H-NMR spectrum of 7b in CDCl3 (400 MHz). 
 
 
Fig. S13: 1H-NMR spectrum of 7c in CDCl3 (400 MHz). 
 
N
H
N
N
O
O
1
4
5
6
7
2 12
10
11
14
1'
2'
4' 5'
H 13
3
8
9 3'
15
16
171819
N
H
N
N
O
O
1
4
5
6
7
2 12
10
11
14
1'
2'
4' 5'
H 13
3
8
9 3'
15
16
171819
155
18 
 
 
Fig. S14: 1H-NMR spectrum of 8c in CDCl3 (400 MHz). 
 
 
Fig. S15: 1H-NMR spectrum of 5d in CDCl3 (500 MHz). 
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Fig. S16: 1H-NMR spectrum of 6d in CDCl3 (500 MHz). 
 
 
Fig. S17: 1H-NMR spectrum of 8d in CDCl3 (400 MHz). 
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Prenylated indolocarbazoles have been reported neither from natural sources, nor by chemical synthetic
approaches. In this Letter, we report a regiospecific prenylation of indolocarbazoles at the para-position
of the indole N-atom by two recombinant enzymes from the dimethylallyltryptophan synthase (DMATS)
superfamily, that is, 5-DMATS from Aspergillus clavatus and FgaPT2 from Aspergillus fumigatus.
 2012 Elsevier Ltd. All rights reserved.Indolocarbazoles are a class of natural products with well
known remarkable biological activities, especially their inhibitory
effects against protein kinases in various organisms. Several of
these compounds have already entered clinical trials for treatment
of cancer and other diseases.1,2 To overcome the activity promiscu-
ity of naturally occurring indolocarbazoles such as staurosporine
and K252d (Fig. 1) toward kinases,3–5 numerous chemical strate-
gies have been developed for the synthesis of their mimetics to
provide specific kinase inhibitors.6,7 Significant progress has also
been achieved in the biosynthetic studies of indolocarbazoles.
Identification and proof of biosynthetic genes for indolocarbazoles
provided additional possibilities to create novel derivatives by
combinatorial biosynthesis.2,8 However, prenylated indolocarbaz-
oles have been reported, neither from natural sources, nor from
chemical synthetic approaches, although diverse prenylated carb-
azoles have been isolated from different sources.6
Prenylated derivatives are formed in the nature by transfer of
n  C5 (n = 1, 2, 3, 4, or larger) units from their active forms, usually
as diphosphate esters, to diverse acceptors. The responsible en-
zymes for the transfer reactions are different prenyltransferases,
which are also successfully used as biocatalysts for the synthesis
of prenylated compounds.9–12 A large group of prenyltransferases
belong to the dimethylallyltryptophan synthase (DMATS) super-
family. Themembers of this superfamily are involved in the biosyn-
thesis of fungal secondary metabolites and catalyzed mainly thell rights reserved.
x: +49 6421 2826678.
S.-M. Li).prenylation of diverse indole derivatives.13 For example, FgaPT2
from Aspergillus fumigatus and 5-DMATS from Aspergillus clavatus
catalyze the prenylation of L-tryptophan at C-4 and C-5, respec-
tively, and therefore function as dimethylallyltryptophan synthases
(Scheme 1).14,15 It has also been demonstrated that some members
of the DMATS superfamily catalyze even the prenylation of
hydroxynaphthalenes and flavonoids.16,17 These results encouraged
us to test the acceptance of indolocarbazoles by members of the
DMATS superfamily.
For this purpose, we synthesized four indolocarbazoles 1a–4a
(Scheme 2). Treatment of indole-3-acetamide with methyl
indolyl-3-glyoxylate in the presence of KOBut afforded the inter-
mediate arcyriarubin A,18 which was converted to N-methylarcyr-
iarubin A by treatment with methyl iodide.19 Arcyriaflavin A (1a)
and its N6-methylated derivative 4a were obtained after oxidativeFigure 1. Structures of staurosporine and K252d.
Scheme 1. Prenyltransfer reactions of 5-DMATS and FgaPT2 for their natural
substrate L-tryptophan.
6862 X. Yu et al. / Tetrahedron Letters 53 (2012) 6861–6864
160cyclization of the two bisindolylmaleimides arcyriarubin A and
N-methylarcyriarubin A, respectively.20,21 Reduction of 1a with
tin metal in AcOH/HCl and LiAlH4 in THF resulted in the formation
of K252c (2a)21 and 7-hydroxy-K252c (3a),22 respectively. The
identities of the obtained compounds were confirmed by NMR
and MS analyses. Unexpectedly, two product peaks 3a and 3a*
were observed in the HPLC chromatogram of 3a (Fig. 2). Reanalysis
of the isolated single peak 3a on HPLC revealed still the presence of
both peaks. Furthermore, the ratios of 3a* to 3a were found to be
nearly identical in all of the incubation mixtures with 3a. However,Figure 2. HPLC chromatograms and prenyl transfer reactions onto indolocarbazoles
catalyzed by 5-DMATS and FgaPT2. The reaction mixtures (100 ll) containing
0.2 lg ll1 of purified recombinant protein, 0.5 mM of aromatic substrate, and
DMAPP in 50 mM Tris–HCl (pH 7.5) were incubated at 37 C for 3 h. Detection was
carried out on a Photodiode array detector and illustrated for absorption at 290 nm.
Scheme 2. Synthesis of bisindolylmaleimides and indolocarbazoles as substrates.a 1H NMR spectrum in DMSO-d6 showed only signals for the
structure of 3a. It seems therefore that 3a* is an isomer of 3a, for
example, a keto–enol tautomer at C-5 and N-6.
The two bisindolylmaleimides arcyriarubin A andN-methylarcyr-
iarubin A, the four indolocarbazoles 1a–4a, and two indolocarbazole
glycosides staurosporine and K252d, which had been isolated from
X. Yu et al. / Tetrahedron Letters 53 (2012) 6861–6864 6863
161Streptomyces nitrosporeus CQT14-24, were then incubated with nine
prenyltransferases from the DMATS superfamily in the presence of
dimethylallyl diphosphate (DMAPP). The tested enzymes included
five cyclic dipeptide prenyltransferases AnaPT, BrePT, CdpC3PT,
CdpNPT, and FtmPT1 with prenylation positions at C-2 or C-3 of the
indole ring,23–27 three dimethylallyltryptophan synthases FgaPT2,
5-DMATS, and 7-DMATS with prenylation positions at C-4, C-5, and
C-7,14,15,28 respectively. One tyrosine O-prenyltransferase SirD29
was also tested.HPLCanalysis showed that 5-DMATS fromAspergillus
clavatus and FgaPT2 from Aspergillus fumigatus displayed more sub-
strate flexibilities toward the tested substances than other enzymes
(data not shown) and were studied in detail.
HPLC analysis of incubationmixtures with a 20 lg of 5-DMATS or
FgaPT2 in 100 ll assay indicated that 1awas poor substrate for both
enzymes. 5-DMATS accepted 1a only with a total conversion yield
of 0.3%,while no product peakwas detected in its incubationmixture
with FgaPT2. Other three indolocarbazoles (2a–4a) were clearly ac-
cepted by both 5-DMATS and FgaPT2 ( Fig. 2). Product formation
was only detected in the incubation mixtures with active, but not in
those with heat-inactivated proteins (by boiling for 20 min, data not
shown). This demonstrated the importance of the oxidation grade at
position C-7. Hydroxylation at this position seems better for accep-
tance by 5-DMATS than with a keto group. Detailed inspection of
the HPLC chromatograms with 2a–4a revealed that FgaPT2 showed
generally a lower activity than 5-DMATS, proving again that different
DMATS enzymes display different preference toward aromatic sub-
strates.17 Furthermore, more than one product peaks were detected
in the reaction mixtures and the main product of both enzymes for
a given substratewas proven tobe identical (seebelow). For example,
2awasconvertedby5-DMATS into2b,2c, and2dwithyieldsof11,11,
and 1.7 %, respectively. 2a was converted by FgaPT2 mainly into 2b
with a yield of 6.7 % (Fig. 2A). 3a/3a* were converted into 3b by 5-
DMATS and FgaPT2 with conversion yields of 42 and 25%, respec-
tively. The non-bridged intermediates of indolocarbazoles, that is,
arcyriarubin A and N-methylarcyriarubin A, were not accepted by 5-
DMATS and FgaPT2, indicating the importance of the presence of
the indolocarbazole skeleton. Glycosides of indolocarbazoles, that is,
staurosporine or K252d (Fig. 1), were also not prenylation substrates
for the enzymes of the DMATS superfamily (data not shown).
For structure elucidation, three enzyme products 2b, 2c, and 2d
were isolated from the incubation mixture of 5-DMATS with 2a
and one each, that is, 3b and 4b, from those with 3a and 4a, respec-
tively. 2b and 3b were also isolated from the reaction mixtures of
FgaPT2 with 2a and 3a. All isolated enzyme products were sub-
jected to MS and NMR analyses.
In the HPLC chromatograms of the incubation mixtures with 3a,
a minor product peak eluted after 3b was also observed (Fig. 2B),
which could be a prenylation product of 3a* or formed by tautom-
erism of 3b. Due to the low quantity, this minor product could not
be isolated and identified. For the same reason, no enzyme product
of 4a with FgaPT2 and 1a with 5-DMATS was isolated.
HR-EI-MS confirmed the monoprenylation in 2b, 2c, 3b, and 4b
and diprenylation in 2d, by detection of the molecular masses that
are 68 and 136 Da larger than those of the respective substrate
(Supplementary Table S1). The main enzyme products of FgaPT2
with 2a and 3a had identical 1H NMR spectra as those of 2b and
3b from the 5-DMATS assays, respectively, proving the same
structure of the enzyme products. The 1H NMR signals at dH
3.48–3.52 (d, 2H-10 or 2H-100), 5.40–5.44 (t sep, H-20 or H-200),
1.77–1.79 (d, 3H-40 or 3H-400), and 1.73–1.75 ppm (d, 3H-50 or
3H-500) in the spectra of 2b, 2c, 2d, 3b, and 4b (Supplementary Figs.
S1–S5, Table S2) revealed clearly the attachment of one regular
dimethylallyl moiety to a C-atom.17,30
In the 1H NMR spectra of the substrates 2a–4a (Supplementary
Figs. S6–S8), the aromatic signals appeared as two identical (4a) or
different sets of four vicinal coupling protons (2a and 3a). Each setcontains two doublets and two triplets with coupling constants in
the range of 7–9 Hz. In comparison, one set of signals in the 1H
NMR spectra of their enzyme products 2b, 2c, 3b, and 4b represent
merely three protons. Two of these protons couple with each other
with coupling constants of 7–9 Hz and the third one appears as a
singlet or doublet with a small coupling constant of less than
2 Hz. These changes indicated that the prenylation had taken place
at position C-2, C-3, C-9, or C-10. Similar phenomenon was also ob-
served in both sets of aromatic signals in the 1H NMR spectrum of
2d, suggesting that one prenylation took place at C-2 or C-3 and
the other at C-9 or C-10. Comparing the signals in the spectra of
2b, 3b, and 4b with those of the respective substrate (Supplemen-
tary Figs. S6–S8) revealed that the H-4 was changed from a doublet
with coupling constants of 7-9 Hz to another doublet with cou-
pling constants small than 2 Hz, which was found in the low field
in 1H NMR spectra at approximately dH 9 ppm due to a character-
istic deshielding effect from the lactam carbonyl,31 confirming the
prenylation at C-3 of 2b, 3b, and 4b. In the 1H NMR spectrum of 2c,
the signal of H-8 rather than that of H-4 was changed from a dou-
blet to a singlet (Figure S6),31 confirming that the prenylation had
taken place at C-9. The structure of 2d was assigned to a product
with two prenyl moieties at C-3 and C-9, since both H-4 and H-8
were altered from doublets to singlets (Supplementary Fig. S6).
This proved that both DMATS enzymes catalyzed the regiospecific
C-prenyltion on the indolocarbazole system, that is, the para-
position to the indole N-atom (C3, C9, or both) and function there-
fore as catalysts for Friedel–Crafts alkylations. A Friedel–Crafts
alkylation catalyzed by strong Lewis acids would involve an allyl
cation. This is also the case for the enzyme-catalyzed Friedel–Crafts
alkylation described in this study. The formation of a dimethylallyl
cation in an enzyme-catalyzed prenyl transfer reaction would be
facilitated by interactions of several basic amino acid residues of
the enzyme with pyrophosphate group of DMAPP.32,33
To elucidate the behavior of 5-DMATS and FgaPT2 toward indo-
locarbazoles, kinetic parameters were determined for the best ac-
cepted substrate 3a with both enzymes by Hanes–Woolf and
Eadia–Hofstee plots. Michaelis–Menten constants (KM) were calcu-
lated to be at 87 and 136 lM for 5-DMATS and FgaPT2, respec-
tively, while turnover numbers (kcat) were found at 6.8 and
7.3 min1. The catalytic efficiency (kcat/KM) of 5-DMATS toward
3a was 1302 s1 M1, that is, 5.0 % of that of its best substrate L-
tryptophan.14 Similarly, A kcat/KM value of 891 s1 M1 was calcu-
lated for FgaPT2 toward 3a, which is 3.0 % of that of L-tryptophan.15
These data provided evidence that dimethylallyltryptophan syn-
thases could also be used for the production of C-prenylated
indolocarbazoles.
In conclusion, the present work demonstrated the acceptance of
indolocarbazoles by fungal dimethylallyltryptophan synthases of
the DMATS superfamily, which expands the potential usage of
these enzymes in the structural modifications. To the best of our
knowledge, this is the first report on the (chemoenzymatic) syn-
thesis of prenylated indolocarbazoles.Acknowledgments
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Experimental section 
Overproduction and purification of the recombinant proteins as well as enzyme assays 
with recombinant proteins 
HPLC conditions for analysis and isolation of the enzyme products 
Spectroscopic analyses 
 
HR-EI-MS and NMR data 
Table S1. HR-EI-MS data of the enzyme products of indolocarbazoles. 
Table S2. 1H-NMR data (400 MHz) of prenylated products in DMSO-d6. Chemical 
shifts (δ) are given in ppm and coupling constants (J) in Hz. 
 
NMR spectra 
Figure S1. 1H-NMR spectrum of 2b in DMSO-d6 (400 MHz). 
Figure S2. 1H-NMR spectrum of 2c in DMSO-d6 (400 MHz). 
Figure S3. 1H-NMR spectrum of 2d in DMSO-d6 (400 MHz). 
Figure S4.1. 1H-NMR spectrum of 3b in DMSO-d6 (400 MHz). 
Figure S4.2. 1H-NMR spectrum of 3b in DMSO-d6 (400 MHz) with addition of D2O. 
Figure S5 1H-NMR spectrum of 4b in DMSO-d6 (400 MHz). 
Figure S6. Comparison of the aromatic signals in the 1H-NMR spectrum of substrate 
2a with those of its prenylated products 2b, 2c and 2d (in DMSO-d6, 400 MHz). 
Figure S7. Comparison of the aromatic signals in the 1H-NMR spectrum of substrate 
3a with that of its prenylated product 3b (in DMSO-d6, 400 MHz). 
Figure S8. Comparison of the aromatic signals in the 1H-NMR spectrum of substrate 
4a with that of its prenylated product 4b (in DMSO-d6, 400 MHz). 
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Experimental section 
 
Overproduction and purification of the recombinant proteins as well as enzyme 
assays with recombinant proteins 
Protein overproduction and purification were carried out as described previously.1, 2 
The enzyme mixtures (100 μl) for determination of the relative activities (Figure 2) 
contained each of 50 mM Tris–HCl (pH 7.5), 0.5 mM aromatic substrate, 0.5 mM 
DMAPP, 5 mM CaCl2, 5 % (v/v) DMSO, 0.15–1.5% (v/v) glycerol and 20 µg of 
purified protein. After incubation at 37°C for 3 h, the reaction mixtures were stopped 
by extraction with ethyl acetate for three times. For structure elucidation, enzyme 
products were isolated from large-scale incubations of 20-50 ml with the same 
condition described above. 
 
HPLC conditions for analysis and isolation of the enzyme products 
The enzyme products of the incubation mixtures were analyzed by HPLC on an 
Agilent series 1200 by using a Multospher 120 RP 18–5 μ column (250 x 4 mm, 5 µm, 
C+S Chromatographie Service, Langerwehe, Germany) at a flow rate of 1 ml•min-1. 
Water (solvent A) and methanol (solvent B) were used as solvents. For analysis of 
enzyme assays with 2a and 3a, a linear gradient of 70-100 % (v/v) solvent B in 15 
min was used. The column was then washed with 100 % solvent B for 5 min and 
equilibrated with 70 % (v/v) solvent B for 5 min. For analysis of enzyme assays with 
4a, a linear gradient of 85-100 % (v/v) solvent B in 15 min was used. The column was 
then washed with 100 % solvent B for 5 min and equilibrated with 85 % (v/v) solvent 
B for 5 min. For isolation of the enzyme products, the same HPLC equipment with a 
Multospher 120 RP 18–5 μ column (250 x 10 mm, 5 µm, C+S Chromatographie 
Service) was used. The flow rate was 2.5 ml•min-1.  
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Spectroscopic analyses 
High-resolution electron impact mass spectrometry (HR-EI-MS) was taken on Auto 
SPEC. Positive HR-EI-MS data of the enzyme products are listed in Table S1. NMR 
Spectra (Figures S1-S8) were recorded on a JEOL ECX-400 spectrometer. Chemical 
shifts (Table S2) were referenced to the signal of DMSO-d6 at 2.50 ppm. 
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HR-EI-MS and NMR data 
 
Table S1. HR-EI-MS data of the enzyme products of indolocarbazoles. 
 
Compound 
 
Chemical 
formula 
HR-EI-MS data  
Deviation (ppm) 
Calculated (M+) Measured 
2b C25H21N3O 379.1685 379.1699 -3.7 
2c C25H21N3O 379.1685 379.1667 4.8 
2d C30H29N3O 447.2311 447.2328 -3.9 
3b C25H21N3O2 395.1634 395.1681 -12.1 
4b C26H21N3O2 407.1634 407.1650 -3.9 
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Table S2. 1H-NMR data of prenylated products in DMSO-d6 (400 MHz). Chemical shifts (δ) are given in ppm and coupling constants (J) 
in Hz. 
Comp
d 
1
2
3
4
10
9
8
11
N
H
N
H
H
N O
5
6
7
1'
2'
3'
4'
5'
12 1311a
7a
7c7b
13a
4a4b
4c
 
2b 
12 1311a
7a
7c7b
13a
4a4b
4c
5
6
7
1'
2'
3'
4'
5'
1
2
3
4
10
9
8
11
N
H
N
H
H
N O
 
2c 
12 1311a
7a
7c7b
13a
4a4b
4c
56
7
1''
2''
3''
4''
5''
1
2
3
4
10
9
8
11
N
H
N
H
H
N O
1'
2'
3'
4'
5'
 
2d 
 
3b 
5
6
7
1'
2'
3'
4'
5'
1
2
3
4
10
9
8
11
N
H
N
H
N OO
14
12 1311a
7a
7c7b
13a
4a4b
4c
 
4b 
Pos. δH, multi., J δH, multi., J δH, multi., J δH, multi., J δH, multi., J 
1 7.61, d, 8.3 7.71, br d, 8.3 7.60, d, 8.2 7.62, d, 8.3 7.67, d, 8.4 
2 7.23, dd, 8.3, 1.5 7.41, ddd, 8.3, 7.1, 1.3 7.22, dd, 8.2, 1.8 7.24, dd, 8.3, 1.4 7.33, dd, 8.4, 1.7 
3 - 7.22, ddd, 7.9, 7.1, 1.0 - - - 
4 9.03, d, 1.5 9.20, br d, 7.9 9.02, br s 8.97, d, 1.4 8.80, d, 1.7 
7 4.95, s 4.94, s 4.93, s 6.38, dd, 10.2, 1.1 - 
8 8.03, br d, 7.8 7.81, br s 7.80, br s 8.36, br d, 7.9 8.96, dd, 8.0, 1.2 
9 7.30, ddd, 7.8, 7.1, 0.9 - - 7.27, ddd, 7.9, 7.1, 0.9 7.31, ddd, 8.0, 7.1, 0.9 
10 7.46, ddd, 8.2, 7.1, 1.1 7.27, dd, 8.3, 1.6 7.26, dd, 8.3, 1.5 7.45, ddd, 8.2, 7.1, 1.2 7.51, ddd, 8.4, 7.1, 1.2 
11 7.77, br d, 8.2 7.69, d, 8.3 7.67, d, 8.3 7.75, br d, 8.2 7.76, dd, 8.4, 0.9 
14 - - - - 3.15, s 
1' 3.49, d, 7.4 3.52, d, 7.4 3.48, d, 7.3 3.49, d, 7.3 3.49, d, 7.3 
2' 5.41, t sep, 7.4, 1.1  5.44, t sep, 7.4, 1.0 5.41, t sep, 7.3, 1.2 5.41, t sep, 7.3, 1.0 5.40, t sep, 7.3, 1.1 
4' 1.79, d, 1.1 1.79, d, 1.0 1.79, d, 1.2 1.79, d, 1.0 1.77, d, 1.1 
5' 1.74, d, 1.1 1.75, d, 1.0 1.74, d 1.74, d, 1.0 1.73, d, 1.1 
1'' - - 3.52, d, 7.4 - -
2'' - - 5.43, t sep, 7.4, 1.1 - -
4'' - - 1.78, d, 1.1 - -
5'' - - 1.74, d - -
NH 
NH 
NH 
11.56, s 
11.29, s 
8.45, s 
11.47, s 
11.39, s 
8.48, s 
11.47, s 
11.29, s 
8.42, s 
11.52, s 
11.29, s 
8.69, br s 
11.98, s 
11.98, s 
- 
OH - - - 6.42, d, 10.2 - 
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NMR spectra 
 
 
 
Figure S1. 1H-NMR spectrum of 2b in DMSO-d6 (400 MHz). 
 
 
 
Figure S2. 1H-NMR spectrum of 2c in DMSO-d6 (400 MHz). 
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Figure S3. 1H-NMR spectrum of 2d in DMSO-d6 (400 MHz). 
 
 
 
 
Figure S4.1. 1H-NMR spectrum of 3b in DMSO-d6 (400 MHz). 
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Figure S4.2. 1H-NMR spectrum of 3b in DMSO-d6 (400 MHz) with addition of D2O. 
 
 
 
 
Figure S5 1H-NMR spectrum of 4b in DMSO-d6 (400 MHz). 
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Figure S6. Comparison of the aromatic signals in the 1H-NMR spectrum of substrate 2a with those of its prenylated products 2b, 2c and 2d (in 
DMSO-d6, 400 MHz). 
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Figure S7. Comparison of the aromatic signals in the 1H-NMR spectrum of substrate 3a with that of its prenylated product 3b (in DMSO-d6, 400 
MHz). 
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Figure S8. Comparison of the aromatic signals in the 1H-NMR spectrum of substrate 4a with that of its prenylated product 4b (in DMSO-d6, 400 
MHz).
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Abstract Fungal prenyltransferases of the dimethylallyl-
tryptophan synthase (DMATS) superfamily share no se-
quence, but structure similarity with the prenyltransferases
of the CloQ/NphB group. The members of the DMATS
superfamily have been reported to catalyze different
prenylations of diverse indole or tyrosine derivatives, while
some members of the CloQ/NphB group used hydroxy-
naphthalenes as prenylation substrates. In this study, we
report for the first time the prenylation of hydroxynaph-
thalenes by the members of the DMATS superfamily. Three
tryptophan-containing cyclic dipeptide prenyltransferases
(AnaPT, CdpNPT and CdpC3PT), one tryptophan C7-
prenyltransferase and one tyrosine O-prenyltransferase
(SirD) were incubated with naphthalene and 11 derivatives.
The enzyme activity and preference of the tested prenyl-
transferases towards hydroxynaphthalenes differed clearly
from each other. For an accepted substrate, however,
different enzymes produced usually the same major
prenylation product, i.e. with a regular C-prenyl moiety at
para- or ortho-position to a hydroxyl group. Regularly, O-
prenylated and diprenylated derivatives were also identified
as enzyme products of substrates with low conversion rates
and regioselectivity. This was unequivocally proven by
mass spectrometry and nuclear magnetic resonance analy-
ses. The KM values and turnover numbers (kcat) of the
enzymes towards selected hydroxynaphthalenes were de-
termined to be in the range of 0.064–2.8 mM and 0.038–
1.30 s−1, respectively. These data are comparable to those
obtained using indole derivatives. The results presented in
this study expanded the potential usage of the members of
the DMATS superfamily for production of prenylated
derivatives including hydroxynaphthalenes.
Keywords Enzyme promiscuity . Fungal indole
prenyltransferase . DMATS superfamily . Prenylated
hydroxynaphthalenes
Introduction
Prenyltransferases catalyze the transfer reactions of a prenyl
moiety from a prenyl donor, usually as diphosphate, to a
terpenoid, serine residue of a protein or an aromatic nucleus.
They are found in all domains of the life and involved in the
biosynthesis of primary and secondary metabolites (Heide
2009; Li 2009; Liang 2009; Yazaki et al. 2009). The
prenylated compounds often possess pharmacological activity
distinct from their non-prenylated precursors (Sings and
Singh 2003; Williams et al. 2000), which makes prenyltrans-
ferases attractive not only for biologists but also for medicinal
chemists and biotechnologists. Significant progress has been
achieved in the last years on the molecular biological,
biochemical and structural biological investigations of
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prenyltransferases for aromatic substrates, such as
benzoic acid, naphthalene or indole derivatives (Heide
2009; Li 2010). A number of indole prenyltransferases
have been identified in fungi, mainly by genome mining,
and characterized biochemically (Li 2010). These
enzymes share clear sequence similarity with the dime-
thylallyltryptophan synthase (DMATS) from Claviceps
purpurea (Tudzynski et al. 1999) and therefore referred as
prenyltransferases of the DMATS superfamily (Haug-
Schifferdecker et al. 2010). The members of the DMATS
superfamily showed significant flexibility towards their
aromatic substrates. Most of them used tryptophan-
containing cyclic dipeptides as natural (AnaPT, FtmPT1
and NotF; Ding et al. 2010; Grundmann and Li 2005; Yin
et al. 2009) or best substrates (CdpNPT and CdpC3PT;
Ruan et al. 2008; Yin et al. 2010c) (Fig. 1a). FgaPT2 and
7-DMATS accepted tryptophan as substrate and function
therefore as DMATS (Fig. 1b) (Kremer et al. 2007;
Unsöld and Li 2005). At higher enzyme concentration,
FgaPT2 accepted also cyclic dipeptides and FtmPT1 and
CdpNPT tryptophan derivatives as prenylation substrates
(Steffan and Li 2009; Zou et al. 2009). SirD shares
significant sequence similarities with other enzymes from
the DMATS superfamily and uses L-tyrosine as natural
substrate (Fig. 1c) (Kremer and Li 2010; Zou et al. 2011).
The enzymes of the DMATS superfamily share almost
no sequence similarity with other known prenyltrans-
ferases, e.g. the soluble prenyltransferases of the CloQ/
NphB group from bacteria and fungi, which catalyze the
prenylation of 4-hydroxyphenylpyruvate, phenazine and
naphthalenes in the biosynthesis of secondary metabolites
(Haug-Schifferdecker et al. 2010; Heide 2009). For
example, the naphthalene prenyltransferases Fnq26, Fur7
and NphB from the CloQ/NphB group are involved in the
biosynthesis of furanonaphthoquinone I (Haagen et al.
2007), furaquinocins (Kumano et al. 2010) and naphterpin
Fig. 1 Prenyl transfer reactions catalyzed by prenyltransferases of the DMATS superfamily towards a cyclic dipeptides; b L-tryptophan and c L-tyrosine
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(Kumano et al. 2008), respectively. An acceptance of
hydroxynaphthalenes by a member of the DMATS super-
family was not reported previously. Correspondingly,
tyrosine or indole derivatives were not prenylated by
enzymes of the CloQ/NphB group.
Interestingly, structure analysis revealed that FgaPT2
and FtmPT1 from the DMATS superfamily contain a PT
barrel (Jost et al. 2010; Metzger et al. 2009), which has
been only found in the bacterial aromatic prenyltrans-
ferases of the CloQ/NphB group (Kuzuyama et al. 2005;
Metzger et al. 2010). This finding prompted us to
investigate the acceptance of naphthalene derivatives by
the members of the DMATS superfamily. Acceptance of
hydroxynaphthalenes by prenyltransferases of the DMATS
superfamily would increase structure diversity of preny-
lated hydroxynaphthalenes by chemoenzymatic synthesis
approaches.
Materials and methods
Chemicals
Dimethylallyl diphosphate (DMAPP) was prepared accord-
ing to the method described for geranyl diphosphate by
Woodside et al. (1988). Naphthalene derivatives of the
highest available purity were purchased from Fluka, TCI,
Acros Organics, Aldrich and Alfa Aesar.
Overproduction and purification of recombinant proteins
Protein overproduction and purification were carried out as
described previously: FgaPT2 (Steffan et al. 2007), FtmPT1
(Grundmann and Li 2005), AnaPT (Yin et al. 2009),
CdpNPT (Yin et al. 2007), CdpC3PT (Yin et al. 2010b),
7-DMATS (Kremer et al. 2007), CTrpPT (Zou et al. 2010)
and SirD (Kremer and Li 2010).
Enzyme assays with different prenyltransferases
The enzymatic reaction mixtures (100 μl) for determination
of the relative activities with different hydroxynaphthalenes
contained 50 mM Tris–HCl (pH 7.5), 5 mM (CdpC3PT and
SirD) or 10 mM CaCl2 (other enzymes), 1 mM aromatic
substrate, 2 mM DMAPP, 0.15–1.5% (v/v) glycerol, 5% (v/v)
dimethyl sulphoxide (DMSO) and 20 μg of purified
recombinant protein. Under this condition, naphthalene (1a,
Table 1) reached a final concentration of 0.2 mM, while
other substrates were dissolved completely. The reaction
mixtures were incubated at 37°C for 1 or 7 h. For structure
elucidation, enzyme products were isolated from large-scale
incubations of 5–70 ml with 0.2–0.3 mg protein per
milliliter assay. For the determination of the kinetic param-
eters, the assays contained DMAPP at final concentrations of
2 or 5 mM (for CdpC3PT) and hydroxynaphthalenes at final
concentrations of 0.02, 0.05, 0.1, 0.2, 0.5, 1, 2 and 5 mM.
The protein amount and incubation time are given in Table 2.
Table 1 List of naphthalene and derivatives used in this study
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The enzyme reactions were terminated by addition of 60 μl
methanol per 100 μl reaction mixtures. The proteins were
removed by centrifugation at 13,000×g for 20 min. For
quantification of the enzyme activity, two independent
incubations were carried out routinely.
Quantification of the enzyme products
Due to the unknown absorption coefficients of the enzyme
products and the low quality of the isolated substances,
conversion rates of the enzyme reactions were calculated
with the help of 1H-NMR spectra. For this purpose,
incubations were taken in a large scale (10 ml) containing
each of 1 mM aromatic substrate, 2 mM DMAPP, 5 or
10 mM CaCl2 as mentioned above and 2 mg of purified
protein. The reaction mixtures were extracted three times
with ethyl acetate after incubation at 37°C for 24 h. After
evaporation of the solvent, the residues of the ethyl acetate
phase containing both substrate and enzyme products were
subjected to 1H-NMR analysis. The conversion rate of a
given substrate was determined by comparison of the
integrals of the enzyme products and the remained substrate
in 1H-NMR spectra. The absorption coefficients of the
enzyme products were then calculated by high-performance
liquid chromatography (HPLC) analysis of the samples
after NMR analysis. For incubations with low conversion
rates, e.g. <5%, ratio of peak areas of the product to sum of
product and substrate was used.
HPLC conditions for analysis and isolation of the enzyme
products
The enzyme products of the incubation mixtures were
analyzed by HPLC on an Agilent series 1200 using a
LiChrospher RP 18–5 column (125×4 mm, 5 μm, Agilent)
at a flow rate of 1 ml min−1. Water with 0.5% trifluoroacetic
Table 2 Kinetic parameters of the tested prenyltransferases
Enzyme/substrate Incubation KM (mM) kcat (s
-1) kcat/KM (s
−1 M−1) Percentf
Protein (μg) Time (min)
AnaPT
1-Naphthol (1b) 10 20 1.30 0.74 569 8.72
1,7-Dihydroxynaphthalene (1g) 10 20 0.30 0.34 1,133 17.4
2,6-Dihydroxynaphthalene (1i) a 20 20 1.90 0.043 23 0.35
3,5-Dihydroxy-2-naphthoic acid (1k) 20 20 0.68 0.063 93 1.43
3,7-Dihydroxy-2-naphthoic acid (1l) 20 20 1.10 0.10 91 1.40
(R)-Benzodiazepinedione b 0.23 1.5 6,522 100
CdpNPT
1-Naphthol (1b) 5 5 0.25 1.30 5,200 1,040
1,6-Dihydroxynaphthalene (1f) c 5 5 0.20 0.16 800 160
Cyclo-L-Trp-L-Trp 2.5 10 0.18 0.09 500 100
CdpC3PT
1-Naphthol (1b) 20 10 1.30 0.31 238 15.6
1,7-Dihydroxynaphthalene (1g)d 20 20 0.37 0.14 378 24.7
Cyclo-L-Trp-L-Leu 1.5 30 0.53 0.81 1,528 100
7-DMATS
1-Naphthol (1b) 20 30 0.83 0.038 46 2.80
1,6-Dihydroxynaphthalene (1f) 10 15 0.29 0.12 414 25.2
1,7-Dihydroxynaphthalene (1g) 10 15 0.064 0.077 1,203 73.2
3,5-Dihydroxy-2-naphthoic acid (1k) 10 20 2.8 0.053 19 1.16
L-Trpe 0.14 0.23 1,643 100
The mean values from two independent experiments were calculated from Hanes–Woolf and Eadie–Hofstee plots
a Due to solubility, the concentration was only tested up to 5 mM
bData were adopted from Yin et al. (2009)
c Substrate inhibition at 0.5 mM or higher concentrations
d Substrate inhibition at 1.0 mM or higher concentrations
e Data were adopted from Kremer et al. (2007)
f kcat/KM obtained by using indole derivatives as substrate was defined as 100%
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acid (TFA; solvent A) and methanol with 0.5% TFA
(solvent B) were used as solvents. For analysis of enzyme
products, a linear gradient of 50–100% (v/v) solvent B in
20 min was used. The column was then washed with 100%
solvent B for 5 min and equilibrated with 50% (v/v) solvent
B for 5 min. For comparison of the enzyme activities
towards 1-naphthol (1b, Table 1) versus tyrosine or indole
derivatives shown in Fig. 2, a linear gradient of 40–100%
(v/v) solvent B in 20 min was used. The column was then
washed with 100% solvent B for 5 min and equilibrated
with 40% (v/v) solvent B for 5 min. Detection was carried
out by a photo diode array detector.
For isolation of the enzyme products, the same HPLC
equipment with a Multospher 120 RP-18 column (250×
10 mm, 5 μm, C+S Chromatographie Service, Langenfeld,
Germany) was used. A linear gradient of 65–100% (v/v)
solvent B in 20 min at a flow rate of 2.5 ml min−1 was
used. The column was then washed with 100% solvent B
Fig. 2 HPLC chromatograms of incubation mixtures of 1-naphthol
(1b) and tyrosine or indole derivatives with purified recombinant
FgaPT2 (4.2 μg), FtmPT1 (5.0 μg), AnaPT (2.0 μg), CdpNPT
(8.0 μg), CdpC3PT (5.0 μg), 7-DMATS (4.5 μg), CTrpPT (20 μg) or
SirD (2.0 μg). The reaction mixtures in 100 μl scale contained 2 mM
DMAPP and 1 mM aromatic substrate and were incubated at 30°C
(FgaPT2 and FtmPT1) or 37°C (other enzymes) for 2 h. Detection was
carried with a diode array detector and illustrated for absorption of 1-
naphthol and indole derivatives at 296 nm. For L-tyrosine, the
absorption at 277 nm was given (S substrate; P product)
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for 8 min and equilibrated with 65% (v/v) solvent for 8 min.
For isolation of the enzyme products from the incubation
mixtures of 1i and 1j, repeated chromatography was carried
out with different gradients. If necessary, acetonitrile instead
of methanol was used as elution solvent.
NMR spectroscopic analysis
The isolated enzyme products were dissolved in 0.3 ml
of CD3OD. Samples were filled into 3 mm thin wall
NMR sample tubes of Wilmad Labglass from Rototec-
Spintec. Spectra were recorded at room temperature on a
JEOL ECX 400 MHz, a Bruker Avance 500 MHz or an
Avance 600 MHz spectrometer. The heteronuclear single
quantum coherence (HSQC) and heteronuclear multiple
bond correlation (HMBC) spectra were recorded with
standard methods (Berger and Braun 2004). For HSQC
spectra, 16 transients were used, while 32–64 transients
were used for the HMBC spectra. 1H spectra were
acquired with 65,536 data points, while 2D spectra were
collected using 4,096 points in the F2 dimension and 512
increments in the F1 dimension. Chemical shifts were
referenced to those of CD3OD. All spectra were pro-
cessed with MestReNova.5.2.2
High-resolution electron impact mass spectra
The isolated products were also analyzed by high-
resolution electron impact mass spectrometry (HR-EI-MS)
on Auto SPEC. Positive HR-EI-MS data of the enzyme
products are as following: 2b, m/z 212.1230 (M+) (calcu-
lated for C15H16O, 212.1201); 2f: m/z 228.1162 (M
+)
(calculated for C15H16O2, 228.1150); 2g, m/z 228.1154
(M+) (calculated for C15H16O2, 228.1150); 2i, m/z 228.1163
(M+) (calculated for C15H16O2, 228.1150); 3i, m/z 228.1146
(M+) (calculated for C15H16O2, 228.1150); 4i, m/z 296.1787
(M+) (calculated for C20H24O2: 296.1776); 5i: m/z
296.1789 (M+) (calculated for C20H24O2, 296.1776); 6i,
m/z 296.1768 (M+) (calculated for C20H24O2, 296.1776);
7i, m/z 296.1762 (M+) (calculated for C20H24O2,
296.1776); 2j, m/z 228.1180 (M+) (calculated for
C15H16O2, 228.1150); 3j, m/z 228.1161 (M
+) (calculated
for C15H16O2, 228.1150); 4j, m/z 228.1159 (M
+) (calculated
for C15H16O2, 228.1150); 5j: m/z 296.1781 (M
+) (calculat-
ed for C20H24O2, 296.1776); 6j, m/z 296.1772 (M
+)
(calculated for C20H24O2, 296.1776); 7j, m/z 296.1773
(M+) (calculated for C20H24O2, 296.1776); 8j, m/z
296.1787 (M+) (calculated for C20H24O2, 296.1776); 9j,
m/z 296.1786 (M+) (calculated for C20H24O2, 296.1776);
2k, m/z 272.1068 (M+) (calculated for C16H16O4,
272.1049); 3k, m/z 272.1087 (M+) (calculated for
C16H16O4, 272.1049); 2l, m/z 272.1083 (M
+) (calculated
for C16H16O4, 272.1049).
Results
1-Naphthol was accepted by seven of eight
prenyltransferases of the DMATS superfamily
For initial investigation, eight prenyltransferases of the
DMATS superfamily including five cyclic dipeptide
prenyltransferases (FtmPT1, AnaPT, CdpC3PT, CdpNPT
and CTrpPT), two dimethylallyltryptophan synthases
(FgaPT2 and 7-DMATS) and one tyrosine O-prenyl-
transferase (SirD) were incubated with the simple naph-
thalene derivative 1-naphthol (1b, Table 1). Enzyme
assays with the respective natural or best substrate
described in previous studies (Grundmann and Li 2005;
Kremer et al. 2007; Kremer and Li 2010; Unsöld and Li
2005; Yin et al. 2007, 2009, 2010c; Zou et al. 2010), i.e.
L-tyrosine for SirD or indole derivatives for other
enzymes, were used as positive controls. HPLC analysis
was used for monitoring of product formation and carried
out under the same condition. As shown in Fig. 2, product
formation was observed in the incubation mixtures of all
of the enzymes with tyrosine or indole derivatives, as
reported previously (Kremer et al. 2007; Kremer and Li
2010; Ruan et al. 2008; Unsöld and Li 2005; Yin et al.
2009, 2010c; Zou et al. 2010). One additional peak each
was also clearly detected in the incubation mixtures of
FgaPT2, FtmPT1, AnaPT, CdpNPT, CdpC3PT, 7-DMATS
and CTrpPT with 1b and DMAPP. Formation of these
peaks was strictly dependent on the presence of DMAPP
and active enzymes (data not shown). These results
demonstrated that these enzymes accepted not only
tryptophan or tryptophan-containing cyclic dipeptides
but also the hydroxynaphthalene 1b as substrate. Product
formation was not observed in the incubation mixture of
SirD with 1b and DMAPP.
Comparison of the relative enzyme activities towards
indole derivatives and 1b revealed a clear preference of
most of the enzymes for indole derivatives (Fig. 2).
However, high conversion rates of 33.9% and 28.8% were
observed in the incubation mixtures of 1b with FgaPT2 and
AnaPT, respectively, although these values are lower than
those with their natural substrates L-tryptophan at 80.4%
and (R)-benzodiazepinedinone at 74.2%. The conversion
rate of CdpNPT with 1b was found to be 60.2%,
significantly higher than that with one of the best substrates
cyclo-L-Trp-L-Trp of 14.8%, (Ruan et al. 2008). Inspection
of the HPLC chromatograms revealed additionally that the
enzyme products of 1b with the seven mentioned indole
prenyltransferases had the same retention time of 18.2 min,
indicating the possibility of the presence of the same
product. The intriguing results obtained with 1b encouraged
us to test the acceptance of more hydroxynaphthalenes by
the members of the DMATS family.
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Different preference of indole prenyltransferases towards
hydroxynaphthalenes
Five enzymes including AnaPT, CdpC3PT, CdpNPT, 7-
DMATS and SirD were selected for incubation with
naphthalene (1a) and 11 derivatives listed in Table 1. The
reaction mixtures containing 5% (v/v) DMSO and 20 μg of
purified protein each were incubated in the presence of
DMAPP for 1 and 7 h. HPLC analysis was used for
monitoring the enzyme product formation. Incubations with
heat-inactivated proteins by boiling the proteins for 20 min
were used as control assays.
As given in Table S1 (Electronic supplementary materi-
al), naphthalene (1a) in a final concentration of 0.2 mM
was accepted by none of the tested enzymes, indicating the
importance of activation of the naphthalene ring, e.g. by
hydroxylation. All of the 11 hydroxynaphthalenes (1b–1l)
were accepted by AnaPT. A conversion rate of more than
10% was observed for eight substrates after 1 h and for ten
after 7 h. 7-DMATS and CdpNPT accepted nine of the 11
substrates after incubation for 1 h. In comparison to AnaPT,
CdpNPT and 7-DMATS, hydroxynaphthalenes were poor
substrates for CdpC3PT and SirD. Although CdpC3PT
accepted most of the tested hydroxynaphthalenes, the
conversion rates were very low (Table S1). Comparison of
the conversion rates showed that 1-naphthol (1b) and 1,7-
dihydroxynaphthalene (1g) were well accepted by AnaPT,
7-DMATS and CdpNPT. In addition, 1,6-dihydroxynaph-
thalene (1f) was found to be the best substrate for 7-
DMATS with conversion rates of 73.3% and 92.6% after
incubation for 1 and 7 h, respectively.
The data in Table S1 showed furthermore that the positions
of the hydroxyl groups are important for the acceptance of
these compounds. Reduction in enzyme activities of more
than 75% was observed for AnaPT, CdpNPT, CdpC3PT and
7-DMATS if the hydroxyl group of 1b was moved from
position C1 to C2 as in the structure of 1c. No product
formation with 1c was detected after incubation with
CdpC3PT for 1 h. Addition of one hydroxyl group to
position C4 of 1b as in the structure of 1d caused even more
loss of enzyme activities. Addition of one hydroxyl group to
C6 at the second ring (1f) increased the activity of 7-DMATS
to 333% after 1 h, in comparison to that of 1b. Placing this
hydroxyl group to C7 (1g) increased slightly the activity of
AnaPT, but strongly that of 7-DMATS, in comparison to
those of 1b. Dihydroxynaphthalenes with one of the
hydroxyl groups at C1 were generally better accepted by
indole prenyltransferases than those with a hydroxyl group at
C2, as detected for 7-DMATS, CdpNPT and CdpC3PT in the
incubation mixtures with 1f and 1i. Similar phenomenon was
also observed in the reaction mixtures of 1g and 1j with
AnaPT, 7-DMATS, CdpNPT and CdpC3PT. Interestingly,
moderate conversion rates of 14–20% after incubation for
1 h were observed for naphthoic acids like 1k with AnaPT
and 7-DMATS as well as 1l with AnaPT.
Same prenyl transfer reaction onto hydroxynaphthalenes
catalyzed by different indole prenyltransferases
For product isolation and structure elucidation, HPLC
chromatograms of incubation mixtures of seven hydrox-
ynaphthalenes (1b, 1f, 1g, 1i, 1j, 1k and 1l) with AnaPT, 7-
DMATS, CdpNPT, CdpC3PT and SirD for 7 h (Fig. 3) are
inspected in detail. Conversion rates of 15% or more were
observed in 14 of the 35 incubation mixtures. With the
exceptions of incubation mixtures of 1i and 1k with AnaPT
and 1j with CdpNPT, 7-DMATS and AnaPT (Fig. 3d–f),
one or one dominant product was detected in these
mixtures. In the case of 1k (Fig. 3f), two products with
comparable yields were observed. Incubations with low
conversions showed more frequently two or more product
peaks, e.g. AnaPT and 7-DMATS with 1i and 1j (Fig. 3d, e)
as well as CdpNPT with 1j (Fig. 3e).
Most interestingly, the major products of one given
substrate with different enzymes had usually the same
retention time (Fig. 3a–f), as observed for 1b mentioned
above (Fig. 2). To prove that the product peaks with the
same retention time deal really with the same compound,
the dominant products of 1b and 1g in the incubation
mixtures of AnaPT, CdpNPT, CdpC3PT and 7-DMATS, i.e.
2b and 2g (Fig. 3a, c), were isolated on HPLC separately
and subjected to 1H-NMR analysis. Similar experiments
were also carried out for 2f from the incubation mixtures of
1f with 7-DMATS and CdpNPT (Fig. 3b) as well as 2j from
those of 1j with AnaPT, 7-DMATS and CdpNPT (Fig. 3e).
The four samples (2b, Fig. 3a) isolated from the incubation
mixtures of AnaPT, CdpNPT, CdpC3PT and 7-DMATS with
1b showed identical 1H-NMR spectra (data not shown) and
confirmed the presence of the identical structure. This
proved that the four enzymes catalyzed the same prenyla-
tion reaction on 1b. It can be deduced that the enzyme
products of FgaPT2, FtmPT1 and CTrpPT with 1b
mentioned above (Fig. 2) have also the same structure as
that of 2b. The same conclusion was also proven to be valid
for 2f, 2g and 2j from different reaction mixtures. In
addition, the products of 1i, 1k and 1l (Fig. 3d, f and g)
were isolated from their incubation mixtures with AnaPT.
para-Position to the hydroxyl group at C1 of naphthalene
ring is the favored prenylation position for indole
prenyltransferases
The main products 2b, 2f, 2g, 2i, 2j, 2k, 3k and 2l were
subjected to MS and NMR analyses. HR-EI-MS (see
‘Materials and methods’) confirmed the monoprenylation
in the isolated enzyme products by detection of molecular
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masses, which are 68 Da larger than the respective
substrates. Inspection of the 1H-NMR data of the isolated
products revealed clearly the presence of signals for a
regular dimethylallyl moiety at δH 3.49–3.73 (d, 2H-1′),
5.17–5.35 (br t, H-2′), 1.78–1.92 (s, 3H-4′), 1.67–1.75 (s,
3H-5′) (Table S2, Electronic supplementary material).
Comparing the signals of the aromatic protons of 2b, 2f,
2g, 2k and 3k with those of the respective substrates (data
not shown), the disappearance of one triplet was observed.
This indicated that the prenyl moiety was very likely
attached to position 2 or 4 of 2f and 2g, position 6 or
8 of 2k and 3k and position 2, 4, 5 or 8 of 2b (please see
Fig. 3 HPLC chromatograms of
incubation mixtures of selected
hydroxynaphthalenes with re-
combinant AnaPT, CdpNPT,
CdpC3PT, 7-DMATS and SirD
after incubation for 7 h. Detec-
tion was carried with a diode
array detector and illustrated for
absorption at 296 nm
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Table S2 for numbering of the naphthalene ring). For
determination of the prenylation position, connectivities in
HMBC of the isolated compounds are taken in consideration
and summarized in Fig. S1 (Electronic supplementary
material). In the HMBC spectra of 2f and 2g, connectivities
from H-1′ of the dimethylallyl moiety at 3.54–3.59 ppm to
C9 at δC 128.9–135.8 ppm confirmed the attachment of the
prenyl residue at position C4. Connectivities from H-1′ to δC
127.8 ppm of C10 in 2k and to δC 148.4 ppm of C-5 in 3k,
proved unequivocally the presence of the prenyl moiety at
position C8 in 2k and position C6 in 3k, i.e. the para- and
ortho-position of the hydroxyl group, respectively. The
observation of two doublets of double doublets at 7.45
(ddd, H-6) and 7.40 (ddd, H-7) in 1H-NMR spectrum and
connectivity from H-1′ to δC 134.0 of C9 in the HMBC
spectrum confirmed the prenylation at position C4 in 2b.
Comparison of the signals for aromatic protons in the
spectra of 2i, 2j and 2l with those of the respective substrates
revealed the disappearance of one doublet with a coupling
constant of about 2–2.5 Hz, indicating the prenylations at
position C1 of 2i and 2j and position C8 of 2l. In the HMBC
spectra of 2i and 2j, connectivities from H-1′ of the
dimethylallyl residue to C2 at δC 150.3–152.8 ppm and to
C10 at δC 129.3–136.1 ppm, proved unambiguously the
attachment of the prenyl moieties at C1 in 2i and 2j. The
observation of H-1′ to δC 150.9 ppm for C7 and δC
128.1 ppm for C10, H-6 to δC 121.4 ppm for C8 in the
HMBC spectrum confirmed the prenylation at position C8 in
2l. The structures of the enzyme products are summarized in
Table S2. 2i and 2j have been also identified as prenylation
products of 1i and 1j by NovQ, an enzyme from the CloQ/
NphB group (Macone et al. 2009; Ozaki et al. 2009).
Inspection of the structures of the enzyme products
revealed clearly that prenylation has preferentially taken
place at para-position of the hydroxyl group at C1, as in the
cases of 2b, 2f, 2g and 2k. If this was not possible, as for
2i, 2j, and 2l, the ortho-position to the hydroxyl group at
C2 was prenylated (Fig. 4). Detection of more than two
product peaks in the incubation mixtures of 1i and 1j
(Fig. 3d, e) indicated the presence of further derivatives, in
addition to the two possible monoprenylated products at
ortho-position to one of the two hydroxyl groups.
O-Prenylated and diprenylated derivatives were identified as
minor products in the incubation mixtures of 1i and 1j
To get structure information of the minor products, 3i, 4i,
5i, 6i and 7i were also isolated by repeated chromatography
Fig. 4 Prenyl transfer reactions catalyzed by prenyltransferases of the DMATS superfamily towards a 1-naphthol and derivatives (1b, 1f, 1g and
1k), b 3,7-dihydroxy-2-naphtholic acid (1l), c 2,6-dihydroxynaphthalene (1i) and d 2,7-dihydroxynaphthalene (1j)
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on HPLC from the incubation mixtures of 1i with AnaPT
(Fig. 3d). In analogous manner, products of 1j were
obtained from the incubation mixtures of AnaPT (3j–9j),
7-DMATS (3j–6j) and CdpNPT (3j and 4j) (Fig. 3e). 1H-
NMR spectra revealed again that products with same
retention times have also same 1H-NMR spectra.
The structures of 3i, 4i, 5i, 6i, 7i, 3j, 4j, 5j and 6j (Fig. 4
and Tables S2 and S3) were elucidated by comparison of
their 1H-NMR spectra with those of the respective substrate
and the aforementioned products 2i and 2j. Characteristic
signals for O-prenyl moieties were found for H-2′ at
approximately 5.5 ppm and for H-1′at 4.6 ppm (Zou et al.
2011). The corresponding signals for C-prenyl groups
appeared in the range of 5.1–5.4 and 3.3–3.7 ppm,
respectively (Kremer and Li 2008; Steffan et al. 2007). In
the case of the O-prenylated derivatives 3i and 4j, the
number and coupling pattern of the aromatic protons were
not changed. For 3j, 5j and 6j, signal for one or two
aromatic protons had disappeared and the structures have
been elucidated by interpretation of the coupling pattern of
the aromatic protons.
The structures of 7j, 8j and 9j were elucidated by
interpretation of the connectivities in their HMBC spectra
(Fig. S1, Electronic supplementary material), as described
for the main products discussed above. All of the structures
were also confirmed by high-resolution electron impact
mass spectrometry. It is obvious that in the incubation
mixtures of substrates with low conversion rates and low
regioselectivity like 1i and 1j, O-prenylation and dipreny-
lation took place more frequently than those with a better
acceptance.
Kinetic parameters of the indole prenyltransferases
towards hydroxynaphthalenes
To get information on the catalytic efficiency of indole
prenyltransferases towards hydroxynaphthalenes, kinetic
parameters of AnaPT, CdpNPT, CdpC3PT and 7-DMATS,
including Michaelis–Menten constants (KM) and turnover
numbers (kcat) of six selected substrates were determined by
Hanes–Woolf and Eadie–Hofstee plots. The obtained data
are given in Table 2 and compared with those of indole
derivatives with the respective enzyme. With an exception
of (R)-benzodiazepinedione for AnaPT, the natural sub-
strates of CdpNPT, CdpC3PT and 7-DMATS are unknown.
Therefore, the best reported indole derivatives were used in
these experiments. Due to the very low conversion, kinetic
parameters of SirD towards hydroxynaphthalenes were not
determined.
The KM values of these enzymes for hydroxynaphtha-
lenes are in the similar concentration range as those for
indole derivatives, at least for some of hydroxynaphtha-
lenes. For example, AnaPT accepted 1g with a KM of
0.30 mM, slightly higher than that for its natural substrate
(R)-benzodiazepindinone at 0.23 mM. Comparable KM
values were found for CdpNPT towards hydroxynaphtha-
lenes and cyclo-L-Trp-L-Trp. Similar or even lower KM
values were observed for CdpC3PT and 7-DMATS. Nota-
bly, low KM value of 0.064 mM was determined for 1g with
7-DMATS, while L-tryptophan was accepted by this
enzyme with a KM value of 0.14 mM.
Maximal reaction velocities of AnaPT, CdpC3PT and 7-
DMATS determined with hydroxynaphthalenes are slightly
slower than those with indole derivatives. Turnover
numbers of AnaPT with 1b and 1g were found to be 0.74
and 0.34 s−1, i.e. 49% and 23% of that with its natural
substrate (R)-benzodiazepinedinone, respectively. For
CdpC3PT, turnover numbers at 0.31 and 0.14 s−1 were
determined for 1b and 1g, i.e. 38% and 17% of that of
cyclo-L-Trp-L-Leu, respectively. Turnover numbers of 7-
DMATS with 1f and 1g were found to be 52% and 33% of
that of its best substrate L-tryptophan. CdpNPT showed a
much higher maximal reaction velocity with 1b and 1f than
with cyclo-L-Trp-L-Trp, approximate 14- and 1.8-fold,
respectively.
As a consequence, the catalytic efficiencies (kcat/KM) of
AnaPT determined with hydroxynaphthalenes were found
to be about 17% of that with (R)-benzodiazepindinone.
This low value is, however, due to the high turnover
number and catalytic efficiency of AnaPT with its natural
substrate. The catalytic efficiencies of AnaPT with 1b and
1g at 569 and 1,133 s−1 M−1 should be categorized as
high. In comparison to the data obtained with AnaPT,
higher relative catalytic efficiencies for hydroxynaphtha-
lenes were calculated for CdpC3PT and 7-DMATS. The
catalytic efficiency of 7-DMATS with 1g was found to be
73.2% of that with L-tryptophan.
Discussion
Prenyltransferases of the DMATS superfamily showed
broad substrate specificity and were successfully used for
production of prenylated tyrosine and indole derivatives by
chemoenzymatic synthesis (Li 2010; Yin et al. 2010c; Zou
et al. 2011). However, prenylation of hydroxynaphthalenes
by these enzymes have not been reported previously.
After initial observation of the acceptance of 1-naththol
(1b) by seven of the eight tested enzymes, we chose AnaPT,
CdpC3PT, CdpNPT, 7-DMATS and SirD for detailed
investigation with 11 hydroxynaphthalenes as potential
prenylation substrates. As shown in Fig. 1, AnaPT,
CdpC3PT and CdpNPT accept tryptophan-containing cyclic
dipeptides as natural or best substrates (Ruan et al. 2008;
Yin et al. 2010a, c). These enzymes are therefore the best
candidates to elucidate the behaviour of very similar indole
746 Appl Microbiol Biotechnol (2011) 92:737–748
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prenyltransferases towards hydroxynaphthalenes. The
dimethylallyltryptophan synthase 7-DMATS catalyzes the
regular C7-prenylation of L-tryptophan derivatives (Kremer
et al. 2007; Kremer and Li 2008). SirD represents a tyrosine
O-prenyltransferase (Kremer and Li 2010). The substrates
and catalyzed prenylation reactions of 7-DMATS and SirD
differ clearly from those of the three cyclic dipeptide
prenyltrasnferases AnaPT, CdpC3PT and CdpNPT. The five
enzymes are therefore the best candidates to elucidate the
behaviour of very different prenyltransferases towards
hydroxynaphthalenes. In this study, we have shown that
the substrate specificity of the members of DMATS
superfamily towards hydroxynaphthalene derivatives did
not correlate with those obtained for tyrosine or indole
derivatives. For example, SirD showed the most flexible
substrate specifity within the DMATS superfamily, accepted
both tyrosine and tryptophan derivatives as substrates and
catalyzed O-, N- and C-prenylation (Zou et al. 2011).
However, hydroxynaphthalenes were poor substrates for
this enzyme and only four of them were accepted with very
low velocities (Table S1, Electronic supplementary materi-
al). Furthermore, in contrast to the different prenylation
patterns and positions of a given indole derivative by
different enzymes, same prenylation products of a hydrox-
ynaphthalene were identified in the reaction mixtures with
different enzymes. As shown in Fig. 3, naphthalenes with a
hydroxyl group at C1 such as 1b, 1f, 1g and 1k produced
usually one dominant product, i.e. with a regular prenyl
moiety at para-position to this hydroxy group. Naphtha-
lenes with a hydroxyl group at C2 such as 1i and 1j showed
a lowed regioselectivity. In addition to the major product
with a regular prenyl moiety at ortho-position of the
hydroxyl group, i.e. 2i and 2j, up to seven minor products
including O-prenylated, C- and C- as well as C- and O-
diprenylated derivatives were obtained from the incubation
mixtures (Fig. 4).
The relative high turnover numbers and catalytic
efficiencies of these enzymes towards hydroxynaphthalenes
provided experimental evidence for their potential applica-
tion as catalysts for chemoenzymatic synthesis of preny-
lated hydroxynaphthalenes. It can be expected that high
efficiency of the prenylation reaction for a given substrate
could be achieved by choice of a suitable indole prenyl-
transferase, as demonstrated in this study.
As mentioned in ‘Introduction’, prenyltransferases of the
DMATS superfamily show no noteworthy sequence simi-
larity with prenyltransferases of the CloQ/NphB group,
which use hydroxynaphthalenes or other nitrogen-free
aromatic compounds as prenylation substrates (Haug-
Schifferdecker et al. 2010; Kumano et al. 2008). However,
they share the common PT barrel in their protein structures
(Jost et al. 2010; Kuzuyama et al. 2005; Metzger et al.
2009, 2010). Structural analysis of FgaPT2 and FtmPT1
revealed the presence of only one reaction chamber (Jost et
al. 2010; Metzger et al. 2010). The acceptance of
hydroxynaphthalenes by enzymes of the DMATS super-
family demonstrates probably just the flexibility of such
reaction chambers. It would be now interesting to investi-
gate the acceptance of tyrosine or indole derivatives by the
members of the CloQ/NphB group.
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Table S1: Conversion rates of the five enzymes towards different substrates after incubation for 1h or 7h 
 
Substrate 
 
Conversion rate （%） 
AnaPT 7-DMATS CdpNPT CdpC3PT SirD 
1h 7h 1h 7h 1h 7h 1h 7h 1h 7h 
naphthalene (1a) - - - - - - - - - - 
1-naphthol (1b) 64.7 91.5 22.0 45.4 84.4 93.3 9.1 14.1 - - 
2-naphthol (1c) 13.3 19.7 5.1 9.7 8.1 14.3 - 0.9 - - 
1,4-dihydroxynaphthalene (1d) 0.7 1.1 - 0.7 1.0 1.3 0.6 0.7 1.8 4.4 
1,5-dihydroxynaphthalene (1e) 6.7 13.2 14.6 37.9 10.3 16.4 0.7 1.1 - - 
1,6-dihydroxynaphthalene (1f) 11.8 17.8 73.3 92.6 21.3 24.7 0.4 2.1 1.1 2.3 
1,7-dihydroxynaphthalene (1g) 68.8 88.7 50.6 88.5 37.3 46.7 3.5 9.8 0.8 1.1 
2,3-dihydroxynaphthalene (1h) 13.8 21.9 9.1 26.4 4.1 6.4 0.5 1.5 - - 
2,6-dihydroxynaphthalene (1i) 14.4 47.7 4.9 13.0 2.1 4.9 - 0.5 1.0 1.3 
2,7-dihydroxynaphthalene (1j) 7.8 18.6 3.1 10.5 7.8 12.1 0.6 1.1 - - 
3,5-dihydroxy-2-naphthoic acid (1k) 14.0 25.7 19.9 59.0 - 0.6 - 0.6 - - 
3,7-dihydroxy-2-naphthoic acid (1l) 20.5 42.7 - - - 0.9 - - - - 
 
-: not detected, conversion rate ≤0.3 % 
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Table S2: 1H- and 13C-NMR data of monoprenylted products in CD3OD. Chemical shifts (δ) are given in ppm and coupling constants (J) in Hz.  
 
Compd 
OH
1
2
3
45
6
7
8
9
10
1'
2'
3'
4' 5'  
2b 
OH
1
2
3
45
8
9
10
1'
2'
3'
4' 5'
HO 6
7
 
2f 
OH
1
2
3
45
6
7
8
9
10
1'
2'
3'
4' 5'
HO
 
2g 
1
2
3
45
6
7
8
9
10
1'
2'
3'
4' 5'
OH
HO
 
 
2i 
1'2'
3'
4' 5'
1
2
3
45
6
7
8
9
10 O
HO  
 
3i 
1
2
3
45
6
7
8
9
10
1'
2'
3'
4' 5'
OHHO
 
 
2j 
Pos. δC δH, multi., J δC δH, multi.,J  δC δH, multi.,J δC δH, multi.,J  δH, multi., J δC δH, multi.,J  
1 152.7 \ 152.8 \ 151.4 \ 120.5 \ 7.04, overlaps c 118.6 \ 
2 108.1 6.72, d, 7.7 105.5 6.52, d, 7.6 108.6 6.64, d, 7.6 150.3 \ \ 152.8 \ 
3 126.4 7.09, d, 7.7 126.9 7.00, d, 7.0 123.5 6.88, d, 7.6 118.9 7.01, overlaps 7.04, dd, 9.2, 2.5a 115.5 6.87, d, 8.8 
4 129.2 \ 127.7 \ 129.4 \ 126.1 7.36, d, 8.8 7.53, d, 8.9b 127.7 7.44, d, 8.8 
5 124.5 7.90, d, 8.4 106.6 7.18, d, 2.4 126.4 7.78, d, 9.1 110.4 7.02, overlaps 7.13, d, 2.4 c 130.6 7.56, d, 8.8 
6 126.5 7.45, ddd, 8.4, 6.8, 1.5 156.1 \ 118.4 7.04, dd, 9.1, 2.6 153.2 \ \ 115.0 6.83, dd, 8.7, 2.4 
7 124.8 7.40, ddd, 8.3, 6.8,1.3 116.7 6.98, dd, 9.1, 2.4 154.8 \ 118.6 7.01, overlaps 7.02, dd, 9.0, 2.5 a 156.0 \ 
8 123.4 8.21, d, 8.4 125.2 8.07, d, 9.0 105.5 7.49, d, 2.6 125.4 7.70, d, 8.7 7.60, d, 8.8 b 105.9 7.12, d, 2.4 
9 134.0 \ 135.8 \ 128.9 \ 131.4 \ \ 124.9 \ 
10 126.5 \ 121.1 \ 128.0 \ 129.3 \ \ 136.1 \ 
11 \ \ \ \ \ \ \ \ \ \ \ 
1' 31.8 3.65, d, 7.3 32.1 3.54, d, 6.8 32.0 3.59, d, 6.8 24.6 3.69, d, 6.6 4.60, overlaps 24.5 3.64, d, 6.7 
2' 124.8 5.33, br.t, 7.0 124.7 5.33, br.t, 6.9 124.9 5.32, br.t, 7.0 124.8 5.17, br.t, 6.7 5.52, m 124.6 5.17, br.t, 6.6 
3' 132.3 \ 132.4 \ 132.1 \ 131.2 \ \ 131.3 \ 
4' 17.5 1.80, s 17.6 1.79, s 17.6 1.78, s 17.7 1.87, s 1.81, s 17.7 1.87, s 
5' 25.5 1.74, s 25.6 1.74, s 25.5 1.73, s 25.4 1.67, s 1.78, s 25.4 1.68, s 
                   a, b, c: exchangeable protons 
            Signals were assigned by comparison of the spectra of the enzyme products with those of the substrate, and with each other, as well as by HSQC and HMBC correlations. 
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                          Table S2 (continued) 
 
Compd 
 
1
2
3
45
6
7
8
9
10
1'
2'
3'
4'
5'
OHHO
 
 
3j 
1'2'
3'
4' 5'
1
2
3
45
6
7
8
9
10 OHO
 
 
4j 
OH
COOH
1
2
3
45
6
7
8
9
10
1'
2'
3' 4'5'
OH
11
 
2k 
 
OH
COOH
1
2
3
45
6
7
8
9
10
1'
2'
3'
4'
5'
11
OH  
 
3k 
OH
COOHHO
1
2
3
45
6
7
8
9
10
1'
2'
3'
4'5'
11
 
 
2l 
Pos. δH, multi., J δH, multi., J δC δH, multi.,J  δC δH, multi.,J  δC δH, multi.,J  
1 6.87, s 7.00, overlaps 129.9 8.64, s 133.2 8.42, s 128.9 8.58, s 
2 \ \ 115.2 \ 115.4 \ 115.2 \ 
3 \ 6.88, dd, 8.9, 2.5 156.9 \ 157.3 \ 155.1 \ 
4 7.35, s 7.59, d, 8.8 107.6 7.57, s 106.3 7.54, s 112.3 7.15, s 
5 7.49, d, 9.1 7.59, d, 8.8 151.5 \ 148.4 \ 126.2 7.44, d, 8.9 
6 6.79, dd, 8.7, 2.4 6.88, dd, 8.8, 2.4 110.8 6.74, d, 7.6 126.6 \ 122.5 7.15, d, 8.8 
7 \ \ 124.6 6.96, d, 7.6 126.9 7.08, d, 8.4 150.9 \ 
8 6.85, d, 2.4 7.00, overlaps 131.0 \ 122.2 7.35, d, 8.5 121.4 \ 
9 \ \ 131.4 \ 131.6 \ 134.7 \ 
10 \ \ 127.8 \ 128.2 \ 128.1 \ 
11 \ \ 173.2 \ 173.3 \ 173.2 \ 
1' 3.38, d, 6.9 4.61, d, 6.6 32.4 3.64, d, 7.0 29.3 3.49, d, 7.3 24.7 3.73, d, 6.8 
2' 5.40, m 5.52, m 124.8 5.29, br.t, 7.1 123.4 5.35, br.t, 7.3 124.4 5.17, br.t, 6.9 
3' \ \ 132.7 \ 133.2 \ 131.6 \ 
4' 1.77, s 1.81, s 17.7 1.84, s 17.7 1.78, s 17.7 1.92, s 
5' 1.74, s 1.79, s 25.7 1.74, s 25.7 1.75, s 25.5 1.68, s 
 
                                         Signals were assigned by comparison of the spectra of the enzyme products with those of the substrate, and with each other, as well as by HSQC and HMBC correlations. 
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Table S3: 1H- and 13C-NMR data of diprenylted products in CD3OD. Chemical shifts (δ) are given in ppm and coupling constants (J) in Hz. 
Compd 
1'
2'
3'4' 5'
1
2
3
45
6
7
8
9
10 OH
HO 1''
2''
3''
4''
5''
 
4i 
1'
2'
3'4' 5'
1
2
3
45
6
7
8
9
10
1''2''
3''
4''5''
OH
HO
5i 
1'
2'
3'4' 5'
1
2
3
45
6
7
8
9
10 O
HO
1''
2''
3''
4''
5''
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Pos. δH, multi., J δH, multi., J δH, multi., J δH, multi., J δH, multi., J δH, multi., J δC δH, multi., J δC δH, multi., J δC δH, multi., J 
1 \ \ \ \ \ 6.83, s 123.0 \ 119.4 \ 105.5 6.96, s 
2 \ \ \ \ \ \ 154.9 \ 153.3 \ 157.2 \ 
3 \ 7.03, d, 9.0 7.23, d, 9.0 7.04, d, 8.8 6.83, d, 8.7 \ 113.5 7.10, d, 8.9 116.1 6.92, d, 8.7 129.7 \ 
4 6.92, s 7.58, d, 9.0 7.49, d, 9.0 7.46, d, 8.8 7.36, d, 9.3 7.27, s 128.1 7.58, d, 8.9 127.8 7.47, d, 8.7 128.3 7.39, s 
5 7.21, d, 2.4  7.05, overlaps 7.12, d, 2.6 7.35, s 7.27, s 130.8 7.62, d, 8.8 130.6 7.60, d, 8.9 129.4 7.52, d, 8.7 
6 \ \ \ \ \ \ 116.4 6.90, dd, 8.8, 2.3 115.9 6.88, dd, 8.8, 2.4 116.1 6.85, dd, 8.7, 2.4 
7 7.00, dd, 9.1, 2.5 7.03, d, 9.0 7.04, overlaps 7.06, dd, 9.3, 2.6 \ \ 156.5 \ 158.2 \ 156.0 \ 
8 7.71, d, 9.1 7.58, d, 9.0 7.76, d, 10.0 7.74, d, 9.3 7.11, s 6.83, s 106.2 7.17, d, 2.2 104.1 7.13, d, 2.4 108.9 6.98, d, 2.3 
9 \ \ \ \ \ \ 125.8 \ 125.6 \ 125.0 \ 
10 \ \ \ \ \ \ 135.8 \ 136.0 \ 136.2 \ 
1' 3.66, d, 6.6 3.69, d, 6.6 3.73, d, 6.6 3.70, d, 6.7 3.62, d, 6.4 3.36, d, 6.8 24.8 3.67, d, 6.6 24.7 3.69, d, 6.6 65.5 4.61, d, 6.5 
2' 5.16, m 5.16, m 5.13, m 5.17, m 5.19, m 5.40, m 124.6 5.14, m 124.9 5.17, m 121.3 5.55, m 
3' \ \ \ \ \ \ 131.6 \ 131.5 \ 138.2 \ 
4' 1.86, s 1.87, s 1.86, s 1.87, s 1.87, s 1.77, s 17.8 1.86, s 17.8 1.90, s 25.7 1.82, s 
5' 1.67, s 1.67, s 1.67, s 1.67, s 1.67, s 1.73, s 25.5 1.67, s 25.6 1.69, s 17.9 1.79, s 
1'' 3.59, d, 7.0 3.69, d, 6.6 4.59, d, 6.8 4.60, d, 6.6 3.38, d, 7.0 3.36, d, 6.8 67.2 4.62, d, 6.7 65.5 4.62, d, 6.5 29.6 3.36, d, 7.4 
2'' 5.37, m 5.16, m 5.51, m 5.52, m 5.41, m 5.40, m 121.6 5.51, m 121.3 5.52, m 123.9 5.34, m 
3'' \ \ \ \ \ \ 138.1 \ 138.0 \ 132.8 \ 
4'' 1.79, s 1.87, s 1.80, s 1.81, s 1.77, s 1.77, s 25.5 1.78, s 25.5 1.81, s 25.6 1.74, s 
5'' 1.77, s 1.67, s 1.73, s 1.78, s 1.74, s 1.73, s 17.8 1.75, s 17.9 1.79, s 17.5 1.72, s 
 Signals were assigned by comparison of the spectra of the enzyme products with those of the substrate, and with each other, as well as by HSQC and HMBC correlations. 
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Figure. S1  HMBC connectivities of enzyme products 2b, 2f, 2g, 2i, 7j, 8j, 9j, 2j, 2k, 
3k and 2l. 
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Figure S2.1  1H-NMR spectrum of 2b in CD3OD (500 MHz) 
 
Figure S2.2  HSQC spectrum of 2b in CD3OD (500 MHz)  
 
 
 
OH
1
2
3
45
6
7
8
9
10
1'
2'
3'
4' 5'
195
7 
 
 
Figure S2.3  HMBC spectrum of 2b in CD3OD (500 MHz) 
 
 
 
Figure S3.1  1H-NMR spectrum of 2f in CD3OD (600 MHz) 
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Figure S3.2  HSQC spectrum of 2f in CD3OD (600 MHz)  
 
 
Figure S3.3  HMBC spectrum of 2f in CD3OD (600 MHz)  
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 Figure S4.1  1H-NMR spectrum of 2g in CD3OD (500 MHz)  
 
 
Figure S4.2  HSQC spectrum of 2g in CD3OD (500 MHz)   
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Figure S4.3  HMBC spectrum of 2g in CD3OD (500 MHz) 
 
 
 
  
Figure S5.1  1H-NMR spectrum of 2i in CD3OD (600 MHz)   
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Figure S5.2  HSQC spectrum of 2i in CD3OD (600 MHz) 
 
 
 
 
Figure S5.3  HMBC spectrum of 2i in CD3OD (600 MHz)   
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Figure S6  1H-NMR spectrum of 3i in CD3OD (500 MHz)   
 
 
 
 
 
Figure S7  1H-NMR spectrum of 4i in CD3OD (500 MHz) 
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Figure S8  1H-NMR spectrum of 5i in CD3OD (500 MHz)   
 
 
 
Figure S9  1H-NMR spectrum of 6i in CD3OD (500 MHz)   
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Figure S10  1H-NMR spectrum of 7i in CD3OD (500 MHz)   
 
 
 
 Figure S11.1  1H-NMR spectrum of 2j in CD3OD (500 MHz)   
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Figure S11.2  HSQC spectrum of 2j in CD3OD (500 MHz)   
 
 
Figure S11.3  HMBC spectrum of 2j in CD3OD (500 MHz)   
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Figure S12  1H-NMR spectrum of 3j in CD3OD (400 MHz) 
 
 
 
 
Figure S13  1H-NMR spectrum of 4j in CD3OD (400 MHz) 
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Figure S14  1H-NMR spectrum of 5j in CD3OD (400 MHz) 
 
 
 
Figure S15  1H-NMR spectrum of 6j in CD3OD (400 MHz) 
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Figure S16.1  1H-NMR spectrum of 7j in CD3OD (600 MHz) 
 
 
Figure S16.2  HSQC spectrum of 7j in CD3OD (600 MHz)  
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Figure S16.3  HMBC spectrum of 7j in CD3OD (600 MHz) 
 
 
 
Figure S17.1  1H-NMR spectrum of 8j in CD3OD (600 MHz) 
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Figure S17.2  HSQC spectrum of 8j in CD3OD (600 MHz)  
 
 
 
Figure S17.3  HMBC spectrum of 8j in CD3OD (600 MHz) 
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Figure S18.1  1H-NMR spectrum of 9j in CD3OD (600 MHz) 
 
 
 
Figure S18.2  HSQC spectrum of 9j in CD3OD (600 MHz)  
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Figure S18.3  HMBC spectrum of 9j in CD3OD (600 MHz) 
 
 
 
 
 Figure S19.1  1H-NMR spectrum of 2k in CD3OD (600 MHz) 
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Figure S19.2  HSQC spectrum of 2k in CD3OD (600 MHz) 
 
 
 
 
 
Figure S19.3  HMBC spectrum of 2k in CD3OD (600 MHz) 
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 Figure S20.1  1H-NMR spectrum of 3k in CD3OD (600 MHz)  
 
 
 
Figure S20.2  HSQC spectrum of 3k in CD3OD (600 MHz) 
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Figure S20.3  HMBC spectrum of 3k in CD3OD (600 MHz) 
 
 
 
Figure S21.1  1H-NMR spectrum of 2l in CD3OD (500 MHz) 
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Figure S21.2  HSQC spectrum of 2l in CD3OD (500 MHz) 
 
 
 
 
Figure S21.3  HMBC spectrum of 2l in CD3OD (500 MHz) 
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Prenylation of Flavonoids by Using a Dimethylallyltryptophan Synthase,
7-DMATS, from Aspergillus fumigatus
Xia Yu[a] and Shu-Ming Li*[a, b]
Prenylated flavonoids including prenylated chalcones and iso-
flavonoids are widely distributed in the nature, predominantly
in plants.[1, 2] Prenylation often improves the affinity for bio-
membranes and the interaction with proteins of a com-
pound,[2] and therefore dramatically increases the biological ac-
tivity. Diverse biological and pharmacological activities such as
antifungal, antibacterial, antiviral, antiparasitic, anti-inflamma-
tory, antitumor, cancer chemoprevention, estrogenic, and anti-
estrogenic activities have been described for prenylated flavo-
noids.[1–3]
Due to the broad pharmacological activities of prenylated
flavonoids, various strategies have been developed for their
regioselective chemical synthesis, especially for C-prenylated
derivatives.[4,5] Meanwhile, significant progress has also been
made in the identification of enzymes that catalyze the transfer
of prenyl moieties onto the flavonoid skeleton.[6] Three mem-
brane-bound prenyltransferases from Sophora flavescens have
been cloned, expressed, and characterized biochemically.[7, 8]
The identified enzymes include a naringenin 8-prenyltransfer-
ase (SfN8DT-1),[8] an isoflavone-specific C6-prenyltransferase
(SfG6DT), and the chalcone-specific isoliquiritigenin dimethylal-
lyltransferase (SfiLDT).[7] Those enzymes showed very high sub-
strate specificities and accepted only their natural substrates or
just a few substances with very similar structures. This feature
prohibits their potential application as catalysts for the chemo-
enzymatic synthesis of prenylated flavonoids. Furthermore,
these membrane-bound enzymes are generally more difficult
to overproduce and purify than soluble enzymes.
Fortunately, it has been demonstrated that some prenyl-
transferases of the CloQ/NphB group from the soil bacteria
Streptomyces are also capable of catalyzing the prenylation of
flavonoids. For example, the 4-hydroxyphenylpyruvate C3-pre-
nyltransferase NovQ also accepted flavonoids and isoflavonoids
as substrates and catalyzed O- and C-prenylations at ring B.[9]
NphB is a hydroxynaphthalene geranyltransferase.[10] This
enzyme also catalyzed O- and C-geranylation at 7-OH or C-6 in
flavonoid and isoflavonoid ring A.[11] The SCO7190 protein, a
homologue of NphB from Streptomyces coelicolor, catalyzed
the prenylation of naringenin at position C-6 in the presence
of dimethylallyl diphosphate (DMAPP).[11] In summary, many
prenylated flavonoids have been produced by using recombi-
nant enzymes. However, only a few such derivatives have a di-
methylallyl moiety at position C-6. No acceptance of flavonoids
by a prenyltransferase from the DMATS superfamily had been
reported prior to this study. This is not surprising because
fungi produce almost no flavonoids. The members of the
DMATS superfamily are secondary-metabolite enzymes of asco-
mycota and mainly involved in the biosynthesis of prenylated
indole alkaloids.[12] They catalyze prenylation at the indole moi-
eties of diverse substrates including tryptophan and trypto-
phan-containing cyclic dipeptides.[12] Recent studies have
shown that several members of the DMATS superfamily also
accept tyrosine or xanthones as natural substrates.[13,14] Fur-
thermore, we have recently demonstrated that some of the
fungal indole prenyltransferases also accept hydroxynaphtha-
lene derivatives, and convert them to prenylated derivatives.[15]
(Hydroxynaphthalenes are natural substrates of some prenyl-
transferases of the CloQ/NphB group.[16]) These results encour-
aged us to test the acceptance of flavonoids, including chal-
cones and isoflavonoids, by members of the DMATS superfami-
ly.
Incubation of up to 30 flavonoids with seven fungal prenyl-
transferases, 7-DMATS, AnaPT, CdpC3PT, CdpNPT, SirD, FtmPT1
and FgaPT2,[12,13] showed that 7-DMATS has a more flexible
substrate specificity towards these compounds than the other
enzymes (data not shown). A detailed study was therefore car-
ried out with 7-DMATS from Aspergillus fumigatus, which cata-
lyzes the prenylation of tryptophan and derivatives at position
C7.[17,18] In total, 16 flavonoids and analogues were incubated
with purified, recombinant 7-DMATS from Escherichia coli in
the presence of DMAPP (Supporting Information).[18] HPLC
analysis was used to monitor product formation. Incubation
with protein that had been heat-inactivated by being boiled
for 20 min was used as a negative control. Product formation
was detected for 14 substrates after incubation with 14 mg pro-
tein per 100 mL assay at 37 8C for 16 h (data not shown), six
yields were more than 12% (1a–6a, Figure 1). Chalcones, iso-
flavonoids, and flavanones were much better accepted than
flavones and flavonols. For example, total conversion yields of
22.8, 18.7, 12.3, 46.2, 24.1, and 14.5%, respectively, were calcu-
lated for the isoflavones 1a and 2a, flavanones 3a, 4a and 5a
as well as for the chalcone 6a. The corresponding flavones of
3a and 4a, that is, apigenin and luteuolin, were also accepted
by 7-DMATS, but only with conversion yields of 3.8 and 8.2%,
respectively. The corresponding flavonols of these compounds,
that is, kaempferol and quercetin, were accepted with conver-
sion yields of 4.7 and 2.7%, respectively.
As shown in Figure 1, one dominant product peak was de-
tected for each of the incubation mixtures of 1a, 2a, 3a, and
6a. In the cases of 4a and 5a, at least two product peaks
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Figure 1. HPLC chromatograms and prenyltransfer reactions catalyzed by 7-DMATS. The absorption at 277 nm is illustrated.
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were observed. To elucidate the structures, nine products were
isolated from the incubation mixtures of these six substrates
and subjected to MS and NMR analyses (Supporting Informa-
tion). HR-EI-MS (Table S1) indicated the presence of one prenyl
moiety each in the enzyme products by showing molecular
masses that are 68 Da larger than those of the respective sub-
strates. The 1H NMR signals at dH=3.21–3.53 (d, 2H-1’), 5.15–
5.35 (m, H-2’), 1.68–1.78 (s, 3H-4’), and 1.62–1.71 ppm (s, 3H-5’;
Figures S1–S9 and Table S2) confirmed the presence of a regu-
lar dimethylallyl moiety. The resonance of H-1’ in the range of
3.21–3.53 ppm proved their attachment to aromatic carbon
atoms.[15] A literature search revealed that the 1H NMR data of
1b, 2b, 3b, 4b, 4c, and 6b corresponded well to those of the
plant metabolites wighteone,[5] gancaonin A,[19,20] 6-prenylnarin-
genin,[21] 6-prenyleriodictyol,[22] sigmoidin B,[23] and 6-dimethyl-
allyl-5,7,9,1’-tetrahydroxydihydrochalcone,[24] respectively.
Comparing the signals in the spectrum of 5b with those of
the substrate (data not shown) revealed that the signals of the
ABX system in ring B were almost unchanged. The singlet at
dH=6.04 ppm represented one aromatic proton in ring A and
indicated that the prenylation was at position C-6 or C-8. The
singlet of 5-OH at dH=12.46 confirmed the attachment of the
dimethylallyl moiety at position C-6.[22] Comparing the signals
of 4d and 5c in the NMR spectra with those of the respective
substrate (data not shown) showed that the ABX systems for
ring B protons in the spectra of substrates had disappeared.
Instead, two doublets with a coupling constant of 8.3 or 8.5 Hz
were observed, thus proving the prenylation at position C-2’
(Figure 1 and Table S2). The structure of 4d was assigned to a
prenylated flavanone isolated from Lycopersicon esculentum
seeds[25] and Erythrina suberose roots.[26] Nearly identical chemi-
cal shifts were given in these works, which clearly differed
from those obtained in this study (all taken in [D6]acetone).
However, no coupling constants were presented in the publi-
cation by Gangwal et al.[25] In the second case, the observed
coupling constant of 2 Hz was too small for the two protons in
ortho- position (H-5’ and H-6’). It can therefore be concluded
that the data obtained in the previous studies[25,26] are inconsis-
tent with the structure of 4d, and that 4d reported in this
study is a new structure. The structures of 5b and 5c have not
been described previously.
From the structures of the enzyme products, it is obvious
that the favorable prenylation position for 7-DMATS was C-6,
between the two hydroxyl groups. C6-prenylated derivatives
were isolated from all of the six investigated substrates. In the
incubation mixtures of four compounds (1a, 2a, 3a, and 6a),
only compounds with C6-prenyl moieties were detected
(Figure 1). Even in the incubation mixture of 5a, in which a
product with prenylation at ring B was also observed, the C6-
prenylated derivative remained the dominant product.
To test the acceptance of prenylated flavonoids, the nine iso-
lated products (0.2–0.4 mm) were incubated with 7-DMATS in
the presence of DMAPP for 16 h and then analyzed by HPLC.
Product peaks were detected in eight of the incubation mix-
tures; no conversion was detected for 2b. Conversion yields of
between 0.9 and 7.7% were calculated for 1b, 3b, 5b, 5c, and
6b. Much higher conversion yields of 71, 100, and 48% were
observed for 4b–d, respectively. Unfortunately, at least three
product peaks were detected in each of the incubation mix-
tures of 4b–d, respectively. Due to the low amounts, the struc-
tures of these products could not be elucidated in this study.
To get information on the catalytic efficiency of 7-DMATS
toward flavonoids, kinetic parameters including Michaelis–
Menten constants (KM) and turnover numbers (kcat) were deter-
mined for 1a–6a by Hanes–Woolf and Eadie–Hofstee plots
and compared to those obtained by using l-tryptophan as
substrate (Table 1). Compounds 1a, 2a, and 6a were found to
have comparable affinities to l-Trp for 7-DMATS (Table 1), with
KM values in the range of 0.07 to 0.16 mm. The KM values of 3a,
4a, and 5a, at about 1 mm, are significantly higher, but still
within the concentration range expected for many secondary-
metabolite enzymes. The turnover numbers were found to be
from 0.019 to 0.39 s1. The calculated catalytic efficiencies (kcat/
Km) of 7-DMATS toward flavonoids are in the range of 20 to
320 s1m1, that is, 1.4–19.0% of that of the best substrate, l-
Trp. These data provide evidence that the tryptophan prenyl-
transferase 7-DMATS can also be used for the production of
prenylated flavonoids, especially for C6- or ring B-prenylated
flavanones and isoflavonoids by chemoenzymatic approach
and therefore complement the production gap of other report-
ed prenyltransferases for prenylated flavonoids.[7,9,11,27] It may
be expected that other members of the DMATS superfamily
from fungi could also be used for the production of prenylated
flavonoids.
Experimental Section
For materials and methods as well as spectra and data see the
Supporting Information.
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Table 1. Kinetic parameters of 7-DMATS toward l-tryptophan and flavo-
noids.
Substrate KM kcat kcat/KM
[mm] [s1] [s1m1] [%][a]
l-Trp[b] 0.14 0.23 1643 100
genistein (1a) 0.16 0.027 171 10.4
biochanin A (2a) 0.07 0.019 261 15.9
naringenin (3a) 0.99 0.023 23 1.4
eriodictyol (4a) 1.26 0.39 312 19.0
hesperetin (5a) 1.10 0.026 24 1.4
phloretin (6a)[c] 0.13 0.036 286 17.4
[a] The kcat/KM obtained with l-tryptophan as substrate was defined as
100%. [b] Data are taken from ref. [18] . [c] Substrate inhibition at 1 mm
or higher concentrations.
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Experimental section 
 
Chemicals 
Dimethylallyl diphosphate (DMAPP) was prepared according to the method 
described for geranyl diphosphate by Woodside et al.. [1] Flavonoids of the 
highest available purity were purchased from Alfa Aesar, Roth and TCI. 
 
Overproduction and purification of the recombinant protein as well as 
enzyme assays with recombinant 7-DMATS 
7-DMATS was overproduced in E. coli and purified as described by Kremer et 
al.[2] The enzymatic reaction mixtures (100 µl) for determination of the relative 
activities with different flavonoids contained 50 mM Tris-HCl (pH 7.5), 10 mM 
CaCl2, 1 mM substrate, 2 mM DMAPP, 0.15 % (v/v) glycerol, 5 % (v/v) DMSO 
and 14 µg of purified recombinant protein. The reaction mixtures were 
incubated at 37 °C for 16 h. The enzyme reactions were terminated by addition 
of 100 µl methanol per 100 µl reaction mixtures. For determination of the 
kinetic parameters, the assays contained DMAPP at a final concentration of 2 
mM and flavonoids at final concentrations of 0.02, 0.05, 0.1, 0.2, 0.5, 1 and 2 
mM. For 1a and 2a, the final concentrations were up to 1 and 0.5 mM, 
respectively. The protein amount was 2 µg (4a) or 7 µg (other substrates), and 
the incubation time was 30 min.  
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HPLC conditions for analysis and isolation of the enzyme products 
The enzyme products of the incubation mixtures were analyzed by HPLC on 
an Agilent series 1200 by using a Multospher 120 RP-18 column (125 x 4 mm, 
5 µm) at a flow rate of 1 ml•min-1. Water (solvent A) and methanol (solvent B) 
were used as solvents. For analysis of enzyme products, a linear gradient of 
50 - 80 % (v/v) solvent B in 10 min and then 80- 100 % (v/v) solvent B in 5 min 
were used. The column was then washed with 100 % solvent B for 5 min and 
equilibrated with 50 % (v/v) solvent B for 5 min. Conversion yields of the 
enzyme reactions were calculated by ratios of peak areas of the product to 
sum of product and substrate detected at 277 nm. For isolation of the enzyme 
products, the same HPLC equipment with a Multospher 120 RP-18 column 
(250 x 10 mm, 5 µm) was used. The flow rate was 2.5 mL•min-1.  
 
Spectroscopic analysis 
High-resolution electron impact mass spectrometry (HR-EI-MS) was taken on 
Auto SPEC. Positive HR-EI-MS data of the enzyme products are listed in 
Table S1. NMR Spectra (Figures S1-S9) were recorded on a JEOL ECA-500 
spectrometer. Chemical shifts (Table S2) were referenced to the signal of 
acetone-d6 or DMSO- d6. 
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HR-EI-MS and 1H- NMR data 
 
Table S1: HR-EI-MS data of the enzyme products of flavonoids. 
 
 
Compound 
 
Chemical formula 
HR-EI-MS data  
Deviation (ppm) Calculated (M+) Measured 
1b C20H18O5 338.1154 338.1165 -3.0 
2b C21H20O5 352.1311 352.1321 -3.0 
3b C20H20O5 340.1311 340.1333 -6.4 
4b C20H20O6 356.1260 356.1238 6.0 
4c C20H20O6 356.1260 356.1262 -0.7 
4d C20H20O6 356.1260 356.1236 6.6 
5b C21H22O6 370.1416 370.1402 3.8 
5c C21H22O6 370.1416 370.1379 10.1 
6b C20H22O5 342.1467 342.1419 14.0 
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Table S2: 1H-NMR data (500 MHz) of prenylated products in (CD3)2CO or DMSO-d6 (4c). Chemical shifts (δ) are given in ppm and coupling 
constants (J) in Hz. 
 
Compd 
1
4
3
2
3''
2''
1''
6'
5'
4'
3'
2'
1'
10
9
8
7
6
5
4''
5''
O
O
OH
HO
OH
 
  
 1b 
7'
1
4
3
2
3''
2''
1''
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5'
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9
8
7
6 5
4''
5''
O
O
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HO
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1
4
3
2
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9
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O
HO
OH
OH
 
 
3b 
1
4
3
2
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1''
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5'
4'
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8
7
6 5
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5''

O
HO
OH
OH
OH
 
4b 
7'
1
4 3
2
3''
2''
1''
6'
5'
4'
3'
2'
1'
10
9
8
7
6
5
4''
5''

O
HO
OH
OCH3
OH
 
5b 
1
4 3
23''
2''
1''
6'
5'
4'
3'
2'
1'9
8
7
6 5
4''
5''

HO OH
OH
OH
 
 
6b1 
Pos. δH, multi., J δH, multi., J δH, multi., J δH, multi., J δH, multi., J δH, multi., J 
1 / / / / / 2.88, t, 7.8 
2 8.15, s 8.18, s 5.43, dd, 12.9, 3.0 5.37, dd, 12.8, 3.0 5.41, dd, 12.6, 3.1 3.33, t, 7.7 
3 
3 
/ 
/ 
/ 
/ 
3.17, dd, 17.1, 12.9 
2.72, dd, 17.1, 3.0 
3.12, overlaps 
2.71, dd, 17.1, 2.9 
3.14, dd, 17.1, 12.6 
2.74, dd, 17.1, 3.1 
/ 
/ 
6 / / / / / / 
8 6.50, s 6.50, s 6.03, s 6.03, s 6.04, s 6.07, s 
2' 7.45, d, 8.8 7.54, d, 8.9 7.39, d, 8.3 7.02, br.s 7.04, d, 2.0 7.09, d, 8.5 
3' 6.90, d, 8.8 7.00, d, 8.9 6.89, d, 8.6 / / 6.74, d, 8.5 
5' 6.90, d, 8.8 7.00, d, 8.9 6.89, d, 8.6 6.86, br.s 6.99, d, 8.2 6.74, d, 8.5 
6' 7.45, d, 8.8 7.54, d, 8.9 7.39, d, 8.3 6.86, br.s 6.96, dd, 8.3, 2.0 7.09, d, 8.5 
7' / 3.84, s / / 3.86, s / 
1'' 3.37, d, 7.2 3.37, d, 7.2 3.25, d, 7.2 3.24, d, 7.1 3.24, d, 7.2 3.24, d, 2.3 
2'' 5.28, m 5.28, m 5.23, m 5.23, m 5.23, m 5.22, m 
4'' 1.78, s 1.78, s 1.75, s 1.75, s 1.75, s 1.74, s 
5'' 1.65, s 1.65, s 1.64, s 1.63, s 1.64, s 1.62, s 
OH 13.33, s 13.30, s 12.47, s 12.47, s 12.46, s 9.49, s 
OH 9.65, s 9.67, s 8.52, s 8.02, s 7.74, s 9.05, s 
OH 8.49, s / / / / 8.05, s 
      1: Addition of D2O was used to prove active protons. 
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                       Table S2 (continued) 
Compd 
1
4
3
2 3''
2''
1''6'
5'
4'
3'
2'
1'
10
9
8
7
6
5
4''
5''
O
HO
OH
OH
OH
 
4c  
1
4
3
2 3''
2''
1''6'
5'
4'
3'
2'
1'
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9
8
7
6
5
4''
5''
O
HO
OH
OH
OH
 
4c2  
1
4
3
2
3'' 2'' 1''
6'
5'
4'
3'2'
1'
10
9
8
7
6
5
4''
5''

O
HO
OH
OH
OH
 
4d 
1
4
3
2
3''
2''
1''
6'
5'
4'
3'2'
1'
10
9
8
7
6
5
4''
5''

O
HO
OH
OCH3
OH
7'
 
5c 
Pos. δH, multi., J δH, multi., J δH, multi., J δH, multi., J 
2 5.36, dd, 12.6, 3.1 5.35, dd, 12.2, 3.0 5.61, dd, 13.3, 2.7 5.65, dd, 13.3, 2.8 
3 
3 
3.12, dd, 17.1, 12.6 
2.71, dd, 17.1, 3.1 
3.13, dd, 17.2, 12.2 
2.67, dd, 17.1, 3.2 
3.17, dd, 17.1, 13.3 
2.65, dd, 17.2, 2.8 
3.19, dd, 17.1, 13.2 
2.67, dd, 17.1, 2.8 
6 5.94, d, 2.2 5.85, s 5.95, s 5.96, s 
8 5.94, d, 2.2 5.85, s 5.95, s 5.96, s 
2' 6.90, d, 2.1 6.75, d, 2.0 / / 
3' / / / / 
5' / / 6.81, d, 8.3 6.93, d, 8.5 
6' 6.81, d, 2.1 6.63, d, 2.0 6.96, d, 8.3 7.08, d, 8.5 
7' / / / 3.88, s 
1'' 3.35, d, 7.4 3.21, d, 7.3 3.53, d, 6.8 3.53, d, 6.9 
2'' 5.35, m 5.26, m 5.16, m 5.15, m 
4'' 1.72, s 1.68, s 1.68, s 1.68, s 
5'' 1.71, s 1.66, s 1.64, s 1.64, s 
OH 12.18, s / 12.19, s 12.19, s 
OH 8.02, s / / 7.57, s 
                                     2: Taken in DMSO- d6.
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Figure S1 1H-NMR spectrum of 1b in (CD3)2CO (500 MHz) 
 
 
Figure S2 1H-NMR spectrum of 2b in (CD3)2CO (500 MHz) 
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Figure S3 1H-NMR spectrum of 3b in (CD3)2CO (500 MHz) 
 
 
Figure S4 1H-NMR spectrum of 4b in (CD3)2CO (500 MHz) 
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Figure S5.1 1H-NMR spectrum of 4c in (CD3)2CO (500 MHz) 
 
 
Figure S5.2 1H-NMR spectrum of 4c in DMSO-d6 (500 MHz) 
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Figure S6 1H-NMR spectrum of 4d in (CD3)2CO (500 MHz) 
 
 
Figure S7 1H-NMR spectrum of 5b in (CD3)2CO (500 MHz) 
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Figure S8 1H-NMR spectrum of 5c in (CD3)2CO (500 MHz) 
 
 
Figure S9.1 1H-NMR spectrum of 6b in (CD3)2CO (500 MHz) 
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Figure S9.2 1H-NMR spectrum of 6b in (CD3)2CO after addition of D2O (500 MHz) 
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References 276AbstractPrenylated natural products often have interesting biological and pharmacological
activities clearly distinct from their nonprenylated precursors. Prenyltransferases are259
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235responsible for the attachment of prenyl moieties to a number of acceptors and con-
tribute significantly to structural and biological diversity of these compounds in nature.
In the past 8 years, significant progress has been achieved in the molecular biological,
biochemical, and structural biological investigation of the prenyltransferases of the
dimethylallyltryptophan synthase (DMATS) superfamily. These soluble enzymes are in-
volved in the biosynthesis of fungal secondary metabolites and mainly catalyze
prenylation of diverse indole derivatives, including tryptophan and tryptophan-
containing cyclic dipeptides. The members of the DMATS superfamily show promising
flexibility toward their aromatic substrates and catalyze highly regio- and stereoselective
prenyltransfer reactions. These features were successfully used for chemoenzymatic syn-
thesis, not only for production of prenylated simple indoles and cyclic dipeptides but
also for prenylated hydroxynaphthalenes and flavonoids, which are usually found in
bacteria and plants, respectively.1. INTRODUCTION
Dimethylallyltryptophan synthase (DMATS) was identified as the firstpathway-specific enzyme in the biosynthesis of ergot alkaloids (Tsai, Wang,
Gebler, Poulter, & Schardl, 1995; Unso¨ld & Li, 2005). It catalyzes the
prenylation of L-tryptophan at C-4 of the indole ring and therefore
functions as an indole prenyltransferase (Steffan, Grundmann, Yin,
Kremer, & Li, 2009; Unso¨ld & Li, 2005). Analysis of a vast volume of
released sequences from fungal genome projects revealed nearly 200
putative genes with sequence homology to DMATS by bioinformatic
approaches (at the beginning of 2012, GenBank). These genes are
classified as prenyltransferase genes of the DMATS superfamily.
Biochemical characterization of the encoded enzymes began in summer
2004 after availability of the genome sequence for Aspergillus fumigatus
(Unso¨ld & Li, 2005). To the end of January 2012, results for 17 such
enzymes have been reported, for example, six from A. fumigatus
(Li, 2009b) and two each from Neosartorya fischeri (Li, 2009b; Yin, Yu,
Xie, & Li, 2010), Aspergillus oryzae (Liu & Walsh, 2009; Zou, Xie,
Linne, Zheng, & Li, 2010), and Aspergillus sp. (Ding et al., 2010).
The characterized enzymes accepted almost only dimethylallyl
diphosphate (DMAPP) as prenyl donor and catalyzed via enzyme-bound
cations the prenyltransfer reactions to aromatic substrates in “regular” or
“reverse” connection (Figs. 13.1 and 13.2) (Luk & Tanner, 2009;
Metzger et al., 2009; Yin et al., 2010; Zou et al., 2010). In the enzyme
products of the “regular” prenyltransferases, for example, 5-DMATS,
Figure 13.2 Examples of enzyme reactions catalyzed by prenyltransferases of the
DMATS superfamily.
Figure 13.1 Regular and reverse prenylations catalyzed by prenyltransferases of the
DMATS superfamily.
261Prenyltransferases of the DMATS Superfamily
2367-DMATS, CpaD, DmaW, FgaPT2, FtmPT1, FtmPT2, andMaPT, (Ding,
Williams, & Sherman, 2008; Grundmann, Kuznetsova, Afiyatullov, & Li,
2008; Grundmann & Li, 2005; Kremer, Westrich, & Li, 2007; Liu &
Walsh, 2009; Markert et al., 2008; Unso¨ld & Li, 2005; Yu, Liu, Xie,
Zheng, & Li, 2012), the prenyl moiety is attached via its C-1 to the
262 Xia Yu and Shu-Ming Li
237aromatic nucleus. In contrast, the “reverse” prenyltransferases, for example,
AnaPT, CdpC3PT, CTrpPT, and FgaPT1 (Unso¨ld & Li, 2006; Yin,
Grundmann, Cheng, & Li, 2009; Yin et al., 2010; Zou et al., 2010),
catalyze connection of the prenyl moieties via C-3 to the aromatic substrate.
The prenyltransferases of the DMATS superfamily are involved in the
biosynthesis of diverse fungal secondary metabolites, especially prenylated
indole alkaloids (Li, 2010). Prenylated indole alkaloids, including a number
of important mycotoxins and drugs, are hybrid natural products containing
both indole and isoprenoid moieties. They are widely distributed in terres-
trial and marine organisms and mainly found in ascomycetes, for example,
members of the generaClaviceps, Penicillium, andAspergillus (Li, 2010). These
compounds often possess biological activities clearly distinct from their non-
prenylated precursors (Jain et al., 2008). Most prenyltransferases of the
DMATS superfamily catalyze prenylation reactions at the indole ring and
play an important role in the biosynthesis of structurally diverse prenylated
indole alkaloids in fungi. Many of these enzymes accept tryptophan and
tryptophan-containing cyclic dipeptides as aromatic substrates and catalyze
regio- and stereospecific prenylation reactions. Asmentioned above,DmaW,
FgaPT2, and MaPT catalyze prenylation of L-tryptophan at C-4 of the indole
ring and function as 4-DMATS. 5-DMATS and 7-DMATS accept also
L-tryptophan as substrate but prenylate it at C-5 and C-7, respectively
(Fig. 13.2). CTrpPT, FtmPT1, and CdpC3PT accept tryptophan-containing
cyclic dipeptides and catalyze regiospecific prenylations at N-1, C-2, and
C-3, respectively. As shown in Fig. 13.2, members of theDMATS superfamily
also accept more complicated indole derivatives as substrates. For example,
FtmPT2, FgaPT1, TdiB, AnaPT, and CpaD use 12,13-dihydroxy
fumitremorgin C, fumigaclavine A, didemethylasterriquinone D, (R)-
benzodiazepinedione, and cyclo-acetoacetyl-L-tryptophan as substrates and
catalyze regiospecific prenylations at the indole ring (Fig. 13.2).
In contrast to the indole prenyltransferases mentioned above, some mem-
bers of theDMATS superfamily accept other aromatic substances as substrates.
For example, SirD is anO-prenyltransferase for tyrosine (Kremer & Li, 2010).
Based on results obtained from knockout mutants, it was suggested that XptA
and XptB are involved in the prenylation of xanthones (Sanchez et al., 2011).
Sequence analysis revealed that the members of the DMATS superfamily
contain no DDxxD motifs, which are essential for binding of prenyl
diphosphate via metal ions, for example, Mg2þ or Mn2þ, in trans-
prenyltransferases (Lu, Liu, & Liang, 2009) in the biosynthesis of terpenoids
or membrane-bound aromatic prenyltransferases in the biosynthesis of
263Prenyltransferases of the DMATS Superfamily
238prenylated flavonoids or benzoic acids (Yazaki, Sasaki, & Tsurumaru, 2009).
Biochemical investigations showed that reactions catalyzed by members of
the DMATS superfamily were independent of metal ions, although Ca2þ
enhanced the reaction velocity (Li, 2010; Steffan et al., 2009). Structural
biological analysis and site-directed mutagenesis experiments have proven
that the formation of prenyl cations is facilitated by binding of the
phosphate residues of DMAPP with several basic amino acids ( Jost et al.,
2010; Metzger et al., 2009; Stec et al., 2008).
Detailed investigations on the substrate specificities of the DMATS en-
zymes in recent years have provided experimental evidence for their effec-
tive use in the production of prenylated compounds. They accepted a
number of structural analogues of their natural substrates such as tryptophan,
tyrosine, or cyclic dipeptides and catalyzed regio- and stereospecific pre-
nylations. Promisingly, prenylated hydroxynaphthalenes or flavonoids can
also be regiospecifically produced by using prenyltransferases of the DMATS
superfamily (Yu & Li, 2011; Yu, Xie, & Li, 2011). These compounds have
not been found in fungi, but in bacteria or plants, respectively.
In this chapter, we provide general protocols for biochemical investiga-
tion of prenyltransferases of the DMATS superfamily, including DNA and
RNA propagation, gene cloning and expression, enzyme assays, and
chemoenzymatic synthesis of prenylated compounds.
2. SPORE PREPARATION1. Prepare sterile 0.1% (v/v) Tween-20 and sterile 20% (v/v) glycerol.
2. Prepare Czapek-Dox with yeast extract solid medium consisting of 3.5%
(w/v) Czapek-Dox, 0.5% (w/v) yeast extract, and 2% (w/v) agar; auto-
clave at 121 C for 20 min; and use for preparation of agar plates.
3. Spread 1000–10,000 spores on each plate and cultivate the plates for
approximately 2 weeks at 26 C in darkness.
4. Wash each plate thoroughly (spores andmycelia) three times with 4 ml of
0.1% Tween-20 and collect and transfer the suspension to sterile 50-ml
Falcon tubes with some autoclaved glass beads with a diameter of
2.85–3.3 mm. Vortex the suspension exhaustively.
5. Filter the suspension over sterile cotton wool. Centrifuge for 5 min at
3000 rpm and resuspend the pellets in 20% (v/v) glycerol (use 100 ml for
spores from one plate). Use fresh spores for inoculation or store them at
80 C.
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2393. CULTIVATION OF FUNGI
Fungal mycelia are used for RNA and DNA isolation.1. Prepare liquid yeast extract medium with sucrose, consisting of 0.6%
(w/v) yeast extract and 0.2% (w/v) sucrose, pH 5.8, for cultivation of
N. fischeri (Yin et al., 2009, 2010) and A. oryzae (Zou et al., 2010).
Solid media for agar plates contain 2% (w/v) agar.
2. Prepare yeast malt extract medium consisting of 0.4% (w/v) yeast extract,
1% (w/v) malt extract, and 0.4% (w/v) glucose, pH 7.3, for cultivation of
Aspergillus clavatus (Yu et al., 2012). Solid media for agar plates contain 2%
(w/v) agar.
3. Spread a small portion of spore suspensions on agar plates and incubate at
30 C or 26 C for 5–7 days.
4. Takemycelia with agar (11 cm) from the agar plates and inoculate into
300-ml Erlenmeyer flasks containing 100 ml liquid medium from step 1
or 2.
5. Cultivate at 26 C or 30 C and 160 rpm in a dark room for 3–7 days.
4. RNA AND DNA ISOLATION AND cDNA Synthesis4.1. RNA isolation and cDNA synthesis
1. Prepare sterile, RNase-free glass and plastic wares and double distilled
water by twice autoclaving.
2. PreparebufferRB/2-mercaptoethanol by adding 20 ml 2-mercaptoethanol
to1 mlofbufferRBfromE.Z.N.A.TMFungalRNAKit (OmegaBio-Tek)
before use.
3. Collect fungal cultures in 50-ml Falcon tubes by centrifugation at
5000 rpm for 5 min.Wash the pellets with ice-cold double distilled water
twice by suspension and centrifugation.
4. Add liquid nitrogen to the pellets and grind the frozen mycelia to a fine
powder in a twice-autoclaved mortar.
5. Take 50 mg of the powder and transfer it to a 1.5-ml microtube. Imme-
diately add 500 ml of buffer RB/2-mercaptoethanol to the tube.
6. Isolate the RNA by using a Homogenization Spin Column (Green)
followed by a HiBindÒ RNA spin column from the kit according to
the manufacturer’s protocol.
7. Use the isolated RNA directly to synthesize cDNA or store it at80 C.
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2408. For synthesis of cDNA, carry out the reaction with RNA in a volume of
20 ml by using Transcriptor High Fidelity cDNA Synthesis Kit (Roche
Diagnostics GmbH).
9. Heat to 85 C for 5 min to inactivate reverse transcriptase. Then store it
at 20 C.
4.2. DNA isolation
1. Prepare sterile phosphate-buffered saline buffer (PBS buffer, 137 mM
NaCl, 2.7 mM KCl, 1.0 mM Na2HPO4, and 0.18 mM KH2PO4).
2. Prepare sterile digestion buffer consisting of 100 mM NaCl, 10 mM
Tris–HCl, 25 mM EDTA, and 0.5% (w/v) SDS, pH 8.0. Add proteinase
K to a final concentration of 0.1 mg ml1 before use.
3. Collect fungal cultures in sterile 50-ml Falcon tubes by centrifugation at
5000 rpm at 4 C for 5 min, and then wash the pellets with ice-cold PBS
buffer twice by suspension and centrifugation.
4. Add liquid nitrogen to the pellets and grind the frozen mycelia to a fine
powder in an autoclaved mortar.
5. Transfer 100 mg of mycelial powder into a sterile 1.5-ml microtube and
add 1.2 ml digestion buffer. Incubate the mixture at 50 C and 160 rpm
for 2 h.
6. Extract twice with 1 volume of phenol/chloroform/isoamyl alcohol
mixture (25:24:1) by inversion for 10 min and centrifuge at 4 C and
4000 rpm for 5–10 min.
7. Add 1/10 volume of ice-cold 3M sodium acetate and 1 volume of ice-
cold isopropanol to the aqueous phase and keep for 20 min at 80 C.
8. Centrifuge at 4 C and 6000 rpm for 30 min and wash the DNA pellets
twice with 3 ml ice-cold 70% (v/v) ethanol.
9. Dry DNA pellets at 60 C for approximately 30 min. Dissolve DNA in
sterile double distilled water and store at 20 C.
5. GENE CLONING
Analysis of genomic DNA and cDNA sequences of the knownprenyltransferase genes of the DMATS superfamily revealed the presence
of one to three short intron sequences at the 30-end of the genes (Steffan
et al., 2009). For heterologous gene expression in Escherichia coli or Saccha-
romyces cerevisiae, these intron sequences must be removed. This can be
achieved by PCR amplification of the coding region from cDNA or by
fusion PCR from genomic DNA.
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2415.1. PCR amplification from cDNA
1. Synthesize cDNA with the Transcriptor High Fidelity cDNA Synthesis
Kit (Roche Diagnostics GmbH) from mRNA as described above
(Section 4.1).
2. Synthesize primers with mutations at the start and stop codon to generate
the respective restriction sites for cloning into expression vector and
His-tagged fusion protein for purification.
3. Use synthesized cDNA as template in a gradient PCR with Taq poly-
merase in a volume of 50 ml to optimize PCR conditions.
4. Carry out PCR amplification in a volume of 50 ml by using ExpandHigh
Fidelity Kit (Roche Diagnostics GmbH) and the conditions in step 3.5.2. Fusion PCR amplification from genomic DNA
Fusion PCR amplification consists of at least two rounds and is therefore
somewhat more complicated than normal PCR. We demonstrate this
approach by using genes containing only one intron as an example (Fig. 13.3):
1. Synthesize two PCR primer pairs: exon1a and exon1b for the first exon
at the 50-end and exon2a and exon2b for the second exon at the 30-end of
the gene. The primers exon1b and exon2a contain approximately 36 bp
overlapping sequence of the two exons. Primers exon1a and exon2b
contain suitable restriction sites at the start and stop codon, respectively,
which are considered for cloning into the expression vector and for
His-tagged fusion protein.Figure 13.3 Amplification of the coding sequence of a gene of interest from gDNA by
two rounds fusion PCR.
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2422. In the first round, amplify the two exons from genomic DNA by using
primers exon1a and exon1b, and exon2a and exon2b, respectively.
Optimize PCR conditions by gradient PCR with Taq polymerase
and carry out PCR amplification by using Expand High Fidelity Kit
(Roche Diagnostics GmbH).
3. Use PCR products of the two exons from the first round PCR as primers
and templates (in a molar ratio of 1:1) for the second round PCR to
obtain the entire coding region. Addition of the primers exon1a and
exon2b to the reaction mixture often enhances the yield of the PCR
amplification.
6. PROTEIN OVERPRODUCTION
The PCR product is subsequently cloned into an expression vectordirectly (Schneider, Weber, & Hoffmeister, 2008; Yin, Ruan, Westrich,
Grundmann, & Li, 2007) or via a cloning vector, for example, pGEM-T
easy or pBlueskript KS () (Grundmann et al., 2008; Grundmann & Li,
2005; Kremer et al., 2007; Markert et al., 2008; Steffan, Unso¨ld, & Li,
2007; Unso¨ld & Li, 2005, 2006). Protein overproduction can be carried
out in E. coli or S. cerevisiae (Steffan et al., 2009).6.1. Protein overproduction in E. coli
6.1.1 Gene induction
Most prenyltransferases of the DMATS superfamily were successfully over-
produced in E. coli strains. The commonly used vectors are pQE60 and
pQE70 with E. coli XL1 Blue or M15 as expression hosts (Kremer et al.,
2007; Yin et al., 2009, 2007, 2010; Yu et al., 2012; Zou et al., 2010).
pRSET B and pET28 or its derivative pHis8 was expressed in E. coli
BL21 (Schneider et al., 2008; Steffan et al., 2007; Unso¨ld & Li, 2006).
For overproduction of soluble proteins in E. coli, the following steps are
involved:
1. Prepare sterile Luria-Bertani (LB) medium consisting of 1.0% (w/v)
tryptone, 1.0% (w/v) NaCl, and 0.5% (w/v) yeast extract.
2. Prepare sterile potassium phosphate buffer (0.17MKH2PO4 and 0.72M
K2HPO4).
3. Prepare sterile Terrific-Broth medium (TB medium, per 900 ml
medium: 12 g tryptone, 24 g yeast extract, and 4 ml glycerol; add
100 ml potassium phosphate buffer before use).
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2434. Transfer the expression plasmid by transformation into calcium-
competent E. coli cells.
5. Inoculate a colony from the LB agar plate or take several microliter
glycerol stocks into glass tubes containing 5 ml LB or TB medium
supplemented with the respective antibiotics. Cultivate at 37 C and
220 rpm overnight.
6. Inoculate 2 ml overnight culture into a 250-ml Erlenmeyer flask con-
taining 100 ml liquid LB or TB medium supplemented with the respec-
tive antibiotics. Grow the cells at 37 C and 220 rpm to an adsorption of
approximately 0.6 at 600 nm.
7. Add isopropyl thiogalactoside (IPTG) to a final concentration of
0.1–2 mM and cultivate the cells for further 6–16 h at 18–37 C before
harvest. Change temperature and IPTG concentration to obtain the
desired recombinant soluble protein.
8. Carry out cultivation in 2000-ml Erlenmeyer flasks containing 1000 ml
medium, if necessary.
9. Collect E. coli cells by centrifugation at 3000 rpm for 20 min and store
the cells at 20 C.6.1.2 Protein purification
His-tagged fusion proteins can be purified by using Ni-NTA agarose and
judged by SDS-PAGE. The amount of Ni-NTA resin, pH value, and im-
idazole concentration in buffers are important factors influencing the yield
and purity of the purified proteins. For condition optimization, please take
these factors into consideration.
1. Prepare lysis buffer (10 mM imidazole, 50 mM NaH2PO4, and 300 mM
NaCl, pH 8.0), wash buffer (20–50 mM imidazole, 50 mM NaH2PO4,
and 300 mM NaCl, pH 8.0), and elution buffer (250 mM imidazole,
50 mM NaH2PO4, and 300 mM NaCl, pH 8.0).
2. All the following steps are carried out at 4 C.
3. Resuspend the frozen E. coli cells in lysis buffer at 2–5 ml g1 wet
weight. Add lysozyme to a final concentration of 1 mg ml1 and incu-
bate for 30 min. Sonicate the cells six times for 10 s, each time at 200 W,
with 10 s for cooling after each burst.
4. Centrifuge the lysate at 13,000 rpm for 30 min to separate soluble
proteins from cellular debris. If the lysate is very viscous, for example,
the lysate of E. coli BL21 cells, add RNAase and DNAase to a final con-
centration of 10 and 5 mg ml1 15 min before sonication, respectively.
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2445. Mix soluble proteins with Ni-NTA agarose resin (Qiagen) according to
the manufacturer’s instructions and stir the mixture for 1 h. The volume
of resin depends on the yield of protein; try 50 ml for the lysate from
100 ml culture first.
6. Load the mixture to a column with bottom sieve. Wash the residue on
the sieve with 4 ml wash buffer twice to remove nonbound proteins.
7. Elute the target protein with 2.5 ml elution buffer and check protein
purity on SDS-PAGE.
8. Change the protein buffer by passing a column with Sephadex G-25, for
example, PD-10 (GE Healthcare), which has been equilibrated with
50 mM Tris–HCl containing 15% (v/v) glycerol, pH 7.5, previously.
9. Collect the purified protein and store aliquots at 80 C for enzyme
assays.6.2. Protein overproduction in S. cerevisiae
6.2.1 Gene expression
A few prenyltransferases were overproduced in S. cerevisiae INVSc1 with
pYES2/NT as expression vector (Grundmann et al., 2008; Markert et al.,
2008; Unso¨ld & Li, 2005). For overproduction of soluble proteins in
S. cerevisiae, the following steps are involved:
1. Prepare sterile minimal medium consisting of 0.67% (w/v) yeast nitrogen
base (without amino acids but with ammonium sulfate), 0.01% (w/v)
each of adenine, arginine, cysteine, leucine, lysine, threonine, and
tryptophan, 0.005% (w/v) each of aspartic acid, histidine, isoleucine,
methionine, phenylalanine, proline, serine, tyrosine, and valine. Add
2% (w/v) agar for a solid medium.
2. Transfer the expression plasmid into S. cerevisiae cells by electroporation
and select the resulting transformants on minimal medium plate.
3. Grow cells in 500-ml Erlenmeyer flasks containing 250 ml liquid mini-
mal medium with 2% (w/v) glucose at 30 C for 36 h.
4. Centrifuge cells at 3000 rpm for 5 min and wash the pellets with liquid
minimal medium without glucose.
5. Transfer the washed cells into 1000-ml Erlenmeyer flasks containing
500 ml induction medium consisting of minimal medium with 1%
(w/v) raffinose and 2% (w/v) galactose. Incubate at 30 C for 16 h before
harvest.
6. Collect the cells by centrifugation at 3000 rpm for 5 min and store them
at 20 C.
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2456.2.2 Protein purification
The purification procedure of proteins from S. cerevisiae is similar to that
from E. coli, that is, breaking cells followed by affinity chromatography with
Ni-NTA agarose.
1. Prepare extraction buffer consisting of 50 mM Tris–HCl, 15% (v/v)
glycerol, 1 mM DTT, and 1 mM phenylmethylsulfonyl fluoride, pH
7.5. Prepare buffers for purification as described in step 1 in Section 6.1.2.
2. All the following steps are carried out at 4 C.
3. Resuspend the resulting yeast pellets (Section 6.2.1) in an adequate
amount of ice-cold water and press the suspension by using an injection
syringe into a mortar with liquid nitrogen. Grind the cells to a fine
powder.
4. Resuspend 1 g powder in 2 ml extraction buffer and stir the mixture for
15 min.
5. Centrifuge the mixture at 13,000 rpm for 15 min to separate soluble pro-
teins from cellular debris and use the supernatant for protein purification.
6. Do the same as steps 5–9 in Section 6.1.2.7. PREPARATION OF STOCK SOLUTIONS FOR
ENZYME ASSAYSStock solutions for DMAPP, tryptophan-containing cyclic dipeptides,
hydroxynaphthalenes, flavonoid aglycones, simple indoles, tyrosine deriva-
tives, and Ca2þ are prepared as follows:
1. Weigh accurately desired amount of a given substance in a 1.5-ml
microtube.
2. Dissolve DMAPP in a calculated volume of 50 mMTris–HCl buffer (pH
7.5) to give a final concentration of 20 mM.
3. Considering the difference in their solubility in aqueous system, stock
solutions of 20 mM, 10 mM, or 4 mM in DMSO, 50 mM Tris–HCl
buffer (pH 7.5), or both are prepared for simple indoles and tyrosine
derivatives. Owing to the inhibiting potential of DMSO for enzyme
reactions, keep the DMSO concentration as low as possible.
4. Dissolve tryptophan-containing cyclic dipeptides, hydroxynaphthalenes,
and flavonoid aglycones in DMSO to give a final concentration of
20 mM.
5. Dissolve CaCl2 in 50 mM Tris–HCl buffer (pH 7.5) to give a final con-
centration of 100 mM.
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2468. BIOCHEMICAL CHARACTERIZATION OF
PRENYLTRANSFERASES8.1. Enzyme assays
Purified prenyltransferases are incubated with different aromatic substrates in
the presence of DMAPP. The reaction mixtures are analyzed on HPLC.
1. In general, each assay (100 ml) contains 50 mM Tris–HCl (pH 7.5), 5 or
10 mM Ca2þ, 1 mM aromatic substrate, 2 mM DMAPP, 0.3–5% (v/v)
glycerol, 0–5%(v/v)DMSO,and1–20 mgofpurified recombinantprotein.
2. Add a calculated volume of 50 mM Tris–HCl (pH 7.5) in a 1.5-ml
microtube to ensure the final volume to be 100 ml, followed by adding
stock solutions of Ca2þ and aromatic substrate.
3. Add DMAPP and protein solution as last assay components and mix
thoroughly by pipetting.
4. Incubate the reaction mixture at 37 C or 30 C for 0.5–7 h and termi-
nate the enzyme reaction by adding 100 ml methanol to the mixture.
5. Centrifuge the mixture at 13,000 rpm for 20 min to remove proteins
before injection on HPLC.
6. Carry out negative controls with heat-inactivated protein by boiling it
for 20 min.
Keep in mind that the reactions catalyzed by the prenyltransferases of the
DMATS superfamily are usually independent of the presence of metal ions.
However, Ca2þ often enhanced the reaction velocity. The optimal Ca2þ
concentration was estimated in the range of 5–10 mM for known enzymes
(Steffan et al., 2009).
8.2. Kinetic parameters
Kinetic parameters of the prenyltransferases for aromatic substrates and
DMAPP are determined in 100 ml assays. Linear dependences of the enzyme
reactions on reaction time and protein amount should be carried out previ-
ously. The values for known prenyltransferases were estimated to be up to
150 min and 20 mg, respectively. The KM values of the best known pre-
nyltransferases of the DMATS superfamily were found to be 1–500 mM
for DMAPP and 2–300 mM for natural or best aromatic substrates.
8.2.1 Kinetic parameter for DMAPP
1. Use natural or the best accepted aromatic substrate for kinetic assays for
DMAPP.
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2472. Dilute the 20 mMDMAPP stock solution to different concentrations for
assays. Always use newly prepared stock solution.
3. Each assay contains 50 mMTris–HCl (pH 7.5), 5 or 10 mMCa2þ, 1 mM
aromatic substrate, 0.3–5% (v/v) glycerol, 0–5% (v/v) DMSO, a given
amount of purified recombinant protein and DMAPP at final concentra-
tions of 0.01, 0.02, 0.05, 0.1, 0.2, 0.5, 1, and 2 mM.
4. Carry out assay incubation and termination and sample preparation for
HPLC in the same manner as described in steps 2–5 of Section 8.1. Use
protein amount and incubation time in the linear region of the reactions.
5. Use assays without DMAPP as negative controls.
6. Adjust DMAPP concentrations and repeat the experiments, if necessary.
8.2.2 Kinetic parameters for aromatic substrates
1. Use the same solvents as described in Section 7 to prepare 100 mM stock
solutions and dilute them to concentrations of 40, 20, 10, 4, 2, 1, 0.4, and
0.2 mM. Owing to limited solubility, stock solutions with a maximal
concentration of 40 or 20 mM are prepared for some substrates.
2. Each assay contains 50 mM Tris–HCl (pH 7.5), 5 or 10 mM of Ca2þ,
2 mM DMAPP, 0.3–5% (v/v) glycerol, 0–5% (v/v) DMSO, a given
amount of purified recombinant protein and aromatic substrate at final
concentrations of 0.01, 0.02, 0.05, 0.1, 0.2, 0.5, 1, 2, and 5 mM. Owing
to different solubility, the maximal concentration can be changed.
3. Carry out assay incubation and termination and sample preparation for
HPLC in the same manner as described in steps 2–5 of Section 8.1.
Use protein amount and incubation time in the linear region of reactions.
4. Use assays without aromatic substrate as negative controls.
5. Adjust the concentrations of aromatic substrate and repeat the experi-
ments, if necessary.
9. CHEMOENZYMATIC SYNTHESIS OF PRENYLATED
COMPOUNDSPrenyltransferases of the DMATS superfamily have been successfully
used for production of prenylated compounds including analogues of their
natural substrates such as simple indoles, tryptophan-containing cyclic dipep-
tides, and tyrosine derivatives (Li, 2009a, 2010; Zou, Xie, Zheng & Li, 2011;
Fig. 13.4). Interestingly, some enzymes from this family are also able to
prenylate hydroxynaphthalenes and flavonoid aglycones, resulting in
formation of prenylated derivatives (Yu & Li, 2011; Yu, Xie & Li, 2011).
Figure 13.4 Chemoenzymatic synthesis achieved by prenyltransferases of the DMATS
superfamily.
273Prenyltransferases of the DMATS Superfamily
2489.1. Incubations
Reactions for chemoenzymatic synthesis and structure elucidation are taken
in large scales (10–50 ml), which are carried out as following:
1. Each assay contains 50 mMTris–HCl (pH 7.5), 5 or 10 mMCa2þ, 1 mM
aromatic substrate, 2 mM DMAPP, 0.3–5% (v/v) glycerol, 0–5% (v/v)
DMSO, and 0.5–4 mg purified recombinant protein for 10 ml assays.
2. First add the calculated volume of 50 mM Tris–HCl (pH 7.5) to a 50- or
100-mlglass flask, followedbyaddingCa2þandaromaticsubstratesolutions.
3. AddDMAPP and protein solution as last components andmix thoroughly.
4. Incubate the mixture at 30 C or 37 C for 16–24 h. Mix occasionally
during the incubation.9.2. Sample preparation for HPLC
Owing to solubility difference of the enzyme products, reactionmixtures are
treated in different ways before purification on an HPLC system.9.2.1 Reaction mixtures with simple indoles and tyrosine derivatives
1. After incubation for 16–24 h, terminate the assays by mixing with an
equal volume of methanol. Centrifuge at 13,000 rpm for 20 min to
remove precipitated proteins.
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2492. Concentrate the resulting supernatant on a rotating vacuum evaporator
at 30 C to a final volume of 1–3 ml before injection onto HPLC.
3. Transfer the sample for HPLC into an autosampler tube or a new reac-
tion tube for manual injection. Keep in mind that insoluble particles in
the samples could block and damage the column and HPLC system. If
the reaction mixture is poorly dissolved, try to improve the solubility
by adding DMSO. However, DMSO in the sample could influence
the chromatographic behavior of the compounds. It is preferable to
centrifuge the samples for 10 min at 13,000 rpm or filter them through
a 13-mm syringe filter (0.2 mm PTFE) before injection, to remove insol-
uble components.
9.2.2 Reaction mixtures with tryptophan-containing cyclic dipeptides,
hydroxynaphthalenes, and flavonoid aglycones
1. After 16–24 h incubation, transfer the reaction mixture to a separatory
funnel and extract it with an equal volume of ethyl acetate three times.
Collect the upper layers (ethyl acetate phase) in a flask.
2. Evaporate solvents with a rotating vacuum evaporator at 30 C to obtain
the residues containing both substrate and enzyme products.
3. Dissolve the residues in methanol (500 ml or more if necessary). As
described in Section 9.2.1, DMSO can also be used to improve the
solubility. It is recommended to centrifuge or filter the sample before
injection.
4. Transfer the sample into an autosampler tube or a new reaction tube for
the application on HPLC.
10. HPLC
HPLC is used for analysis and purification of the enzyme products.10.1. HPLC components
1. Use an HPLC system equipped with a photo diode array detector and an
autosampler, if possible.
2. Use an RP-18 column (2504 mm, 5 mm) for analyzing enzyme assays
and RP-18 column (25010 mm, 5 mm) for purifying enzyme
products.
3. Use solvents A and B as mobile phases for analyzing enzyme assays.
Solvent A: water with 0.5% (v/v) trifluoroacetic acid (TFA); solvent
B: methanol with 0.5% (v/v) TFA.
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2504. Use solvents C and D for purification. Solvent C: water without acid;
solvent D: methanol without acid. TFA in the mobile phase for reverse
phase HPLC sharpens the peaks and improves resolution. However, it
can influence the stability of some compounds and is better not used
in the mobile phases for substance isolation.
5. Use flow rate of 1 ml min1 for analysis and 2.5 ml min1 for purifica-
tion of the enzyme products.
6. Set detection wavelength between 250 and 300 nm.10.2. HPLC conditions
10.2.1 Analysis of enzyme assays with simple indoles or tyrosine
derivatives as substrates
1. Equilibrate the HPLC column with 20% (v/v) solvent B in A for 5 min.
2. Inject the sample and use a linear gradient from 20% (v/v) solvent B in A
to 100% (v/v) solvent B in 15 min for separation.
3. Rinse the column with 100% (v/v) solvent B for 5 min and equilibrate
subsequently with 20% (v/v) solvent B in A for 5 min.10.2.2 Purification of prenylated products of simple indoles or
tyrosine derivatives
1. Equilibrate the HPLC column with 20% (v/v) solvent D in C for 8 min.
2. Inject the sample and use a linear gradient from 20% (v/v) solvent D in C
to 100% (v/v) solvent D for 30 min for separation.
3. Rinse the column with 100% (v/v) solvent D for 8 min and equilibrate
subsequently with 20% (v/v) solvent D in C for 8 min.
4. For assays with more than one product, optimize the method for better
separation, if necessary.
5. Collect product peaks and evaporate at 30 C to dryness.
6. Use the purified products for NMR and MS analyses.10.2.3 Analysis of enzyme assays with tryptophan-containing cyclic
dipeptides, hydroxynaphthalenes, or flavonoid aglycones
as substrates
1. Equilibrate the HPLC column with 40% (v/v) solvent B in A for 5 min.
2. Inject the sample and use a linear gradient from 40% (v/v) solvent B in A
to 100% (v/v) solvent B for 15 min for separation.
3. Rinse the column with 100% (v/v) solvent B for 5 min and equilibrate
subsequently with 40% (v/v) solvent B in A for 5 min for elution.
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25110.2.4 Purification of prenylated tryptophan-containing cyclic
dipeptides, hydroxynaphthalenes, or flavonoid aglycones
1. Equilibrate the HPLC column with 40% (v/v) solvent D in C for 8 min.
2. Inject the sample and use a linear gradient from 40% (v/v) solvent D in C
to 100% (v/v) solvent D for 30 min for separation.
3. Rinse the column with 100% (v/v) solvent D for 8 min and equilibrate
subsequently with 40% (v/v) solvent D in C for 8 min for elution.
4. For assays with more than one product, optimize the method for better
separation, if necessary.
5. Do the same as described in steps 5 and 6 in Section 10.2.2.11. SUMMARY
Prenyltransferases of the DMATS superfamily mainly catalyze theprenylation of diverse indole derivatives and are involved in the biosynthesis
of indole alkaloids in ascomycetes. Recent studies have revealed that these
enzymes showed high tolerance toward diverse tryptophan and tyrosine de-
rivatives and accepted even hydroxynaphthalenes and flavonoid aglycones as
substrates. They usually catalyze regio- and stereospecific prenylations and
can be used as efficient catalysts for chemoenzymatic synthesis of novel
prenylated compounds, which can be then tested for their biological activ-
ities in drug discovery and development programs. Therefore, these enzymes
are attractive not only for biologists but also for biotechnologists and medic-
inal chemists. We hope that the described procedures for biochemical char-
acterization of prenyltransferases in this chapter can meet the challenges for
finding additional enzymes to be used as novel catalysts.
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6 Conclusions and future prospects
In this thesis, novel strategies for chemoenzymatic synthesis of prenylated compounds were
developed by function elucidation of indole prenyltransferases as well as by substrate
promiscuity study.
Firstly, three indole prenyltransferases of the DMATS superfamily were characterized. The
C3-prenyltransferase CdpC3PT from N. fischeri catalyzed reverse prenylation of tryptophan-
containing cyclic dipeptides of the indole ring and the formation of a 6/5/5/6 tetracyclic ring
system. Five monoprenylated and one diprenylated derivatives were obtained from five cyclic
dipeptides containing L-form tryptophanyl moiety. 5-DMATS was identified from A. clavatus
and proven to catalyze the regiospecific C5-prenylation of indole derivatives. It is the first
enzyme reported to catalyze prenylation at position C-5 of indole derivatives and fills
herewith the last gap in the search for indole prenyltransferases regarding their prenylation
positions. Twelve C5-prenylated derivatives of simple indole derivatives were produced. In
contrast to the low flexibility of NotF from Aspergillus sp. MF297-2, we demonstrated that the
NotF homologue BrePT from A. versicolor showed substrate promiscuity for at least twelve
substrates from which reversely C2-prenylated products were produced and subsequently
identified by MS and NMR analyses. The broad substrate promiscuity and high
regiospecificity of CdpC3PT, 5-DMATS and BrePT provides experimental evidence for their
application as effective biocatalysts for chemoenzymatic synthesis. The natural substrates of
CdpC3PT and 5-DMATS can’t be detected in this thesis. Concerning BrePT, it can be
speculated that the natural substrate of BrePT should be brevianamide F based on the high
sequence similarity of BrePT with NotF.
Subsequently, CdpC3PT, 5-DMATS and BrePT obtained in this thesis as well as other
known indole prenyltransferases of the DMATS superfamily were successfully applied for
chemoenzymatic synthesis of prenylated derivatives. AnaPT, CdpC3PT and CdpNPT
constructed eight prenylated pyrroloindoline diketopiperazine stereoisomers with one 6/5/5/6
tetracyclic framework and six prenylated pyrroloindoline diketopiperazine stereoisomers
containing one 6/5/5/6/5 pentacyclic framework from cyclo-Trp-Ala and cyclo-Trp-Pro
isomers, respectively. Experimental data in this thesis provided information on the structure
dependence of the stereoselectivity of these enzymes towards the tested cyclic dipeptides.
The stereoselectivity of AnaPT and CdpC3PT was largely dependent on the configuration of
tryptophanyl moiety in substrates and always complemented to each other, while CdpNPT
showed lower stereoselectivity but higher conversion ability. Indolocarbazoles were also
accepted by indole prenyltransferases. 5-DMATS and FgaPT2 were capable to catalyze
regiospecific prenylation of indolocarbazoles at the para-position of the indole N-atom. Five
prenylated indolocarbazoles were generated in this study. Since prenylated indolocarbazoles
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have been reported neither from natural sources, nor by chemical synthetic approaches, this
is the first report on prenylated indolocarbazoles.
Indole prenyltransferases of the DMATS superfamily also showed substrate specificity
towards hydroxynaphthalene derivatives, which were substrates for enzymes of the
CloQ/NphB group. In contrast to the different prenylation patterns and positions of a given
indole derivative by different enzymes, the same major prenylated products were identified in
the reaction mixtures with hydroxynaphthalenes, i.e. with a regular C-prenyl moiety at para-
or ortho-position to a hydroxyl group. O-prenylated and diprenylated derivatives were also
identified as enzyme products in incubation mixtures with low conversion. Twenty prenylated
hydroxynaphthalenes have been isolated in this study. Furthermore, 7-DMATS showed the
capability to catalyze C-prenylation of flavonoids, which were substrates for the members of
the UbiA superfamily. Regularly C6-prenylated flavonoids were identified in all of six
investigated flavonoids as enzyme products, revealing that the catalytic preference of
prenylation at position C-6 between two hydroxyl groups in flavonoids by 7-DMATS.
These results expand the potential usage of prenyltransferases of the DMATS superfamily as
biocatalysts for chemoenzymatic synthesis, and meanwhile, increase the structural diversity
of prenylated compounds and provide new opportunities for drug discovery and development.
In addition to the works on indole prenyltransferases, another two genes involved in the
biosynthetic pathway of the prenylated indole alkaloid HAS were successfully cloned, i.e. the
putative O-methyltransferase gene hasC and the putative cytochrome P450 gene hasH. The
gene hasC was cloned into pQE60 and overexpressed in E. coli. Recombinant His6-HasC
was successfully overproduced and detected by SDS-PAGE. Three expression vectors have
been constructed for the overexpression of hasH, including the normal expression vectors
with myc epitope tag or His6-tag and the co-expression vector containing the reductase gene
NFIA_083630. Unfortunately, due to time limit of scholarship, these projects can’t be finished.
For the future prospects, the following works should be performed:
(1) Further investigation on the putative O-methyltransferase gene hasC and the putative
cytochrome P450 gene hasH from A. fumigatus.
(2) Investigation on the prenylation of indole alkaloids by prenyltransferases of the
CloQ/NphB group and the UbiA superfamily.
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